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 Disinfection processes provide a necessary barrier against waterborne infectious diseases; yet, water 
disinfectants inadvertently generate environmentally hazardous chemicals called disinfection by-products 
(DBPs). While a number of individual DBPs have been found to be mutagenic, cytotoxic, genotoxic, 
carcinogenic, teratogenic and developmentally toxic, the precise mechanisms of toxic action by DBPs is 
largely unknown. With the recent findings of toxicity pattern associated with halogen and nitrogenous 
functional groups, haloacetic acids (HAAs) and haloacetonitriles (HANs) were selected as representative 
carbonaceous and nitrogenous DBPs to make comparisons in terms of genomic DNA damage induction, 
repair efficiency of induced DNA lesions, and cell cycle alteration using Chinese hamster ovary (CHO) 
cells as a model mammalian cell system. Both HAAs and HANs are alkylating agents with a halogen 
atom attached on their carbon atom next to the functional group. The potency of cytotoxicity and 
genotoxicity induction by monoHAAs and monoHANs is associated with the propensity of the halide to 
leave the molecule, iodide > bromide > chloride.  
 The microplate-based single cell gel electrophoresis assay was modified to include liquid holding 
recovery time to measure the reduction of genomic DNA damage level over time. The repair efficiency 
for monoHAA-induced lesions by CHO cells followed the rank order of iodoacetic acid > chloroacetic 
acid >> bromoacetic acid. MonoHAN-induced lesions were repaired more efficiently than monoHAA-
induced lesions without consistent significant associations among the three monoHANs. Consequently, 
the contribution of the halogen atom did not correlate well with DNA repair kinetics.  
 HAN treatment followed by the release from the treatment resulted in CHO cells with abnormally 
high levels of DNA content, which was not observed in HAA-treated cells. It appeared that HANs 
adversely affected cell cycle progression by interfering with cell division. Altered cell ploidy affects 
genome instability and is widely associated with cancer progression. HAN-mediated disruption of the cell 
cycle and the generation of aberrant aneuploid cells may contribute to cancer induction and to adverse 
iii 
 
pregnancy outcomes associated with consumption of disinfected water observed in epidemiological 
studies. This is the first study that identifies significant cell cycle alterations by a class of DBPs.   
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 Chemical disinfection has provided protection against microbiological contamination and greatly 
suppressed outbreaks of waterborne diseases [1]. In the United States the first use of chlorine for 
disinfection goes back to 1908 in New Jersey [2]. In water works practice, disinfection aims to inactivate 
pathogenic organisms in the water (primary disinfection) and to maintain a disinfectant residual in the 
treated water throughout the distribution system to prevent bacterial re-growth (secondary disinfection). 
Chemical disinfectants are effective for inactivating pathogenic organisms, however, with their high 
oxidizing ability they also react with natural organic matter (NOM), anthropogenic contaminants and 
bromide/iodide to form environmentally hazardous chemicals called disinfection byproducts (DBPs) [3, 
4]. DBP formation is affected by NOM concentration, pH, temperature, disinfectant concentration and 
reaction time [5, 6]. Commonly used chemical disinfection agents include free chlorine, combined 
chlorine (also known as chloramines), chlorine dioxide and ozone, and each of them produces DBPs with 
different chemical class distributions [7, 8]. Since the first discovery of DBPs in 1974 [9, 10], significant 
efforts were expended to elucidate DBP formation, occurrence and health effects. To date more than six 
hundred DBPs have been identified; the most abundant chemical class of DBP in chlorinated water is 
trihalomethanes (THMs), followed by haloacetic acids (HAAs) [11].  
 Rook, a Dutch water chemist, reported the formation of chloroform and the other THMs in 
chlorinated drinking water and showed that the THMs were produced by reactions between chlorine and 
NOM in raw surface waters [9]. After the National Cancer Institute (NCI) published results of a rodent 
cancer bioassay on chloroform in 1976 [12], health concerns associated with chloroform and THMs 
rapidly lead to the adoption of drinking water guidelines and standards to control DBPs and to minimize 
consumers’ exposure to these potentially hazardous chemicals. In 1979, the U.S. Environmental 
Protection Agency (U.S. EPA) issued the Total Trihalomethane Rule under the Safe Drinking Water Act 
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with a regulatory standard for THM4 (sum of chloroform, bromodichloromethane, 
chlorodibromomethane, and bromoform) at 100 µg/L as a running annual average of four quarterly 
samples [13]. The U.S. EPA published the final Stage 1 Disinfectants/Disinfection By-Product (D/DBP) 
Rule in 1998 with the lowered THM4 maximum contaminant level (MCL) to be 80 µg/L. The Stage 1 
D/DBP Rule established a new MCL of 60 µg/L for the sum of five of the haloacetic acids (HAA5), as 
well as for bromate (10 µg/L) and chlorate (1.0 mg/L). Thereafter, the final Stage 2 D/DBP Rule was 
published in 2006. The Stage 2 D/DBP Rule maintains the same numeric MCLs from the Stage 1, but 
adds modifications to compliance monitoring design and compliance determinations [14, 15].  
 Epidemiology studies and laboratory animal studies were conducted to determine whether exposure 
to these agents in drinking water increases human health risks, particularly reproductive and 
developmental effects and cancer. Toxicological studies demonstrated that certain DBPs cause cancer in 
the liver, kidney and/or large intestine of laboratory animals and that particular DBPs cause adverse 
reproductive or developmental effects [16, 17]. On the other hand, epidemiological studies associated 
increased risk for bladder, colon and rectal cancers with long-term consumption of chlorinated surface 
waters [18]. Other epidemiological studies indicated adverse reproductive or developmental health effects, 
such as spontaneous abortion or fetal abnormalities [19, 20]. Therefore, animal toxicology studies have 
failed to demonstrate the induction of cancer at the sites indicated by epidemiological studies [17]. None 
of the DBPs identified are plausible bladder cancer carcinogens and they cannot account for the cancer 
risks projected from epidemiological studies [21].   
 There are several factors that could explain the discrepancies in the target organ of cancer between 
epidemiological studies and rodent single chemical bioassays. Most bioassays on DBPs cannot account 
for the effect of genetic factors and health status, which is likely to be much greater in heterogeneous 
human populations than in laboratory animals [17]. Also there is an effect from exposure to multiple 
DBPs, which could interact additively or synergistically [22]. A large percentage of DBPs have not been 
identified [11] and most of the identified DBPs have not been adequately evaluated for their toxicity or 
carcinogenicity [23].  
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 The toxic properties of DBPs have been studied for over the past 30 years, yet a systematic 
quantitative evaluation of DBPs was lacking until recently [23]. The most complete systematic DBP 
toxicity database consists of >70 DBPs analyzed for chronic cytotoxicity and acute genotoxicity in 
Chinese hamster ovary (CHO) cells, which made their toxic potency comparable across various chemical 
classes [24]. From this DBP database, the impact of halogen atom on toxicity within a set of matched 
compounds was determined. When the combined cytotoxicity and genotoxicity index values were 
calculated for a set of 18 DBPs with matched halogen analogues, and were averaged as a function of the 
halogen species, iodinated DBPs were demonstrated to be substantially more cytotoxic and genotoxic 
than their brominated and chlorinated analogues [24]. Comparison between 26 carbonaceous DBPs (C-
DBPs; defined as those not containing nitrogen) and 29 nitrogenous DBPs (N-DBPs; DBPs containing 
nitrogen) showed that the N-DBPs were substantially more cytotoxic and genotoxic than C-DBPs [24]. It 
is worth noting that currently there are no U.S. EPA-regulated N-DBPs or iodinated DBPs.  
 Due to the more stringent Stage 2 D/DBP Rule, many U.S. utilities have switched, or are switching 
from free chlorine to combined chlorine since chloramination significantly reduces the formation of 
regulated DBPs [25]. In the U.S. EPA nationwide occurrence study, iodinated THM yield was highest 
with chloramination disinfection systems, in particular for those plants that did not use ozone or chlorine 
as a pre-oxidant [4]. Detection of the higher level of iodinated THM in chloramination systems raised the 
concern of adverse public health consequences [23]. Contributions from treated wastewater discharge and 
algal activity in drinking water supplies can lead to elevated levels of dissolved organic nitrogen (DON), 
which may promote formation of emerging N-DBPs of health concern (e.g. haloacetonitriles, 
nitrosamines) [26-32]. 
 The research in this dissertation focuses on two chemical classes of DBPs; the haloacetic acids 
(HAAs) and haloacetonitriles (HANs) as representative C-DBPs and N-DBPs. Both chemical classes 
have relatively high occurrence levels in finished water, although HAAs generally form at much higher 
concentrations (Table 1.1). HAAs and HANs are both alkylating agents with one or more halogen atoms 
attached on their carbon atom (α-carbon) next to the functional group (Figure 1.1, 1.2). In both HAAs and 
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HANs, dihalogenated and trihalogenated species are generally more prevalent; in a survey of 12 U.S. 
drinking water treatment plants, the median levels of dichloroacetic acid (DCAA) and trichloroacetic acid 
(TCAA) were 15 µg/L and 5.8 µg/L, respectively, while monochloroacetic acid (CAA) was 5.5 µg/L at 
the maximum. Likewise, the median levels of dichloroacetonitrile (DCAN) and bromochloroacetonitrile 
(BCAN) were 0.7 µg/L and 0.8 µg/L, respectively, while the median level of chloroacetonitrile (CAN) 
was 0.05 µg/L (Table 1.1) [11]. The primary interest of this study is to make a comparison focusing on 
the toxicity pattern associated with halogen and nitrogenous functional groups, thus, monohalogenated 
species were selected as model compounds. Toxic effects of these selected DBP were compared in terms 
of genomic DNA damage induction, repair efficiency of induced DNA lesions, and cell cycle alteration 
using CHO cell as a model mammalian cell.  
 
1.2 Haloacetic Acids 
 HAAs are detected in finished drinking water [11] and chlorinated effluents from wastewater 
treatment plants [33] as well as in recreational pool waters [34]. In chlorinated water, HAAs are the 
second most common class of DBPs [11] (Figure 1.1). The sum of five HAAs (monochloro-, dichloro-, 
trichloro-, monobromo- and dibromoacetic acid), or HAA5, is regulated at a maximum contaminant level 
of 60 μg/L [14, 35].  All five regulated HAAs were mutagenic in bacteria [36] and induced genomic DNA 
damage in mammalian cells in vitro [37, 38]. A comparative systematic analysis of chronic cytotoxicity 
and acute genomic DNA damaging capacity of 12 individual HAAs in mammalian cells was reported [39]. 
Some of the HAAs are developmentally toxic [40-42] but not clastogenic in human TK6 cells [43]. 
Carcinogenicity has been shown for DCAA, TCAA, bromochloroacetic acid (BCAA) and dibromoacetic 
acid (DBAA), but not for CAA [17, 44-46]. Recently the tumorgenicity of iodoacetic acid (IAA) was 
established [47]. 
 MonoHAA has a single halogen substituent at the α-carbon, which can undergo SN2 substitution 
reaction. The association of toxic potency and halogen substitution was first realized by Richard and 
Hunter, with the rank order of IAA > bromoacetic acid (BAA) > CAA > fluoroacetic acid for their 
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developmental toxicity [42]. Later, the level of toxic potency was shown to follow the rank order of IAA 
> BAA > CAA in Salmonella typhimurium mutagenicity [36], forward mutation in Chinese hamster ovary 
(CHO) cells [48], and DNA damage induction in CHO cells [37] and human cells [49]. This universal 
pattern of rank order of IAA > BAA > CAA was associated with the inhibition of glyceraldehyde-3-
phosphate dehydrogenase activity [50, 51], a first demonstration of molecular mechanisms of toxic action 
by haloacetic acid DBPs.  
 
1.3 Haloacetonitriles 
 Haloacetonitriles consists of a cyano group attached to the α-carbon atom with halogen substitution 
(Figure 1.2). Both α-carbon and cyano carbon can serve as a reactive center [52].  HANs are not currently 
regulated by U.S. EPA, but the World Health Organization set the guideline value for dichloroacetonitrile 
(DCAN) and dibromoacetonitrile (DBAN) at 20 µg/L and 70 µg/L, respectively [53] 
(http://www.who.int/water_sanitation_health/dwq/gdwq3rev/en/). The major species of HANs are DCAN, 
trichloroacetonitrile (TCAN), DBAN and bromochloroacetonitrile (BCAN) and these species are 
sometimes referred as HAN4. Occurrence and toxicological studies often center around these four species.  
 Early in the 1980s dihaloacetonitriles were quantified in chlorinated natural waters [54]. The research 
activity into nitrogenous DBPs (N-DBPs), in which HANs are categorized, has increased partly because 
water providers are increasingly treating water sources which are impacted by algae blooms and 
municipal wastewater plant effluent discharge, both key sources of dissolved organic nitrogen (DON) that 
serve as N-DBP precursors. Population growth and rising water use is likely to make this issue more 
prevalent during the remainder of this century [31]. Also, recent mammalian cell tests have shown that 
HANs, haloacetamide and halonitromethanes are all far more cyto- and genotoxic than the regulated 
THMs and HAAs [24, 55, 56]. Many reactive N-DBP precursors are amino acids or amines, which are 
well-studied sub-categories of organic matter [31]. DCAN was shown to form from chlorination of 
aspartic acid and tryptophan with the yield of 0.06 mol/(mol precursor) and 0.09 mol/(mol precursor), 
respectively [57]. Trehy et al. also showed that aspartic acid produces 0.69 (mol DCAN)/(mol precursor) 
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at pH 6.4 [58]. DCAN can form from the nitrogen rich fraction of organic matter with high yield [29]. 
However, it is worth noting that these laboratory-based formation potential tests tend to overestimate the 
conversion yield compared to actual water treatment plants since formation potential tests are designed to 
maximize DBP formation.  
 Nationwide occurrence studies showed that the concentration for the sum of 9 species of chlorinated 
and/or brominated HANs in finished water from 12 U.S. water treatment plants was from non-detectable 
to 14 µg/L (median: 3 µg/L) [11]. An occurrence study of effluents from 23 U.S. municipal wastewater 
treatment plants measured the HAN concentration from 0.9 to 30 µg/L (median: 16 µg/L) in chlorinated 
effluents and non-detectable to 12 µg/L (median: 0.3 µg/L) in chloraminated effluents [33]. Recently 
HANs were shown to form as an electrochemical oxidation by-product of landfill leachate; DCAN and 
BCAN constituted 19-25% of the total concentration of organo-chlorinated compounds [59], especially 
DCAN at the concentration of 104 – 424 µg/L. HAN formation in biological systems in vivo from 
residual hypochlorite in drinking water was also reported [60]. 
 Salmonella typhimurium mutagenicity was reported for chloroacetonitrile (CAN), DCAN, 
trichloroacetonitrile (TCAN), and BCAN without metabolic activation, and CAN and bromoacetonitrile 
(BAN) with metabolic activation [61-63]. CAN, DCAN, TCAN, BAN and DBAN induced DNA damage 
in HeLa S3 cells [61] and sister chromatid exchange in Chinese hamster ovary (CHO) cells [63]. 
Clastogenicity of HANs was observed in Pleurodeles waltl larvae [62] but not in polychromatic 
erythrocytes in CD-1 mice [63]. The alkylating potential of the HANs followed the order DBAN > BCAN 
> CAN > DCAN > TCAN in a cell-free reaction system while the rank order of producing DNA strand 
breaks in cultured human lymphoblastic cells was TCAN > BCAN > DBAN > DCAN > CAN [64, 65]. 
HANs reacted toward calf thymus DNA in vitro with the reactivity rank order of BAN > CAN > DCAN > 
TCAN to form 7-(cyanomethyl)guanine [66]. When administered orally to rats, the HANs were 
metabolized to cyanide and excreted in the urine as thiocyanate. The extent of thiocyanate excretion was 
CAN > BCAN > DCAN > DBAN >> TCAN [65]. DCAN, but not DBAN, was shown to be an effective 
7 
 
inducer of aneuploidy in oocytes of Drosophila melanogaster; the potency of nitriles was attributed to 
cyanide toxicity [67]. 
 DBAN, BCAN, and CAN were tumor initiators in the mouse skin with topical applications [63], but 
DBAN is the only haloacetonitrile that has been adequately studied for carcinogenic potential in 
laboratory animals [17, 68]. In rats, increased incidences of neoplasm were observed in the oral cavity 
and granular stomach, whereas in mice, increased incidences of squamous cell neoplasms were observed 
in the forestomach [68]. Based on the carcinogenicity, quantitative structure toxicity relationship model 
calculated the contribution of DBAN to lifetime risk of cancer to be approximately 3 – 10× more potent 
than the regulated THMs [21]. 
 Several cases of developmental toxicity were reported for HANs. Treatment of Long-Evans rats with 
TCAN and DCAN resulted in reduced fertility and increased early implantation failure [69]. DCAN 
caused soft tissue and skeletal malformation in the surviving fetuses when DCAN was dosed to pregnant 
Long-Evans rats [70]. Ahmed et al. indicated that fetal brain update of CAN/metabolites induced 
oxidative stress that lead to increased apoptotic neural cell death in developing mouse brain [71]. 
Intrauterine exposure to low levels of CAN decreased fetal body weight and induced malformations in the 
musculoskeletal system in mice [72]. 
 Although there are numerous toxicology studies on HANs, a systematic comparative toxicology study 
including iodoacetonitrile (IAN) was not published until 2007 by Muellner et al. [55]. Genotoxicity and 
cytotoxicity of HANs using CHO cells were rank ordered as DBAN > BAN ≈ IAN > BCAN > DCAN > 
CAN > TCAN for chronic cytotoxicity, and IAN > BAN ≈ DBAN > BCAN > CAN > TCAN > DCAN 
for acute genotoxicity [55].  
 
1.4 Rationale for Research 
 Association of toxic potency with halogen substitution pattern was found in mouse whole embryo 
culture, with the rank order of IAA > BAA > CAA [42]. Subsequently, the same pattern was found in 
bacteria [36], CHO cells [37, 48] and human cells [49]. However, the repair efficiency of monoHAA-
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induced lesions followed the different rank order of IAA > CAA > BAA [73]. These data initiated a 
question: would different halogen substitution result in different level of DNA lesions? Biological systems 
have DNA repair capacity for DNA damage to maintain genomic integrity and stability. Basic DNA repair 
mechanisms include direct DNA repair, base excision repair, nucleotide repair, mismatch repair, 
homologous recombination repair and non-homologous end joining [74]. Different rates of genomic DNA 
repair should indicate different DNA lesions and/or different distributions of DNA lesions. Thus, it would 
be interesting to assess if a different rank order in DNA repair kinetics would be observed with a class of 
N-DBPs, which is discussed in Chapter 3. Single cell gel electrophoresis assay (Figures 1.3 and 1.4) was 
modified to include liquid holding recovery time to measure the repair rate of genomic DNA damage 
(Figure 1.5).  
 DNA damage induction, DNA damage repair, and cell cycle regulation are strongly associated. In 
response to DNA damage, cells can activate checkpoints at critical stages in the cell cycle that prevent 
cells from progressing through the cell cycle [74, 75]. Attene-Ramos et al. [49] conducted a human 
toxicogenomic analysis of monoHAAs focusing on DNA damage signaling pathways. Transcriptome 
profiles impacted by the monoHAAs included genes related to double strand DNA break repair, cell cycle 
arrest, and apoptosis (programmed cell death) regulation, among which the number of modulated genes 
involving cell cycle regulation was the highest. It would be interesting to assess if the selected DBPs, 
monoHAAs and monoHANs would alter the cell cycle progression and if different cell cycle alteration 
would be observed between these chemicals classes. This is the first study that identified cell cycle 
alterations by a class of DBPs.   
 Different from prokaryotic cells, eukaryotic cells have the distinct cell cycle. The cell cycle is divided 
into interphase (G1, S, and G2 phases) and the mitotic phase (M phase) (Figure 1.6 (A)). In the G1 phase, 
the cells are preparing for DNA synthesis. S phase is the period of DNA synthesis and G2 phase is the 
period when the cells prepare for mitosis. In addition, cells may go into permanent arrest (G0). Since each 
chromosome is duplicated during the S phase (2N → 4N; N values denote DNA content as a multiple of 
the normal haploid genome), cells in G2 phase have double the amount of DNA (4N) than cells in G1 
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phase (2N) (Figure 1.6 (B)). Cell cyclin proteins regulate the cell’s progression through the stages of the 
cell cycle [76]. Activation of checkpoints prevent cells from progressing through the cell cycle for a 
defined period of time so that there is a longer period available for DNA repair prior to replication, 
leading to a commensurate reduction in mutation frequency [77]. 
 The variation in the DNA content of cells can be measured using flow cytometry (Figure 1.7). Flow 
cytometry is a system for sensing cells or particles as they move in a liquid stream through a laser (light 
amplification by stimulated emission of radiation)/light beam past a sensing area [78]. The fluorochrome 
propidium iodide binds DNA in a proportional and linear fashion; the intensity of fluorescence is 
recorded at a single cell level and obtained frequency distribution represents cells with different DNA 
content, which can represents cell cycle progression [79] (Figures 1.6 (B), 1.7 (A), and 1.8).  
  
1.5 Research Objectives 
 Even though nearly 40 years have passed since the first discovery of DBPs, the mode of toxic action 
of DBPs is largely unclear. A comparative and systematic analysis is still lacking. The objective of this 
research is to develop insights for the mode of toxic action of DBPs by focusing on monohaloacetic acids 
and monohaloacetonitriles, which are selected as representative carbonaceous and nitrogenous DBPs. 
Although occurrence and toxicity studies primarily involve dihalo- and trihalo-species, focusing on the 
simpler monohalogenated species makes it possible to compare the effect of halogen atoms, and the effect 
of chemical functional group. In this dissertation DNA repair kinetics and cell cycle alteration are used as 
endpoints for making comparison of these two chemical groups. The objectives of specific chapters are:  
 Conduct a DNA repair kinetics study to determine the efficiency of repair of genomic DNA 
lesions induced by monohaloacetic acids (Chapter 2) (Figure 1.5). 
 Conduct a DNA repair kinetics study to determine the efficiency of repair of genomic DNA 
lesions induced by monohaloacetonitriles, and compare the repair kinetics to that of 
monohaloacetic acids (Chapter 3) (Figure 1.5). 
 Determine the cell cycle alteration induced by monohaloacetonitriles (Chapter 4) (Figure 1.8). 
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 Determine the cell cycle alteration induced by monohaloacetic acids (Chapter 5) (Figure 1.8). 
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Tables and Figures 
 
 
Table 1.1 Summary of haloacetic acid and haloacetonitriles measured in finished water at drinking water 
treatment plants (data from [11]). 
 
DBP Minimum (µg/L) Median (µg/L) Maximum (µg/L) 
Haloacetic acids       
Monochloroacetic acid ND ND 5.5 
Monobromoacetic acid ND ND 1.6 
Dichloroacetic acid 2.2 15 22 
Bromochloroacetic acid 1.7 4.4 18 
Dibromoacetic acid ND 2.6 11 
Trichloroacetic acid ND 5.8 20 
Bromodichloroacetic acid ND 3.7 12 
Dibromochloroacetic acid ND 2.1 7.2 
Tribromoacetic acid ND ND 2.0 
Haloacetonitriles       
Chloroacetonitrile ND 0.05 0.9 
Bromoacetonitrile ND ND 0.2 
Dichloroacetonitrile ND 0.7 5 
Bromochloroacetonitrile ND 0.8 2 
Dibromoacetonitrile ND 0.5 2 
Trichloroacetonitrile ND ND 0.1 
Bomodichloroacetonitrile ND ND ND 
Dibromochloroacetonitrile ND ND ND 























Figure 1.3 Representative image of single cell gel electrophoresis assay illustrating genomic DNA 









Figure 1.4 Flowchart of the measurement of genomic damage induction using microplate-based single 
cell gel electrophoresis assay.  
 
Set up 40,000 cells/well 
in 96-well microplate
Incubate for 16 – 20 h,
5% CO2 @ 37 C
Remove medium
Wash cells with HBSS
Treat cells with a specific 
DBP in serum-free medium
for 4 h, 5% CO2 @ 37 C
Wash and harvest cells
Make microgels (cells + 
low melting point agarose 
on microscope slide) 





Lyse cells to produce 
naked nuclei
Count live and dead 








Figure 1.5 Flowchart for measurement of DNA damage repair rate. 
  
Set up 40,000 cells/well 
in 96-well microplate
Incubate for 16 – 20 h,
5% CO2 @ 37 C
Remove medium
Wash cells with HBSS
Treat cells with a specific 
DBP in serum-free medium
for 4 h, 5% CO2 @ 37 C
Remove the chemical 
and wash cells
Make microgels (cells + 
low melting point agarose 






Lyse cells to produce 
naked nuclei
Incubate for designated 
times, 5% CO2 @ 37 C
Harvest cells





Figure 1.6 (A) Schematic outline of eukaryotic cell cycle and cellular DNA content. (B) Representation 



























































Figure 1.7 (A) Fluorochrome propidium iodide emits strong fluorescence when intercalated into DNA 








Propidium iodide (PI) 
intercalate















Set up 2  105 cells/well 
in 6-well plate
Incubate for 16 – 20 h,
5% CO2 @ 37 C
Remove medium
Wash cells with HBSS
Treat cells with a specific 
DBP in serum-free medium
for 4 h, 5% CO2 @ 37 C
Remove the chemical 
and wash cells
Fix cells with 
70% ethanol
Add fresh medium 
with serum
Rinse cells with 
cold PBS
Incubate cells with propidium 
iodide and RNase
Incubate cells 
@ −22 C 
Incubate for designated 
times, 5% CO2 @ 37 C
Harvest cells
No post-incubation With post-incubation
Count cells
Flow cytometric 





MAMMALIAN CELL DNA DAMAGE AND REPAIR KINETICS OF 







 Haloacetic acids (HAAs) are the second most common class of chlorinated water disinfection by-
products (DBPs). The single cell gel electrophoresis genotoxicity assay using Chinese hamster ovary 
(CHO) cells was modified to include liquid holding recovery time to measure genomic DNA damage and 
repair kinetics of three monoHAAs: chloroacetic acid (CAA), bromoacetic acid (BAA), and iodoacetic 
acid (IAA). The rank order of genotoxic potency was IAA > BAA > CAA from previous research. The 
concentration of each HAA was chosen to generate approximately the same level of genotoxic damage. 
No cytotoxicity was expressed during the 24-h liquid holding period. Nuclei from CHO cells treated with 
BAA showed the lowest rate of DNA repair (t50 = 296 minutes) compared to CAA or IAA (t50 = 134 and 
84 minutes, respectively). The different rates of genomic repair expressed by IAA or CAA versus BAA 
suggest that different distributions of DNA lesions are induced. The use of DNA repair coupled with 
genomic technologies may lead to the understanding of the biological and genetic mechanisms involved 
in toxic responses induced by DBPs. 
 
2.1 Introduction 
 The drinking water community provides an exceedingly important public health service by generating 
high quality, safe and palatable tap water. Each day approximately 250,000 public water purification 
facilities in the United States provide drinking water to 90% of the population [1]. During the twentieth 
century the outbreak of waterborne diseases including typhoid and cholera were greatly suppressed 
                                                     
 
1
 Reprinted with permission from Komaki, Y.; Pals, J.; Wagner, E. D.; Mariñas, B. J.; Plewa, M. J., Mammalian cell 
DNA damage and repair kinetics of monohaloacetic acid drinking water disinfection by-products. Environ. Sci. 
Technol. 2009, 43, (21), 8437-42. Copyright 2009 American Chemical Society. 
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through disinfection [2]. However, disinfectants react with natural constituents, e.g., organic matter, 
bromide and iodide, in source water and form disinfection by-products (DBPs); this unintended 
consequence may cause negative health effects [3]. In order to reduce exposure, the U.S. Environmental 
Protection Agency (U.S. EPA) promulgated the Stage 1 Disinfectants and Disinfection Byproducts Rule 
(DBPR) in 1998 [4] and the Stage 2 DBPR in 2006 [5]. In chlorinated water, haloacetic acids (HAAs) are 
the second most common class of DBPs [6]. The sum of five HAAs (monochloro-, dichloro-, trichloro-, 
monobromo- and dibromoacetic acid) is regulated at a maximum contaminant level of 60 μg/L [4, 5].   
 The occurrence, genotoxicity and carcinogenicity of the HAAs were recently reviewed [7]. All five 
regulated HAAs were mutagenic in bacteria [8] and induced genomic DNA damage in mammalian cells 
in vitro. Among the three monohaloacetic acids, iodoacetic acid (IAA) was the most cytotoxic and 
genotoxic followed by bromoacetic acid (BAA) and chloroacetic acid (CAA) [9, 10]. The rank order of 
their toxicity correlated with their electrophilic reactivity and the carbon-halogen bond dissociation 
energy [9]. The rank order of teratogenic potency (neural tube developmental defects in mouse embryos) 
was IAA > BAA > CAA [11, 12].  In general, brominated acetic acids were consistently more cytotoxic 
and more genotoxic than the corresponding chlorine substituted acids [7].  
 Although there are many studies on the induction of DNA damage by DBPs, little information exists 
on the repair of DBP-induced DNA lesions [13, 14]. In the literature there is no systematic analysis of the 
DNA repair kinetics of regulated DBPs nor is there an example of correlating chemical structure activity 
relationships and repair. The aim of this research was to characterize the genotoxicity induced by 
monoHAAs in mammalian cells and determine the kinetics of DNA repair. We employed HAA 
concentrations that induced approximately equivalent genotoxic effects. Our hypothesis was that if DNA 
lesions induced by these HAAs were similar then no statistical difference would be observed in the 
kinetics of DNA repair. If the different halogens (I, Br, Cl) induced different DNA lesions then the DNA 





2.2 Materials and Methods 
2.2.1 Reagents  
 General reagents were purchased from Fisher Scientific Co. (Itasca, IL) and Sigma Chemical Co. (St. 
Louis, MO). Bromoacetic (BAA) and chloroacetic acid (CAA) were purchased from Fluka Chemical Co. 
(Buchs, Switzerland). Iodoacetic acid (IAA) was purchased from Aldrich Chemical Co. (Milwaukee, WI). 
Cell culture F12 medium and fetal bovine serum (FBS) were purchased from Fisher Scientific Co. The 
HAAs were dissolved in dimethyl sulfoxide (DMSO) and stored at −22°C in sealed, sterile glass vials.  
 
2.2.2 Chinese hamster ovary cells 
 Clone 11-4-8 of the transgenic Chinese hamster ovary (CHO) cell line AS52 was used [15]. The cells 
were maintained in F12 medium containing 5% FBS, 1% antibiotic-antimycotic solution (Invitrogen, 
Carlsbad, CA) and 1% glutamine, and grown in 100 mm glass culture plates at 37°C in a humidified 
atmosphere of 5% CO2.  
 
2.2.3 Treatment conditions 
 The day before treatment, 4 × 10
4
 CHO cells were plated in 200 μL of F12 + 5% FBS medium per 
well in a sterile flat-bottom 96-well microplate. The next day, the cells were washed with Hank’s 
balanced salt solution (HBSS) and treated with the HAAs in F12 medium without FBS in a total volume 
of 25 μL for 4 hours at 37°C, 5% CO2. The wells were covered with AlumnaSeal™. The concentrations 
of the HAAs for the DNA repair studies were first determined so that similar levels of genomic DNA 
damage were induced. The concentrations were 6 mM, 60 μM, and 25 μM for CAA, BAA and IAA, 
respectively. After treatment, the solution was aspirated and the cells were washed 2× with HBSS. The 
cells from one well were immediately harvested and microgels were prepared for the determination of 
DNA damage with no time for repair. F12 medium without FBS (100 µL) was added to the other wells, 
and the microplate was returned to the incubator for designated times. This recovery period (liquid 




2.2.4 Single cell gel electrophoresis  
 Single cell gel electrophoresis (SCGE, or the Comet assay) quantitatively measures genomic DNA 
damage induced in individual nuclei of treated cells [16, 17] and has been used as a predictor of 
carcinogenic activity [18]. The Comet assay is rapid and sensitive, and detects lesions including DNA 
single-strand and double-strand breaks, incomplete excision repair sites, and alkali-labile sites. The assay 
combined with liquid holding allows for a quantitative analysis of DNA repair [13, 14, 17, 19, 20].  
 Detailed methods for preparation of SCGE slides and electrophoresis have been published previously 
[9, 10]. After treatment the cells were detached with 50 μL of a 0.005% trypsin solution in HBSS, 
followed by the addition of 70 μL F12 + 5% FBS. An aliquot was analyzed for acute cytotoxicity with the 
trypan blue dye exclusion assay [21]. The remaining cell suspension was embedded in a layer of low 
melting point agarose prepared in phosphate-buffered saline on clear microscope slides that were pre-
coated with 1% solution of normal melting point agarose prepared with deionized water. Two SCGE 
microgels were prepared from the suspension harvested from each well. The microgels were placed in 
lysing solution (2.5 M NaCl, 1% sodium lauryl sarcosinate, 100 mM Na2EDTA, 10 mM Tris, pH 10 with 
1% Triton X-100 and 10% DMSO) overnight at 4°C.  
 The DNA of the nuclei was denatured for 20 minutes in electrophoresis buffer (1 mM Na2EDTA and 
300 mM NaOH, pH 13.5). The SCGE microgels were electrophoresed for 40 minutes at 25 V and 300 
mA (0.72 V/cm) at 4°C. After neutralization with 400 mM Tris buffer (pH 7.5) the microgels were 
dehydrated in cold methanol for 20 minutes, dried for 5 minutes at 50°C, and stored at room temperature. 
For analysis, the microgels were hydrated in water at 4°C for 20 minutes, and then the nuclei were stained 
with 65 μL of an ethidium bromide solution (20 μg/mL) and rinsed in cold water. The microgels were 
kept at 4°C and analyzed within a 4-hour time period.  
 Fifty randomly chosen nuclei per microgel were analyzed with a Zeiss fluorescence microscope 
(excitation filter of BP 546/10 nm, barrier filter of 590 nm) and a computerized image analysis system 
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(Komet version 3.1, Kinetic Imaging Ltd., Liverpool, UK). The digitalized data were automatically 
transferred from the CCD camera to a computer-based spreadsheet for statistical analysis.  
 
2.2.5 Statistical analysis 
 Each experiment was independently repeated three times. The data were transferred to Excel 
spreadsheets (Microsoft Corp., Redmond, WA) and analyzed using SigmaStat 3.1, SigmaPlot 8.0 
programs and TableCurve 2D (SPSS Inc. Chicago, IL). The primary measure of DNA damage and repair 
was the percent of the DNA that had migrated from the nucleus into the microgel (% tail DNA). 
 The distributions of the % tail DNA values are not normal. In order to conduct parametric statistical 
analysis the mean % tail DNA value was calculated for each microgel. The mean % tail DNA values for 
each experimental group were averaged. According to the central limit theorem, these averaged mean 
values were normally distributed [22]; the data were analyzed using a two-way analysis of variance test 
statistic. The mean % tail value from the HAA-treated cells with no recovery time was set at 100% and 
compared with concurrently treated cells after designated periods of liquid holding. If a significant F 
value of P ≤ 0.05 was obtained, a Holm-Sidak multiple-comparison was conducted in order to determine 
if there was a significant difference in the rate of DNA repair among the monoHAAs. 
 
2.3 Results and Discussion 
 All three monoHAAs induced genomic DNA damage. In this study the concentration of each HAA 
was selected to induce similar levels of genotoxic damage. The % tail DNA for each HAA at 0-time liquid 
holding was normalized to a value of 100% that allowed for a direct comparison of the rates of DNA 
repair.  
 
2.3.1 Liquid holding time and cytotoxicity 
 CHO cell viability was determined throughout a 60-hour time period under liquid holding conditions 
(F12 medium without FBS). More than 55 hours of liquid holding time caused a decline in viability 
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(Figure 2.1). There was no decrease in viability during the 24-hour liquid holding period that was used for 
the DNA repair experiments. 
 
2.3.2 DNA repair kinetics 
 DNA repair kinetics was determined for IAA, BAA, and CAA using SCGE and a liquid-holding 
protocol [16, 17] (lower plot, Figure 2.2). The data for each DNA repair curve were regressed using 
curvilinear curve fitting as well as regression based on first order kinetics (Table 2.1). The time required 
to affect 50% repair of the originally induced DNA damage (t50) was calculated by sigmoidal or first order 
regression analysis within the 0 – 24 hour liquid holding time. With sigmoidal regression, the t50 values 
for IAA, CAA and BAA were 84, 134 and 296 minutes, respectively (Table 2.1). The values were similar 
with first order regression. Using first order regression analysis, bimodal repair kinetics was observed. 
These bimodal repair curves may be due to the diversity of DNA lesions induced by the HAAs. Apurinic 
sites, single strand DNA breaks, and damaged bases can be repaired more efficiently and rapidly as 
compared to DNA crosslinks and DNA double strand breaks. These latter lesions induce serious genomic 
damage and require more cellular processing for repair [23]. The calculated first order repair rate (during 







, respectively. The rate of repair of BAA-induced lesions was different from the repair rates of CAA 
or IAA. Acute cytotoxicity was not observed throughout the liquid holding period (upper plot, Figure 2.2). 
 
2.3.3 Repair of DNA damage induced by the monohaloacetic acids 
 Cells treated with BAA expressed a lower rate of DNA repair compared to IAA or CAA (Figure 2.2). 
To determine if there were significant differences in DNA repair at each liquid holding time we used a 
balanced multivariant analysis of variance (ANOVA) with a Holm-Sidak pairwise multiple comparison 
test (Table 2.2). A significant difference in DNA repair kinetics was expressed by CHO cells exposed to 
BAA as compared to IAA or CAA. The DNA repair kinetics for CAA and IAA were statistically similar. 
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2.3.4 Frequency distribution of repaired nuclei 
 The levels of % tail DNA for each monoHAA as a function of liquid holding time were analyzed with 
frequency distribution histograms. Figure 2.3 illustrates the dynamics of genomic DNA repair in which 
the nucleus was the unit of measure. For each nucleus the distribution of DNA migration during each 
liquid holding time was plotted. The concentrations of monoHAAs were chosen to generate 
approximately similar levels of biological damage. The 0-hour liquid holding time (Figure 2.3, far left 
panel of stacked plots) shows that CAA and IAA induced similar profiles of DNA damage. The damage 
induced by BAA with no liquid holding was much broader with fewer nuclei with the highest % tail DNA 
values but also many nuclei with lower amounts of damage. As the liquid holding time progressed from 3 
to 24 hours, the levels of DNA damage in each treatment group diminished shifting the distributions to 
the left in each panel. However, the population of nuclei damaged by BAA showed lesser repair as 
compared to CAA and IAA (two center vertical panels). Few unrepaired nuclei remained after 24-hour 
liquid holding (Figure 2.3, far right panel). DNA damage histograms for the untreated negative controls 
are presented in Figure 2.4; over a 24-hour time period no significant difference was observed in DNA 
damage distributions. The level of completeness for the repair of DNA damage induced by each 
monoHAA can be observed by comparing the 24-hour liquid holding distribution (Figure 2.3, far right 
panel) with that of the negative control (Figure 2.4).  
 With no liquid holding time for repair, the mean of the % tail DNA was 60.5, 50.3, and 67.3 for IAA, 
BAA and CAA, respectively. After 24 hours of liquid holding the mean % tail DNA values were 7.5, 12.0 
and 7.2, respectively. Liquid-holding recovery significantly shifted the distributions to lower % tail DNA 
values; IAA showed the most rapid shift, CAA the next and BAA the slowest (Figure 2.3). The mean % 
tail DNA values of the negative control did not change significantly: 4.8% without liquid holding, 4.1% 
after 5 hours and 4.3% after 24 hours liquid holding recovery time (Figure 2.4).  
 The different rates of genomic repair that are expressed by IAA or CAA versus BAA suggest that 
different DNA lesions and/or different distributions of DNA lesions are induced. Since the concentration 
of each haloacetic acid was chosen to generate approximately the same level of genotoxic damage, the 
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null hypothesis was that there would be no difference in the DNA repair kinetics if similar DNA lesions 
were induced by the three haloacetic acids. The data do not support the null hypothesis. Currently there is 
not a complete analysis of the types of DNA lesions induced by the haloacetic acids.  
 Cemeli et al. showed that the antioxidant butylated hydroxyanisole or catalase substantially reduced 
IAA-induced mutagenicity in Salmonella typhimurium and reduced genomic DNA damage in CHO cells 
[24]. Oxidative stress may be a biological mechanism contributing to the genotoxicity of IAA. Oxidative 
stress has been linked with the toxicity of other DBPs including 3-chloro-4-(dichloromethyl)-5-hydroxy-
2(5H)-furanone (MX) [25], bromate [26-29], and chloroacetonitrile [30]. Oxidative stress-induced DNA 
damage ranges from individual base damage to single strand and double strand DNA breaks [23]. DNA 
repair of oxidative stress-induced lesions may be relatively fast if mediated by DNA glycosylases [31] or 
require more time if the lesion is a double strand DNA break [32]. 
 Recent toxicogenomic data indicate that non-cytotoxic concentrations of BAA preferentially 
modulate the expression of human genes involved in double strand DNA (dsDNA) break repair [33]. 
Double strand breaks are one of the most toxic and mutagenic lesions and require more time for repair 
than other types of DNA damage [32]. dsDNA breaks must be repaired to restore the integrity, stability 
and reproducibility of the genome. XRCC3-241 is a mutant allele for dsDNA break repair; humans who 
carry this allele express higher risks of bladder cancer [34]. It is intriguing that bladder cancer is 
associated with the consumption of disinfected drinking water [35]. 
 The use of DNA repair coupled with genomic technologies may lead to the understanding of the 
biological and genetic mechanisms that are involved in toxic responses induced by DBPs. Such 
knowledge may lead to the identification of biomarkers that may be employed in feed-back loops to aid 
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Tables and Figures 
 
 







t50 (min, sigmoidal 
regression) 
t50 (min, first order 
regression) 
IAA 25 µM 64-69-7 84 85 
BAA 60 µM 79-08-3 296 319 






Table 2.2 Two-way Analysis of Variance for DNA repair of CHO cells treated with IAA, BAA or CAA 





Difference of Means P 
CAA vs. IAA 0 1.42×10
−13
 0.99 
CAA vs. BAA 0 4.26×10
−14
 0.99 
BAA vs. IAA 0 9.95×10
−14
 0.99 
CAA vs. IAA 1 4.08 0.58 
CAA vs. BAA * 1 25.22 0.001 
BAA vs. IAA * 1 21.14 0.005 
CAA vs. IAA * 2 15.70 0.03 
CAA vs. BAA * 2 19.35 0.009 
BAA vs. IAA * 2 35.05 0.0001 
CAA vs. IAA  3 12.79 0.08 
CAA vs. BAA * 3 23.35 0.002 
BAA vs. IAA * 3 36.136 0.0001 
CAA vs. IAA 4 11.46 0.1 
CAA vs. BAA * 4 19.90 0.007 
BAA vs. IAA * 4 31.36 0.0001 
CAA vs. IAA 5 7.49 0.3 
CAA vs. BAA 5 13.87 0.06 
BAA vs. IAA * 5 21.36 0.004 
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Figure 2.1 CHO cell viability throughout a 60-hour time period with cells maintained under liquid 
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Figure 2.2 Comparative genomic DNA repair kinetics in CHO cells for chloroacetic acid (CAA), 
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Figure 2.3 Histograms illustrating the distributions of SCGE % tail DNA values from CHO cells treated 
with bromoacetic acid (BAA), chloroacetic acid (CAA) and iodoacetic acid (IAA) without and with 3, 




































Figure 2.4 Histograms illustrating the distributions of SCGE % tail DNA values from the CHO cell 
negative controls at 0, 5 and 24 hour liquid-holding recovery. No significant difference was observed 











 Haloacetonitriles (HANs) are a chemical class of DBPs that form from reactions between 
disinfectants and organic nitrogen agents present in source waters. Increasing use of source waters 
impacted by wastewater effluents, algal blooms, or anthropogenic contaminants may enhance the 
formation of HANs. HANs are cytotoxic, mutagenic, genotoxic and developmentally toxic. DNA damage 
induction, DNA damage repair and cell cycle regulation are strongly associated. Measuring the efficiency 
of DNA damage repair should provide an insight on HAN-induced lesions and the impact of different 
halogen atom substitution.   
 The single cell gel electrophoresis (SCGE) assay was used to 1) determine the induction of single and 
double strand DNA breaks and 2) determine the DNA repair kinetics of HAN-induced genetic damage. In 
addition, the plating efficiency of HAN-treated cells was evaluated. The SCGE assay demonstrated that 
the monoHANs were genotoxic, with the descending rank order of IAN > BAN > CAN. Induced genomic 
DNA damage was repaired with very similar rates among the HANs. The contribution of the halogen 
atoms in each HAN on DNA repair kinetics appeared to be different from previously measured HAAs, 
suggesting differences in the modes of toxic action between these two chemical groups.   
 
3.1 Introduction 
 Disinfection processes provide a primary defense against waterborne infectious disease [1] yet in 
addition to inactivating pathogens disinfectants can also react with precursors, mainly natural organic 
matter, in source waters to form disinfection byproducts (DBPs). Many DBPs are genotoxic, carcinogenic 
and teratogenic [2, 3]. Epidemiological studies have linked chlorinated water consumption with cancer 
and adverse reproductive outcomes [4]. Recent in vitro mammalian cell toxicity assays demonstrated that 
haloacetonitriles (HANs), haloacetamides, and halonitromethanes were significantly more geno- and 
44 
 
cytotoxic than regulated trihalomethanes (THMs) and haloacetic acids (HAAs) [5-7] and this raised 
interests toward investigating nitrogenous disinfection byproducts (N-DBPs) [8]. Moreover, the 
increasing use of source waters impacted by municipal wastewater effluent discharge or algal blooms may 
promote N-DBP formation due to elevated levels of organic nitrogen content [9-14]. HANs are a 
chemical class of DBPs first identified in the 1980s [15, 16] and were known to form from the 
chlorination of amino acids [17] as well as during chloramination [18]. HANs are widely detected in 
water treatment plants and disinfected wastewater effluents [19, 20] as well as in swimming pool water 
[21, 22]. Besides the ingestion route, HANs can be absorbed via percutaneous absorption [23, 24].  
 The metabolism and toxicity of HANs were reviewed previously [25]. Toxicological studies of HANs 
primarily involved chlorinated and brominated HANs. Chloroacetonitrile (CAN), dichloacetonitrile 
(DCAN), trichloroacetonitrile (TCAN) and bromochloroacetonitrile (BCAN) were mutagenic in 
Salmonella typhimurium [26-28]. HANs bound to DNA and produced DNA strand breaks in human 
cultured lymphoblastic cells; however, there was no correlation between these two endpoints [29]. CAN 
and DCAN can cross the placental barrier and accumulate in the fetal brain [30-32]. Dibromoacetonitrile 
(DBAN) was found to be carcinogenic in rats and mice [3, 33] and the contribution of this HAN to 
lifetime risk of cancer was calculated to be higher than that of THMs using a quantitative structural 
toxicity relationship model [34]. A systematic toxicology study including iodinated HAN was not 
published until 2007; in vitro mammalian cell toxicity demonstrated a descending rank order of DBAN > 
bromoacetonitrile (BAN) ≈ iodoacetonitrile (IAN) > BCAN > DCAN > CAN > TCAN for chronic 
cytotoxicity, and IAN > BAN ≈ DBAN > BCAN > CAN > TCAN > DCAN for acute genotoxicity [7].  
 The objective of this study was to enhance our knowledge of the genotoxicity of HANs using Chinese 
hamster ovary (CHO) cells.  The single cell gel electrophoresis (SCGE) assay was used to 1) determine 
the induction of single and double strand DNA breaks and 2) determine the DNA repair kinetics of the 
induced genetic damage. The SCGE assay is a sensitive tool for quantifying genomic DNA damage and 
repair [35-39]. SCGE was also used as a predictor of carcinogenic activity [40]. SCGE is widely used for 
applications including human biomonitoring, genotoxicity, ecological monitoring and as a tool to 
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investigate DNA damage and repair in different cell types in response to a wide range of DNA-damaging 
agents [37, 41]. SCGE assay allows for repair kinetics experiments by measuring the remaining 
unrepaired DNA as a function of time [42-47]. This approach determines the efficiency of the repair 
process toward different DNA lesions. Biological systems have DNA repair capability for DNA damage 
to maintain genomic integrity and stability. Basic DNA repair mechanisms include direct DNA repair, 
base excision repair, nucleotide excision repair, mismatch repair, homologous recombination, and non-
homologous end joining [48]. DNA repair kinetic experiments may provide insights on HAN-induced 
lesions and if they persist as a result of different halogen atom substitution. Moreover, a comparison with 
previously conducted HAA repair kinetics may provide insights on the contribution of halogen atoms 
among different chemical groups, such as HANs and HAAs. In this work, DNA repair kinetics and the 
plating efficiency of HAN- and HAA-treated cells were investigated. It is commonly believed that 
eukaryotic cells delay the cell cycle to allow DNA repair to proceed. A damage recognition sensor triggers 
a signal transduction cascade and downstream effectors toward cell cycle arrest [49-53]. The checkpoint 
response is also associated with mutagenic translesion DNA synthesis [54]. We therefore hypothesized 
that faster translesion repair might be associated with induced cell cycle arrest. 
 
3.2 Materials and Methods 
3.2.1 Reagents  
 General reagents were purchased from Fisher Scientific Co. (Itasca, IL) and Sigma-Aldrich Co. (St. 
Louis, MO). Iodoacetonitrile (98%, CAS# 624-75-9), bromoacetonitrile (97%, CAS# 590-17-0) and 
chloroacetonitrile (99%, CAS# 107-14-2) were purchased from Sigma-Aldrich. Bromoacetic acid (≥ 99%, 
CAS# 79-08-3) and chloroacetic acid (≥ 99%, CAS# 79-11-8) were purchased from Fluka Chemical Co. 
(Buchs, Switzerland). Iodoacetic acid (≥ 99%, CAS# 64-69-7) was purchased from Aldrich Chemical Co. 
(Milwaukee, WI). HANs and HAAs were diluted in dimethyl sulfoxide (DMSO) at 1 mol/L and stored at 
−22°C. 
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3.2.2 Chinese hamster ovary cells and culture media 
 Transgenic Chinese hamster ovary (CHO) cells line AS52 clone 11-4-8 [55, 56] were maintained in 
modified Ham’s F12 medium (Mediatech, Inc., Manassas, VA) supplemented with 5% fetal bovine serum 
(FBS), 1% L-glutamine and 1% antibiotic-antimycotic solution (10 units/mL penicillin G sodium, 10 
µg/mL streptomycin sulfate, 25 µg/mL amphotericin B, 0.85% saline; Invitrogen, Carlsbad, CA). The 
cells exhibit normal morphology, express cell contact inhibition and grow as a monolayer without 
expressing neoplastic foci. The cells were grown in 100-mm glass culture plates at 37°C in a humidified 
atmosphere containing 5% CO2. 
 
3.2.3 Treatment conditions 
 The day before treatment, 4 × 10
4
 CHO cells were plated in 200 μL of F12+5% FBS per well in a 
sterile flat-bottom 96-well microplate. The next day, the cells were washed with divalent cation-free 
Hank’s balanced salt solution (HBSS) and treated with the HANs in serum-free F12 medium in a total 
volume of 25 μL for 4 hours at 37°C, 5% CO2. The wells were covered with AlumnaSeal™ to prevent 
chemical volatilization. After treatment, the solution was aspirated and the cells were washed twice with 
HBSS. The cells from one well were immediately harvested and microgels were prepared for the 
determination of DNA damage with no time for repair. Fresh serum-free F12 medium (100 µL) was 
added to the other wells, and the microplate was returned to the incubator for designated times. This 
recovery period (liquid holding time) allowed for cells to repair their induced lesions. 
 
3.2.4 Single cell gel electrophoresis  
 The SCGE assay is rapid, sensitive, and detects lesions including DNA single-strand and double-
strand breaks, incomplete excision repair sites, and alkali-labile sites. The assay combined with liquid 
holding allows for a quantitative analysis of DNA repair [39, 42-47]. Detailed methods for preparation of 
SCGE slides and electrophoresis have been published previously [57-59]. After treatment the cells were 
detached with 50 μL of a 0.025% trypsin + 0.01% EDTA solution in HBSS, followed by the addition of 
47 
 
70 μL F12 + 5% FBS. A 10 µL aliquot was analyzed for acute cytotoxicity with the trypan blue dye 
exclusion assay [60] to ensure that cell viability exceeds 70% [61]. The remaining cell suspension was 
mixed with the same volume of 1% low melting point agarose (LMA), and layered onto clear microscope 
slides pre-coated with 1% normal melting point agarose. After the first layer of LMA solidified, another 
layer of 0.5% LMA was applied. Two SCGE microgels were prepared from the suspension harvested 
from each well. The microgels were immersed in lysing solution (2.5 M NaCl, 1% sodium lauryl 
sarcosinate, 100 mM Na2EDTA, 10 mM Tris, pH 10 with 1% Triton X-100 and 10% DMSO) overnight at 
4°C.  
 The DNA of the nuclei in the SCGE microgels was denatured for 20 minutes in electrophoresis buffer 
(1 mM Na2EDTA and 300 mM NaOH, pH 13.5) followed by electrophoresis at 25 V and 300 mA 
(0.72 V/cm) for 40 minutes at 4°C. After neutralization with 400 mM Tris buffer (pH 7.5) the microgels 
were dehydrated in cold methanol for 20 minutes, dried for 5 minutes at 50°C, and stored at room 
temperature. For analysis, the microgels were hydrated in water at 4°C for 20 minutes, and then the nuclei 
were stained with 65 μL of an ethidium bromide solution (20 μg/mL). Fifty randomly chosen nuclei per 
microgel were analyzed with a Zeiss fluorescence microscope (excitation filter of BP 546/10 nm, barrier 
filter of 590 nm) and a computerized image analysis system (Comet Assay IV, Perspective Instruments 
Ltd., Suffolk, UK). The digitalized data were automatically transferred from the CCD camera to a 
computer-based spreadsheet for statistical analysis.  
 
3.2.5 Plating efficiency 
 CHO cells were treated in the identical condition as DNA repair kinetics experiments except that cells 
were treated in multiple wells concurrently. After 4-hour treatment, the solution was aspirated, and the 
cells were washed twice with 100 µL HBSS. The cells were harvested with 0.025% trypsin + 0.01% 
EDTA solution in HBSS. The cell number was counted with Beckman Coulter Z1 Particle Counter 
(Beckman Coulter, Inc.) and adjusted to 3×10
4
 cells/mL. In the new flat-bottom tissue culture 96-well 
microplate, one column of eight wells was reserved for the blank control consisting of 200 µL of F12+5% 
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FBS. Titered cells of 100 µL were aliquoted into one column plus 100 µL F12+5% FBS. To prevent 
volatilization of medium, a sheet of sterile AlumnaSeal™ (RPI Corporation, Mt. Prospect, IL) was 
pressed over the wells before covering the microplate with a lid. The microplate was placed on a rocking 
platform for 10 minutes to uniformly distribute the cells, and then was placed in a tissue culture incubator 
for 72 hours. After incubation, each well was gently aspirated, fixed in 100% methanol for 10 minutes, 
and stained for 10 minutes with a 1% crystal violet solution in 50% methanol. The plate was gently 
washed, and 50 µL of a DMSO:methanol (3:1, v/v) solution was added to each well and allowed to 
contact for 10 minutes. The plate was then analyzed in SpectraMax microplate reader (Molecular Devices, 
LLC, Sunnyvale, CA) at 595 nm. The blank-corrected absorbency value of the concurrent negative 
control (cells treated with medium only) was set at 100%. The absorbency for each treatment group well 
was converted into a percentage of the negative control. For each concentration, eight replicate wells were 
analyzed per experiment and each experiment was independently repeated at least three times. 
 
3.2.6 Statistical analysis 
 Each experiment was independently repeated at least three times. The data were transferred to Excel 
spreadsheets (Microsoft Corp., Redmond, WA) and analyzed using SigmaPlot 11.0 program (Systat 
Software, Inc. San Jose, CA). The primary measure of DNA damage and repair was the percent of the 
DNA that had migrated from the nucleus into the microgel (% tail DNA). 
 The distributions of the % tail DNA values are not normal. In order to conduct parametric statistical 
analysis the mean % tail DNA value was calculated for each microgel. The mean % tail DNA values for 
each experimental group were averaged. According to the central limit theorem, these averaged mean 
values were normally distributed [62]; the data were analyzed using a two-way analysis of variance 
(ANOVA) test statistic. The mean % tail value from the HAA-treated cells with no recovery time was set 
at 100% and compared with concurrently treated cells after designated periods of liquid holding. If a 
significant F value of P ≤ 0.05 was obtained, a Holm-Sidak multiple-comparison was conducted in order 




3.3.1 Genomic DNA damage induction 
 Dose-response associations have been observed for genomic DNA damage induced by all three 
monoHANs with the rank order of IAN ≈ BAN >> CAN (Figure 3.1, lower panel) without inducing 
cytotoxicity (Figure 3.1, upper panel). The data for DNA damage induction were regressed using 
sigmoidal curve fitting. Based on the concentration-response curves, the HAN concentrations inducing 
60 % tail DNA were selected for the experiments on DNA repair kinetics. These concentrations were 
selected as 60 µM for IAN and BAN, and 1200 µM for CAN (Table 3.1).  
 
3.3.2 DNA repair kinetics 
 CHO cells were treated in multiple plates concurrently with single concentrations per chemical for 
4 hours. After treatment, the cells were washed and the cells from one well were immediately harvested. 
Fresh serum-free F12 medium was added to the rest of the wells and after different liquid holding times (1, 
2, 3, 4, 5, 10 and 24 hours), cells were harvested and SCGE microgels were prepared. The % tail DNA for 
each HAN at 0 time liquid holding was normalized to a value of 100%. CHO cell viability was 
determined under liquid holding conditions (serum-free F12 medium) previously and a decline in cell 
viability was not observed until 40 hours [46]. Thus 24 hours of liquid holding by itself did not cause 
cytotoxicity. DNA damage induced by HANs was repaired and reduction of genomic DNA damage over 
time was evaluated with a two-way ANOVA analysis (Figure 3.2, lower panel, Table 3.2). No cytotoxicity 
was observed throughout the liquid holding DNA repair time (Figure 3.2, upper panel). CAN-induced 
lesions were repaired most efficiently and the level of unrepaired DNA damage at 3 hour liquid holding 
was not significantly different from 24-hour liquid holding (P = 0.066). The repair process for BAN-
induced lesions was less efficient and the unrepaired DNA damage went down to the level at 24-hour 
liquid holding only after 5 hours; the genomic damage level at 4-hour liquid holding was still statistically 
different from that for 24-hour liquid holding (P < 0.001). IAN-induced lesions were repaired down to the 
level at 24-hour liquid holding after 4 hours (P = 0.114).  
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 The data for each DNA repair curve were regressed using exponential decay fitting. The time required 
to affect 50% repair of the originally induced DNA damage (t50) was calculated. The t50 values for CAN, 
BAN and IAN were 55, 90 and 81 minutes, respectively. 
 To determine if there were significant differences in DNA repair at each liquid holding time, a 
balanced multivariant analysis of variance with a Holm-Sidak pairwise multiple comparison test was 
conducted (Table 3.3).  Significant difference in unrepaired DNA damage level was observed between 
BAN and IAN (P = 0.014) at 1-hour liquid holding, between CAN and BAN, and CAN and IAN at 2-
hour liquid holding (P < 0.001 for both), between CAN and BAN, and CAN and IAN at 3-hour liquid 
holding (P < 0.001 and P = 0.011, respectively), and between CAN and BAN at 4-hour liquid holding (P 
= 0.007).  
 
3.3.3 Frequency distribution of repaired nuclei 
 The distribution of % tail DNA values of individual nuclei was analyzed as a function of liquid 
holding time. Figures 3.3 and 3.4 present histograms that illustrate the dynamics of genomic DNA repair 
with the nucleus as the unit of measure. The 0-hour liquid holding time (Figure 3.3, far left panel of 
stacked plots) shows that all HANs expressed similar profiles of DNA damage, which confirmed that the 
selected concentrations of HANs generated approximately similar levels of genomic damage. As the 
liquid holding time progressed, the levels of DNA damage migrated toward the left in each panel. After 3-
hour liquid holding, the level of DNA damage in each treatment group diminished. However, the 
population of nuclei with higher DNA damage was somewhat more abundant for BAN-treated cells. Few 
unrepaired nuclei remained after 5 hours (Figure 3.3, two right panels). The DNA damage histogram for 
the untreated negative controls are presented in Figure 3.4; no difference was observed in DNA damage 
distribution over 24 hours. With no liquid holding time, the mean of the % tail DNA ± standard error of 
the mean (SE) was 1.89 ± 0.22, 70.2 ± 3.6, 72.6 ± 3.6 and 61.1 ± 1.6 for negative control, CAN, BAN and 
IAN, respectively. After 24-hour liquid holding, the mean % tail DNA values were 1.44 ± 0.15, 6.21 ± 
0.65, 6.78 ± 0.85 and 7.04 ± 0.53, respectively.  
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3.3.4 Plating efficiency of HAN-treated cells  
 The ability of cells to proliferate after exposure to HANs was examined to determine the association 
of cell growth repressed by cell cycle alteration due to DNA repair. From the CHO cell acute genotoxicity 
concentration-response curves of HANs (Figure 3.1), HAN concentrations that induced 20%, 40%, and 
60% tail DNA values were chosen (IAN at 45 µM, 53 µM, 60 µM, BAN at 43 µM, 52 µM, 60 µM, CAN 
at 460 µM, 790 µM, 1200 µM) (Table 3.1). To compare these data with previous DNA repair kinetics for 
HAAs, plating efficiency was also measured for chloroacetic acid (CAA), bromoacetic acid (BAA) and 
iodoacetic acid (IAA). The HAA concentrations were chosen from those used for the DNA repair kinetic 
experiments (25 µM for IAA, 60 µM for BAA, and 6 mM for CAA) [46]. Lower and higher 
concentrations than the concentrations used for DNA repair kinetic study were chosen for comparison as 
well (15 µM and 35 µM for IAA; 30 µM and 90 µM for BAA; 5 mM and 7 mM for CAA). After the 4-
hour cell treatment, the cells were washed and harvested. Equal number of treated cells as well as 
concurrent negative control cells was plated onto a new 96-well microplate. The resulting cell densities 
after 72 hours were compared to their negative controls, which was set to 100%. Measurements of the 
plating efficiency of HAA- and HAN-treated CHO cells are shown in Figures 3.5 and 3.6. Cell growth 
was suppressed for both groups of DBPs, and revealed a concentration-response relationship. At the 
chemical concentration used for DNA repair kinetics, the mean ± SE cell density was 56.0 ± 0.9%, 74.4 ± 
2.9%, 60.4 ± 4.1%, 64.4 ± 1.5%, 14.6 ± 0.9% and 1.0 ± 0.6% for CAA, BAA, IAA, CAN, BAN and IAN, 
respectively.   
 
3.4 Discussion 
 Previously published DNA repair kinetics study with three monoHAAs revealed that different rates of 
genomic repair was expressed by IAA or CAA versus BAA, which suggested that different DNA lesions 
and/or different distributions of DNA lesions were induced [46]. The DNA repair kinetics experiments 
with HANs was conducted to extend the DNA repair kinetic database to a class of N-DBPs. CHO cells 
were treated with a single concentration per chemical for 4 hours. After the treatment, cells were washed 
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and the remaining unrepaired DNA was monitored over time. Because the concentration of each HAN 
was chosen to generate approximately the same level of genotoxic damage, the null hypothesis was that 
there would be no difference in the DNA repair kinetics if similar DNA lesions were induced by all three 
HANs. 
 The association between the rate of DNA repair and the halogen group was not as distinct for the 
HANs as for the HAAs. A significant difference in unrepaired genomic damage level was observed in 
BAA-treated cells as compared to IAA and CAA at 1, 2, 3 and 4 hour liquid holding [46]. On the contrary, 
although some significant differences amongst HANs were observed at specific time periods, the 
difference was not consistent for an individual HAN (based on the halogen leaving group) as it was 
observed in HAAs. The combination of BAN and CAN showed the biggest difference in their repair; the 
unrepaired genomic damage levels were different at 2, 3, and 4 hour liquid holding times between CAN- 
and BAN-treated cells. The unrepaired genomic damage levels of CAN- and IAN-treated cells were 
different only at the 3 and 4 hour liquid holding time. The calculated t50 vales for CAN, BAN and IAN 
were 55, 90 and 81 minutes, respectively, whereas those for CAA, BAA, and IAA were 134, 296 and 84 
minutes, respectively [46]. The lesions induced by HANs were repaired with greater efficiency as 
compared to the HAA-induced lesions, which suggested that different types of DNA lesions were induced 
by the HAAs and the HANs. The HAAs were shown to inhibit glyceraldehyde-3-phosphate 
dehydrogenase, a key enzyme in glucose metabolism, which may lead to reactive oxygen species 
formation [63, 64]. BAA-treated cells may have a higher level of double strand DNA breaks [65], which 
may be associated with the slower rate of repair of BAA-induced DNA lesions.  
 Another observation that suggests different mode of action by HAAs and HANs is cell morphology 
after treatment with these chemicals. HAN-treated cells looked round after 4-hour treatment after visual 
inspection under a microscope but regained normal spindle morphology with time during the liquid 
holding. HAA-treated cells looked all spindle after the treatment (data now shown). Cell morphology 
change seemed more severe with the same level of treatment with BAN and IAN than with CAN.  
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 One may question that the washing steps after treatment or liquid holding may remove cells lacking 
the ability to stick to the surface of the microplate. At each sampling time cells were washed and only 
adherent cells were collected for DNA repair measurement. Floating cells were observed microscopically 
at each sampling point for HAN-treated cells. Those cells could be dead or may have been undergoing 
cell division. Supernatant and cell washing solution were collected into a microcentrifuge tube and cell 
viability was examined with the trypan blue dye exclusion assay [60]. The number of floating cells was 
low so that accurate determination of cell viability was difficult. Thus it was concluded that the floating 
cells were not as abundant as to affect the measured DNA repair rate.  
 DNA damage induction, DNA repair and cell cycle progression are strongly associated. Cell cycle 
delay occurs to allow DNA repair to take place [48]. Plating efficiency was measured for HAAs and 
HANs at the concentration that induces equivalent genomic damage. Cell growth should slow down if cell 
cycle is severely delayed and faster repair might be associated with cell cycle arrest. At the concentration 
used for DNA repair kinetics, the suppression of cell growth followed the order of CAA (56.0% of 
resulting cell density compared to negative control cells) > IAA (60.4%) > BAA (74.4%) for HAAs and 
IAN (~0%) > BAN (14.6%) > CAN (64.4%) for HANs. The least suppression of cell growth and slow 
DNA repair rate of BAA-treated cells may indicate that cell cycle was not delayed in BAA-treated cells 
thus repair for BAA-induced lesions was inefficient. However, a good association of DNA repair kinetics 
and plating efficiency measurement was not observed for either HAAs or HANs. 
 Table 3.4 summarizes several relevant physiochemical properties calculated with the Spartan program 
(www.wavefun.com) for monoHANs and monoHAAs (J. Pals, 2013, unpublished data). Electrophiles 
(electro deficient) such as HANs form covalent bonds with nucleophilic (electron rich) sites on biological 
targets. Covalent bond formation between reacting molecules can be described by the properties of their 
outermost orbitals. The highest energy orbital that contains electrons is called highest occupied molecular 
orbital (HOMO) and the lowest energy orbital that is vacant is called lowest unoccupied molecular orbital 
(LUMO) [66]. EHOMO and ELUMO in the entry of Table 3.4 are the frontier molecular orbital energies for 
those orbitals. Electrophiles and nucleophiles are classified as either soft (relatively polarizable) and hard 
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(relatively nonpolarizable) and softness (σ) or hardness (η) of certain compound can be calculated using 
EHOMO and ELUMO. Furthermore, the values for σ and η can be used to calculate the electrophilic index (ω) 
of the compound, which reflects the tendency of the electrophile to form adducts with a given biological 
nucleophile [66]. A partition coefficient, log P, describes solubility and C-X bond length describes the 
propensity of halogen leaving group, which are also listed in Table 3.4.  
 To determine biological mechanisms for monoHAN- and monoHAA-mediated toxicity, multiple 
correlation analyses were conducted  with the physicochemical and toxicological characteristics of these 
monoHANs using the Pearson’s Product Moment test (Table 3.5). The concentrations used for DNA 
repair kinetic experiments (CAN at 900 µM, BAN at 60 µM, IAN at 60 µM, CAA at 6000 µM, BAA at 
60 µM and IAA at 25 µM) were entered for the correlation test (listed as genomic potency in Table 3.5). 
Mild correlation was observed between t50 and log P (r = −0.636) and between C-X bond length and the 
genomic potency (r = −0.650).  Hardness and softness correlated mildly with the genomic potency (r = 
0.678 and −0.623, respectively) but not with t50. The strongest correlation was observed between t50 and 
the electrophilic index (r = −0.800) but the electrophilic index did not correlate with the genomic potency 
(r = −0.400). Electrophiles react with nucleophiles with a significant selectivity, which is determined by 
their relative softness or hardness. Electrophilic index was successfully associated with electrophile-
nucleophile interactions [66]. It is interesting the t50 value, not the genomic potency related well with the 
electrophilic potency. Future research is required to understand this correlation and to extend the DNA 
repair kinetic database.  
 In conclusion, HAN-induced DNA lesions were repaired more efficiently than HAA-induced lesions. 
DNA repair rates were not very different among three HANs regardless of the halogen groups compared 
to the difference in HAA-treated cells. The lack of an association between DNA repair rate and plating 
efficiency was confirmed. DNA repair kinetics should be extended to different DBP chemical group, such 
as haloacetamide and halonitromethanes, and also dihalogenated- and trihalogenated-DBPs. Efforts to 
elucidate the mechanism of cell cycle alterations by HAAs and HANs are the subject of Chapter 4. These 
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Iodoacetonitrile 0.99 4.52 × 10
-5
 5.33 × 10
-5
 5.94 × 10
-5
 
Bromoacetonitrile 0.99 4.30 × 10
-5
 5.20 × 10
-5
 5.94 × 10
-5
 
Chloroacetonitrile  0.99 4.61 × 10
-4
 7.88 × 10
-4







 is the coefficient of determination for the regression analysis upon which HAA concentration was 
calculated for each level of genomic DNA damage. 
b
Genotoxicity metric as the percentage of DNA that 
migrated into the microgel from the nucleus under SCGE conditions. No acute cytotoxicity was observed 





Table 3.2 Statistical analysis of the CHO cell DNA repair kinetics data.  
 
Two Way Analysis of Variance Comparison among HAN versus each time point for DNA 
repair. 
 
General Linear Model 
 
Dependent Variable: SCGE  
 
Source of Variation  DF   SS   MS    F    P   
HAN 2 2266.080 1133.040 19.254 <0.001  
Time (h) 7 168110.106 24015.729 408.095 <0.001  
HAN x Time (h) 14 3076.882 219.777 3.735 <0.001  
Residual 184 10828.110 58.848    
Total 207 186721.260 902.035    
 
 
Main effects cannot be properly interpreted if significant interaction is determined. This is because the size of a 
factor's effect depends upon the level of the other factor. 
 
The effect of different levels of HAN depends on what level of Time (h) is present.  There is a statistically 
significant interaction between HAN and Time (h).  (P = <0.001) 
 
Power of performed test with alpha = 0.0500:  for HAN : 1.000 
Power of performed test with alpha = 0.0500:  for Time (h) : 1.000 
Power of performed test with alpha = 0.0500:  for HAN x Time (h) : 0.992 
 
Least square means for HAN :  
Group Mean SEM  
CAN 28.781 0.858 
BAN 35.983 0.959 
IAN 35.067 0.959 
 
 
Least square means for Time (h) :  
Group Mean SEM  
0.000 100.000 1.513  
1.000 51.184 1.513  
2.000 38.120 1.513  
3.000 23.379 1.513  
4.000 17.919 1.513  
5.000 16.536 1.513  
10.000 9.094 1.513  
24.000 9.983 1.513  
 
 
Least square means for HAN x Time (h) :  
Group Mean SEM  
CAN x 0.000 100.000 2.426  
CAN x 1.000 48.201 2.426  
CAN x 2.000 23.047 2.426  
CAN x 3.000 15.639 2.426  
CAN x 4.000 13.056 2.426  
CAN x 5.000 14.374 2.426  
CAN x 10.000 6.640 2.426  
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Table 3.2 (cont.) 
 
CAN x 24.000 9.289 2.426  
BAN x 0.000 100.000 2.712  
BAN x 1.000 57.413 2.712  
BAN x 2.000 42.651 2.712  
BAN x 3.000 29.459 2.712  
BAN x 4.000 23.071 2.712  
BAN x 5.000 16.084 2.712  
BAN x 10.000 10.069 2.712  
BAN x 24.000 9.118 2.712  
IAN x 0.000 100.000 2.712  
IAN x 1.000 47.940 2.712  
IAN x 2.000 48.663 2.712  
IAN x 3.000 25.039 2.712  
IAN x 4.000 17.631 2.712  
IAN x 5.000 19.150 2.712  
IAN x 10.000 10.573 2.712  




All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
 
Comparisons for factor: Time (h) within CAN 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
0.000 vs. 10.000 93.360 27.213 <0.001 0.002 Yes  
0.000 vs. 24.000 90.711 26.441 <0.001 0.002 Yes  
0.000 vs. 4.000 86.944 25.343 <0.001 0.002 Yes  
0.000 vs. 5.000 85.626 24.959 <0.001 0.002 Yes  
0.000 vs. 3.000 84.361 24.590 <0.001 0.002 Yes  
0.000 vs. 2.000 76.953 22.431 <0.001 0.002 Yes  
0.000 vs. 1.000 51.799 15.099 <0.001 0.002 Yes  
1.000 vs. 10.000 41.561 12.114 <0.001 0.002 Yes  
1.000 vs. 24.000 38.911 11.342 <0.001 0.003 Yes  
1.000 vs. 4.000 35.144 10.244 <0.001 0.003 Yes  
1.000 vs. 5.000 33.827 9.860 <0.001 0.003 Yes  
1.000 vs. 3.000 32.561 9.491 <0.001 0.003 Yes  
1.000 vs. 2.000 25.154 7.332 <0.001 0.003 Yes  
2.000 vs. 10.000 16.407 4.782 <0.001 0.003 Yes  
2.000 vs. 24.000 13.758 4.010 <0.001 0.004 Yes  
2.000 vs. 4.000 9.991 2.912 0.004 0.004 No  
3.000 vs. 10.000 8.999 2.623 0.009 0.004 No  
2.000 vs. 5.000 8.673 2.528 0.012 0.005 No  
5.000 vs. 10.000 7.734 2.254 0.025 0.005 No  
2.000 vs. 3.000 7.408 2.159 0.032 0.006 No  
4.000 vs. 10.000 6.416 1.870 0.063 0.006 No  
3.000 vs. 24.000 6.350 1.851 0.066 0.007 No  
5.000 vs. 24.000 5.085 1.482 0.140 0.009 No  
4.000 vs. 24.000 3.767 1.098 0.274 0.010 No  
24.000 vs. 10.000 2.649 0.772 0.441 0.013 No  
3.000 vs. 4.000 2.583 0.753 0.452 0.017 No  
5.000 vs. 4.000 1.318 0.384 0.701 0.025 No  
3.000 vs. 5.000 1.265 0.369 0.713 0.050 No  
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Table 3.2 (cont.) 
 
Comparisons for factor: Time (h) within BAN 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
0.000 vs. 24.000 90.882 23.694 <0.001 0.002 Yes  
0.000 vs. 10.000 89.931 23.446 <0.001 0.002 Yes  
0.000 vs. 5.000 83.916 21.878 <0.001 0.002 Yes  
0.000 vs. 4.000 76.929 20.056 <0.001 0.002 Yes  
0.000 vs. 3.000 70.541 18.391 <0.001 0.002 Yes  
0.000 vs. 2.000 57.349 14.952 <0.001 0.002 Yes  
1.000 vs. 24.000 48.294 12.591 <0.001 0.002 Yes  
1.000 vs. 10.000 47.344 12.343 <0.001 0.002 Yes  
0.000 vs. 1.000 42.587 11.103 <0.001 0.003 Yes  
1.000 vs. 5.000 41.329 10.775 <0.001 0.003 Yes  
1.000 vs. 4.000 34.342 8.953 <0.001 0.003 Yes  
2.000 vs. 24.000 33.532 8.742 <0.001 0.003 Yes  
2.000 vs. 10.000 32.582 8.494 <0.001 0.003 Yes  
1.000 vs. 3.000 27.953 7.288 <0.001 0.003 Yes  
2.000 vs. 5.000 26.567 6.926 <0.001 0.004 Yes  
3.000 vs. 24.000 20.341 5.303 <0.001 0.004 Yes  
2.000 vs. 4.000 19.580 5.105 <0.001 0.004 Yes  
3.000 vs. 10.000 19.390 5.055 <0.001 0.005 Yes  
1.000 vs. 2.000 14.762 3.849 <0.001 0.005 Yes  
4.000 vs. 24.000 13.952 3.638 <0.001 0.006 Yes  
3.000 vs. 5.000 13.375 3.487 <0.001 0.006 Yes  
2.000 vs. 3.000 13.191 3.439 <0.001 0.007 Yes  
4.000 vs. 10.000 13.002 3.390 <0.001 0.009 Yes  
4.000 vs. 5.000 6.987 1.822 0.070 0.010 No  
5.000 vs. 24.000 6.966 1.816 0.071 0.013 No  
3.000 vs. 4.000 6.389 1.666 0.097 0.017 No  
5.000 vs. 10.000 6.015 1.568 0.119 0.025 No  
10.000 vs. 24.000 0.951 0.248 0.805 0.050 No  
 
 
Comparisons for factor: Time (h) within IAN 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
0.000 vs. 10.000 89.427 23.315 <0.001 0.002 Yes  
0.000 vs. 24.000 88.460 23.063 <0.001 0.002 Yes  
0.000 vs. 4.000 82.369 21.475 <0.001 0.002 Yes  
0.000 vs. 5.000 80.850 21.079 <0.001 0.002 Yes  
0.000 vs. 3.000 74.961 19.543 <0.001 0.002 Yes  
0.000 vs. 1.000 52.060 13.573 <0.001 0.002 Yes  
0.000 vs. 2.000 51.337 13.384 <0.001 0.002 Yes  
2.000 vs. 10.000 38.090 9.931 <0.001 0.002 Yes  
1.000 vs. 10.000 37.367 9.742 <0.001 0.003 Yes  
2.000 vs. 24.000 37.123 9.679 <0.001 0.003 Yes  
1.000 vs. 24.000 36.400 9.490 <0.001 0.003 Yes  
2.000 vs. 4.000 31.032 8.090 <0.001 0.003 Yes  
1.000 vs. 4.000 30.309 7.902 <0.001 0.003 Yes  
2.000 vs. 5.000 29.513 7.694 <0.001 0.003 Yes  
1.000 vs. 5.000 28.790 7.506 <0.001 0.004 Yes  
2.000 vs. 3.000 23.624 6.159 <0.001 0.004 Yes  
1.000 vs. 3.000 22.901 5.971 <0.001 0.004 Yes  
3.000 vs. 10.000 14.466 3.771 <0.001 0.005 Yes  
3.000 vs. 24.000 13.499 3.519 <0.001 0.005 Yes  
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5.000 vs. 10.000 8.577 2.236 0.027 0.006 No  
5.000 vs. 24.000 7.610 1.984 0.049 0.006 No  
3.000 vs. 4.000 7.408 1.931 0.055 0.007 No  
4.000 vs. 10.000 7.058 1.840 0.067 0.009 No  
4.000 vs. 24.000 6.091 1.588 0.114 0.010 No  
3.000 vs. 5.000 5.889 1.535 0.126 0.013 No  
5.000 vs. 4.000 1.519 0.396 0.693 0.017 No  
24.000 vs. 10.000 0.967 0.252 0.801 0.025 No  






Table 3.3 Two-way Analysis of Variance for DNA repair of CHO cells treated with IAN, BAN or CAN 
(Holm-Sidak pairwise multiple comparison). 
 
Comparison 





CAN vs BAN 0 0 1 
CAN vs IAN 0 1.28 × 10
-13
 1 
BAN vs IAN 0 1.28 × 10
-13
 1 
CAN vs BAN 1 9.21 0.012 
CAN vs IAN 1 0.26 0.943 
BAN vs IAN * 1 9.47 0.014 
CAN vs BAN * 2 19.60 <0.001 
CAN vs IAN * 2 25.62 <0.001 
BAN vs IAN 2 6.01 0.119 
CAN vs BAN * 3 13.82 <0.001 
CAN vs IAN * 3 9.40 0.011 
BAN vs IAN 3 4.42 0.251 
CAN vs BAN * 4 10.01 0.007 
CAN vs IAN 4 4.58 0.21 
BAN vs IAN 4 5.44 0.158 
CAN vs BAN 5 1.71 0.639 
CAN vs IAN 5 4.78 0.191 
BAN vs IAN 5 3.07 0.425 
CAN vs BAN 10 3.43 0.347 
CAN vs IAN 10 3.93 0.281 
BAN vs IAN 10 0.50 0.896 
CAN vs BAN 24 0.17 0.963 
CAN vs IAN 24 2.25 0.537 
BAN vs IAN 24 2.42 0.529 
 





















Chloroacetonitrile ClCH2CN 1.81 1.04 -12.4 3.64 8.02 0.125 1.196 
Bromoacetonitrile BrCH2CN 1.96 1.16 -11.23 3.23 7.23 0.138 1.107 
Iodoacetonitrile ICH2CN 2.18 1.55 -10.03 2.03 6.03 0.166 1.327 
Chloroacetic acid ClCH2COOH 1.78 0.22 -12.17 4.67 8.42 0.119 0.835 
Bromoacetic acid BrCH2COOH 1.93 0.34 -11.05 4.28 7.67 0.130 0.747 
Iodoacetic acid ICH2COOH 2.16 0.73 -9.9 2.7 6.30 0.159 1.029 
 












t50 (min) Genomic potency (µM) 
C-X bond length -0.191 -0.650 
log P -0.636 -0.570 
EHOMO -0.00458 -0.618 
ELUMO 0.553 0.655 
Hardness 0.288 0.678 
Softness -0.311 -0.623 
Electrophilic index -0.800 -0.400 







Figure 3.1 Genotoxicity of CAN, BAN, and IAN in the SCGE assay in CHO cells after 4 hours of 


















































































Figure 3.2 DNA repair kinetics in CHO cells treated with CAN (1200 µM), BAN (60 µM) and IAN (60 
µM) for 4 hours and then maintained in fresh serum-free F12 medium for 0, 1, 2, 3, 4, 5, 10 and 24 hours 
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Figure 3.3 Histograms illustrating the distributions of SCGE % tail DNA values from CHO cells treated 
with chloroacetonitrile (CAN), bromoacetonitrile (BAN), and iodoacetonitrile (IAN) without and with 1, 
3, 5 and 24 hour liquid holding recovery time. 
  




























































































































Figure 3.4 Histograms illustrating the distributions of SCGE % tail DNA values from the CHO cell 


































Figure 3.5 Plating efficiency of HAA-treated CHO cells.   
HAAs
Mean CHO cell density as the Percentage 
of the Negative Control (±SE)
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  Haloacetonitriles (HANs) are a chemical class of disinfection byproducts (DBPs) that form from 
reactions between disinfectants and dissolved nitrogen precursors, the latter more prevalent in water 
sources impacted by algae bloom and municipal wastewater effluent discharge. HANs were demonstrated 
to be genotoxic, thus subsequent effects in mammalian cell cycle was investigated. Treating Chinese 
hamster ovary (CHO) cells with monoHANs followed by the release from the treatment resulted in 
abnormally high DNA content over time. It appeared that HANs adversely affected the cell cycle 
progression by interfering with cell division. Presumably HAN-treated cells underwent another cell cycle 
and became tetraploid, and further progression of cell cycle resulted in induction of high ploidy cells. 
There are accumulating evidences of transient tetraploid state proceeding aneuploidy in cancer 
progression. It is possible that HAN disruption of the normal cell cycle and the generation of aberrant 
cells with abnormal number of chromosomes may contribute to cancer induction and adverse health 
outcomes associated with consumption of disinfected water. This is the first demonstration of the 
induction of high ploidy by a class of DBPs. 
 
4.1 Introduction 
 Water disinfection results in the formation of environmentally hazardous chemicals called 
disinfection by-products (DBPs). Exposure to DBPs is associated with urinary bladder cancer and adverse 
pregnancy outcomes [1]. Haloacetonitriles (HANs) are a chemical class of DBPs that form from reactions 
between disinfectants (e.g., chloramines) and dissolved nitrogen precursors (e.g., amino acids) [2-6]. The 
research activity into nitrogenous DBPs (N-DBPs), in which HANs are categorized, has increased partly 
because recent in vitro mammalian cell tests have shown that the HANs, haloacetamide and 
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halonitromethanes are all far more cyto- and genotoxic than the regulated trihalomethanes (THMs) and 
haloacetic acids (HAAs) [7-10]. 
 Population growth and rising water supply demand is putting stress on water sources availability; 
water providers are increasingly using water sources which are impacted by algae bloom and municipal 
wastewater effluent discharge, which may promote N-DBP formation due to elevated levels of organic 
nitrogen content [5, 6, 11-13]. Utilities are exploring new disinfectant combinations to reduce the 
formation of regulated DBPs but some alternative disinfection schemes may promote N-DBP formation 
[5]. HANs are not currently regulated by U.S. Environmental Protection Agency (EPA), but the World 
Health Organization set the guideline value for dichloroacetonitrile (DCAN) and dibromoacetonitrile 
(DBAN) at 20 µg/L and 70 µg/L, respectively [14]. The major species of HANs are DCAN, 
trichloroacetonitrile (TCAN), DBAN and bromochloroacetonitrile (BCAN) and these species are 
sometimes referred as HAN4. HANs measured in the nationwide occurrence studies of 12 U.S. water 
treatment plants ranged up to 14 µg/L (median: 3 µg/L) [15]. HANs were also measured in chlorinated 
municipal wastewater treatment plant effluents (median: 16 µg/L) as well as in chloraminated wastewater 
effluents (median: 0.3 µg/L). Recently HANs were shown to form as an electrochemical oxidation by-
product of landfill leachate [16]. HANs can also form in biological systems in vivo from residual 
hypochlorite in drinking water [17]. HAN formation in swimming pool is reported, where HANs can be 
absorbed through dermal exposure [18, 19]. 
 Several HANs are known to interact with DNA molecules [20] and also are mutagenic in Salmonella 
typhimurium [21-23], genotoxic in mammalian cells [8, 22, 23], clastogenic [24] and developmentally 
toxic [25, 26]. DCAN, but not DBAN, was shown to be an effective inducer of aneuploidy in oocysts of 
Drosophila melanogaster [27]. The metabolism and toxicity of HANs have been reviewed extensively 
[28]. DBAN was recently shown to be carcinogenic [29] and its contribution to lifetime risk of cancer by 
HANs was calculated to be approximately 3 – 10× as potent as trihalomethanes (THMs), a regulated class 
of DBPs, using quantitative structural toxicity relationship program [30]. Chloroacetonitrile (CAN) and/or 
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its metabolites were shown to cross the placenta and accumulate in fetal brain tissues in mice where it 
caused oxidative stress and neural apoptosis [31, 32].  
 While broad range of toxicological data is available in the literature, they often times center around 
chlorinated and brominated HANs. Systematic genotoxicity study including iodinated HANs has not been 
published until 2007; in vitro mammalian cell toxicity demonstrated a descending rank order of 
dibromoacetonitrile (DBAN) > bromoacetonitrile (BAN) ≈ iodoacetonitrile (IAN) > BCAN > DCAN > 
CAN > TCAN for chronic cytotoxicity, and IAN > BAN ≈ DBAN > BCAN > CAN > TCAN > DCAN 
for acute genotoxicity [8]. The comparative, quantitative systematic cyto- and genotoxicity study on 
halogenated DBPs using a non-neoplastic Chinese hamster ovary (CHO) cells revealed a rank order of 
cyto- and genotoxicity following the rank order of iodinated DBPs (I-DBPs) > brominated DBPs (Br-
DBPs) > chlorinated DBPs (Cl-DBPs). HAN cyto- and genotoxicity in CHO cells follow the same 
halogen order [8] as well as HAAs [33], for which molecular mechanism of toxic action has associated 
the genotoxicity induction with propensity of the halogen to leave the group [34] (Figure 4.1).  
 DNA damage in eukaryotic cells is strongly associated with cell cycle modulation. A damage 
response pathway triggered by genetic insults regulates cell cycle arrest and apoptosis (programmed cell 
death) as well as controls the activation of DNA repair pathways [35]. Eukaryotic cell cycle consists of 
interphase (G0/G1, S, and G2) and mitotic (M) phase (Figure 4.2 (A)). Each chromosome is duplicated 
during S phase (2N→4N; N values denote DNA content as a multiple of the normal haploid genome); 
cells in G2 phase have four copies of chromosomes (4N) whereas cells in G1 phase have two copies (2N). 
Cells divide in M phase, where chromosome condensation, chromosome alignment and separation, 
daughter cell separation (cytokinesis) occur (Figure 4.2 (B)). Progress of cell cycle is strictly monitored to 
ensure the genome integrity and correct separation of newly replicated sister chromatids. Nuclear DNA 
must be duplicated once and only once at each cell cycle [36]. The cell cycle is controlled in a directional 
and sequential pattern by cell cycle regulators, complexes of proteins called cyclins and cyclin-dependent 
kinases (Cdks). These cyclin:Cdk complexes are responsible for promoting cell survival by protecting the 
cell from replicating damaged DNA or from mutations that may lead to aberrant and uncontrolled cell 
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growth (neoplasia). Each cyclin:Cdk complex in the cell cycle acts as a checkpoint and can halt 
progression through the cell cycle and either arrest progression or induce apoptosis [37-40]. Since HANs 
are mutagenic, genotoxic and clastogenic, they are likely to affect mammalian cell cycle. There is no 
systematic analysis of the cell cycle alteration by a class of DBPs in the literature, with all three halogens 
included (I, Br and Cl). In this study, CHO cells are treated with CAN, BAN and IAN and subsequent cell 
cycle profile was monitored. Flow cytometry was used to measure the cell cycle distribution, combined 
with plating efficiency measurement and DNA strand break analysis. Flow cytometric analysis is a widely 
used technique to monitor the progression of cell cycle by quantifying fluorescent dye incorporation to 
DNA [41, 42]. The intensity of the fluorescence is recorded at a single cell level and the obtained 
frequency distribution represents cells with different DNA content based on the cell cycle progression. 
The objective of this research was to determine if HANs could alter the cell cycle of treated mammalian 
cells.  
 
4.2 Materials and Methods 
4.2.1 Reagents 
 General reagents were purchased from Fisher Scientific Co. (Itasca, IL) and Sigma-Aldrich Co. (St. 
Louis, MO). Iodoacetonitrile (98%, CAS# 624-75-9), bromoacetonitrile (97%, CAS# 590-17-0) and 
chloroacetonitrile (99%, CAS# 107-14-2) were purchased from Sigma-Aldrich. HANs were diluted in 
dimethyl sulfoxide (DMSO) at 1 mol/L and stored at −22°C. Ethylmethane sulfonate (EMS, CAS# 62-50-
0) was diluted in DMSO at 2.5 mol/L and stored at −22°C. Cytosine-β-D-arabino-furanoside 
hydrochloride (AraC, CAS# 64-74-9) was dissolved in Ham’s F12 medium at 100 mM and stored at 
−22°C. Propidium iodide (95%, CAS# 25535-16-4) was purchased from Acros Organics (Morris Plains, 
NJ) and dissolved in sterile distilled-deionized water at 1.0 mg/mL. RNase A (20 mg RNase A/mL in 50 





4.2.2 Cells and culture media 
 Transgenic Chinese hamster ovary (CHO) cells line AS52 clone 11-4-8 [43, 44] were maintained in 
modified Ham’s F12 medium (Mediatech, Inc., Manassas, VA) supplemented with 5% fetal bovine serum 
(FBS), 1% L-glutamine and 1% antibiotic-antimycotic solution (10 units/mL penicillin G sodium, 10 
µg/mL streptomycin sulfate, 25 µg/mL amphotericin B, 0.85% saline; Invitrogen, Carlsbad, CA). The 
cells exhibit normal morphology, express cell contact inhibition and grow as a monolayer without 
expressing neoplastic foci. The cells were grown in 100-mm glass culture plate or in 75-cm
2
 tissue culture 
flask at 37°C in a humidified atmosphere of 5% CO2. Cell doubling time was 14 hours.  
 
4.2.3 Cell treatment 
 Unsynchronized CHO cells were plated in sterile flat-bottom 6-well tissue culture plates at 2 × 10
5
 
cells/well/(2 mL F12+5% FBS). When the post-incubation was longer than 26 hours, initial cell loading 
was reduced to 5 × 10
4
 cells/well/(2 mL of F12+5% FBS) for the negative control. After 16 – 20 hours of 
incubation, cells were rinsed twice with 1 mL of Hank’s balanced salt solution (HBSS) without divalent 
cations, and treated with each chemical in 1 mL of serum-free F12 for 4 hours at 37°C, 5% CO2. Multiple 
wells were used per treatment group as needed. A sheet of sterile AlumnaSeal™ (RPI Corporation, Mt. 
Prospect, IL) was pressed over the wells before covering the plate with a lid to prevent crossover 
contamination between wells due to volatilization.  
 
4.2.4 Flow cytometric analysis of cell cycle 
 After the 4-hour treatment, the solution was aspirated, and the cells were washed twice with 1 mL 
HBSS. The cells were harvested immediately (0 hour sample) with 0.5× trypsin (0.05% trypsin, in HBSS 
with 0.2 g/L EDTA, without calcium, magnesium, Hyclone Laboratories, South Logan, UT), or 2 mL of 
drug-free F12+5% FBS were added and incubated for designated times. The post-treatment incubation 
times allowed cells to accumulate at intervals where there was cell cycle blockage. Harvested cells were 
counted with Beckman Coulter Z1 Particle Counter (Beckman Coulter, Inc., Brea CA), and acute 
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cytotoxicity was determined using the trypan blue dye exclusion assay [45]. In order to determine their 
DNA content, harvested cells were fixed in 70% ice cold ethanol. Samples were stored for up to one week 
at −22°C. The fixed cells were rinsed with cold phosphate buffered saline (PBS) twice and then incubated 
for 30 minutes at 37°C with 50 µg/mL of the DNA fluorochrome propidium iodide, a marker of DNA 
content, in a solution containing 200 µg/mL of RNase A. Cell fluorescence was measured with a 
Biosciences LSR II flow cytometry analyzer (San Jose, CA). Propidium iodide was excited by a 488 nm 
laser line (laser diode) and fluorescence emission was collected through 695/40 nm band-pass filter. The 
data were analyzed using multicycle DNA analysis using FCS Express version 4 (De Novo Software, Los 
Angeles, CA) and aggregated cells were gated out.  
 
4.2.5 Cell visualization 
 For microscopic investigation of cell morphology, cells were treated as described above and adherent 
cells at 0, 26, and 52 hours of post-incubation were imaged using a 10× objective with phase contrast in 
an inverted microscope (Olympus, Center Valley, PA). Alternatively, cells at 0, 26, and 52 hours of post-
incubation were harvested and closer inspection images of the suspended cells were taken using a 40× 
bright field illumination objective. The resulting images were saved as 8-bit grayscale files in TIFF 
format.  
 
4.2.6 Plating efficiency 
 After a 4-hour treatment period, the solution was aspirated, and cells were washed twice with 1 mL 
HBSS. The cells were then harvested with 0.5× trypsin (0.025% trypsin+0.1 g/L EDTA). The cell number 
was counted with Beckman Coulter Z1 Particle Counter and adjusted to 3 × 10
4
 cells/mL. In a flat-bottom, 
tissue culture 96-well microplate, one column of eight wells was reserved for the blank control consisting 
of 200 µL of F12+5% FBS. Titered cells of 100 µL were aliquoted into one column plus 100 µL F12+5% 
FBS. To prevent volatilization of medium, a sheet of sterile AlumnaSeal™ (RPI Corporation, Mt. 
Prospect, IL) was pressed over the wells before covering the microplate with a lid. The microplate was 
80 
 
placed on a rocking platform for 10 minutes to uniformly distribute the cells, and then was placed in a 
tissue culture incubator for 72 hours. After incubation, each well was gently aspirated, fixed in 100% 
methanol for 10 minutes, and stained for 10 minutes with a 1% crystal violet solution in 50% methanol. 
The plate was gently washed, and 50 µL of a DMSO:methanol (3:1, v/v) solution was added to each well 
and allowed to contact for 10 minutes. The plate was then analyzed in SpectraMax microplate reader 
(Molecular Devices, LLC, Sunnyvale, CA) at 595 nm. The blank-corrected absorbency value of the 
negative control was set at 100%. The absorbency for each treatment group well was converted into a 
percentage of the negative control. For each concentration, eight replicate wells were analyzed per 
experiment and each experiment was independently repeated at least three times. 
 
4.2.7 DNA strand break analysis using single cell gel electrophoresis 
 Cells at 0 and 26 hour post-incubation were harvested and analyzed for DNA strand breaks. Briefly, 
after HBSS rinse, cells were detached with 400 µL of 0.5× trypsin (0.025% trypsin+0.1 g/L EDTA) 
followed by the addition of 300 µL F12+5% FBS. A 120 µL of cell suspension was mixed with 120 µL of 
1% low melting point agarose (LMA) in PBS, and 90 µL of the mixture was applied onto clear 
microscope slides that were pre-coated with a layer of 1% normal melting point agarose prepared in 
deionized water. After the first LMA layer was solidified, another layer of 0.5% LMA was applied. Two 
microgels were prepared from each treatment group. Acute cytotoxicity was also determined to ensure 
that cell viability was over 70% [46]. The cellular membrane and cytoplasm as well as almost all histones 
were removed by an overnight immersion in lysing solution (2.5 M NaCl, 1% sodium lauryl sarcosinate, 
100 mM Na2EDTA, 10 mM Tris, pH 10 with 1% Triton X-100, and 10% DMSO) at 4°C. The microgels 
were placed in alkaline buffer (1 mM EDTA and 300 mM NaOH, pH 13.5), where DNA were denatured 
for 20 minutes followed by electrophoresis at 25 V and 300 mA (0.72 V/cm) for 40 minutes at 4°C. The 
microgels were neutralized in 400 mM Tris buffer (pH 7.5), dehydrated in cold methanol, dried at 50°C 
and stored in a covered slide box at room temperature. For analysis, the microgels were rehydrated in cold 
water and stained with 65 µL of 20 µg/mL ethidium bromide solution. Individual nuclei were analyzed 
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with a Zeiss fluorescence microscope (excitation filter of BP 546/10 nm, barrier filter of 590 nm) 
integrated with a CCD camera. Digitized image was analyzed with Comet Assay IV (Perceptive 
Instruments Ltd., Suffolk, UK). The percentage of DNA in the tail (% tail DNA) is the primary 
measurement as the DNA genomic damage since it bears a linear relationship to break frequency, and is 
relatively unaffected by threshold setting [47, 48].  
 
4.3 Results 
 The initial loading of cells was determined based on the cell doubling time of 14 hours (data not 
shown). Since CHO cells grow as a monolayer, they exert cell contact inhibition when they become 
confluent. Xenobiotics can exhibit different cell-cycle specificities in different cell growing cell status 
[49] thus care was taken when optimizing the initial cell loading so that cell cycle arrest was not induced 
by cell contact inhibition. With the initial cell density of 2 × 10
5
 cells/well, negative control cells could 
grow exponentially up to 26 hours of post-incubation. When the post-incubation exceeded 26 hours, 
initial cell loading for negative control was reduced to 5 × 10
4
 cells/well. The cell loading for HAN 
treatment group was kept at 2 × 10
5
 cells/well since the cell number did not increase for the first 26 hours 
of post-incubation (discussed below).  
 
4.3.1 Optimization of duration of post-incubation  
 The duration of post-incubation after 4 hour treatment was first optimized using AraC as a positive 
control. AraC is a dideoxy-analogue of nucleoside, which has been used clinically as an antiviral and 
antitumor agent. The major intracellular form of AraC is the triphosphate derivative (AraCTP) and it 
inhibits DNA synthesis by being incorporated into nucleic acids, particularly DNA. The replacement of 
dCTP by AraCTP leads to termination of almost all polynucleotide chain after the incorporation of the 
analogue [50]. Since cells cannot divide upon termination of DNA strand elongation, AraC is a good cell 
cycle arrest inducer [49, 51]. In order to observe the cell cycle arrest, cells that have halted at certain cell 
cycle checkpoint needs to accumulate. Cell cycle profile of AraC-treated CHO cells was remarkably 
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different compared to that of negative control CHO cells (Figure 4.3). Cell cycle distribution is displayed 
as 2N, 2N-4N, and 4N instead of G1, S, G2/M since flow cytometric analysis using propidium iodide 
cannot distinguish if 4N cells are diploid (baseline is two pairs of chromosomes; this is the normal state) 
at G2/M or tetraploid cells (baseline is four pairs of chromosome; usually the consequence of failure in 
cell division) at G1 [41]. AraC 100 µM effectively induced cell cycle blockages, and 4N at 14, 20, 26 hour 
of post-incubation for AraC-treated cells was 90.1%, 59.7%, and 78.4%, respectively, whereas 4N at 14, 
20, 26 hour of post-incubation for negative control cells was 30.7%, 13.3%, and 14.7%, respectively. 
AraC 50 µM also resulted in comparable cell cycle modulation and shifted the cell cycle toward 4N. 
Based on the comparison of cell cycle distribution between negative control cells and AraC-treated cells, 
26 hour was determined to be the observation window.  
 
4.3.2 Optimization of HAN concentration 
 Preliminary experiments demonstrated that CHO cells treated with HAN concentrations of 1200 µM 
CAN, 60 µM BAN, and 60 µM IAN, as was used for DNA repair kinetics study (Chapter 3), caused 
excessive cytotoxicity after 26 hours of post-incubation. Treatment concentration was optimized 
empirically so that cell cycle blockage would be induced without causing excessive cytotoxicity. CHO 
cells were treated with incremental HAN concentrations for 4 hours and left in fresh F12+5% FBS for 26 
hours. Cell cycle alternation became prominent with increasing concentrations (Figure 4.4) without 
excessive cell killing (Table 4.1). All three HANs demonstrated they were capable of shifting the cell 
cycle distribution toward high ploidy in concentration-dependent manner. Concentrations of 900 µM 
CAN, 12 µM BAN, and 6 µM IAN were chosen for subsequent experiments.   
 
4.3.3 Effect of initial cell loading 
 To examine the effect of cell confluency on the cell cycle modulation, CHO cells were plated at  2 × 
10
5
/well/(2 mL F12+5% FBS) or 4 × 10
5
/well/(2 mL F12+5% FBS) in a 6-well tissue culture plate. These 
cells at different density were treated with HANs in parallel and cell cycle distribution after 26 hour post-
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incubation was observed (Figure 4.5). Negative control cells with high cell density have suppressed 2N-
4N population (23.9%) compared to the low density cells (53.2%), which indicates the suppression of cell 
growth (cell cycle arrest) due to cell contact inhibition. IAN- and BAN-treated cells showed distinctly 
different cell cycle profiles depending on the cell density. When cells were treated with BAN at low cell 
density, cell population was shifted toward high ploidy (≥4N = 58.7%) after 26 hour post-incubation 
while BAN treatment at high cell density did not shift the cell population toward high ploidy as much 
(≥4N = 25.2%). Likewise, IAN treatment at high density resulted in cells with ≥4N content DNA as 
39.6% as opposed to 89.5% when cells were treated at low density. Cell cycle alteration by CAN 
treatment was not affected by cell density; the cell population distribution was 18.2% (2N), 17.7% (2N-
4N) and 64.1 % (4N) at low cell density and 20.9% (2N), 21.1% (2N-4N) and 58.0% (4N) at high cell 
density. 
 
4.3.4 Time-course observation of HAN-treated cells 
 To determine the time point when HAN treatment exerted cell cycle alteration during post-incubation, 
HAN-treated cells were collected at 0, 8, 17, 26, 34, 43 and 52 hour post-incubation (Figures 4.6 and 4.7). 
After 8 hours, IAN-treated cells started to shift toward 4N. After 17 hours, 2N cell population nearly 
disappeared (2N = 2.55%) and cells started to accumulate at 8N (9.67%). IAN-treated cells accumulated 
at 8N in direct proportion to incubation time (8.05% and 23.6% at 26 and 34 hours, respectively) but 8N 
cells decreased to 12.6% at 43 hours followed by 8.11 % at 52 hours of post-incubation. A similar pattern 
was observed for CAN and BAN-treated cells. Cell accumulation at 8N was not observed for negative 
control cells. The accumulation of 8N cells coincided with the suppression of cell growth (Figure 4.8). 
Rather than increasing, IAN-treated cells decreased the cell number from 3.39 × 10
5
 cell/well immediate 
after the treatment to 2.13 × 10
5
 cell/well at 34 hour post-incubation, followed by an increase to 3.73 × 
10
5
 cell/well at 52 hour post-incubation. BAN-treated cells decreased in number for the first 17 hours of 
post-incubation (3.27 × 10
5
 cell/well to 2.14 × 10
5
 cell/well), and gradually increased thereafter up to 4.27 
× 10
5
 cell/well. The number of CAN-treated cells decreased to 1.71 × 10
5
 cell/well at 26 hours of post-
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incubation and never exceeded the cell number at 0 hour. Cell viability was over 90% for all treatment 
groups during the observed post-incubation. 
 
4.3.5 Cell cycle alternation by ethylmethane sulfonate 
 Although AraC is a potent cell cycle blocker, the mode of action of AraC is the incorporation into 
DNA strand elongation, which does not happen with HAN. HANs are known to form DNA adducts [20] 
and these adducts may contribute to cell cycle alterations by HANs. Ethylmethane sulfonate (EMS) is a 









-thymine with the ratio of N-versus O-alkylation of ~30 [52, 53], 
and it is widely used as a model compound [54]. EMS-treated cells shifted the cell distribution toward 4N 
at 26 hour post-incubation (41.0% for EMS-treated cells as opposed to 20.2% for negative control cells), 
and the (2N-4N) + 4N population was higher at 52 hour post-incubation (74.2% for EMS-treated cells as 
opposed to 47.5% for negative control cells) (Figure 4.9). However, EMS-treated cells did not express a 
large percentage of 8N cells. 
 
4.3.6 Cell visualization 
 Microscopic investigation demonstrated normal spindle-shape cell morphology for the negative 
control cells (Figure 4.10). Treatment for 4 hours with HANs changed the cell morphology to round shape. 
After 26 hours of incubation, HAN-treated cells still looked mostly round rather than normal elongated 
spindle shape. After another 26 hours, HAN-treated cells showed spindle shape, but the size of the spindle 
looked larger compared to negative control cells. The difference of cell size is more prominent with the 
imaging of harvested cells (Figure 4.11). Harvested cells are spherical because they were isolated from 
the plate wells using trypsin. Negative control cells exhibited similar cell size at 0, 26 and 52 hour post-
incubation, but HAN-treated cells at 26 and 52 hour post-incubation were larger and more variable 
compared to negative control cells. Treatment with 10 mM EMS and 50 µM AraC did not change the 
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morphology of CHO cells right after the 4-hour treatment, but these agents also made cells larger at 26 
and 52 hour post-incubation.  
 
4.3.7 Plating efficiency 
 The ability of cells to proliferate after exposure to HANs was examined to determine the association 
of cell growth suppression with cell cycle alteration. After treatment for 4 hours, cells were washed and 
collected. Equal numbers of treated cells were plated onto a new 96-well plate and the resulting cell 
densities after 72 hours were compared to their concurrent negative controls. The concurrent negative 
controls had their mean density set to 100%. HAN-treated cell growth was suppressed and at the 
concentrations used for cell cycle analysis, the mean (±SE: standard error of the mean) cell densities 
compared to their concurrent negative controls were 14.0 ± 0.8%, 28.9 ± 1.8%, and 27.2 ± 1.8% for 900 
µM CAN, 12 µM BAN, and 6 µM IAN, respectively. Cells treated with10 mM EMS or 100 µM AraC 
also had suppressed cell growth with mean cell density of at 34.9 ± 0.7% and 46.8 ± 1.2%, respectively, 
compared to their concurrent negative controls (Figure 4.12).  
 
4.3.8 DNA strand breaks 
 Alkaline single cell gel electrophoresis detects incompletely repaired DNA damage, as alkali labile 
sites, as well as DNA single and double strand breaks. CHO cells were collected immediately after the 
chemical treatment as well as after 26 hours post-incubation, embedded in agarose on a microscope slide 
and lysed prior to examining the electrophoretic migration of genomic DNA. Treatment with 900 µM 
CAN resulted in extensive DNA migration (% tail DNA = 60.7), which reduced to % tail DNA of 7.72 
after 26 hours post-incubation. BAN at 12 µM induced moderate DNA migration (% tail DNA = 23.2) 
and reduced to negative control level (% tail DNA = 0.11). IAN at 6 µM induced a weak level of strand 






 Eukaryotic cells have multiple checkpoints to ensure the integrity of the genome and cell division [38, 
55, 56]. DNA integrity checkpoints monitor DNA status and prevent inappropriate transitions into S 
phase and mitosis when aberrations are detected. DNA damage causes cell cycle delay before S phase, 
during replication and before mitosis [57]. Proliferating cells that traverse through G1 or G2 phases can 
respond to genotoxic stress by activating checkpoints that impose shorter or durable cell-cycle arrests in 
G1 or G2, before re-entry into S phase or mitosis [58]. Cells that experience genotoxic stress during DNA 
replication only delay their progression through S phase in a transient manner, and if damage is not 
repaired during this delay they exit S phase and arrest later when reaching G2 checkpoint. The replication 
checkpoint, the S-M checkpoint, and the intra-S-phase checkpoint do not requires p53, which is the key 
target of the sustained G1 (G1-S) checkpoint that arrests the cell cycle in G1 phase [59]. A subject review 
indicated that the checkpoint may contribute to the generation of mutations rather than their prevention 
through translesion DNA synthesis regulation [60]. 
 Eukaryotic organisms usually contain a diploid complement of chromosomes. The diploid state (2N) 
enables sexual reproduction and facilitates genetic recombination. Although some plants and fungi can 
deviate from diploid, the normal state of the animal cell is diploid. Duplication of mammalian nuclear 
DNA is restricted to only once each time the cell divides. However, the chromosome complement can 
differ within an organism by cell type, and in many cancer cells the number and the structure of each 
chromosome can be highly variable [61, 62].  HANs are known to induce DNA damage detectable by 
SCGE assay [8] with the descending rank order of IAN > BAN > CAN (Figure 4.1). Thus the association 
of genotoxic damage with cell cycle arrest is of interest.  
 This is the first research study that has identified cell cycle alteration by a class of DBPs. It was 
shown in this study that HAN treatment shifted the cell cycle distribution toward 4N after 26 hours of 
post-incubation (Figure 4.4). Interestingly, DNA strand breaks induced by HANs were mostly repaired 
after 26 hours (Figure 4.13). At first this cell cycle shift was interpreted as G2 cycle arrest, but extending 
the post-incubation up to 52 hours as well as time-course analysis revealed the presence of an 
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accumulating 8N cell population (Figure 4.6). It appeared that 4N cells further went through another cell 
cycle. Accumulation of 8N cells was most pronounced for IAN-treated cells at 34 hours of post-
incubation (23.6%). The accumulation of 4N and 8N cell population may reflect the inhibitory effect of 
HANs into the mitotic entry. Alternatively, cell proliferation may proceed without progression to mitosis. 
IAN treatment almost eliminated 2N cell population (2.55%) as early as 17 hours of the post-incubation 
(Figure 4.6). AraC is a strong positive control but it only affects the DNA strand elongation in S phase. 
The fact that not all the cells were affected by AraC can be seen in the microscopic imaging of AraC-
treated cells after 52 hours of post-incubation (Figure 4.10). There are cells with equivalent sizes with 
negative control cells as well as much larger cells. CHO cells were not synchronized at the time of 
chemical treatment and that explains why only a fraction of the cells was affected by AraC treatment. The 
fact that the 2N cell population in IAN-treated cells was eliminated at 17 hours post-incubation indicates 
that IAN can act on cells at any point of cell cycle and affect high ploidy.  
 HANs have two reactive centers: (a) displacement of a halogen atom at α-carbon by SN2 reaction, and 
(b) addition at the partially positively charged carbon of cyano groups [63] (Figure 4.14). BAN and CAN 
were shown to react with calf thymus DNA at guanine base to form a 7-(cyanomethyl)guanine DNA 
adduct [20]. The rank order of cell cycle alteration (Figure 4.4) and the rank order of DNA damage 
induction (Figure 4.1) follows the same order (IAN > BAN > CAN), which may signal a mechanism that 
involves the α-carbon. HAN treatment was thus compared to EMS, which is a well-established alkylating 
agent that forms (mostly ethyl) adducts at the N- and O-atoms in DNA bases [52, 53]. Alkyl DNA 
adducts exhibit different stabilities. In general, O-alkylations are highly mutagenic and genotoxic, 
whereas N-alkylations are cytotoxic but less mutagenic [54, 64]. EMS at a concentration of 10 mM 
induced substantial amount of DNA strand breaks in CHO cells after 4 hour treatment [65]. In this study 
EMS-treated cells shifted the cell cycle distribution toward 2N-4N and 4N DNA content compared to 
concurrent negative control but did not proceed to 8N state (Figure 4.9). Treatment of CHO cells with 10 
mM EMS suppressed the cell growth (Figure 4.12) and resulted in larger cells after 26 and 52 hours of 
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post-incubation (Figure 4.10). Lack of accumulation of 8N cells indicates that direct alkylation of DNA 
cannot account for the cytogenetic toxicity of the HANs.    
 Cytometric analysis only quantifies dye-incorporation to examine DNA content and does not reflect 
the biological complexity of the cell cycle. Sakaue-Sawano and colleagues reported that an inhibitor of 
DNA topoisomerase II halted HeLa (immortal cancer cell line derived from human adenocarcinoma) and 
normal murine mammary gland (NMuMG) cells at the G2/M checkpoint but NMuMG cells then overrode 
the checkpoint and underwent nuclear mis-segregation or avoided the checkpoint and entered the 
endoreplication cycle, in which cells increased their genomic DNA content without dividing [41]. Cell 
cycle progression is dependent upon the coordinated regulation of ubiquitination, and they harnessed this 
system to develop a genetically encoded fluorescence indicator of cell cycle progression (Fucci: 
Fluorescent Ubiquitination-based cell cycle indicator). NMuMG/Fucci2 cell nuclei progressed from 
yellowish green (indication of S/G2/M) to red (indication of G1) without undergoing cell division. No 
cellular features consistent with M phase were seen, including nuclear envelope breakdown and 
chromosome condensation, during the yellowish green to red color conversion. Increases in cellular DNA 
content suggested a transition from the mitotic to endoreplication cycles by bypassing mitosis and 
cytokinesis (separation of cytoplasm of daughter cells). NMuMG/Fucci2 cells underwent only one round 
of DNA endoreplication generating large red nuclei, confirming cells remained tetraploid for an extended 
period up to 96 hours in the presence of 10 µM etoposide (topoisomerase II inhibitor; topoisomerase II 
segregates chromosomes at cell division). A small fraction of the NMuMG cells was observed to go 
through multiple endoreplication cycles in the presence of 1 – 3 µM etoposide. Time-lapse high-
resolution imaging analysis at the single cell level combined with population analysis allowed Sakaue-
Sawano et al. [41] to explore the processes of cell cycle alteration in great detail. Conventional flow 
cytometric cell cycle analysis that only quantifies dye-incorporation may have misinterpreted the long-
lasting tetraploid state as G2 arrest. Flow cytometric analysis in this study only measured propidium 
iodide incorporation into DNA and thus cannot distinguish if 4N cells are diploid at G2/M or tetraploid 
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cells at G1. That is why the cell cycle distribution is displayed as 2N, 2N-4N, 4N and 4N-8N and 8N in 
Figures 4.3 – 4.7, and 4.9.  
 Polyploid cells in a diploid organism can form by three general mechanisms: 1) cell fusion, 2) a 
developmental process known as endoreplication, and 3) a variety of defects that result in an abortive cell 
cycle. Endoreplication is an example that polyploidy of cells within an organism can be programmed as a 
feature of normal development and can be seen in Drosophila salivary glands or mammalian 
megakaryocytes. During this specialized cell cycle, cells skip mitosis and proceed through several rounds 
of DNA replication, resulting in autopolyploid cells (multiples of a single genome), which generally do 
not proliferate further. Abortive cell cycles arise from a variety of defects in different aspects of cell 
division: DNA replication, dissolving sister-chromatid cohesion, mitotis spindle function and cytokinesis. 
Many of the defects that result in abortive cell cycles trigger checkpoint responses that block cell-cycle 
progression or, in some cases, trigger apoptosis [61].  
 Various checkpoints exist at the mitosis to ensure the fidelity of cell replication, alignment of all 
chromosomes at methaphase, formation of mitotic spindle, and interaction of kinetochores with spindle 
microtubules. Andreassen and colleagues treated mitotic CHO cells with chemical agents that inhibit 
different stages of mitosis (disruption of either the function of mitotic checkpoints or the coordination of 
mitotic event) and all chemicals forced CHO cells out of mitosis without undergoing cell division. After 
two additional cell cycles tetraploid cells remained viable and rapidly became aneuploid [66].  
 When animal cells become tetraploid, they acquire extra centrosomes that could potentially 
compromise the assembly of a bipolar spindle. Centrosome is a structure that serves as the main 
microtubule-organizing center in animal cells and define the spatial organization of the microtubule 
cytoskeleton [67]. Multipolar mitosis leads to aneuploidy [61]. Aneuploidy (state of abnormal 
chromosome number and content) is the most commonly observed genetic alteration in many types of 
tumors [62]. Populations of tetraploid cells are found in a variety of human tumors where they may act as 
precursors of aneuploidy and tumorigenesis [68, 69]. Animal cells have self-defense system to eliminate 
tetraploid cells, called “tetraploidy checkpoint”. Tetraploidy checkpoint enhances the fidelity of cell 
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proliferation by preventing aneuploidization by inducing the tetraploid cells to withdraw from the cell 
cycle before DNA replication [70, 71].  
 Andreassen and colleagues showed that tetraploid state itself act as a checkpoint to arrest cells in G1 
regardless of the induction mechanism of tetraploidy [71]. Nontransformed primary rat embryo fibroblasts 
(REF)-52 cells went indefinitely into tetraploid G1 arrest upon drug-induced mitotic failure. G1 arrest 
involved inactive Cdk2 kinase (required for G1-S progression), hypophosphorylated retinoblastoma 
protein (pRB) (a gatekeeper of the pathway of activation of S phase and entry into a new cell cycle), and 
elevated levels of cell cycle progression regulating protein p21
WAF1
, and cyclin E. Similar tetraploid G1 
arrest was obtained with nontransformed mouse NIH3T3 and human IMR-90 cells. On the other hand, 
transformed derivative of REF-52 cells with inactivated p53 (p53DD cell) did not arrest but accumulated 
with 8N DNA content with mitotic activity. After release from the drug treatment, p53DD cells proceeded 
through a full cell cycle and became highly aneuploid with DNA content ranging from < 2N to 4N.  
 Arrest in the G1 phase of the cell cycle is mainly mediated by the p53 tumor suppressor, a 
transcription factor that induces cell cycle arrest, damage repair, and apoptosis [72]. The cell cycle effects 
of p53 activation include induction of transcription of Cdk inhibitor p21. The induction of p21 in response 
to DNA damage is the major mechanisms enforcing arrest in G1 in response to DNA damage [58]. Drug-
induced mitosis exit induced indefinite G1 arrest in nontransformed REF-52 cells [71] but not in CHO 
cells [66]. CHO cells that became tetraploid following exposure to 2-aminopurine (protein kinase 
inhibitor), taxol (microtubule assembly inhibitor), ICRF-193 (topoisomerase II-dependent DNA 
decatenation inhibitor). or dihydrocytochalasin B (actin assembly inhibitor) all became aneuploid within 
30 hours, which represents two subsequent cell divisions after release from treatment.   
 The parental cell line of CHO AS52 is CHO-K1 [44]. CHO-K1 contains a single missense mutation 
at position 633 (codon 211). This base difference corresponds to an amino acid change from threonine 
(ACA) to lysine (AAA) in the DNA-binding domain and CHO-K1 lacks the ability to induce G1 
checkpoint [73-75]. Hu et al. identified the p53 status in CHO-K1 as mutant protein due to its high 
spontaneous levels that are non-inducible after X-irradiation [73]. On the other hand, Tzang et al. 
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concluded that the mutation does not have effect on the functional properties of the p53 protein and the 
lack of G1 arrest of CHO-K1 is likely p53-independent; rather, Tzang attributed the inability of CHO-K1 
for G1 arrest to deficiency of p21 (Waf1/Cip1) expression since transfecting the CHO-K1 cells with a 
wild-type human p53 gene failed to retrieve the ability of G1 arrest upon X-ray irradiation [74]. However, 
it is reported that sequence-specific binding function is lost in point-mutated p53 proteins and many of the 
mutant p53 can act as dominant negative to inhibit this activity of the wild-type p53 [72, 76]. Combined 
with the report from Hu et al. [73], it is most likely that the function of p53 in CHO-K1 is somewhat 
compromised.  
 Since the CHO AS2 cell used in this study is a derivative of CHO-K1 cell, it is most likely that the 
gene encoding p53 in AS52 carries the same mutation as in K1 cell line. HAN-treated CHO AS52 cells 
showed accumulation of cells with > 4N DNA content after 17 hours of post-incubation. The high ploidy 
cells accumulated with time but the proportion of high ploidy cells went down after 34 hours of post-
incubation. It is not likely that 8N cells could segregate normally to become diploid. Polyploid cells 
cannot overcome the issue of multipolar mitosis, which leads to aneuploidy [61]. When synchronized 
mitotic cells were treated with mitosis inhibitor, resulting aneuploidy cell cycle distribution was wide 
spread of DNA content ranging from 2N to more than 8N without distinct peaks [66, 71]. The “noisy” cell 
cycle profile of IAN-treated cells at 34, 43, and 52 hours may be an indication of aneuploidy cells (Figure 
4.6). A small cell population can be observed in subG1 region of BAN-treated cells at 26, 34 and 43 hours. 
Cell cycle profile of CAN-treated cells did not appear as sharp as the concurrent negative control cells, 
but not as diffuse as the IAN-treated cells. It may be questioned why distinct peaks are observed in the 
cell cycle profiles of HAN-cells instead of broad distribution as was seen in [71], after accumulation of 
8N cells. An explanation may be that cells are not synchronized at the treatment and that HANs acted on 
cells at a specific cell cycle stage. It may be argued that an aneuploid cell population may have been lost 
at sample collection since cells at designated post-incubation were rinsed with HBSS first and 
subsequently trypsinized. Floating cells were observed by visual inspection but accurate quantification of 
detached cells was not practically possible. A preliminary experiment examined the hypothesis that 
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collecting only adherent cells would not bias the cell cycle population. Parallel wells were prepared for 
CAN at 900 µM, BAN at 12 µM, IAN at 6 µM and EMS at 10 mM. Cells were collected right after the 4-
hour treatment (= 0 hour), and 26 and 52 hour post-incubation. One well was rinsed with HBSS first and 
trypsinized to collect only adherent cells. From the other well, rinsing solution and harvested cell 
suspension were collected to count whole cells (floating cells + adherent cells). There were no significant 
differences in cell cycle profile between whole cells and adherent cells in any treatment groups (data not 
shown) thus the hypothesis was accepted, and only adherent cells were collected hereafter.   
 The cell number of IAN- and BAN-treated cells started to increase after 34 hours. Increase of the cell 
number may imply that there was an “unaffected cell population” retaining their normal ploidy, and that 
this unaffected population may have corresponded to distinct peaks in the cell cycle profiles at later post-
incubation times. Nevertheless, it is difficult to conclude the fate of cells with different DNA content 
without a real-time observation at a single cell level. 
 Andreassen et al. successfully induced tetraploid CHO cells by override of cell cycle chekpoints, 
inhibition of microtubule assembly, inhibition of topoisomerase II and inhibition of cleavage furrow 
formation [66]. In order for a cell to be a tetraploid, it has to attempt mitosis. Progression of cell cycle 
may be necessary for HANs to exert their toxicity. When initial CHO cell loading was 4 × 10
5
 cells/well, 
cell cycle alteration by BAN and IAN was not as prominent as for cells with the initial loading of 2 × 10
5
 
cells/well (Figure 4.5). With the higher cell density it is very likely more cells exerted cell contact 
inhibition during the 4-hour treatment and/or early in the post-incubation, thus the progression of cell 
cycle was suppressed. There might be less number of cells that attempted mitosis with high cell density.  
 The HAN treatment condition was first chosen from the DNA repair kinetics work (Chapter 3). The 
respective concentrations of 60 µM, 60 µM, and 1200 µM for IAN, BAN, and CAN turned out to be too 
high for the ploidy analysis. Almost all cells were dead after 26 hours of post-incubation with IAN at 60 
µM and BAN at 60 µM, and cells treated with CAN at 1200 µM were half detached from the surface of 




















). Moreover, during the post-incubation, serum-free medium was used 
for DNA repair kinetics and complete medium was used for cell cycle analysis; cell cycle progression was 
doubly suppressed by cell confluence status and serum starvation for the repair experiment. HAN 
concentrations were lowered to 6 µM, 12 µM, and 900 µM for IAN, BAN, and CAN, respectively, for the 
cell cycle analysis. The same trend was observed for the HAN-treated cell plating efficiency. The 
concentration range for plating efficiency in this work is lower (2 – 8 µM for IAN, 2 – 14 µM for BAN, 
and 200 – 1200 µM for CAN) when cell treatment was at low cell density in this work (Figure 4.12) 
compared to the higher concentration range for plating efficiency at confluence (45 – 60 µM for IAN, 43 
– 60 µM for BAN, and 460 – 1200 µM for CAN, Chapter 3). It was also demonstrated that contact-
inhibited mouse cells displayed a very strong suppression of UV-C-induced apoptosis when they were 
treated in a confluent state, which supported their conclusion of proliferation dependence of the induction 
of apoptosis by UV-C light [42].  
 In conclusion, it appears HAN could induce tetraploid cells by inducing mitotic failure in CHO AS52 
cells. Due to the lack of G1 arrest of CHO cells, HAN-treated cells underwent another cell cycle and 
became tetraploid. Further progression of cell cycle resulted in induction of high ploidy cells (> 4N). 
Tetraploid cells can be induced by override of cell cycle checkpoints, inhibitions of microtubule assembly, 
inhibition of topoisomerase II and inhibition of cleavage furrow formation [66], some of which could be a 
mechanism of toxic action of HANs. In p53-competent cells, tetraploid checkpoint triggers apoptosis to 
eliminate tetraploid cells [71]. The lack of subG1 population may confirm the lack of p53-dependent 
apoptosis pathway in CHO AS52 cells.   
 Mutations of the p53 tumor suppressor gene are common in various types of human cancer [77]. 
Alterations in the p53 tumor suppressor gene appear to be important in the development of many human 
tumors. The wild-type p53 gene has a polymorphism at codon 72 that presents the arginine (CGC) or 
proline (CCC) genotype, which has been associated with increased risk or urothelial cancer in smokers 
[78]. Thus induction of aneuploidy by HANs may be a threat to vulnerable subpopulations.  
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 There are accumulating evidences of transient 4N state proceeding aneuploidy in cancer progression 
[39, 69]. Aneuploidy is a hallmark of tumorigenesis [39]. An increase in ploidy generally affects genome 
instability [61]. Polyploid fission yeast undergoes chromosome missegragation at a high frequency. 
Tetraploid budding yeast cells showed increased sensitivity to gamma irradiation and to other DNA-
damaging agents. If it is also true for mammalian cells, HANs-exposed cells may become susceptible to 
other DNA-damaging agents.  
 Epidemiological studies have associated DBPs with urinary bladder cancer but rodent single-chemical 
bioassays have not been able to demonstrate tumor induction at the same organ sites [1, 79]. There are no 
mechanistic data on how regulated organic DBPs can contribute to bladder cancer. We have yet to 
identify a plausible causal agent for adverse human health outcomes. Induction of aneuploidy in HAN-
treated cells may imply HANs as a player in cancer induction and adverse pregnancy outcomes associated 
with long-term exposure to disinfected drinking water. Due to increasing stress on source water 
availability, many utilities seek alternative disinfection processes or alterations to chlorination practices. 
Regulated DBPs are used as general indicators for DBP control but many scientists believe that regulated 
DBPs do not account for the adverse health outcomes identified by epidemiology studies. Identification of 
major DBP components associated with adverse health outcomes from disinfected drinking water will aid 
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Tables and Figures 
 
 
Table 4.1 Trypan blue cytotoxicity of HAN-treated cells at incremental concentrations. After 26 hours of  
post-incubation. 
 
CAN Viability (%) BAN Viability (%) IAN Viability (%) 
0 µM 99.5 0 µM 100.0 0 µM 100.0 
700 µM 95.8 9 µM 98.9 2 µM 100.0 
750 µM 99.3 10 µM 97.9 3 µM 96.0 
800 µM 96.9 11 µM 99.0 4 µM 98.0 
850 µM 95.8 12 µM 98.2 6 µM 94.3 
900 µM 95.3 13 µM 95.9 8 µM 98.9 





Figure 4.1 Genomic DNA damage in CHO cells by monohaloacetic acids and monohaloacetonitriles 
(data from [8, 33]).    
 
DBP Concentration (M)












































































































Figure 4.3 Cell cycle profiles of CHO cells treated without or with 100 µM of AraC at various time 
points during post-incubation. (A) Cell cycle profiles obtained with LSR II flow cytometer. CHO cells 
were treated with 0 µM or 100 µM of AraC (top and lower panel, respectively) for 4 hours and harvested 
at various time points during post-incubation. Arrows indicate the 2N and 4N DNA containing cells from 
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Figure 4.4 Cell cycle profiles of CHO cells treated with various concentrations of HANs at 26 hour post-
incubation. (A) Flow cytometric diagram obtained with LSR II flow cytometer. CAN (top), BAN 
(middle), and IAN (bottom) at listed concentrations. Arrows indicate the 2N and 4N DNA containing 
cells from the left. (B) The cell cycle distributions were calculated using the FCS Express software. CAN 
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Figure 4.5 Cell cycle profiles of CHO cells treated at different initial cell loading. (A) Flow cytometric 
diagram obtained with LSR II flow cytometer. Initial cell loading of 2 × 10
5
 cells/well (top), and 4 × 10
5
 
cells/well (bottom). Arrows indicate the 2N and 4N DNA containing cells from the left. (B) The cell cycle 
distributions were calculated using the FCS Express software. 2 × 10
5
 cells/well (left), 4 × 10
5
 cells/well 
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Figure 4.6 Cell cycle profiles of CHO cells at 0, 8, 17, 26, 34, 43, and 52 hour post-incubation. Treatment 
conditions are negative control, 900 µM CAN, 12 µM BAN, and 6 µM IAN. Cell cycle profiles were 
obtained with LSR II flow cytometer. Arrows indicate the 2N, 4N and 8N DNA containing cells from 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.7 CHO cell cycle distributions at 0, 8, 17, 26, 34, 43, and 52 hour post-incubation. The cell 
cycle distribution was calculated using the FCS Express software. (A) Negative control, (B) CAN at 900 
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Figure 4.8 CHO cells viability (top) and growth (bottom) curves during post-incubation after treated 
without or with 900 µM CAN, 12 µM BAN, 6 µM IAN, 50 µM AraC, or 10 mM EMS. 
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Figure 4.9 Cell cycle profiles of CHO cells at various points during post-incubation. (A) Cell cycle 
profiles obtained with LSR II flow cytometer. CHO cells were treated without or with 10 mM EMS for 4 
hours and harvested at 0, 26, and 52 hour post-incubation. Arrows indicate the 2N and 4N DNA 
containing cells from the left. (B) The cell cycle distribution calculated with the FCS Express software. 
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Figure 4.10 Microscopic images of adherent cells with 10× phase contrast objective. CHO cells were 
observed at 0, 26, and 52 hour post-incubation. Treatment conditions are negative control, 900 µM CAN, 
12 µM BAN, 6 µM IAN, 10 mM EMS or 50 µM AraC.   
Scale bar: 100 µm
Negative 
control










Figure 4.11 Microscopic images of harvested cells with 40× bright field illumination objective. CHO 
cells were harvested and observed at 0, 26, and 52 hour post-incubation. Treatment conditions are 
negative control, 900 µM CAN, 12 µM BAN, 6 µM IAN, 10 mM EMS or 50 µM AraC.   















Figure 4.12 Cell density analysis of CHO cells exposed to HANs for 4 hours, washed, harvested and 
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Figure 4.13 DNA strand breaks measured by single cell gel electrophoresis assay. Treated cells were 
harvested at 0 hour and 26 hour post-incubation. 
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Figure 4.14 Two schemes for reactions of HANs with biological nucleophiles such as amino acids and 
DNA bases (Nuc:). (A) Displacement of halogen atom at α-carbon by SN2 substitution reaction. (B) 














 Haloacetic acids (HAAs) and haloacetonitriles (HANs) are commonly found disinfection byproducts 
(DBPs) in drinking water. MonoHAAs and monoHANs have a similar chemical structure; both groups 
have a single halogen substituent at their α-carbon. They both induced genomic DNA damage with the 
rank order of iodinated > brominated > chlorinated analogues but repair efficiency of the induced lesions 
did not follow the same halogen order between these two groups. MonoHANs were shown to induce 
abnormally high DNA content in treated Chinese hamster ovary (CHO) cells and monoHAAs were 
expected to induce cell cycle delay as well. CHO cells were treated with chloroacetic acid, bromoacetic 
acid and iodoacetic acid using a wide range of concentrations followed by incubation in fresh medium to 
allow for cell accumulation. Cell cycle profile of HAA-treated cells was not notably different from 
negative control cells. Accumulation of abnormally high DNA content was not observed in the HAA-
treated cells. Differences between treatment with monoHAAs and monoHANs in both DNA repair 
kinetics and cell cycle alteration suggested a fundamental difference in the mechanism of toxic action of 
these two classes of DBPs.  
 
5.1 Introduction 
 Chemical disinfectants has been used as an effective defense against pathogens, yet because of their 
oxidizing potency they also react with ubiquitous natural organic matter, anthropogenic contaminants and 
bromide/iodide to form environmentally hazardous chemicals called disinfection byproducts (DBPs) [1]. 
Chlorine, chloramines, ozone and chlorine dioxide are common water disinfectants used today and they 
produce DBPs with different distributions [2]. In chlorinated water, haloacetic acids (HAAs) are the 
second most common class of DBPs after trihalomethanes [3]. The sum of five HAAs, chloroacetic acid 
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(CAA), dichloroacetic acid (DCAA), trichloroacetic acid (TCAA), bromoacetic acid (BAA) and 
dibromoacetic acid (DBAA), is regulated at a maximum contaminant level of 60 μg/L [4, 5]. HAAs are 
mutagenic in bacteria [6] and mammalian cells [7], induce genomic DNA damage in mammalian cells in 
vitro [8-11] and are developmentally toxic [12-14]. Carcinogenicity has been proven for DCAA, TCAA, 
bromochloroacetic acid (BCAA) and DBAA, but not for CAA [15-18]. Recently tumorgenicity of 
iodoacetic acid (IAA) was established [19]. 
 Monohaloacetic acids have a single halogen substituent at the α-carbon. The association of toxic 
potency and halogen substitution was first realized by Richard and Hunter, with the rank order of IAA> 
BAA > CAA > fluoroacetic acid for their developmental toxicity [14]. Subsequently, the level of 
cytotoxic and genotoxic potency was found to follow the rank order of IAA > BAA > CAA in bacteria [6], 
Chinese hamster ovary (CHO) cells [7, 8] and human cells [11]. The potency of peroxisome proliferator-
activated receptor α activation also followed the order of IAA > BAA > CAA in a primary hepatocytes 
culture [20]. MonoHAAs inhibits the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activity in a 
concentration-dependent manner with the rank order of IAA > BAA >> CAA [21, 22]. The rate of 
inhibition of GAPDH and the genotoxic potency of HAAs were highly correlated, which suggested that 
GAPDH inhibition, the reduction of pyruvate and ATP levels, and the generation of reactive oxygen 
species induced as a mode of cytotoxic and genotoxic action of monoHAAs [21-23].  
 Attene-Ramos et al. [11] conducted a human cell toxicogenomic analysis of monoHAAs focusing on 
DNA damage signaling pathways. Transcriptome profiles impacted by the monoHAAs included genes 
related to double strand DNA break repair, cell cycle arrest, and apoptosis regulation. The number of 
modulated genes involving cell cycle regulation and apoptosis control was the highest among those with 
altered gene expression. In response to DNA damage, cells can activate checkpoints at critical stages in 
the cell cycle that prevent cells from progressing through the cell cycle [24, 25]. In this way, there is a 
longer period available for DNA repair prior to replication, leading to a suppression of mutation 
frequency [26]. Induction of abnormally high DNA content was observed in monohaloacetonitriles 
(monoHANs)-treated cells (Chapter 4). MonoHAAs and monoHANs have a similar chemical structure in 
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that both chemical groups have a single halogen substituent at the α-carbon. However, although they 
induce genomic DNA strand breaks with the same rank order of iodinated > brominated > chlorinated 
analogues [8, 27], they were shown to produce different DNA repair kinetics and associated effect of the 
halogen leaving group (Chapter 3). Cell cycle alteration was observed with HAN-treated cells (Chapter 4) 
and thus it would be interesting to study if differences in altered cell cycle progression in HAA-treated 
cells would reflect the differences in DNA repair kinetics. In this study, CHO cells were treated with 
monoHAAs and cell cycle profiles were determined using flow cytometry. Flow cytometry can quantify 
dye incorporation to DNA, which reflect the progression in mammalian cell cycle [28]. The objective of 
this study was to determine if monoHAAs alter the cell cycle of CHO cells and if that cell cycle alteration 
resembles HAN-induced cell cycle alteration.  
 
5.2 Materials and Methods  
5.2.1 Reagents  
 General reagents were purchased from Fisher Scientific Co. (Itasca, IL) and Sigma-Aldrich Co. (St. 
Louis, MO). Bromoacetic acid (≥ 99%, CAS# 79-08-3) and chloroacetic acid (≥ 99%, CAS# 79-11-8) 
were purchased from Fluka Chemical Co. (Buchs, Switzerland). Iodoacetic acid (≥ 99%, CAS# 64-69-7) 
was purchased from Aldrich Chemical Co. (Milwaukee, WI). HANs and HAAs were diluted in dimethyl 
sulfoxide (DMSO) at 1 mole/L and stored at −22°C. 
   
5.2.2 Chinese hamster ovary cells and culture media 
 Transgenic Chinese hamster ovary (CHO) cells line AS52 clone 11-4-8 [29, 30] were maintained in 
modified Ham’s F12 medium (Mediatech, Inc., Manassas, VA) supplemented with 5% fetal bovine serum 
(FBS), 1% L-glutamine and 1% antibiotic-antimycotic solution (10 units/mL penicillin G sodium, 10 
µg/mL streptomycin sulfate, 25 µg/mL amphotericin B, 0.85% saline; Invitrogen, Carlsbad, CA). The 
cells exhibit normal morphology, express cell contact inhibition and grow as a monolayer without 
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expressing neoplastic foci. The cells were grown in 100-mm glass culture plate or 75-cm
2
 tissue culture 
flask at 37°C in a humidified atmosphere of 5% CO2. 
 
5.2.3 Cell treatment and flow cytometric analysis of cell cycle 
 Unsynchronous CHO cells were plated in sterile flat-bottom 6-well tissue culture plates at 2 × 
10
5





 free-Hank’s balanced salt solution (HBSS), and treated with each chemical in 1 mL of serum-
free F12 medium for 4 hours at 37°C, 5% CO2. Multiple wells were used per treatment group as needed. 
A sheet of sterile AlumnaSeal™ (RPI Corporation, Mt. Prospect, IL) was pressed over the wells before 
covering the plate with a lid to prevent crossover contamination between wells due to volatilization. After 
the 4-hour treatment, the solution was aspirated, and the cells were washed twice with 1 mL HBSS. The 
cells were harvested immediately (0 hour sample) with 0.5× trypsin (0.05% trypsin, in HBSS with 0.2 g/L 
EDTA, without calcium, magnesium, Hyclone Laboratories, South Logan, UT), or 2 mL of drug-free 
F12+5% FBS were added and incubated for designated times. The post-treatment incubation times 
allowed cells to accumulate at intervals where there was cell cycle blockage. Harvested cells were 
counted with Beckman Coulter Z1 Particle Counter (Beckman Coulter, Inc., Brea CA) and also acute 
cytotoxicity was determined using the trypan blue dye exclusion assay [31]. In order to determine their 
DNA content, harvested cells were fixed in 70% ice cold ethanol. Samples were stored for up to one week 
at −22°C. The fixed cells were rinsed with cold phosphate buffered saline (PBS) twice and then incubated 
for 30 minutes at 37°C with 50 µg/mL of the DNA fluorochrome propidium iodide, a marker of DNA 
content, in a solution containing 200 µg/mL of RNase A. Cell fluorescence was measured in the 
Biosciences LSR II flow cytometry analyzer (San Jose, CA). Propidium iodide was excited by a 488 nm 
laser line (laser diode) and its emission was collected through a 695/40 nm band-pass filter. The data were 
analyzed using multicycle DNA analysis using FCS Express version 4 (De Novo Software, Los Angeles, 




5.2.4 Plating efficiency 
 CHO cells were treated in 6-well tissue culture plates in the same way as for cell cycle analysis. After 
a 4-hour treatment, the solution was aspirated, and the cells were washed twice with 1 mL HBSS and 
harvested with 0.025% trypsin + 0.01% EDTA in HBSS. The cell number was counted with Coulter 
counter and adjusted to 3 × 10
4
 cells/mL. In the flat-bottom, tissue culture 96-well microplate, one 
column of eight wells was reserved for the blank control consisting of 200 µL of F12+5% FBS. Titered 
cells of 100 µL were aliquoted into one column plus 100 µL F12+5% FBS. To prevent volatilization of 
culture medium, a sheet of sterile AlumnaSeal™ was pressed over the wells before covering the 
microplate with a lid. The microplate was placed on a rocking platform for 10 minutes to uniformly 
distribute the cells, and then it was placed in a tissue culture incubator for 72 hours. After incubation, 
each well was gently aspirated, fixed in 100% methanol for 10 minutes, and stained for 10 min with a 1% 
crystal violet solution in 50% methanol. The plate was gently washed, and 50 µL of a DMSO:methanol 
(3:1, v/v) solution was added to each well for 10 minutes. The plate was then analyzed in SpectraMax 
microplate reader (Molecular Devices, LLC, Sunnyvale, CA) at 595 nm. The blank-corrected absorbency 
value of the negative control was set at 100%. The absorbency for each treatment group well was 
converted into a percentage of the negative control. For each concentration, eight replicate wells were 
analyzed per experiment and each experiment was independently repeated at least three times. 
 
5.2.5 Single cell gel electrophoresis  
 To examine the induction of genomic DNA damage in different physical conditions in 96-well 
microplates and 6-well plates, single cell gel electrophoresis (SCGE) assay was conducted in parallel. The 
SCGE assay is rapid and sensitive, and detects lesions including DNA single-strand and double-strand 
breaks, incomplete excision repair sites, and alkali-labile sites [32, 33]. Detailed methods for preparation 
of SCGE slides and electrophoresis have been published previously [8, 9, 34].  
 The day before treatment, CHO cells were plated in a sterile flat-bottom 96-well microplate at 4 × 10
4
 
CHO cells/(200 μL of F12+5% FBS)/well or in a sterile flat-bottom 6-well tissue culture plates at 2 × 105 
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cells/ (2 mL F12+5% FBS)/well. The next day, the cells were washed with HBSS and treated with the 
HAAs in serum-free F12 medium in a total volume of 25 μL in 96-well microplate and 1 mL in 6-well 
plate in parallel for 4 hours at 37°C, 5% CO2. The wells were covered with AlumnaSeal™ to prevent 
chemical volatilization. After treatment, the solution was aspirated and the cells were washed twice with 
HBSS. The cells in 96-well microplate were detached with 50 μL of a 0.025% trypsin+0.01% EDTA 
solution in HBSS, followed by addition of 70 μL F12+5% FBS. A 10 µL aliquot was analyzed for acute 
cytotoxicity with the trypan blue dye exclusion assay [31] to ensure that cell viability exceeds 70% [35]. 
The remaining cell suspension was mixed with the same volume of 1% of low melting point agarose 
(LMA), and layered onto clear microscope slides pre-coated with 1% normal melting point agarose. The 
cells in 6-well plate were detached with 400 μL of a 0.025% trypsin+0.01% EDTA solution in HBSS, 
followed by addition of 1 mL F12+5% FBS. A 120 µL of cell suspension was mixed with 120 µL of 1 % 
LMA and applied onto pre-coated microscope slides. After the first layer of LMA solidified, another layer 
of 0.5% LMA was applied. Two SCGE microgels were prepared from the suspension harvested from 
each well. The microgels were immersed in lysing solution (2.5 M NaCl, 1% sodium lauryl sarcosinate, 
100 mM Na2EDTA, 10 mM Tris, pH 10 with 1% Triton X-100 and 10% DMSO) overnight at 4°C.  
 The DNA of the nuclei in the SCGE microgels was denatured for 20 minutes in electrophoresis buffer 
(1 mM Na2EDTA and 300 mM NaOH, pH 13.5) followed by electrophoresis at 25 V and 300 mA (0.72 
V/cm) for 40 minutes at 4°C. After neutralization with 400 mM Tris buffer (pH 7.5) the microgels were 
dehydrated in cold methanol for 20 minutes, dried for 5 minutes at 50°C, and stored at room temperature. 
For analysis, the microgels were hydrated in water at 4°C for 20 minutes, and then the nuclei were stained 
with 65 μL of an ethidium bromide solution (20 μg/mL). Fifty randomly chosen nuclei per microgel were 
analyzed with a Zeiss fluorescence microscope (excitation filter of BP 546/10 nm, barrier filter of 590 
nm) and a computerized image analysis system (Comet Assay IV, Perspective Instruments Ltd., Suffolk, 
UK). The digitalized data were automatically transferred from the CCD camera to a computer-based 
spreadsheet for statistical analysis. The percentage of migrated DNA out of nucleus (% tail DNA) was 




5.3.1 Examination of HAA concentration for cell cycle analysis 
 The initial loading of cells and post-incubation time for cell cycle observation were determined 
previously (Chapter 4). The duration of 26 hour post-incubation allows cells to accumulate where cell 
cycle is delayed or blocked and the initial cell loading of 2 × 10
5
 cells/well ensures the exponential cell 
growth up to 26 hours. The HAA concentrations that were used for DNA repair kinetics were 6 mM CAA, 
60 µM BAA and 25 µM IAA [36]. These concentrations were used as a starting point. However, no 
notable cell cycle alteration was observed with these concentrations. Thus to determine the optimum 
HAA concentration for cell cycle experiments, CHO cells were treated with a wide range of HAA 
concentrations and cell cycle of HAA-treated cells after 26 hour post-incubation was analyzed. Figure 5.1 
displays the cell cycle profile obtained with the LSR II flow cytometer as well as cell cycle distribution 
calculated using the FCS Express software. Cell cycle distribution is displayed by DNA content as 2N, 
2N-4N and 4N, which correspond to cells in G1, S and G2/M phase, respectively. With CAA at 2 – 8 mM, 
BAA at 30 – 150 µM, and IAA at 10 – 60 µM, no notable cell cycle alteration was observed compared to 
concurrent negative controls (Figure 5.1). The concentration of BAA was raised up to 500 µM. The 4N 
cell population increased with BAA concentration: 4.70% (0 µM), 3.14 % (100 µM), 10.5% (200 µM), 
9.79% (300 µM), and 17.4% (400 µM), 17.9% (500 µM) (Figure 5.2). 
 
5.3.2 Examination of the duration of post-incubation for cell cycle analysis 
 Although the duration of post-incubation was determined as 26 hours previously and that observation 
window allowed for detection of cell cycle alteration by HANs (Chapter 4), the duration of post-
incubation was re-examined with IAA. CHO cells were treated with IAA at 50 µM for 4 hours in a 6-well 
plate. Treated cells were washed twice with HBSS and fresh F12+5% FBS was added. After 4 and 8 
hours, the cells were collected and the cell cycle profile was analyzed (Figure 5.3). The cell cycle 
population was 47.8% (2N), 12.3% (2N-4N), 39.9% (4N) for negative control cells and 44.3% (2N), 
15.3% (2N-4N), and 40.3% (4N) for IAA-treated cells at 4 hour post-incubation and they were not 
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notably different as observed in HAN-treated cells. Similarly, difference was not observed in cell cycle 
population at 8 hour post-incubation; the cell cycle population with 2N, 2N-4N and 4N content were 
45.4%, 47.5%, 7.1%, respectively, for negative control cells, and 44.7%, 45.9%, and 9.4%, respectively, 
for IAA-treated cells.   
  
5.3.3 Plating efficiency 
 CHO cells were treated in the 6-well tissue culture plate for 4 hours, washed and harvested. Equal 
number of treated cells was plated onto a new 96-well microplate and the resulting cell densities after 72 
hours were compared to their concurrent negative controls. Within the concentrations tested, CAA and 
IAA did not suppress the cell growth except for the highest concentration used. The mean ± standard error 
(SE) cell densities compared to their concurrent negative controls was 81.2 ± 1.8% for CAA at 8 mM and 
84.6 ± 4.8% for IAA at 30 µM. On the other hand, BAA-treated cells demonstrated repressed cell growth 
over the concentration range tested; the resulting cell densities compared to the negative control was 94.5 
± 4.7% (30 µM), 72.9 ± 6.0% (60 µM), 52.6 ± 3.1% (90 µM), 56.3 ± 3.6% (120 µM) and 50.0 ± 4.2% 
(150 µM) (Figure 5.4).  
 
5.3.4 DNA strand breaks in different test systems 
 SCGE assay was conducted with CHO cells treated in a 96-well microplate with high cell density (the 
same condition as the genomic DNA damage induction and DNA repair kinetics) and in a 6-well plate 
with low cell density (the same condition as cell cycle analysis). The genomic DNA induction was 
generally lower when cells were treated in 6-well plate with low cell density. At the highest 
concentrations tested, CAA at 7 mM induced % tail DNA of 8.38 and 4.85 (Figure 5.5), BAA at 100 µM 
induced % tail DNA of 22.4 and 2.45 (Figure 5.6), and IAA at 30 µM induced % tail DNA of 26.8 and 






 Eukaryotic cells have multiple checkpoints to ensure the integrity of the genome and cell division 
[37-39]. DNA integrity checkpoints monitor DNA status and prevent inappropriate transitions into S 
phase and mitosis when aberrations are detected [24, 25]. Recent human cell toxicogenomic analysis 
focusing DNA damage signaling pathway demonstrated that gene expression involving cell cycle 
regulation was most affected [11]. Also, delayed cell cycle progression was reflected in the cell growth 
suppression in HAA-treated human cells. These results provided motivation to proceed to the cell cycle 
analysis of HAA-affected cells.  
 Chapter 4 demonstrated that the monoHANs induced abnormally high DNA content in treated cells. 
MonoHAAs and monoHANs have similar chemical structure in that both chemical groups have a single 
halogen substituent at the α-carbon. They both induced genomic DNA strand breaks with the rank order 
of iodinated > brominated > chlorinated analogues [8, 27] but induced DNA lesions were repaired with 
different efficiency (Chapter 2, 3). Thus we were interest if different cell cycle alteration can be observed 
in HAA-treated cells as reflected by the different DNA repair kinetics. We expected stronger cell cycle 
arrest in HAA-treated cells due to the associated DNA lesions that should cause longer processing time. 
Contrary to the anticipation, HAAs did not produce as distinct cell cycle alteration when compared to 
those by HANs; abnormally high DNA content or changes in cell ploidy was not observed in HAA-
treated cells in any of the conditions tested, which suggested a fundamentally different molecular 
mechanism of toxic action between HAAs and HANs.  
 It was suggested that HAN toxicity was dependent on mitosis and proliferation (Chapter 4). The 
treatment of high-density CHO cells with chloroacetonitrile (CAN) at 1200 µM, bromoacetonitrile (BAN) 
at 60 µM and iodoacetonitrile (IAN) at 60 µM followed by incubation in serum-free medium did not kill 
the cells after 24 hours (Chapter 3), but the treatment concentrations needed to be lowered to 900 µM 
CAN, 12 µM BAN and 6 µM IAN to avoid excessive cell killing when the cells were treated at low 
density followed by incubation in medium with serum for 26 hours (Chapter 4). Cell cycle progression 
was suppressed in the former case. This suggested the proliferation dependence of HAN toxicity.  
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 It appeared that the effect of cell proliferation state was completely opposite for HAA toxicity; the 
toxic potency of HAAs was weaker when cells were treated at low density. HAA treatment of CHO cells 
at low cell density did not repress the cell growth as much as when cells were treated at high cell density. 
The plating efficiency of HAA-treated cells at low density in a 6-well plate was 97.1 ± 1.4% for CAA at 6 
mM, 72.9 ± 6.0% for BAA at 60 µM, and 96.9 ± 4.0% for IAA at 25 µM. When plated cells were 
confluent at the treatment, the plating efficiency was 56.0 ± 0.9% for CAA at 6 mM, 74.4 ± 2.9% for 
BAA at 60 µM, and 60.4 ± 4.1% for IAA at 25 µM (Chapter 3). BAA-treated cells had the similar plating 
efficiency in these two different treatment conditions, but when cells were treated at low density, IAA and 
CAA did not suppress the cell growth.  
 In order to further examine if the toxic potency of HAAs was weaker when cells were treated at low 
density, genomic DNA damage induction was measured using SCGE assay. The day before treatment, 
CHO cells were plated in a sterile flat-bottom 96-well microplate at 4 × 10
4
 CHO cells/(200 μL of 
F12+5% FBS)/well or in a sterile flat-bottom 6-well tissue culture plates at 2 × 10
5
 cells/(2 mL F12+5% 


















), respectively. After 16 – 20 hour incubation, the cells were treated with HAAs at various 
concentrations. The variables were minimized by setting up the 96-well microplate and 6-well plate on 
the same day using the same cell suspension, and by treating the cells at the same time with the same 
chemical dilution. The genomic DNA induction was generally lower when cells were treated in 6-well 
plate with low cell density (Figures 5.5, 5.6, and 5.7).  
 There is an evidence that HAAs do not directly interact with genomic DNA but generate reactive 
oxygen species (ROS) that leads to induction of toxicity and DNA damage. The co-treatment of IAA with 
antioxidants reduced the IAA-mediated mutagenicity in Salmonella typhimurium and genomic DNA 
damage induction in CHO cells [40]. Dibromoacetic acid and bromochloroacetic acid induced oxidative 
stress in male B6C3F1 mice [41]. MonoHAAs was shown to inhibit glyceraldehydes-3-phosphate 
dehydrogenase [21, 22], which may lead to ROS production. It is possible that the low cell density state 
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as in the 6-well plate dissipated the ROS into the system due to the higher availability of medium per cells. 
Also, excess availability of pyruvate in F12 medium may have attenuated monoHAA-induced genomic 
DNA. Future experiments are required to understand this result.   
 In conclusion, cell cycle alteration was not strongly observed in monoHAA-treated cells. Since 
monoHAA-induced DNA lesions required longer processing time than monoHAN-induced lesions as 
demonstrated in Chapter 2 and 3, strong cell cycle delay was expected in HAA-treated cells. The 
difference of monoHAAs and monoHANs in both DNA repair kinetics and cell cycle alteration suggested 
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Tables and Figures 
 
 
Figure 5.1 HAA concentration optimization. (A) Cell cycle profiles obtained with LSR II flow cytometer. 
CAA (top), BAA (center), IAA (bottom). Arrows indicate the 2N and 4N DNA containing cells from the 
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Figure 5.2 BAA concentration was raised up to 500 µM. (A) Cell cycle profile obtained with the LSR II 
flow cytometer. Arrows indicate the 2N and 4N DNA containing cells from the left. (B) The cell cycle 
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Figure 5.3 The duration of post-incubation of 4 and 8 hours was examined after treatment with IAA at 50 
µM. (A) Cell cycle profile obtained with LSR II flow cytometer. Arrows indicate the 2N and 4N DNA 
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Figure 5.4 Cell density analysis of CHO cells exposed to HAAs for 4 hours, washed and harvested, and 




Mean CHO cell density as the Percentage 
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Figure 5.5 CAA-mediated genomic DNA damage measured with single cell gel electrophoresis assay. 

































































Figure 5.6 BAA-mediated genomic DNA damage measured with single cell gel electrophoresis assay. 



































































Figure 5.7 IAA-mediated genomic DNA damage measured with single cell gel electrophoresis assay. 









































































 This research aimed to compare the toxic properties of haloacetic acids (HAAs) and haloacetonitriles 
(HANs), as representative carbonaceous and nitrogenous DBPs using Chinese hamster ovary cell as a 
model mammalian cell system. These classes of DBPs are commonly found in drinking water and both 
classes are mutagenic, genotoxic, teratogenic and developmentally toxic in a wide variety of biological 
systems. MonoHAAs and monoHANs have a similar chemical structure, a single halogen substituent at 
their α-carbon, where substitution reactions can occur with a halogen atom as a leaving group. Both the 
HAAs and HANs induce genomic DNA damage with the rank order of iodinated > brominated > 
chlorinated analogues. DNA damage in eukaryotic cells is strongly associated with DNA repair and cell 
cycle progression. In order to provide insights on the mechanism of toxic action of these two classes of 
DBPs, the repair rate of induced DNA lesions and the occurrence of cell cycle alterations were examined.  
 The microplate-based single cell gel electrophoresis assay was modified to include liquid holding 
recovery to measure the reduction of genomic DNA damage level over time. The DNA lesions induced 
by monoHANs were repaired more efficiently than HAA-induced lesions. Within HAAs, BAA-induced 
lesions were repaired least efficiently compared to those induced by IAA and CAA. HAN-induced lesions 
did not express constant differences in the repair efficiency among the three homologs. Also the impact of 
halogen atom substitution was not consistent between two chemical classes. 
 Cytometric analysis demonstrated remarkable differences in the effects on cell cycle progression 
induced by the monoHAAs and monoHANs on post-treatment CHO cells. HAN-induced cell cycle 
modulation was concentration-dependent and also followed the genotoxicity rank order pattern of I > Br > 
Cl. HAN-treated cells accumulated cells with abnormally high levels of DNA content and had repressed 
cell growth. However, DNA strand breaks were not present when cell cycle alteration was observed 
during post-incubation. HAN-mediated cell cycle was mitosis- and proliferation-dependent, which 
suggested that HAN treatment induced mitotic failure in CHO cells and DNA content accumulation in the 
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HAN-treated cells. However, HAA-treated cells did not demonstrate any significant effect on post-
treatment cell cycle progression. The difference of monoHAAs and monoHANs in both DNA repair 
kinetics and cell cycle alterations indicate that fundamental differences in the mechanism of toxic action 
exist for these classes of DBPs.  
 This study demonstrated the efficacy provided by the use of multiple toxicity endpoints to address 
possible adverse health outcomes associated with exposure to disinfection byproducts. The experimental 
designs developed for the DNA repair kinetics and cell cycle alteration may lead to novel toxicity 
endpoints that could be incorporated in the battery of DBP toxicity evaluation. The severity of cell cycle 
modulation and the resulting aneuploidy of HAN-treated cells indicate that HANs may play a major role 
in cancer induction and adverse pregnancy outcomes associated with long-term exposure to disinfected 
drinking water. With the increasing stress on source waters due to water scarcity, many utilities seek 
alternative disinfection processes or alterations to chlorination practices. Regulated DBPs currently are 
employed as indicators for DBP control but many scientists believe that these regulated DBPs do not fully 
account for the adverse health outcomes identified by epidemiology studies. Identification of major DBP 
classes associated with adverse health outcomes from disinfected drinking water will aid in developing 
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Table A.1 Raw data of cell viability throughout a 60-hour time period with cells maintained under liquid 
holding conditions. Cell numbers were counted in triplicate.  
 
Liquid holding time  
(hours) 
Live Dead Live Dead Live Dead % Cell viability 
0 131 7 114 14 129 15 91.22 
8 100 4 131 5 109 2 96.87 
26 113 10 141 7 116 2 95.12 
32 148 16 116 4 129 14 92.04 
38 131 14 112 14 124 7 91.29 
48.5 116 14 126 10 108 11 90.91 
51 113 16 127 12 119 23 87.56 
53 106 11 106 8 137 20 89.95 
60 112 49 138 40 116 44 73.35 











x = col(1) 
y = col(2) 
reciprocal_y = 1/abs(y) 
reciprocal_ysquare = 1/y^2 
[Parameters] 
a = max(y) ''Auto {{previous: 93.5032}} 
b = if(max(y)>0, xwtr(x,y,.5)/4, -xwtr(x,y,.5)/4) ''Auto {{previous: -5.67684}} 
x0 = x50(x,y,.5) ''Auto {{previous: 68.2979}} 
[Equation] 
f= a/(1+exp(-(x-x0)/b)) 
fit f to y 
''fit f to y with weight reciprocal_y 








R = 0.95742268 Rsqr = 0.91665818 Adj Rsqr = 0.89284623 
 
Standard Error of Estimate = 2.4887  
 
  Coefficient Std. Error t P  
a 93.5032 1.1937 78.3304 <0.0001  
b -5.6768 1.5892 -3.5721 0.0091  
x0 68.2979 2.3645 28.8852 <0.0001  
 
Analysis of Variance:  
  DF SS MS F P  
Regression 2 476.8749 238.4375 38.4957 0.0002  
Residual 7 43.3571 6.1939  
Total 9 520.2320 57.8036  
 
PRESS = 104.3011  
 
Durbin-Watson Statistic = 2.6076  
 
Normality Test:  K-S Statistic = 0.2246 Significance Level = 0.6353 
 
Constant Variance Test:  Passed (P = 0.8379) 
 
Power of performed test with alpha = 0.0500: 0.9990 
 
Regression Diagnostics: 
Row Predicted Residual Std. Res. Stud. Res. Stud. Del. Res.  
1 93.5026 -2.2831 -0.9174 -1.0452 -1.0534  
2 93.5009 3.3652 1.3522 1.5396 1.7527  
3 93.4489 1.6668 0.6697 0.7534 0.7276  
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Table A.2 (cont.) 
 
4 93.3471 -1.3097 -0.5262 -0.5832 -0.5536  
5 93.0556 -1.7621 -0.7080 -0.7684 -0.7434  
6 90.7289 0.1802 0.0724 0.0833 0.0772  
7 89.2635 -1.7025 -0.6841 -0.8420 -0.8223  
8 87.5862 2.3623 0.9492 1.2330 1.2902  
9 75.9054 -2.5587 -1.0281 -1.3819 -1.5003  
10 74.6125 2.0404 0.8199 1.2311 1.2877  
 
Influence Diagnostics:  
Row Cook'sDist Leverage DFFITS  
1 0.1086 0.2297 -0.5752  
2 0.2343 0.2287 0.9544  
3 0.0502 0.2097 0.3748  
4 0.0259 0.1859 -0.2645  
5 0.0350 0.1510 -0.3135  
6 0.0007 0.2447 0.0439  
7 0.1217 0.3400 -0.5902  
8 0.3484 0.4074 1.0698  
9 0.5135 0.4465 -1.3475  
10 0.6340 0.5565 1.4425  
 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop.  5% Pop.  95%  
1 93.5026 90.6823 96.3229 86.9768 100.0285  
2 93.5009 90.6867 96.3151 86.9777 100.0241  
3 93.4489 90.7541 96.1437 86.9763 99.9215  
4 93.3471 90.8099 95.8844 86.9385 99.7557  
5 93.0556 90.7690 95.3422 86.7420 99.3692  
6 90.7289 87.8176 93.6402 84.1632 97.2946  
7 89.2635 85.8321 92.6949 82.4512 96.0758  
8 87.5862 83.8299 91.3425 80.6046 94.5678  
9 75.9054 71.9731 79.8377 68.8276 82.9832  





Table A.3 Raw data of the comparative genomic DNA repair kinetics in CHO cells for chloroacetic acid 
(CAA), iodoacetic acid (IAA), and bromoacetic acid (BAA). 
 
CAA 6 mM       
Liquid holding time  
(hours) 
%T compared  
to 0-hr 
Standard error  
of the mean 
% Cell viability 
0 100.0000 1.7376 96.70 
1 65.6467 3.6168 94.38 
2 55.8418 4.7360 98.77 
3 42.4971 6.7360 96.47 
4 43.1029 2.3404 99.09 
5 33.5174 7.1442 96.59 
24 15.1674 4.2768 98.03 
    
BAA 60 µM       
Liquid holding time  
(hours) 
%T compared  
to 0-hr 
Standard error  
of the mean 
% Cell viability 
0 100.0000 0.9820 98.26 
1 90.8643 4.8186 97.19 
2 75.1934 11.4845 95.52 
3 65.8421 6.7913 95.60 
4 63.0035 3.9422 97.07 
5 47.3868 3.3435 96.53 
24 20.7838 2.3102 90.09 
    
IAA 25 µM 
   
Liquid holding time  
(hours) 
%T compared  
to 0-hr 
Standard error  
of the mean 
% Cell viability 
0 100.0000 2.2584 96.56 
0.5 70.3823 8.5730 96.20 
1 69.7274 6.8941 97.22 
1.5 43.3533 2.2991 97.63 
2 40.1440 4.7579 98.60 
2.5 36.2164 5.4431 97.90 
3 29.7061 4.2074 98.73 
3.5 28.9711 2.2605 98.96 
4 31.6431 2.3565 100.00 
4.5 30.4182 2.0769 99.04 
5 26.0237 2.5295 97.74 









x = col(1) 
y = col(2) 
reciprocal_y = 1/abs(y) 
reciprocal_ysquare = 1/y^2 
[Parameters] 
a = max(y)-min(y) ''Auto {{previous: 4065.59}} 
b = xwtr(x,y-min(y),.5)/4 ''Auto {{previous: -2.79955}} 
x0 = x50(x,y-min(y),.5) ''Auto {{previous: -11.0281}} 
y0 = min(y) ''Auto {{previous: 17.8924}} 
[Equation] 
f= y0+a/(1+exp(-(x-x0)/b)) 
fit f to y 
''fit f to y with weight reciprocal_y 







R = 0.98542405 Rsqr = 0.97106056 Adj Rsqr = 0.94212113 
 
Standard Error of Estimate = 6.4875  
 
  Coefficient Std. Error t P  
a 4065.5904 198202.1554 0.0205 0.9849  
b -2.7995 2.0910 -1.3389 0.2730  
x0 -11.0281 159.5618 -0.0691 0.9492  
y0 17.8924 6.4971 2.7539 0.0705  
 
Analysis of Variance:  
  DF SS MS F P  
Regression 3 4236.7713 1412.2571 33.5549 0.0083  
Residual 3 126.2638 42.0879  
Total 6 4363.0350 727.1725  
 
PRESS = 88606.4738  
 
Durbin-Watson Statistic = 2.3036  
 
Normality Test:  K-S Statistic = 0.1322 Significance Level = 0.9991 
 
Constant Variance Test:  Passed (P = 0.6019) 
 
Power of performed test with alpha = 0.0500: 0.9984 
 
Regression Diagnostics: 
Row Predicted Residual Std. Res. Stud. Res. Stud. Del. Res.  
1 95.5094 4.4906 0.6922 3.9328 (+inf)  
2 72.5089 -6.8622 -1.0578 -1.5803 -3.1519  
146 
 
Table A.4 (cont.) 
 
3 56.2587 -0.4169 -0.0643 -0.0824 -0.0674  
4 44.8110 -2.3139 -0.3567 -0.4158 -0.3497  
5 36.7630 6.3398 0.9772 1.2136 1.3889  
6 31.1133 2.4041 0.3706 0.5146 0.4400  
7 17.9074 -2.7400 -0.4223 -4.1085 (+inf)  
 
Influence Diagnostics:  
Row Cook'sDist Leverage DFFITS  
1 120.9552 0.9690 (+inf)  
2 0.7692 0.5520 -3.4984  
3 0.0011 0.3924 -0.0541  
4 0.0155 0.2642 -0.2095  
5 0.1997 0.3516 1.0228  
6 0.0615 0.4814 0.4240  
7 395.1251 0.9894 (+inf)  
 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop.  5% Pop.  95%  
1 95.5094 75.1855 115.8332 66.5384 124.4804  
2 72.5089 57.1699 87.8479 46.7884 98.2295  
3 56.2587 43.3258 69.1916 31.8964 80.6210  
4 44.8110 34.1996 55.4223 21.5976 68.0244  
5 36.7630 24.5204 49.0057 12.7600 60.7661  
6 31.1133 16.7883 45.4384 5.9843 56.2424  












x = col(7) 
y = col(8) 
reciprocal_y = 1/abs(y) 
reciprocal_ysquare = 1/y^2 
[Parameters] 
a = max(y)-min(y) ''Auto {{previous: 149.841}} 
b = xwtr(x,y-min(y),.5)/4 ''Auto {{previous: -3.2507}} 
x0 = x50(x,y-min(y),.5) ''Auto {{previous: 0.422673}} 
y0 = min(y) ''Auto {{previous: 20.6092}} 
[Equation] 
f= y0+a/(1+exp(-(x-x0)/b)) 
fit f to y 
''fit f to y with weight reciprocal_y 







R = 0.99476894 Rsqr = 0.98956524 Adj Rsqr = 0.97913047 
 
Standard Error of Estimate = 3.8487  
 
  Coefficient Std. Error t P  
a 149.8415 112.8701 1.3276 0.2763  
b -3.2507 1.5453 -2.1036 0.1261  
x0 0.4227 4.7969 0.0881 0.9353  
y0 20.6092 3.9340 5.2388 0.0135  
 
Analysis of Variance:  
  DF SS MS F P  
Regression 3 4214.1103 1404.7034 94.8335 0.0018  
Residual 3 44.4369 14.8123  
Total 6 4258.5472 709.7579  
 
PRESS = 4800.4290  
 
Durbin-Watson Statistic = 3.0233  
 
Normality Test:  K-S Statistic = 0.2042 Significance Level = 0.8975 
 
Constant Variance Test:  Passed (P = 0.7810) 
 
Power of performed test with alpha = 0.0500: 1.0000 
 
Regression Diagnostics: 
Row Predicted Residual Std. Res. Stud. Res. Stud. Del. Res.  
1 100.3939 -0.3939 -0.1024 -0.3131 -0.2599  
2 88.8944 1.9699 0.5118 0.6455 0.5680  
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Table A.5 (cont.) 
 
3 77.7016 -2.5082 -0.6517 -0.8642 -0.8142  
4 67.2933 -1.4512 -0.3771 -0.4547 -0.3848  
5 58.0172 4.9863 1.2956 1.5756 3.0976  
6 50.0581 -2.6713 -0.6941 -1.2067 -1.3735  
7 20.7153 0.0686 0.0178 0.5613 0.4844  
 
Influence Diagnostics:  
Row Cook'sDist Leverage DFFITS  
1 0.2047 0.8931 -0.7512  
2 0.0615 0.3713 0.4365  
3 0.1416 0.4313 -0.7090  
4 0.0235 0.3123 -0.2593  
5 0.2973 0.3239 2.1438  
6 0.7363 0.6692 -1.9533  
7 78.1255 0.9990 15.2571  
 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop.  5% Pop.  95%  
1 100.3939 88.8189 111.9690 83.5416 117.2462  
2 88.8944 81.4312 96.3577 74.5516 103.2373  
3 77.7016 69.6580 85.7453 63.0484 92.3549  
4 67.2933 60.4486 74.1381 53.2624 81.3243  
5 58.0172 51.0469 64.9875 43.9246 72.1098  
6 50.0581 40.0388 60.0774 34.2339 65.8822  











x = col(4) 
y = col(5) 
reciprocal_y = 1/abs(y) 
reciprocal_ysquare = 1/y^2 
[Parameters] 
a = max(y)-min(y) ''Auto {{previous: 2172.73}} 
b = xwtr(x,y-min(y),.5)/4 ''Auto {{previous: -1.51751}} 
x0 = x50(x,y-min(y),.5) ''Auto {{previous: -5.0206}} 
y0 = min(y) ''Auto {{previous: 20.8428}} 
[Equation] 
f= y0+a/(1+exp(-(x-x0)/b)) 
fit f to y 
''fit f to y with weight reciprocal_y 







R = 0.97792049 Rsqr = 0.95632848 Adj Rsqr = 0.93995167 
 
Standard Error of Estimate = 6.0033  
 
  Coefficient Std. Error t P  
a 2172.7309 51774.0889 0.0420 0.9676  
b -1.5175 0.9132 -1.6617 0.1351  
x0 -5.0206 40.6832 -0.1234 0.9048  
y0 20.8428 5.1441 4.0517 0.0037  
 
Analysis of Variance:  
  DF SS MS F P  
Regression 3 6313.5262 2104.5087 58.3953 <0.0001  
Residual 8 288.3123 36.0390  
Total 11 6601.8385 600.1671  
 
PRESS = 2080.1444  
 
Durbin-Watson Statistic = 2.3989  
 
Normality Test:  K-S Statistic = 0.1353 Significance Level = 0.9705 
 
Constant Variance Test:  Passed (P = 0.7831) 
 
Power of performed test with alpha = 0.0500: 1.0000 
 
Regression Diagnostics: 
Row Predicted Residual Std. Res. Stud. Res. Stud. Del. Res.  
1 97.5022 2.4978 0.4161 0.1345 0.1260  
2 76.5349 -6.1527 -1.0249 -0.3633 -0.3427  
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3 61.1921 8.5353 1.4218 0.6993 0.6751  
4 50.0178 -6.6645 -1.1102 -0.9525 -0.9462  
5 41.9075 -1.7635 -0.2938 -1.2842 -1.3482  
6 36.0358 0.1806 0.0301 0.0379 0.0355  
7 31.7925 -2.0864 -0.3475 -0.3833 -0.3619  
8 28.7300 0.2411 0.0402 0.0431 0.0403  
9 26.5218 5.1213 0.8531 0.9192 0.9091  
10 24.9306 5.4875 0.9141 1.0027 1.0031  
11 23.7847 2.2391 0.3730 0.4205 0.3978  
12 20.8428 -7.6186 -1.2691 -2.4618 -4.6765  
 
Influence Diagnostics:  
Row Cook'sDist Leverage DFFITS  
1 -0.0050 10.5623 (+inf)  
2 -0.0371 8.9581 (+inf)  
3 -0.1518 5.1335 (+inf)  
4 -0.3937 2.3586 (+inf)  
5 7.4658 0.9477 -5.7372  
6 0.0002 0.3716 0.0273  
7 0.0080 0.1779 -0.1684  
8 0.0001 0.1315 0.0157  
9 0.0340 0.1386 0.3647  
10 0.0511 0.1690 0.4523  
11 0.0120 0.2134 0.2072  
12 4.1859 0.7342 -7.7731  
 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop.  5% Pop.  95%  
1 97.5022 52.5112 142.4933 50.4296 144.5749  
2 76.5349 35.1011 117.9688 32.8497 120.2202  
3 61.1921 29.8265 92.5576 26.9074 95.4767  
4 50.0178 28.7574 71.2781 24.6476 75.3880  
5 41.9075 28.4311 55.3840 22.5877 61.2274  
6 36.0358 27.5972 44.4745 19.8231 52.2486  
7 31.7925 25.9532 37.6319 16.7678 46.8172  
8 28.7300 23.7101 33.7499 14.0044 43.4556  
9 26.5218 21.3679 31.6757 11.7500 41.2936  
10 24.9306 19.2399 30.6214 9.9631 39.8982  
11 23.7847 17.3895 30.1798 8.5354 39.0340  








Table A.7 Two-way Analysis of Variance for DNA repair of CHO cells treated with chloroacetic acid 
(CAA), bromoacetic acid (BAA) and iodoacetic acid (IAA). Holm-Sidak pairwise comparison. 
 
Two Way Analysis of Variance  CHO SCGE DNA Repair Kinetics of CAA, IAA and BAA 
Multivariate ANOVA   Friday, March 06, 2009, 7:50:01 AM 
 




Dependent Variable: TM response  
 
Source of Variation  DF   SS   MS    F    P   
HAA 2 11086.049 5543.024 34.981 <0.001  
LHT 5 51001.238 10200.248 64.372 <0.001  
HAA x LHT 10 3271.643 327.164 2.065 0.036  
Residual 90 14261.198 158.458    
Total 107 79620.127 744.113    
 
 
The difference in the mean values among the different levels of HAA is greater than would be expected by chance 
after allowing for effects of differences in LHT.  There is a statistically significant difference (P = <0.001).  To 
isolate which group(s) differ from the others use a multiple comparison procedure. 
 
The difference in the mean values among the different levels of LHT is greater than would be expected by chance 
after allowing for effects of differences in HAA.  There is a statistically significant difference (P = <0.001).  To 
isolate which group(s) differ from the others use a multiple comparison procedure. 
 
The effect of different levels of HAA depends on what level of LHT is present.  There is a statistically significant 
interaction between HAA and LHT.  (P = 0.036) 
 
Power of performed test with alpha = 0.0500:  for HAA : 1.000 
Power of performed test with alpha = 0.0500:  for LHT : 1.000 
Power of performed test with alpha = 0.0500:  for HAA x LHT : 0.521 
 
Least square means for HAA :  
Group Mean  
CAA 56.768  
IAA 49.541  
BAA 73.715  
Std Err of LS Mean = 2.098 
 
Least square means for LHT :  
Group Mean  
0.000 100.000  
1.000 75.413  
2.000 57.060  
3.000 46.015  
4.000 45.916  
5.000 35.643  
Std Err of LS Mean = 2.967 
 
Least square means for HAA x LHT :  
Group Mean  
CAA x 0.000 100.000  
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Table A.7 (cont.) 
 
CAA x 1.000 65.647  
CAA x 2.000 55.842  
CAA x 3.000 42.497  
CAA x 4.000 43.103  
CAA x 5.000 33.517  
IAA x 0.000 100.000  
IAA x 1.000 69.727  
IAA x 2.000 40.144  
IAA x 3.000 29.706  
IAA x 4.000 31.643  
IAA x 5.000 26.024  
BAA x 0.000 100.000  
BAA x 1.000 90.864  
BAA x 2.000 75.193  
BAA x 3.000 65.842  
BAA x 4.000 63.004  
BAA x 5.000 47.387  
Std Err of LS Mean = 5.139 
 
 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
 
Comparisons for factor: HAA 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
BAA vs. IAA 24.174 8.148 2.022E-012 0.017 Yes  
BAA vs. CAA 16.947 5.712 0.000000142 0.025 Yes  
CAA vs. IAA 7.227 2.436 0.0168 0.050 Yes  
 
 
Comparisons for factor: LHT 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
0.000 vs. 5.000 64.357 15.338 7.646E-027 0.003 Yes  
0.000 vs. 4.000 54.084 12.889 3.758E-022 0.004 Yes  
0.000 vs. 3.000 53.985 12.866 4.183E-022 0.004 Yes  
0.000 vs. 2.000 42.940 10.234 9.356E-017 0.004 Yes  
1.000 vs. 5.000 39.770 9.478 3.478E-015 0.005 Yes  
1.000 vs. 4.000 29.496 7.030 0.000000000387 0.005 Yes  
1.000 vs. 3.000 29.398 7.006 0.000000000431 0.006 Yes  
0.000 vs. 1.000 24.587 5.860 0.0000000751 0.006 Yes  
2.000 vs. 5.000 21.417 5.104 0.00000184 0.007 Yes  
1.000 vs. 2.000 18.353 4.374 0.0000327 0.009 Yes  
2.000 vs. 4.000 11.143 2.656 0.00936 0.010 Yes  
2.000 vs. 3.000 11.045 2.632 0.00998 0.013 Yes  
3.000 vs. 5.000 10.372 2.472 0.0153 0.017 Yes  
4.000 vs. 5.000 10.274 2.448 0.0163 0.025 Yes  
3.000 vs. 4.000 0.0986 0.0235 0.981 0.050 No  
 
 
Comparisons for factor: LHT within CAA 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
0.000 vs. 5.000 66.483 9.148 0.000 0.003 Yes  
0.000 vs. 3.000 57.503 7.912 0.000 0.004 Yes  
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0.000 vs. 4.000 56.897 7.829 0.000 0.004 Yes  
0.000 vs. 2.000 44.158 6.076 0.000 0.004 Yes  
0.000 vs. 1.000 34.353 4.727 0.000 0.005 Yes  
1.000 vs. 5.000 32.129 4.421 0.000 0.005 Yes  
1.000 vs. 3.000 23.150 3.185 0.002 0.006 Yes  
1.000 vs. 4.000 22.544 3.102 0.003 0.006 Yes  
2.000 vs. 5.000 22.324 3.072 0.003 0.007 Yes  
2.000 vs. 3.000 13.345 1.836 0.070 0.009 No  
2.000 vs. 4.000 12.739 1.753 0.083 0.010 No  
1.000 vs. 2.000 9.805 1.349 0.181 0.013 No  
4.000 vs. 5.000 9.585 1.319 0.191 0.017 No  
3.000 vs. 5.000 8.980 1.236 0.220 0.025 No  
4.000 vs. 3.000 0.606 0.0834 0.934 0.050 No  
 
 
Comparisons for factor: LHT within IAA 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
0.000 vs. 5.000 73.976 10.179 0.000 0.003 Yes  
0.000 vs. 3.000 70.294 9.672 0.000 0.004 Yes  
0.000 vs. 4.000 68.357 9.406 0.000 0.004 Yes  
0.000 vs. 2.000 59.856 8.236 0.000 0.004 Yes  
1.000 vs. 5.000 43.704 6.013 0.000 0.005 Yes  
1.000 vs. 3.000 40.021 5.507 0.000 0.005 Yes  
1.000 vs. 4.000 38.084 5.240 0.000 0.006 Yes  
0.000 vs. 1.000 30.273 4.165 0.000 0.006 Yes  
1.000 vs. 2.000 29.583 4.071 0.000 0.007 Yes  
2.000 vs. 5.000 14.120 1.943 0.055 0.009 No  
2.000 vs. 3.000 10.438 1.436 0.154 0.010 No  
2.000 vs. 4.000 8.501 1.170 0.245 0.013 No  
4.000 vs. 5.000 5.619 0.773 0.441 0.017 No  
3.000 vs. 5.000 3.682 0.507 0.614 0.025 No  
4.000 vs. 3.000 1.937 0.267 0.790 0.050 No  
 
 
Comparisons for factor: LHT within BAA 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
0.000 vs. 5.000 52.613 7.239 0.000 0.003 Yes  
1.000 vs. 5.000 43.478 5.982 0.000 0.004 Yes  
0.000 vs. 4.000 36.996 5.091 0.000 0.004 Yes  
0.000 vs. 3.000 34.158 4.700 0.000 0.004 Yes  
1.000 vs. 4.000 27.861 3.834 0.000 0.005 Yes  
2.000 vs. 5.000 27.807 3.826 0.000 0.005 Yes  
1.000 vs. 3.000 25.022 3.443 0.001 0.006 Yes  
0.000 vs. 2.000 24.807 3.413 0.001 0.006 Yes  
3.000 vs. 5.000 18.455 2.539 0.013 0.007 No  
1.000 vs. 2.000 15.671 2.156 0.034 0.009 No  
4.000 vs. 5.000 15.617 2.149 0.034 0.010 No  
2.000 vs. 4.000 12.190 1.677 0.097 0.013 No  
2.000 vs. 3.000 9.351 1.287 0.201 0.017 No  
0.000 vs. 1.000 9.136 1.257 0.212 0.025 No  




Table A.7 (cont.) 
 
Comparisons for factor: HAA within 0 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
CAA vs. IAA 1.421E-013 1.955E-014 1.000 0.017 No  
CAA vs. BAA 4.263E-014 5.866E-015 1.000 0.025 No  
BAA vs. IAA 9.948E-014 1.369E-014 1.000 0.050 No  
 
 
Comparisons for factor: HAA within 1 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
BAA vs. CAA 25.218 3.470 0.001 0.017 Yes  
BAA vs. IAA 21.137 2.908 0.005 0.025 Yes  
IAA vs. CAA 4.081 0.561 0.576 0.050 No  
 
 
Comparisons for factor: HAA within 2 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
BAA vs. IAA 35.049 4.823 0.000 0.017 Yes  
BAA vs. CAA 19.352 2.663 0.009 0.025 Yes  
CAA vs. IAA 15.698 2.160 0.033 0.050 Yes  
 
 
Comparisons for factor: HAA within 3 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
BAA vs. IAA 36.136 4.972 0.000 0.017 Yes  
BAA vs. CAA 23.345 3.212 0.002 0.025 Yes  
CAA vs. IAA 12.791 1.760 0.082 0.050 No  
 
 
Comparisons for factor: HAA within 4 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
BAA vs. IAA 31.360 4.315 0.000 0.017 Yes  
BAA vs. CAA 19.901 2.738 0.007 0.025 Yes  
CAA vs. IAA 11.460 1.577 0.118 0.050 No  
 
 
Comparisons for factor: HAA within 5 
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
BAA vs. IAA 21.363 2.939 0.004 0.017 Yes  
BAA vs. CAA 13.869 1.908 0.060 0.025 No  







Table A.8 Raw data of the histograms illustrating the distributions of SCGE % tail DNA values from 
CHO cells treated with chloroacetic acid without and with 1, 2, 3, 4, 5 and 24 hour liquid-holding 
recovery. 
 
LH_0h LH_1h LH_2h LH_3h LH_4h LH_5h LH_24h 
       
1.89816 1.77412 1.16929 0.482543 0.350030 0 0 
7.39122 2.59485 1.46925 0.529053 0.353541 0 0 
8.00026 3.34571 1.62063 0.607267 0.641992 0 0 
14.3215 3.35549 1.62280 0.779692 0.838712 0 0 
15.3750 3.39348 1.68511 1.26777 1.70883 0.148729 0 
16.0592 3.95373 1.92082 1.28495 1.85396 0.196121 0 
18.7389 4.26208 2.03675 1.28776 1.98630 0.289881 0 
19.2952 4.41890 2.64310 1.49251 2.69055 0.384716 0 
21.0806 4.56261 3.07576 1.51283 2.78892 0.414667 0 
22.5384 4.58761 3.28975 1.70365 3.02022 0.448623 0 
22.9453 4.65933 3.31564 1.75470 3.12454 0.478664 0 
25.9863 4.76807 3.33981 1.77765 3.28541 0.488387 0 
27.1813 5.11083 3.47893 1.82869 3.38324 0.531871 0 
27.5630 5.14193 4.17077 1.83651 3.50514 0.540641 0 
28.0050 5.21619 4.35420 1.84580 3.64082 0.576870 0 
29.8275 5.45530 4.90067 1.90539 3.89074 0.603571 0 
31.2193 5.51990 5.08070 1.92470 4.06167 0.614740 0 
32.2386 6.00556 5.32571 2.00791 4.08896 0.615207 0 
32.8749 6.15730 5.41289 2.10000 4.08972 0.630892 0 
32.9964 7.80491 5.51314 2.13922 4.15777 0.700391 0.0808468 
33.7740 7.94536 6.01529 2.27459 4.16729 0.710434 0.138006 
33.9724 8.31093 6.16920 2.79064 4.44365 0.736958 0.154044 
34.1381 8.85729 6.52334 3.00173 4.45763 0.750094 0.160460 
35.9517 10.3555 7.38441 3.03040 4.52910 0.759171 0.239990 
35.9907 10.6110 7.50076 3.06186 4.72121 0.792267 0.256281 
36.7876 10.6532 8.15320 3.21584 5.07226 0.819058 0.266110 
37.1009 10.9274 8.55583 3.33348 5.12261 0.942236 0.304608 
37.2197 11.1704 8.57860 3.46350 5.15331 1.00684 0.308193 
37.4286 11.4310 8.77739 3.61654 5.17934 1.01790 0.314668 
37.4890 11.5695 8.81375 3.78041 5.18826 1.13393 0.319999 
37.5309 11.6917 8.81682 4.26299 5.23506 1.15095 0.321096 
37.7241 11.9239 8.91645 4.34719 5.41999 1.22039 0.340884 
38.0050 12.0145 9.22742 4.47698 5.57999 1.22538 0.350860 
38.5558 12.9912 9.47527 4.67889 5.83256 1.40237 0.357560 
38.7435 13.0612 9.65651 4.69599 5.95190 1.52265 0.371352 
38.7927 13.7958 9.79066 4.74216 6.06289 1.52789 0.381534 
39.1583 13.8053 9.82831 4.89648 6.07137 1.53866 0.381579 
39.3033 13.8135 9.83719 4.96933 6.11791 1.54519 0.393645 
39.4289 14.4146 9.89110 5.31258 6.18442 1.61218 0.413302 
39.5685 14.5021 10.2702 5.44492 6.33499 1.64745 0.416770 
40.0943 14.8086 10.5414 5.51565 6.34564 1.68684 0.423316 
41.1504 15.0653 10.6251 5.75446 6.44886 1.69394 0.426014 
41.2008 15.2647 11.0245 6.08772 6.62914 1.71788 0.443669 
41.4843 15.4527 11.2362 6.11111 7.34096 1.72778 0.448801 
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41.5773 15.6326 11.5932 6.15696 7.44516 1.75717 0.464367 
41.8024 16.0957 11.6632 6.15888 7.58022 1.75831 0.469015 
41.8853 16.0959 11.7837 6.16124 7.86144 1.76557 0.471124 
42.7538 16.3362 11.8102 6.25887 7.88376 1.80173 0.472750 
43.5761 16.4091 11.9174 6.32208 7.89158 1.97704 0.486529 
43.7446 17.0214 12.2850 6.46884 8.46538 2.05753 0.490868 
44.0778 17.3285 12.4460 6.64745 8.71526 2.15650 0.498766 
44.3715 17.7385 12.8290 6.70308 8.86905 2.18418 0.519064 
44.5412 17.7458 12.8527 6.78007 8.91000 2.26551 0.545962 
44.6001 17.9831 12.8990 6.90868 9.05967 2.30724 0.547500 
44.6705 18.1465 12.9304 7.14435 9.22028 2.35108 0.558472 
44.8967 18.3341 13.4411 7.15651 9.26245 2.35883 0.562203 
45.0677 18.7882 13.5392 7.24044 9.36710 2.41625 0.568106 
45.1431 19.1552 13.5874 7.34831 9.65808 2.54205 0.570116 
45.3590 19.5629 13.7845 7.40378 9.72747 2.58395 0.588025 
45.3693 19.8115 14.1012 7.40834 10.2318 2.59986 0.594232 
45.5849 20.7844 14.2238 7.51876 10.2652 2.61510 0.594853 
46.2216 21.1039 14.2949 7.55922 10.2807 2.65567 0.596218 
46.4027 21.5205 14.5445 7.74696 10.3095 2.72047 0.640699 
46.4252 22.2985 14.7532 7.92849 10.5129 2.82028 0.646924 
46.8002 23.3823 14.9065 7.95708 10.9494 2.85123 0.649090 
47.8239 24.0946 14.9432 8.01726 10.9868 2.91446 0.659185 
47.8806 24.1207 14.9657 8.19154 11.1901 2.91677 0.679834 
47.9484 25.1399 15.0406 8.21362 11.3067 3.01478 0.681980 
48.0237 25.8794 15.7120 8.25374 11.5203 3.06245 0.702359 
48.2850 25.9305 15.8329 8.28889 11.5948 3.07344 0.708176 
48.5354 26.7125 15.8480 8.40720 11.7167 3.38766 0.709348 
49.3044 26.7225 16.0067 8.46684 11.9505 3.54013 0.720234 
49.6102 26.9324 16.8826 8.67575 12.1361 3.59080 0.722307 
49.8943 27.5139 17.2734 8.75467 12.2843 3.60676 0.727039 
51.1183 27.6363 17.5234 8.80430 12.3702 3.62238 0.745446 
51.3893 28.3406 17.8296 9.07924 12.4311 3.69019 0.760113 
51.9270 28.4564 18.2510 9.17667 12.5170 3.72629 0.770382 
52.5346 29.0681 18.4494 9.25706 12.5536 3.77720 0.771286 
52.9054 29.2274 18.5267 9.42419 12.6047 4.04968 0.781912 
53.0287 29.5457 18.9170 9.57692 12.7513 4.07496 0.789531 
53.6418 30.0179 19.0773 9.79433 12.7707 4.13724 0.789655 
53.9699 30.0861 19.2755 9.95698 12.8348 4.36412 0.826512 
54.2048 30.2376 19.4095 10.3194 13.1344 4.44183 0.826905 
54.2759 30.7207 20.3666 10.4319 13.3919 4.44294 0.850715 
54.4144 30.8079 20.8902 10.4416 13.4940 4.45117 0.871834 
54.4763 30.8369 21.1579 10.4565 13.6837 4.50930 0.873851 
54.6678 30.9512 21.5969 10.6277 13.7041 4.61657 0.907581 
54.6983 31.0758 21.6521 10.6987 13.8211 4.62599 0.937309 
54.8863 31.3732 21.9781 10.7154 13.8616 4.79998 0.983015 
55.4208 31.5942 22.4423 10.8061 14.0998 4.85177 0.983981 
55.9893 31.7248 22.4442 10.8349 14.3275 4.91408 0.99189 
56.0106 31.7383 22.4499 10.9538 14.7054 4.96918 1.00992 
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56.4772 31.8711 22.7809 10.9636 15.1455 4.97124 1.02686 
56.6316 32.2336 22.9808 11.0214 15.2125 5.01713 1.03752 
56.7080 32.7337 23.2279 11.1355 15.4233 5.13521 1.03785 
56.8418 33.0218 23.4042 11.2826 15.6909 5.14173 1.06812 
57.1074 33.0817 23.4863 11.8629 15.8304 5.19782 1.07062 
57.1991 33.2297 24.2411 12.1460 15.8494 5.42776 1.07507 
57.2233 33.4164 24.7252 12.2308 16.0950 5.44417 1.07923 
57.5054 33.4769 25.0337 12.2479 16.2661 5.73717 1.10754 
57.8425 33.4950 25.0814 12.4356 16.3305 5.90226 1.10895 
57.9123 33.5998 25.3364 12.5451 16.5587 5.90493 1.11299 
58.4381 33.8048 25.8968 12.6782 16.8633 6.11333 1.12745 
59.1624 33.8385 26.0070 12.7307 16.8673 6.22841 1.15067 
59.1912 33.8575 26.1277 13.4415 17.0508 6.23411 1.16601 
59.2117 33.8687 26.6492 13.4428 17.1184 6.32961 1.17061 
59.7406 34.0069 26.7238 13.5895 17.3953 6.77653 1.20620 
59.7601 34.3206 27.1719 13.6198 17.5146 6.98630 1.21527 
60.3936 34.4319 27.2982 13.8153 17.5919 7.03433 1.23452 
60.4289 34.6865 27.4858 14.2361 17.6424 7.08749 1.25067 
60.5303 34.9810 28.1111 14.4146 17.7401 7.25115 1.26284 
60.9584 34.9929 28.1303 14.7433 17.9507 7.28821 1.27197 
61.1963 35.4880 28.3188 15.1534 17.9908 7.35173 1.28150 
61.3347 35.5934 28.8220 15.1732 18.1509 7.41179 1.28156 
61.7614 35.6941 28.9220 15.3637 18.1684 7.50885 1.31095 
61.9165 36.1317 29.0952 15.4150 18.5311 7.58459 1.35160 
62.0060 36.1754 29.1700 15.4553 18.6842 7.71378 1.36850 
62.1465 36.3512 29.2909 15.9930 18.7141 7.78236 1.36871 
62.1996 36.5398 29.3561 16.1811 19.4553 7.79552 1.41674 
62.5267 36.6105 29.4571 16.2292 19.5516 7.99974 1.44654 
62.6414 36.8366 30.0550 16.2293 19.6179 8.03869 1.46682 
62.7677 36.9324 30.2016 16.2437 19.7414 8.07551 1.51980 
62.8837 37.0396 30.2352 16.6120 20.1416 8.21676 1.59799 
63.3507 37.1507 30.3593 16.9115 20.3958 8.35725 1.60433 
63.4483 37.2243 30.3762 17.1388 20.4815 8.39504 1.66802 
63.4824 37.4063 30.7503 17.1948 20.7771 8.46295 1.68321 
63.5203 37.7167 30.7997 17.5563 20.9831 8.65736 1.71867 
63.5534 37.8914 30.9274 17.9019 20.9948 8.70048 1.74663 
63.8465 37.9406 31.0861 17.9380 21.1744 8.75706 1.76670 
64.0501 38.0923 31.4230 18.2069 21.5116 8.76450 1.79632 
64.1817 38.2787 31.5169 18.3361 21.6751 8.86750 1.80421 
64.5666 39.2078 31.5701 18.3369 21.9149 9.25295 1.88057 
64.7755 39.4304 31.7355 18.4881 22.0514 9.34673 1.88319 
64.9193 39.4835 31.7405 18.5094 22.1161 9.42093 1.91744 
65.2833 39.5415 31.8006 18.5150 22.1200 9.66672 1.93813 
65.4122 39.7488 31.9951 18.5324 22.4679 9.69090 1.95188 
65.4267 40.1414 32.2353 18.6880 23.6986 9.85090 1.97305 
65.4490 40.1842 32.8060 18.8611 23.9672 10.2934 2.03622 
65.5276 40.3493 33.1388 19.0281 24.1544 10.7458 2.12081 
65.7769 40.9129 33.3142 19.0490 24.4063 10.7978 2.15059 
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65.7986 41.0975 33.5751 19.1604 24.4911 10.9413 2.18292 
65.8179 41.3890 33.8732 19.1959 24.8429 11.0844 2.20451 
65.8795 41.6215 34.1241 19.2270 25.2252 11.1739 2.20904 
66.0052 41.9791 34.2013 19.3532 25.4817 11.1968 2.26019 
66.0318 42.3914 34.4009 19.9478 25.6872 11.4581 2.26554 
66.4653 42.5544 34.5058 20.2047 25.7861 11.7724 2.35333 
66.5489 42.5847 35.0071 20.2545 26.0040 11.8490 2.35556 
66.7550 42.7408 35.8920 20.5492 26.3381 11.9564 2.38607 
67.0405 43.4471 35.8988 20.8246 26.3766 12.2137 2.42031 
67.0662 43.4931 35.9284 21.5638 26.4338 12.2545 2.44167 
67.2971 43.5215 36.3006 22.4590 26.6305 12.8122 2.46047 
67.5533 43.7783 36.3259 22.5031 26.7012 12.9124 2.47967 
68.0369 43.8098 36.3483 22.7206 26.7924 12.9288 2.48573 
68.1695 43.9632 36.6656 22.7786 26.9461 13.0132 2.56485 
68.2711 44.3015 36.8206 22.8772 27.3607 13.0624 2.67199 
68.5208 44.4385 37.1515 22.9601 27.4072 13.1244 2.67245 
68.6261 44.6922 37.4520 23.1028 27.5070 13.1837 2.78009 
68.7324 45.0764 37.4567 23.1164 27.5321 13.9763 2.79452 
68.7461 45.0875 37.4734 24.4441 27.5772 14.0264 2.86296 
68.7863 45.0932 37.4787 25.0046 27.9648 14.0519 2.87065 
68.9943 45.3377 37.6077 25.1087 28.1116 14.1325 2.90980 
69.0488 45.4005 37.7939 25.1551 28.2300 14.4841 2.94761 
69.1251 45.4868 37.9778 25.6249 28.3775 14.5737 2.95299 
69.2787 45.4939 38.1209 25.8334 28.5060 14.6134 2.98804 
69.5482 46.0861 38.1410 26.1527 28.5521 14.7436 3.00695 
69.8598 46.2573 38.3156 26.1645 28.5581 14.9133 3.13932 
69.8795 46.3503 38.7817 26.1811 28.5774 15.0953 3.16561 
69.8805 46.3651 39.3053 26.3955 28.6196 15.2539 3.20850 
69.9315 46.6603 39.8885 26.6361 28.7613 15.8866 3.21365 
70.3967 47.1017 39.8945 27.2032 28.9332 16.1117 3.24208 
70.4060 47.1741 39.9972 27.3127 29.4694 16.1298 3.30670 
70.6888 47.4222 40.5332 27.3728 29.6541 16.3337 3.38491 
70.8514 47.8018 41.0549 27.8607 29.9574 16.5740 3.40661 
70.9906 47.8343 41.2904 28.1110 30.3791 16.6295 3.41881 
71.0322 47.8864 41.4207 28.2148 30.4197 17.2086 3.42789 
71.2235 48.1516 41.8465 28.3230 30.4676 17.3502 3.50654 
71.3834 48.1897 42.1042 28.8264 30.5382 17.5145 3.52099 
71.4157 48.2020 42.3182 29.2484 30.6876 17.8965 3.52923 
71.4751 48.2726 42.5520 29.3013 30.9981 17.9123 3.53259 
71.9664 48.7052 42.7158 29.4391 31.2371 18.0219 3.55815 
72.0408 48.7169 42.7363 29.4972 31.3370 18.0495 3.56510 
72.1169 49.5623 42.7493 30.4112 31.4320 18.3635 3.61193 
72.1846 49.8467 42.8791 31.0027 31.9415 18.3801 3.75118 
72.3709 49.8847 43.0946 31.0204 32.4503 18.4230 3.78466 
72.4642 50.2439 43.1154 31.4540 32.8623 18.7573 3.78856 
72.9687 50.3088 43.1739 31.6138 33.4627 18.7919 3.79030 
73.0699 50.3192 43.5247 31.9385 33.4979 18.8177 3.82858 
73.1178 50.6214 43.6730 32.6793 33.5456 19.3185 3.83966 
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73.1906 50.6238 44.0493 32.7358 33.8498 19.6769 3.86969 
73.2937 50.7831 44.1224 32.8934 34.1343 20.3196 3.91801 
73.7330 50.9122 44.1415 33.5773 34.5232 20.6369 3.92312 
73.8175 51.2421 45.2970 33.5863 34.6666 20.9039 3.94850 
73.8358 51.3716 45.4607 33.7617 35.2948 21.1614 3.98940 
73.8802 51.5229 45.4976 34.3360 35.3273 21.2176 4.01784 
74.5400 51.8358 45.5969 34.4514 35.4112 21.5798 4.03037 
74.6608 52.2023 46.0050 35.4504 35.6387 22.1417 4.03037 
74.6753 52.2240 46.4447 35.7638 36.2523 22.2078 4.05095 
74.9080 52.3135 46.7951 35.8683 36.6818 22.6356 4.07220 
75.0025 52.4082 46.8245 36.0447 36.8123 23.1120 4.10316 
75.0067 52.4974 47.0852 36.2536 36.8287 23.4068 4.14425 
75.3542 52.9621 47.1283 36.4839 36.8744 24.1093 4.16046 
75.5233 53.1154 47.5949 36.5052 37.2649 24.3856 4.20154 
75.5740 53.4818 48.3689 37.6834 37.3876 24.8214 4.30792 
75.6679 53.5145 48.4340 37.8010 37.6004 25.1054 4.32742 
75.7667 53.5227 49.0332 38.1049 37.7627 26.7049 4.49064 
76.0405 53.5408 49.2462 38.1674 37.8330 27.7758 4.59134 
76.1249 53.7746 49.2777 38.5484 37.8689 27.9195 4.59502 
76.2192 53.8699 49.3786 38.6538 37.9554 27.9840 4.63470 
76.2863 54.5477 49.5517 38.8870 38.3320 28.2051 4.63533 
76.4718 54.7531 49.9610 40.2914 38.4417 28.5494 4.74321 
76.4835 54.8839 50.2015 40.4638 38.4528 29.1238 4.78612 
76.5848 56.2589 50.3797 40.5633 38.4555 29.1717 4.84615 
76.6478 56.3927 50.5276 40.7097 38.5183 29.5400 4.89069 
76.7660 56.4115 50.5461 41.0484 38.5343 29.7184 5.09582 
76.9729 56.5518 50.5612 41.2592 38.6735 29.8568 5.12540 
77.0952 56.5780 50.9760 41.6620 38.7998 30.2314 5.16302 
77.0982 56.9554 51.0750 41.6849 39.0109 30.4008 5.20879 
77.0991 57.3085 51.4197 41.7486 39.0166 32.2971 5.21097 
77.3131 57.3628 51.7648 43.1041 39.1185 32.3922 5.27940 
77.5215 57.4039 51.7773 43.5580 39.2384 32.4156 5.33590 
77.6165 57.6923 51.8825 43.6382 39.2506 32.6815 5.34577 
77.6320 58.0432 52.6871 43.6455 39.6778 32.7782 5.37263 
77.6755 58.0655 52.9705 43.8434 39.9389 33.0810 5.40667 
77.7665 58.6723 53.0168 44.1652 40.0847 33.0868 5.44062 
78.0162 59.5949 53.8129 44.2848 40.2242 33.2865 5.46017 
78.0416 60.0784 53.8412 44.4309 40.2626 34.2763 5.49140 
78.0873 60.5033 54.1744 44.7214 40.8374 34.3262 5.51818 
78.1452 60.8341 54.5266 45.0921 41.4938 34.5558 5.59912 
78.3773 61.0240 54.6407 45.7910 41.8169 34.5627 5.67074 
78.3891 61.1997 54.6794 46.1040 42.3636 34.5906 5.85374 
78.4777 61.4793 55.1572 46.4831 42.5351 34.6482 5.86007 
78.4959 61.5517 55.4104 46.4903 42.6392 34.9587 5.94080 
78.5435 61.6072 55.5023 46.8901 42.7282 35.9118 5.96894 
78.6766 61.8707 55.6151 46.9145 42.9645 35.9668 6.00709 
78.6976 61.9286 55.6294 47.3870 43.2914 36.6474 6.05015 
78.7841 62.0916 55.6320 47.8488 43.3943 36.8200 6.13273 
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78.8600 62.7945 55.6640 48.2302 43.4280 37.1967 6.15175 
79.0939 63.2479 55.7788 48.3234 43.6158 37.2268 6.15540 
79.6473 63.2510 56.0324 48.3264 43.9333 37.7066 6.17994 
79.6873 63.7026 56.0603 48.3796 43.9565 37.7921 6.33010 
79.9799 63.8257 56.1254 48.5697 44.1826 38.0049 6.39699 
80.1317 63.9884 56.7201 49.0392 44.3099 38.3963 6.40890 
80.2049 64.0294 56.7307 49.2114 44.4553 39.2665 6.45471 
80.4886 64.5289 56.7358 49.3486 44.5539 39.5267 6.45972 
80.8087 64.6686 57.0334 49.4432 44.8650 40.0749 6.49373 
80.8346 64.7020 57.4683 50.3897 44.8772 40.1753 6.60618 
80.8924 65.2897 57.9163 50.4459 46.0745 40.7107 6.70553 
80.9818 65.5157 57.9361 50.6498 46.1065 40.8433 6.73492 
81.0334 66.1214 58.1721 50.8564 46.2416 41.3021 6.78849 
81.0693 66.3170 58.2534 50.9682 46.3263 41.5878 6.84975 
81.2523 66.3789 58.4856 51.3548 46.4649 41.6996 6.87091 
81.3633 67.0465 58.8079 51.3734 46.7627 41.8136 6.88238 
81.5749 67.0576 58.8875 51.5766 46.9020 41.8981 6.99425 
81.5988 67.2772 58.9408 51.7930 46.9503 42.3553 7.02957 
82.1061 67.4535 59.2072 51.8419 47.2941 42.6584 7.12467 
82.1669 67.5113 59.4822 51.9596 47.3291 42.9795 7.14795 
82.1780 67.7781 59.9154 52.0025 47.8108 44.2724 7.47934 
82.2562 67.7902 60.3092 52.3394 48.4717 44.7142 7.57612 
82.3107 69.6118 60.3941 52.5059 48.7726 45.3310 7.63380 
82.4037 69.8032 61.0509 52.8066 48.8073 45.6046 7.67688 
82.4696 70.0140 61.2655 53.4224 48.9842 46.1532 7.70104 
82.4986 70.1887 61.2892 53.5041 49.3691 46.7454 7.72406 
82.7153 70.4670 61.6331 53.6365 49.5068 47.8487 7.80497 
82.9325 70.5708 62.0998 53.9060 49.5834 48.0944 7.82346 
82.9692 70.5783 62.4167 54.1294 49.6399 50.4413 7.86882 
83.0994 70.9181 63.0612 54.3133 49.8853 50.6080 7.92955 
83.3118 71.0882 63.4231 54.9186 50.8813 50.8168 7.96036 
83.3425 71.3808 63.6767 55.0789 51.2195 52.1457 8.01677 
83.4245 71.3969 63.7868 55.8273 52.6798 53.1795 8.04830 
83.4914 71.9836 64.1853 56.0914 54.0095 53.3503 8.50333 
83.5686 72.4192 64.7631 56.5232 54.0822 53.5211 8.55134 
83.5754 72.6086 65.2533 57.2189 54.3403 55.2030 8.69077 
83.7845 72.6562 65.4510 57.7044 54.5578 56.7411 8.75986 
83.8238 73.3625 65.5143 59.0303 54.6476 57.1240 9.06653 
83.9344 73.5007 66.1267 59.1145 55.4654 57.7208 9.20712 
84.0731 73.5652 66.4863 60.8307 56.2124 58.0728 9.22870 
84.3391 74.6572 66.6803 61.0424 56.3218 58.2025 9.55736 
84.3752 76.1434 66.7403 61.9892 56.3701 58.4242 9.57864 
84.3782 76.7683 66.8813 62.8933 56.8899 58.6146 9.67728 
84.4854 76.9912 67.2381 63.7757 58.2442 58.8480 9.71964 
84.5637 77.3347 67.8000 64.5516 58.2828 61.7688 9.75133 
85.0535 77.8959 68.3788 64.9791 58.7276 62.2380 9.77275 
85.1598 78.4472 68.6121 65.4592 60.3931 62.2580 9.81424 
85.2469 78.6101 68.9936 68.2160 60.9010 62.8396 9.83628 
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85.3449 79.2764 70.0923 68.5319 61.5459 65.2431 9.87821 
85.4557 79.6210 72.5319 69.1048 63.5871 66.2725 10.2282 
85.6731 80.2971 72.6986 69.8794 64.2027 66.3652 10.6903 
85.6807 80.4100 73.2221 70.1614 64.9107 67.8455 10.8451 
85.8216 80.5047 73.8006 70.3688 65.8702 68.9266 10.9429 
86.2697 81.0870 75.1063 70.6155 68.6585 70.0337 10.9855 
86.2791 81.1323 75.7316 70.6788 70.8078 70.4059 10.9981 
86.2917 82.4307 76.3749 70.7257 72.5679 70.5599 11.0136 
86.3886 83.7925 76.9179 71.0776 74.3719 70.9934 11.0719 
86.4182 85.1371 78.3113 72.7913 74.4413 75.5793 11.1179 
86.5326 85.2350 78.5276 73.6660 81.4663 77.8335 11.2573 
86.7809 85.9876 79.6538 74.5566 81.4724 78.7976 11.3302 
86.9058 87.1466 86.8656 78.4499 81.5506 80.7001 11.7910 
87.2931 88.6443 89.5709 83.4172 81.7990 80.9494 11.7918 
87.4354 88.9822 90.2665 88.8817 84.2838 84.6904 12.4074 
87.5262 93.5679 91.5425 89.3336 85.5011 90.1872 12.6249 
87.6504 
     
12.7054 
87.8650 
     
12.9336 
88.1693 
     
12.9972 
88.2779 
     
13.3760 
88.3035 
     
13.4564 
88.3230 
     
13.7047 
88.3251 
     
13.8943 
88.3579 
     
14.7948 
88.5540 
     
14.8290 
88.5684 
     
15.0182 
88.9346 
     
15.9526 
89.5730 
     
16.5896 
89.6015 
     
17.7509 
89.6155 
     
18.0214 
89.6878 
     
18.2497 
89.6939 
     
18.6275 
89.7878 
     
18.7202 
89.9481 
     
19.2617 
90.2357 
     
19.7831 
90.3589 
     
20.2298 
90.5157 
     
20.2817 
90.6805 
     
20.5614 
90.8555 
     
20.9337 
90.8839 
     
22.2604 
91.0796 
     
22.5333 
91.1337 
     
23.8128 
91.2539 
     
23.8880 
91.6053 
     
24.1199 
91.6773 
     
24.1782 
91.7474 
     
24.2760 
92.0823 
     
24.4222 
92.4171 
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92.5441 
     
25.8861 
92.7075 
     
28.9321 
92.7191 
     
29.7889 
92.7481 
     
30.1330 
92.7926 
     
30.9538 
92.9197 
     
36.5969 
92.9393 
     
37.0907 
93.0586 
     
37.7085 
93.5973 
     
41.3614 
93.7435 
     
49.7953 
93.7621 
     
54.3988 
93.7636 
     
57.7578 
93.8237 
     
57.8155 
94.4617 
     
59.4862 
94.7185 
     
68.4189 
94.7746 
     
70.8857 
95.4379 
     
73.4599 
98.3215 






Table A.9 Raw data of the histograms illustrating the distributions of SCGE % tail DNA values from 
CHO cells treated with bromoacetic acid without and with 1, 2, 3, 4, 5 and 24 hour liquid-holding 
recovery. 
 
LH_0h LH_1h LH_2h LH_3h LH_4h LH_5h LH_24h 
       
1.09666 1.29940 1.66620 0.732319 0.453507 0.294216 0.224926 
1.42283 2.65633 2.62503 0.955142 0.600620 0.640939 0.286862 
3.12683 5.49852 3.12556 0.961374 0.772081 0.768654 0.293668 
4.22903 8.21766 3.14566 1.03240 1.03703 0.774926 0.315953 
5.76477 8.40428 3.24547 1.07134 1.35429 0.807261 0.333389 
5.97487 9.95728 3.56065 1.48010 1.42242 0.890267 0.479498 
7.41226 10.0694 3.60688 1.54529 1.42911 1.01836 0.524173 
7.91857 10.6771 4.40058 1.68078 2.00171 1.05843 0.563811 
9.48337 11.3689 4.65385 1.84901 2.08350 1.07983 0.565986 
10.0933 11.5059 4.88941 1.96864 2.14517 1.08551 0.613075 
10.2858 12.4314 5.04619 2.02544 2.16871 1.13672 0.628614 
10.5264 12.6824 6.31435 2.13685 2.19426 1.21549 0.649479 
12.6905 13.2133 6.64394 2.19717 2.20665 1.28741 0.688622 
12.9485 13.5112 6.82940 2.24385 2.23967 1.41307 0.700107 
13.4350 13.5283 7.72659 2.42345 2.26058 1.55658 0.734889 
13.8821 13.9412 8.14138 2.74722 2.37336 1.59376 0.741270 
15.0287 14.0735 8.16478 3.23905 2.38978 1.60425 0.830427 
15.1438 14.8618 8.25480 3.28995 2.60566 1.60720 0.855867 
15.5046 15.1819 9.18469 3.35317 2.79775 1.67389 0.898520 
15.6487 15.2011 9.19701 3.81939 2.81202 1.69563 0.906166 
16.1897 15.2100 9.30631 3.86799 3.07896 1.79014 0.916526 
18.4253 15.8154 9.49591 3.87404 3.22815 1.86041 0.921815 
19.6120 17.3136 9.70040 4.26277 3.37166 1.86926 0.949078 
19.7484 17.5227 10.2263 4.47075 3.45478 1.87851 0.955428 
20.3202 17.8665 10.2573 4.54499 3.51138 2.01292 0.998819 
20.5430 18.0539 10.3871 4.68267 3.63834 2.17596 1.00302 
20.7742 18.3124 10.9167 5.41589 3.66680 2.19733 1.01031 
20.8377 18.5113 11.1532 5.56586 4.50489 2.34170 1.05416 
20.8783 18.5954 11.3443 5.58413 4.59940 2.50257 1.10489 
21.0544 19.1456 11.6040 6.18863 5.17258 2.51935 1.16688 
21.0773 19.1874 12.1711 6.39282 5.69084 2.60718 1.19321 
23.1099 19.5522 12.7959 6.89663 5.76056 2.76528 1.21668 
23.1359 19.5821 12.7991 7.20113 5.77570 2.85524 1.22568 
23.7171 19.8336 13.3610 7.21536 5.81127 2.94822 1.24625 
24.0415 19.8813 14.3746 7.38543 5.89151 3.39613 1.25227 
24.1958 19.8831 14.4939 7.75977 6.27036 3.60581 1.27137 
24.2824 20.2600 14.7116 8.12358 6.59591 3.75969 1.28005 
24.6218 20.3891 14.7332 8.22596 6.63519 3.90089 1.35811 
24.7165 20.7605 15.4598 8.26189 6.68194 3.92280 1.37011 
24.9854 21.0527 15.6444 8.34262 7.16090 4.10494 1.42648 
25.3057 21.2175 15.9216 8.53496 7.17994 4.14354 1.42793 
25.3119 21.3454 16.3211 8.53776 7.30625 4.17513 1.43377 
25.5217 22.1687 16.3708 9.22511 7.44569 4.79986 1.44220 
25.5533 22.6140 16.3824 9.25548 7.49363 5.01713 1.47707 
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25.5651 22.8048 16.6612 9.39302 8.11156 5.48318 1.49729 
25.6547 22.9340 17.0190 9.52477 8.33115 5.53361 1.53349 
25.8676 23.1029 17.2345 9.63285 8.58649 5.66361 1.57145 
25.9248 23.1664 17.3484 9.68705 8.70622 5.67012 1.62404 
26.2087 23.5484 17.6263 10.3178 9.85394 5.74451 1.63189 
26.4943 23.6612 17.7025 11.1356 10.1132 5.91318 1.64619 
26.5633 23.9088 17.7072 11.1666 10.3216 6.07570 1.65756 
26.5974 24.5334 18.1108 11.6015 10.4798 6.25979 1.80206 
26.9372 24.6189 18.2816 11.6193 10.5578 6.34196 1.84415 
26.9880 25.2466 18.8532 11.7263 10.7455 6.50972 1.84986 
27.8664 25.4057 18.8969 11.8168 11.6994 6.57001 1.85039 
28.2994 25.4387 19.5696 11.8931 11.7151 6.77993 1.85564 
28.6864 25.4528 19.6003 12.4079 12.0233 6.84412 1.93654 
29.2030 25.5858 19.7108 12.5099 12.0335 7.10327 1.94548 
29.2903 25.7238 20.0637 12.7070 12.0863 7.10701 1.97661 
29.5874 25.8490 20.1123 13.2210 12.2360 7.12876 1.99077 
29.7888 26.2829 20.1591 13.2834 12.2910 7.26396 1.99171 
30.1029 26.4888 20.3468 13.3454 12.3428 7.36014 2.02787 
30.1664 26.9960 20.4256 13.7689 12.4097 7.69451 2.09390 
30.2274 27.0956 20.4858 13.8455 12.6021 7.88887 2.16513 
30.3970 27.2096 20.6039 14.0685 13.4104 7.90987 2.16614 
30.6921 27.3058 20.6067 14.3347 13.5820 7.94689 2.29880 
30.6959 27.5137 20.9914 14.4628 13.7208 8.06642 2.30022 
30.8406 27.6446 21.3361 14.8832 14.1709 8.28730 2.30494 
30.8513 28.1058 21.3414 14.8912 14.3983 8.32468 2.42938 
31.4866 28.3105 21.3449 14.9102 14.5605 8.53095 2.46166 
31.8371 28.5600 21.4443 15.8145 14.6766 8.82330 2.50473 
32.3907 28.7024 21.4545 16.0798 14.7682 8.89829 2.54696 
32.4032 29.6553 21.8250 16.1245 15.0774 8.98401 2.65772 
32.4647 29.8391 21.9417 16.3185 15.1473 9.00249 2.73266 
32.4778 29.8597 22.1624 16.6100 15.2155 9.06538 2.78938 
32.7458 30.0702 22.3687 17.0383 15.2960 9.08820 2.82976 
32.7476 30.2688 22.5844 17.3746 15.4589 9.16338 2.83004 
33.5753 30.4464 22.6480 17.9045 15.6564 9.25001 2.83866 
33.9538 30.4902 22.6485 18.7881 15.7630 9.63293 2.87639 
34.8950 31.0373 22.7139 19.3483 16.1859 9.69994 2.88687 
36.1732 31.0507 23.0568 19.4518 16.3148 9.85730 2.89257 
36.5595 31.2317 23.1565 19.4639 16.3396 9.86264 2.93173 
36.6180 31.2418 23.3064 19.8900 17.0132 9.88294 2.93708 
36.6865 31.2592 23.3518 20.1052 17.1270 9.98805 2.95099 
36.9840 31.3931 23.4517 20.2601 17.8338 10.0244 2.96542 
37.0481 31.4759 23.6615 20.3247 17.8524 10.0666 2.98098 
37.0497 31.5123 23.6666 20.4498 18.1814 10.5096 3.06000 
37.0918 32.0073 23.6930 20.7130 18.3851 10.6109 3.15139 
37.4179 32.0210 23.9639 20.9164 18.4126 10.8614 3.28627 
37.4329 32.2166 24.0208 20.9760 18.7779 11.1122 3.44215 
37.7896 32.3910 24.3359 21.0985 18.8106 11.1916 3.45070 
37.8363 32.4891 24.3579 21.3548 18.8602 11.2233 3.47092 
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38.0074 32.5067 24.4332 21.4924 19.4175 11.2996 3.48775 
38.0901 32.5451 24.4953 21.6134 19.4743 11.3450 3.50252 
38.1714 32.8819 24.6219 21.6796 19.4873 11.3473 3.50467 
38.6683 32.9495 24.7630 21.7167 19.6706 11.3782 3.51975 
38.7762 33.1883 24.8661 22.2350 19.7119 11.5394 3.58674 
38.8846 33.3320 25.6433 22.3100 19.7931 11.5493 3.64870 
39.0857 33.5571 25.6829 22.6690 20.0722 11.9294 3.71377 
39.2014 33.6678 25.8288 22.7061 20.2132 12.1074 3.73607 
39.7709 33.7213 26.0420 22.7291 21.3054 12.1401 3.74837 
39.8708 34.2809 26.2160 22.8386 21.7946 12.2634 3.77347 
39.8954 34.3155 26.2686 23.0784 21.8317 12.4554 3.79541 
39.9835 34.6779 26.3431 23.3177 22.0827 12.5398 3.80658 
40.2677 34.9066 26.4015 23.3449 22.2309 12.5846 3.96530 
40.3796 34.9167 26.4074 23.4182 22.3942 12.6538 4.00805 
41.3988 35.0517 26.5586 23.5775 22.6197 13.0230 4.19750 
41.4772 35.0632 27.0839 23.7904 22.6476 13.2316 4.24142 
41.5623 35.2705 27.2211 23.8470 23.2057 13.7922 4.30075 
42.4664 35.3492 27.4263 23.9635 23.2384 13.8883 4.32007 
42.5413 35.5804 27.5364 24.1406 23.2735 14.0589 4.33249 
42.6192 35.8783 27.7433 24.7194 23.6096 14.2245 4.37861 
42.6877 36.0168 27.8276 24.7736 23.7272 14.2481 4.42483 
42.7072 36.1296 27.8531 24.9656 23.8526 14.3848 4.43445 
42.9941 36.2919 27.8566 25.1626 23.9978 14.5426 4.48667 
43.0316 36.7589 28.3814 25.4889 24.1084 14.5573 4.49213 
43.1138 36.9352 28.4138 26.0375 24.2895 14.6003 4.82547 
43.4831 37.0884 28.5123 26.0704 24.5929 14.9051 4.92107 
43.6227 37.1409 28.9432 26.2964 24.7471 14.9544 5.01552 
43.6761 37.1616 29.0950 26.3779 24.7651 15.5201 5.11605 
43.9087 37.4394 29.4598 26.7462 25.0180 15.8073 5.18368 
44.9779 37.7295 29.9847 26.9149 25.0551 15.8317 5.23983 
45.3210 37.9197 29.9980 26.9598 25.2958 15.9602 5.29267 
45.5224 38.0267 31.2111 27.3133 25.3540 15.9617 5.34297 
45.5627 38.0754 31.3072 27.3433 25.5676 16.6244 5.34922 
45.7633 38.0993 31.3566 27.6222 25.9095 16.7775 5.38703 
45.9881 39.0376 31.3924 27.6661 25.9628 16.8364 5.42884 
46.2682 39.6177 31.4672 27.7765 26.0966 17.0597 5.47761 
46.3505 39.9239 31.5495 27.8355 26.2296 17.1345 5.51593 
46.5112 40.0576 31.6005 28.1002 26.2651 17.2454 5.55947 
47.0126 40.1980 31.6281 28.5070 26.3467 17.4345 5.61138 
47.2192 40.3695 31.7329 28.9433 26.4278 18.0312 5.70738 
47.4915 40.6116 32.0567 29.0212 26.6240 18.6502 5.72762 
47.6575 41.2456 32.0880 29.1432 26.8505 18.9409 5.79326 
47.7903 41.7210 32.4772 29.1799 26.8567 18.9767 5.81551 
48.3575 41.7944 32.9687 29.3604 26.9123 19.1502 5.88925 
48.7303 41.8048 33.0245 29.4495 26.9781 19.3530 5.92795 
48.8565 41.8415 33.1442 29.4758 27.3763 19.4091 5.94040 
48.9959 41.8615 33.2932 29.6343 27.3951 19.6307 6.05564 
49.3783 41.8945 33.5672 29.6466 27.8578 19.7604 6.11916 
166 
 
Table A.9 (cont.) 
 
49.7600 42.0627 33.7580 29.6522 28.1353 19.9352 6.55295 
49.9521 42.1004 33.9563 29.7003 28.1446 19.9367 6.76777 
50.0500 42.4171 34.0229 29.9318 28.6814 20.1245 7.02880 
50.1951 42.6543 34.0697 30.0803 28.7096 20.1345 7.03739 
50.2015 42.7259 34.3201 30.0948 29.5284 20.2852 7.04122 
50.4818 42.7461 34.5204 30.4453 29.6680 20.4439 7.08427 
50.9394 42.9416 34.5786 30.4853 29.7219 20.5065 7.28451 
50.9808 43.2365 34.5819 30.8787 29.9432 20.5113 7.36935 
51.0678 43.3166 34.9247 31.0430 31.0583 20.5714 7.37193 
51.1238 43.5136 35.0997 31.4176 31.1293 20.7773 7.38807 
51.1287 43.8060 35.2114 31.5005 31.2175 20.8233 7.39831 
51.2752 44.0709 35.7364 31.5472 31.2494 20.9762 7.42322 
51.4651 44.1619 35.8542 31.7667 31.3905 21.1819 7.50202 
51.4958 44.4873 35.8545 31.7722 31.4023 21.1854 7.50701 
51.6322 45.1525 36.0504 31.9539 31.4310 21.2933 7.67471 
51.6910 45.2445 36.1016 31.9801 31.4512 21.4343 7.84899 
52.1373 45.3204 36.1176 32.0314 31.5219 21.5231 7.99462 
52.2630 45.6087 36.1405 32.3530 31.5445 21.8857 8.14083 
52.4906 45.7078 36.2476 32.3834 31.6555 21.8971 8.27211 
52.7858 45.7616 36.4550 32.4799 32.0773 22.1322 8.34287 
52.8660 45.7700 36.5441 32.5882 32.5005 22.1480 8.40547 
53.0635 45.9324 36.6901 32.7640 32.6703 22.5471 8.69030 
53.7449 46.2495 36.7829 32.7880 33.1188 23.3712 8.71362 
53.7935 46.2655 36.8615 32.8510 33.4488 23.6283 8.84133 
53.9166 46.6744 37.1274 33.0121 33.8569 23.7329 8.96382 
54.0197 46.9439 37.1560 33.0365 34.1474 23.9954 8.97643 
54.0582 47.0015 37.4153 33.4250 34.3136 24.1342 9.02249 
54.1240 47.2320 37.6346 33.5306 34.4537 24.2931 9.21168 
54.2278 47.4570 38.0499 33.5859 34.5056 24.6151 9.29181 
54.4909 47.7540 38.1544 33.6152 34.8377 24.9948 9.31940 
54.7154 47.8086 38.4705 33.7944 34.8412 25.1358 9.34121 
54.8134 47.8559 38.5024 34.2606 34.8993 25.2216 9.43300 
54.8692 48.2588 39.1536 34.4688 35.2628 25.2611 9.43596 
55.0530 48.2917 39.1907 34.5175 35.4945 25.6762 9.64557 
55.4726 48.5301 39.2944 34.7112 35.5211 25.6966 9.74861 
55.6380 48.7911 39.3474 34.8546 36.6653 25.7283 9.80327 
55.7472 49.1832 39.4172 35.0785 36.6809 25.7496 9.88027 
55.7956 49.2179 39.6354 35.2983 36.8387 25.7645 9.97572 
56.3368 49.2777 39.9349 35.3947 37.1448 25.8052 10.0537 
56.5637 49.5789 40.3059 35.6425 37.1778 25.8059 10.0826 
56.5655 49.5844 40.4819 35.8944 37.2180 25.9854 10.1594 
56.5831 50.1653 40.5327 36.0780 37.4736 26.3304 10.1701 
56.6020 50.1777 40.5432 36.0805 37.5739 26.3476 10.1907 
56.9362 50.2823 40.7099 36.0913 37.9673 26.3541 10.3024 
57.0738 50.8877 40.8083 36.2927 38.1641 26.4322 10.5322 
57.2749 51.1408 40.8307 36.3519 38.7954 26.4413 10.7269 
57.5532 51.1820 40.8349 36.4849 39.0139 26.5867 10.9234 
57.8516 51.2541 40.9508 36.6350 39.3222 26.7956 10.9501 
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58.0255 51.3321 41.0075 36.6581 39.3929 26.9448 11.0856 
58.2236 51.6024 41.2045 36.8672 39.4158 27.0423 11.3196 
58.3215 52.2566 41.2763 37.0163 39.9485 27.2056 11.3484 
58.5824 52.3024 41.4808 37.0164 40.0235 27.5116 11.5067 
59.0512 52.7866 41.5625 37.2510 40.4072 27.5935 11.7702 
59.3541 52.7876 41.8255 37.9702 40.4898 27.8890 12.0572 
59.5360 52.9559 41.8338 38.0272 40.5298 28.5532 12.1529 
59.7306 52.9935 41.8399 38.0321 40.6386 28.5770 12.2765 
59.8150 53.0707 42.0951 38.1751 41.0277 28.9734 12.2895 
59.9738 53.0996 42.2938 38.4508 41.3491 29.1224 12.4436 
60.1154 53.4178 43.0171 38.5498 41.5062 29.2077 12.5900 
60.4733 54.5641 43.8801 39.1141 41.6187 29.3123 12.7068 
60.8460 54.8820 44.1998 39.4180 41.7080 29.4822 12.9427 
61.0028 54.9549 44.2870 39.5576 41.8918 29.5212 13.1544 
61.0755 55.0334 44.3803 39.7293 41.9630 30.0154 13.3331 
61.3336 55.1615 44.4428 39.9518 42.1379 30.2737 13.3413 
61.3900 55.1670 45.2717 40.4270 42.1721 30.4504 13.7857 
61.5923 55.2236 45.5883 40.6364 42.3364 30.4577 13.7881 
61.6546 55.4797 45.8573 40.6484 42.3442 30.8363 13.8333 
61.8674 55.5190 45.8635 40.6817 42.5094 31.4054 13.9936 
61.8785 55.5641 45.9611 40.7775 42.5651 32.5476 14.3072 
61.9073 55.6457 46.1760 40.8468 43.3316 32.6798 14.3582 
61.9658 55.7468 46.2831 41.2560 43.3451 32.7531 14.5752 
62.0057 55.7942 46.3112 41.8369 43.5799 32.8624 14.6129 
62.4850 55.8356 46.3356 42.2079 43.9545 32.9291 14.6712 
62.5925 55.8656 46.4190 42.7031 44.2642 33.5860 14.6841 
62.8609 56.5266 46.4794 42.8201 44.3382 34.0036 14.9014 
62.8916 56.5308 46.7071 43.0181 44.3824 34.0523 14.9128 
63.1485 56.5687 46.7576 43.3398 44.4521 34.1903 15.0594 
63.9912 56.6328 46.7651 43.4156 44.7017 34.4551 15.1188 
64.5560 56.7211 46.8553 43.6742 44.7368 34.4661 15.3727 
64.7010 56.7461 47.3622 43.7415 44.8445 34.6014 15.6355 
64.8655 56.7968 47.6107 44.0684 45.1357 35.3167 15.6815 
65.0034 57.3320 47.6826 44.1982 45.1536 35.5924 15.6981 
65.6617 57.3551 48.3109 44.2841 45.6241 36.7391 16.1895 
65.7021 57.5854 48.5296 44.3606 45.8081 36.9855 16.5355 
65.7021 57.7525 48.7094 44.3735 45.9376 37.0805 16.6859 
66.2952 59.1184 48.8250 44.4299 46.4048 37.0870 16.8008 
66.5304 59.1955 48.9147 45.2948 47.0855 37.2236 16.8269 
66.5309 59.2160 49.1616 45.4236 47.3383 37.6895 16.9414 
66.7773 59.6014 49.9207 45.4480 47.7164 37.7654 17.0577 
66.8183 60.1565 49.9565 45.5689 48.2522 38.0491 17.0973 
66.9136 60.4918 50.0440 45.6170 48.4150 38.1754 17.3361 
67.2066 60.9619 50.2186 46.1816 48.4256 38.3866 17.4057 
67.7311 61.0211 50.4272 47.4518 48.8496 38.8390 17.4591 
67.7843 61.4439 50.5309 47.5600 49.0347 39.0534 17.7778 
67.8073 61.9906 51.0639 48.1668 49.2272 39.1612 18.7536 
68.5261 62.0707 51.1315 48.6762 49.3316 39.2337 18.9134 
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68.5753 62.4578 51.2814 48.7641 49.5938 39.2666 18.9725 
69.3540 62.6622 51.3861 48.9515 49.7886 39.2936 19.0767 
69.7347 62.6653 51.3930 49.4909 49.9814 39.3557 19.2698 
70.1019 62.9419 51.4606 49.5461 50.1450 39.6241 19.3560 
70.3723 63.3545 51.4825 49.6371 50.3707 39.9607 19.9518 
70.4142 63.9519 51.6661 49.7876 50.4514 40.7793 19.9722 
71.8927 64.2040 51.9636 49.9411 50.9096 40.9883 20.1121 
71.9317 64.2687 52.3269 50.0404 51.1070 41.5760 20.3552 
72.2292 64.4566 52.4605 50.7054 51.3328 41.5849 20.7714 
72.7077 64.8952 52.6997 50.8937 51.7779 41.6694 21.0058 
73.2234 64.9622 52.8512 51.0957 52.2693 41.7234 21.9807 
73.4491 65.1983 53.1988 51.1565 52.2847 42.3231 22.0767 
73.6090 65.2128 53.2675 51.5730 52.5461 42.3718 22.3904 
73.6830 65.5334 53.4861 51.9145 52.6362 42.7521 22.8992 
73.7318 65.6481 53.7140 52.2462 52.7151 42.9056 23.0613 
73.8894 66.4572 53.8273 52.7773 53.1008 43.0460 23.5965 
73.9627 66.5596 54.4825 53.0758 53.4426 43.4368 23.9920 
74.7190 67.0206 54.6954 53.6085 53.5443 43.6535 24.2225 
75.7939 67.3117 54.8202 53.8413 53.8246 43.7241 24.8080 
76.1410 67.8795 55.6392 53.9455 54.8670 43.9162 25.2756 
76.9511 68.4192 55.6727 54.3477 55.1002 44.8783 25.4490 
77.1603 69.0251 55.6800 54.8418 55.3162 45.2612 25.6696 
77.6609 69.1856 55.7728 55.1589 56.0073 45.8009 25.9426 
77.7020 69.5556 55.8806 55.4111 56.1623 46.2667 26.7344 
78.2813 69.8512 55.8844 55.6483 56.8496 46.6093 27.2109 
78.8585 70.0916 55.8999 56.1966 57.0949 47.0311 27.7002 
79.1999 70.3770 56.0954 56.4948 57.1500 47.2793 28.0039 
79.2170 70.8638 56.3610 57.0145 57.7653 47.9936 28.2598 
79.2236 71.0921 57.5451 57.2820 58.3490 48.0843 28.3408 
79.5874 71.1922 57.6248 57.2867 58.5968 48.2191 28.5545 
79.9081 71.9249 57.7186 57.3572 58.7672 49.3524 28.6497 
80.7570 73.1418 57.8671 57.8761 59.0504 50.2134 28.6924 
80.9371 73.3117 58.8418 58.8086 59.2898 50.3625 29.2744 
81.4611 73.8878 58.8481 59.0487 59.7813 50.9823 29.8901 
82.4733 73.9528 59.3316 59.1463 59.9940 51.3339 30.1437 
83.0166 75.3788 59.4371 59.2748 60.3607 51.8060 30.3062 
83.2127 75.4605 59.4712 59.5441 60.4682 52.1857 30.6542 
83.3079 75.4614 59.6114 59.7104 60.4845 52.6056 31.4537 
83.5289 75.7871 60.2650 60.0081 60.8398 53.2590 31.5048 
83.5681 76.1293 60.4709 60.0755 60.9320 53.3918 32.0212 
84.4412 76.4186 60.6144 60.8206 60.9801 53.5548 32.4975 
84.8584 77.4247 60.9986 61.1841 61.0861 55.3021 32.7388 
85.1961 78.1238 62.4307 61.3963 61.2292 56.1149 32.7436 
85.6690 79.6611 62.4503 62.4406 61.2435 57.9929 33.0213 
85.9226 79.7674 63.5956 63.3578 61.4191 58.1528 33.2449 
86.0946 79.9178 63.9928 63.5085 62.6262 58.6522 33.3605 
86.3058 80.6922 64.6850 63.5725 65.7769 60.2884 33.4824 
86.6068 82.2696 65.2867 65.1058 66.8333 61.7895 33.6537 
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86.6394 82.4904 65.7883 66.4859 67.5708 62.1971 33.9218 
86.9955 82.6356 66.0979 66.7454 68.0959 62.3692 35.1177 
87.1887 82.8691 67.2224 67.9959 68.3263 62.5107 39.2926 
87.7490 82.9778 67.6439 68.2722 69.3842 62.8671 39.6555 
88.4195 83.2235 67.7148 68.3186 72.5180 63.8531 39.8458 
88.4476 83.3625 69.5364 70.1384 73.0610 63.9951 41.7221 
88.5693 83.8520 71.1566 74.1158 73.1239 64.3122 42.7230 
88.7060 84.0864 73.2490 75.9663 74.2562 65.2271 45.6129 
88.7193 84.7074 74.1329 76.8967 74.7358 65.5544 51.2236 
88.9589 84.9534 75.3101 77.4399 76.6413 65.6090 51.4708 
89.2089 85.2147 79.1332 78.3958 77.9924 67.6042 55.7047 
90.1395 85.5312 81.9663 78.4279 80.8780 68.7560 56.8447 
90.1971 86.1444 84.8562 83.5083 81.0300 74.3100 65.2504 
90.3992 88.6616 85.6530 86.7360 81.5380 75.5530 65.6011 
91.6730 93.6343 85.8885 88.5826 85.7251 82.1206 74.8182 






Table A.10 Raw data of the histograms illustrating the distributions of SCGE % tail DNA values from 
CHO cells treated with iodoacetic acid without and with 1, 2, 3, 4, 5 and 24 hour liquid-holding recovery. 
 
LH_0h LH_1h LH_2h LH_3h LH_4h LH_5h LH_24h 
       
2.22366 2.26277 0.191662 0.495869 0 0.294315 0 
5.30440 2.40745 0.261931 0.677269 0.501511 0.358234 0 
8.24983 3.74413 0.270235 0.687445 0.519606 0.362456 0 
8.84009 3.79435 0.390688 0.736305 0.519933 0.489646 0 
9.45031 4.88617 0.610922 0.744554 0.532629 0.503114 0 
9.80738 4.89493 0.688975 0.764794 0.614943 0.518148 0 
10.4836 5.13540 0.757676 0.782869 0.672697 0.573825 0 
12.4220 5.26063 1.04870 0.809370 0.885445 0.576568 0.133527 
13.1135 7.05863 1.08254 0.847884 0.946738 0.600313 0.228061 
13.6057 7.23076 1.33898 0.882508 0.965346 0.602311 0.256325 
13.6836 8.69497 1.34263 1.00805 0.992736 0.712896 0.261468 
14.0771 8.88937 1.36292 1.06295 1.08409 0.733655 0.279522 
14.5453 8.96562 1.44828 1.08123 1.16393 0.743638 0.333932 
15.4418 9.36911 1.47295 1.12728 1.25782 0.819561 0.362280 
15.7567 9.39547 1.61420 1.16583 1.35994 0.901277 0.403659 
15.9679 9.54214 1.68235 1.27042 1.42985 0.926589 0.481601 
16.0546 9.81670 1.69153 1.27566 1.45723 0.948348 0.485547 
16.2403 9.82092 1.77528 1.33017 1.46009 0.961940 0.492235 
16.3143 10.0180 1.87158 1.33155 1.56322 0.964763 0.536527 
16.5563 11.2886 2.25932 1.38130 1.60183 1.01598 0.576431 
17.1509 12.0991 2.35477 1.39820 1.63412 1.11308 0.581497 
18.0973 12.1191 2.49750 1.45127 1.77459 1.17245 0.589785 
18.6227 12.1509 2.61851 1.45653 1.80836 1.19688 0.621510 
21.8385 12.1738 2.62798 1.49364 1.82971 1.23071 0.621515 
22.2700 12.2983 2.67527 1.56335 1.88358 1.24152 0.630447 
22.3949 13.0304 2.85674 1.56722 1.88796 1.26189 0.635906 
22.4733 15.5188 2.98714 1.65384 1.95895 1.28300 0.685816 
23.2834 15.5688 3.00601 1.71533 1.98464 1.34272 0.764381 
23.3655 15.7862 3.06191 1.79170 2.00412 1.39081 0.787839 
23.4819 15.9074 3.36803 1.83146 2.14423 1.39221 0.793161 
24.1817 16.0034 3.38289 1.84602 2.25420 1.39928 0.874143 
24.1958 16.0064 3.41406 1.85174 2.33398 1.41181 0.885594 
24.3718 16.2421 3.48511 1.95125 2.36604 1.41189 0.908379 
24.9594 16.9602 3.65882 1.97979 2.38091 1.45664 0.966828 
25.2742 17.0076 3.69214 2.01081 2.56830 1.46445 0.985104 
25.7348 18.0890 3.82058 2.01246 2.60606 1.50234 1.03289 
25.9335 18.2445 3.90502 2.02778 2.76390 1.54768 1.08296 
26.0804 18.3219 4.19202 2.10397 2.78009 1.71480 1.13192 
26.3425 18.3234 4.25757 2.19112 2.86798 1.72883 1.19086 
26.4546 18.6216 4.31895 2.30414 2.91371 1.74949 1.20109 
26.7943 18.6625 4.33826 2.32739 3.02680 1.75075 1.20880 
26.8677 19.2516 4.36582 2.33359 3.37306 1.77403 1.45025 
27.8646 19.8730 4.37891 2.38529 3.39586 1.87982 1.50156 
28.1732 20.2874 4.39181 2.49231 3.46701 1.95945 1.58241 
28.3549 20.5267 4.52444 2.61448 3.51537 2.01653 1.63030 
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28.6677 21.1950 4.53555 2.69089 3.55230 2.04196 1.75011 
28.7559 21.8772 4.63244 2.69688 3.62260 2.05107 1.79595 
28.8729 21.9754 4.69212 2.73625 3.74788 2.20814 1.83774 
30.4823 22.1218 4.69271 2.76675 3.97260 2.27746 1.94480 
30.7282 22.1439 4.84426 2.78093 4.15777 2.34846 2.17728 
31.0324 23.0875 5.04250 2.78176 4.21699 2.36129 2.24634 
31.1610 23.7659 5.35286 2.95738 4.33617 2.43982 2.25898 
31.3572 23.9770 5.67237 2.98074 4.35641 2.46731 2.26563 
31.4106 24.0045 5.71534 2.98408 4.53913 2.49335 2.35011 
31.7611 24.1165 5.73507 3.08498 4.88923 2.50019 2.36254 
31.8499 24.2412 5.92996 3.28843 4.89806 2.56097 2.43877 
32.3778 24.2932 6.12192 3.29418 4.91451 2.60234 2.44152 
32.3937 24.3450 6.54870 3.36461 5.11232 2.68148 2.44360 
33.8527 25.2099 6.94649 3.45318 5.36065 2.72855 2.61709 
33.8643 25.5997 7.18128 3.48553 5.39335 2.76314 2.72706 
34.2656 25.7288 7.42753 3.60953 5.44585 2.83373 2.79663 
34.8311 26.2373 7.57491 3.63507 5.46974 2.83429 2.92629 
34.9261 26.4843 7.64612 3.65816 5.53013 3.00264 2.99729 
35.0854 26.7701 7.98822 3.71106 5.54137 3.06344 3.03024 
35.6064 26.8970 8.01106 3.78840 5.69404 3.29277 3.11075 
35.6212 26.9500 8.09944 3.79520 5.75746 3.31436 3.13070 
36.0997 27.3577 8.22125 3.80353 5.83001 3.61870 3.24339 
36.5583 27.8554 8.28117 3.94298 6.31277 3.62521 3.26110 
36.7910 28.1782 8.40055 4.01680 6.42983 3.62722 3.35492 
36.8172 28.4018 8.42914 4.05545 6.45713 3.77870 3.54287 
37.2319 28.9597 8.45348 4.08676 6.60595 3.87009 3.75743 
37.2680 29.1164 8.47059 4.15903 7.03956 3.93339 3.91350 
37.3269 29.1449 8.65895 4.20612 7.06331 4.07581 3.93388 
38.1631 29.1997 8.68041 4.30869 7.12873 4.19748 4.00938 
38.4654 29.6072 8.75122 4.43395 7.20060 4.19960 4.03959 
39.0385 29.8486 8.94127 4.54216 7.20317 4.23518 4.06907 
40.0270 30.0662 9.06070 4.58513 7.24176 4.24486 4.34938 
40.0428 30.2713 9.38983 4.60144 7.27155 4.25317 4.45390 
41.1870 30.3491 9.39381 4.67944 7.53188 4.26286 4.60309 
41.2221 30.5080 9.53549 4.83108 7.79957 4.26658 4.70645 
42.0323 30.5425 9.68454 4.83715 7.82491 4.31949 4.86115 
42.1312 30.9212 10.2106 4.89323 8.16614 4.33107 4.92435 
42.2395 31.0017 10.3256 4.92849 8.17564 4.39326 4.95841 
42.9873 31.0202 10.5050 4.97815 8.20174 4.51031 5.10819 
43.0961 31.0814 10.6906 4.98021 8.38555 4.53895 5.25226 
43.3106 31.0972 10.7181 5.09863 8.44147 4.62430 5.49695 
43.9618 31.7754 10.8296 5.29670 8.44794 4.82492 5.61583 
44.4299 32.8873 11.2031 5.32650 8.48874 5.08124 5.94650 
44.6279 32.9689 11.3700 5.44335 8.48979 5.15353 6.00391 
45.0516 33.0010 11.5154 5.45129 8.66336 5.16505 6.05233 
45.0821 33.0676 11.5403 6.08192 8.75502 5.35986 6.24773 
45.0856 33.1392 11.7826 6.25059 8.78797 5.47048 6.38891 
45.1341 33.1495 11.9123 6.31737 8.80531 5.50540 6.74108 
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45.1878 33.5063 11.9200 6.52274 9.07941 5.60133 6.76008 
45.5111 33.6396 12.0308 6.74377 9.18809 5.63165 6.77059 
45.8574 33.6575 12.0739 6.77978 9.21217 5.63656 6.87237 
45.9766 33.9897 12.2775 7.13467 9.36759 5.78487 7.06629 
46.2256 34.3478 12.6380 7.19471 9.41906 5.99335 7.15848 
47.6191 34.6175 12.7439 7.20541 9.54469 5.99729 7.25515 
47.6949 34.8688 13.0246 7.48919 9.59345 6.04834 7.33618 
47.7699 34.9163 13.0293 7.58127 9.61647 6.16097 7.52769 
47.9861 35.0302 13.1085 7.73621 9.69869 6.19511 7.60133 
48.3197 35.3997 13.4776 7.83210 9.89738 6.27348 7.92392 
48.6630 35.4310 13.7887 7.95255 10.0426 6.27841 8.10108 
48.7973 35.6130 14.4750 8.06993 10.1325 6.44526 8.18255 
49.2755 35.6884 14.6212 8.12250 10.2925 6.67614 8.25717 
49.8778 35.7550 14.6580 8.25609 10.3107 6.73133 8.32422 
50.8032 35.9430 14.6591 8.27785 10.3716 6.78031 8.36446 
51.0269 35.9731 14.7746 8.36591 10.5662 7.05665 8.42749 
51.3365 35.9999 14.9545 8.53873 10.6124 7.20839 8.79240 
52.3686 36.2915 15.0150 9.01559 10.6328 7.37112 8.83174 
52.7389 36.3844 15.4134 9.51640 10.9288 7.57697 9.00951 
52.8835 36.5579 15.4726 9.53841 10.9451 7.78274 9.12581 
53.4387 36.6209 15.5063 9.56033 10.9629 7.79228 9.24972 
53.7082 37.0802 15.5489 9.61734 11.0921 7.84977 9.31150 
53.9663 37.2093 15.6403 9.71153 11.1656 7.89077 10.1502 
54.0031 37.5283 15.7705 9.94892 11.2058 7.93650 10.1904 
54.0598 38.2833 16.2890 10.0820 11.3651 8.19500 10.4880 
54.1982 38.3062 16.5048 10.0978 11.9837 8.26329 11.3820 
54.2043 38.5923 16.5905 10.1752 12.1779 8.26407 11.3881 
54.3797 38.7478 17.0791 10.2120 12.3556 8.31208 11.4539 
54.5246 38.7777 17.1148 10.3632 12.3709 8.48978 11.8324 
54.5654 38.8520 17.1826 10.3976 12.5522 8.65767 11.9282 
54.8257 38.9167 17.3306 10.4560 12.5663 8.70505 12.0869 
55.0921 39.4589 17.5653 10.6978 12.8231 8.93084 12.1730 
55.3997 40.3686 17.7827 10.7993 12.8504 8.96973 12.3810 
55.7869 40.5194 17.8478 10.8575 12.9548 9.05218 12.6446 
55.8580 40.6295 17.9647 11.0472 13.3445 9.14169 13.2540 
56.1786 40.6872 18.0285 11.5288 13.5310 9.19518 14.0117 
56.3113 40.7915 18.1994 11.7937 13.7779 9.28882 14.0324 
56.4344 40.9117 18.3722 11.9264 14.0270 9.38376 15.1126 
56.8593 41.0952 18.4127 12.0070 14.1155 9.72480 15.6228 
56.9508 41.1785 18.8956 12.1354 14.1185 10.0724 16.2674 
57.2437 41.9929 19.7957 12.1644 14.3375 10.2169 18.5396 
57.6181 42.2130 20.0194 12.3407 14.4198 10.2938 19.0951 
57.7113 42.3657 20.1842 12.6011 14.4692 10.5188 19.4643 
57.8692 42.4771 20.7020 12.9851 14.5522 10.5733 19.4855 
57.8796 43.1974 21.1696 13.0878 14.8344 10.6512 20.2319 
57.9044 43.8366 21.2595 13.1272 14.9363 10.6990 20.7542 
57.9085 44.4447 21.5157 13.3242 15.1795 10.7475 21.5910 
57.9753 44.5647 21.5325 13.3969 15.2171 10.9302 21.8347 
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58.1144 44.6123 21.5481 13.6723 15.4249 10.9406 24.3817 
58.5550 44.6225 21.8425 14.0182 15.4736 11.2157 27.4797 
58.6982 45.3260 21.8743 14.0388 15.6340 11.2229 27.9591 
58.8343 45.9841 22.1027 14.1654 15.7045 11.2337 30.2278 
59.6550 46.0397 22.4232 14.1873 15.7155 11.3612 35.3916 
60.5560 46.2245 22.7151 14.2040 16.1462 11.6631 39.4776 
61.6742 46.4054 23.4321 14.2801 16.1575 12.0045 42.4262 
61.7313 46.5746 23.5357 14.3680 16.1946 12.0446 50.7432 
62.1088 47.1524 23.9130 14.6113 16.5830 12.2114 71.4806 
62.1263 47.8480 24.0608 14.7741 16.6449 12.2695 
 
62.3355 48.2593 24.2904 14.8942 16.7304 12.2738 
 
62.4591 49.2181 24.3109 14.9211 16.9607 12.3028 
 
62.4684 49.6425 24.4120 15.1454 18.0632 12.6226 
 
62.9277 49.7757 24.5329 15.2544 18.3102 12.6710 
 
62.9384 49.9801 24.9660 15.8155 18.5397 12.9277 
 
63.0238 50.0069 25.2274 16.0025 19.7977 12.9645 
 
63.0255 50.0570 25.3503 16.0493 19.8317 13.1518 
 
63.5592 50.0617 25.4203 16.3148 20.6160 13.5998 
 
63.7292 50.1941 25.5667 16.5383 21.0144 13.8931 
 
63.7503 50.2960 25.6538 16.6414 21.3090 14.6890 
 
63.8291 50.7695 25.7679 16.9034 21.5066 15.0809 
 
63.9805 50.7942 25.8106 16.9365 21.8911 15.2060 
 
64.1590 51.3394 26.3319 17.0591 21.9165 15.3770 
 
64.3231 51.6391 26.5977 17.3028 22.1731 15.6736 
 
64.3378 51.6889 26.6735 17.4617 22.5452 15.9949 
 
64.3467 53.2729 26.7095 17.5773 23.4207 16.5505 
 
64.4020 53.6079 26.8437 17.7073 23.8012 17.1427 
 
64.5918 53.6471 27.0481 18.0084 23.9633 17.5738 
 
64.6118 54.0124 27.0494 18.3593 24.1133 17.8371 
 
64.6976 54.0933 27.9309 19.0061 24.3795 17.8812 
 
64.7371 54.6168 28.3039 19.5767 24.7636 18.4507 
 
64.9955 54.6573 28.9528 19.7679 25.0736 18.9634 
 
65.0337 54.7360 29.5485 19.8789 25.1317 19.8031 
 
65.0602 54.8026 29.5810 20.1791 25.1684 20.4408 
 
65.1231 55.1988 29.6518 20.2790 25.1996 21.0489 
 
65.2140 55.2483 30.6926 20.4827 25.2497 21.0844 
 
65.3120 55.4508 31.0524 21.6162 25.5584 21.1801 
 
65.5518 55.7827 31.4328 21.7802 26.3794 21.2434 
 
65.6320 55.8689 32.2772 22.2766 26.5584 21.2857 
 
65.7636 56.0542 32.3260 22.7078 27.3556 21.3155 
 
65.7774 56.1296 32.5775 23.4588 27.6263 21.5734 
 
65.8174 56.1398 33.7345 23.6234 27.6636 22.1570 
 
65.8340 56.4757 33.9139 24.3865 27.7616 22.1594 
 
65.9150 56.8632 34.0260 24.6469 28.5628 22.3842 
 
66.3143 56.9968 34.7883 24.7310 28.6904 22.4094 
 
66.6854 57.1358 34.9244 24.9439 28.8977 22.6406 
 
66.9221 57.2315 35.3789 25.3361 29.5182 23.4184 
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67.4171 57.5958 36.3950 26.1077 30.1477 24.4355 
 
68.0131 57.9643 37.0430 26.6048 30.9938 24.4393 
 
68.1016 58.1159 37.4164 26.6059 31.0024 24.5621 
 
68.2652 58.5143 37.9735 26.9356 31.0301 24.9081 
 
68.4007 58.8007 38.2164 27.2518 31.4271 24.9543 
 
68.6030 59.3306 39.2080 28.7344 31.8736 25.0240 
 
68.6132 59.3758 39.4035 28.9095 31.9559 25.0822 
 
69.4010 59.4657 39.9929 29.3894 32.3917 25.2448 
 
69.4205 60.0386 40.4928 29.4222 32.9550 25.3344 
 
69.6263 60.0969 40.8771 29.5364 33.0116 25.4404 
 
69.8781 60.3800 41.0267 29.9164 33.0644 25.4991 
 
69.9650 60.6541 41.3016 30.2188 33.6212 26.4372 
 
70.0874 60.7439 42.1899 31.2710 34.1411 26.6523 
 
70.2505 60.8490 42.2441 31.8965 34.2349 26.8793 
 
70.4244 60.9868 42.3129 34.8671 34.3581 26.9194 
 
70.4599 61.5635 42.7147 35.8793 34.4268 27.4073 
 
70.6483 61.8760 43.1162 36.1658 34.7563 27.4271 
 
70.7071 61.9303 43.2866 37.1526 34.8642 27.4492 
 
70.7231 62.3470 43.7904 37.6977 34.9344 27.9573 
 
70.7476 63.5093 43.8835 38.1764 35.0029 28.6965 
 
71.0015 63.6471 44.3268 38.1768 35.1196 29.8750 
 
71.4349 63.7578 44.6765 38.2550 35.1748 30.3530 
 
71.4661 63.8262 44.6776 38.3448 35.5531 30.5576 
 
71.8793 64.6103 44.7143 38.6741 35.7780 31.5217 
 
72.0203 65.8693 45.3217 39.2970 35.8050 32.8219 
 
72.1775 66.9638 46.3604 39.7809 37.2512 33.0650 
 
72.4639 67.0608 46.7027 39.8259 39.0717 34.4309 
 
72.6216 67.7946 46.7978 40.0956 39.3716 34.6582 
 
72.6238 67.9951 46.9447 40.2220 39.8367 34.7736 
 
72.6334 68.1762 47.0083 40.4294 40.9133 35.1722 
 
72.7792 68.5564 47.5504 40.6030 41.0550 35.4923 
 
72.7956 69.5252 48.4033 40.8476 41.7600 37.1772 
 
73.0187 69.6063 48.9351 42.5751 42.3474 37.9983 
 
73.4030 69.7016 48.9779 43.3797 42.4843 38.0056 
 
73.5999 69.7450 49.5010 45.0503 42.5524 39.0511 
 
73.6530 70.8413 50.9597 45.5207 43.1610 39.0747 
 
73.7855 71.3925 51.2579 46.5836 44.1992 39.1466 
 
73.7861 72.3441 51.5829 48.5332 45.1845 39.6667 
 
73.8170 73.1115 52.1891 49.2604 45.2411 39.7650 
 
73.8638 73.4360 52.7037 49.6855 45.3765 41.3455 
 
74.0034 73.8021 53.2836 49.9456 45.5622 41.5941 
 
74.3542 73.8580 55.3207 51.3217 45.7247 41.9627 
 
74.4482 73.8624 55.3611 52.1553 45.9350 42.1522 
 
74.4553 74.4017 56.3469 52.7183 46.0441 42.1616 
 
74.6182 75.6144 56.5020 54.2287 47.0904 42.8367 
 
74.7221 75.9732 57.0286 54.4678 47.7622 45.6791 
 
74.9172 76.2113 57.1103 55.8198 47.9738 45.7965 
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75.3959 77.1737 58.2410 56.6955 49.1139 46.8808 
 
75.6692 77.4431 59.7715 57.4124 51.2145 48.4898 
 
75.8094 78.3312 61.3750 58.8668 54.8246 49.8784 
 
75.8877 79.1541 62.8625 59.1486 55.8622 51.9324 
 
75.9284 79.5003 64.6122 63.7716 56.6409 52.2045 
 
76.6778 80.7513 72.5494 64.8556 57.6698 58.3346 
 
76.8100 81.3215 73.5204 67.4691 57.9968 58.7768 
 
76.9920 82.0075 75.1110 69.3642 60.4418 59.6570 
 
77.2256 82.8830 77.3333 71.3724 61.0264 60.2691 
 
77.2810 83.4124 80.1169 72.9057 63.5908 63.6108 
 
77.6559 83.6813 80.3934 78.8736 74.5732 66.9671 
 
77.6579 89.2887 83.8889 84.9899 76.7490 79.2056 
 
77.7864 90.5201 89.2179 89.0381 77.2850 83.5153 
 
77.9528 
      
77.9661 
      
77.9967 
      
78.0530 
      
78.1601 
      
78.3463 
      
78.5871 
      
78.7394 
      
78.7905 
      
78.9358 
      
79.2068 
      
79.2687 
      
79.2719 
      
79.3565 
      
79.4951 
      
80.1991 
      
80.8129 
      
80.8307 
      
81.0456 
      
81.0890 
      
81.1930 
      
81.2041 
      
81.3072 
      
81.3390 
      
81.3423 
      
81.4803 
      
81.4925 
      
81.5652 
      
81.7789 
      
81.7852 
      
81.8519 
      
81.9088 
      
82.0255 
      
82.1559 
      
82.5918 
      
176 
 
Table A.10 (cont.) 
 
82.6019 
      
82.6880 
      
82.7190 
      
82.8155 
      
82.9375 
      
83.0475 
      
83.0555 
      
83.2049 
      
83.2602 
      
83.6022 
      
83.6405 
      
83.6579 
      
83.8015 
      
84.1311 
      
84.1581 
      
84.2934 
      
84.3495 
      
84.7251 
      
85.0776 
      
85.1268 
      
85.5163 
      
85.5613 
      
85.5719 
      
85.6982 
      
85.7564 
      
85.8332 
      
86.1233 
      
86.2920 
      
86.3442 
      
86.3629 
      
86.6348 
      
87.0410 
      
87.1347 
      
87.4011 
      
87.5138 
      
87.5327 
      
87.6047 
      
87.7767 
      
87.9164 
      
88.6335 
      
88.6469 
      
89.0639 
      
89.0804 
      
89.4531 
      
89.4896 
      
89.6863 
      
90.2221 
      
90.2363 
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90.4960 
      
90.5902 
      
90.8106 
      
90.9084 
      
91.0229 
      
91.1310 
      
91.7309 
      
91.7540 
      
92.2705 
      
93.0282 
      
93.4731 
      
93.6651 
      
93.8386 
      
94.4862 
      
94.5506 
      
95.0381 
      
96.0386 




Table A.11 Raw data of the histograms illustrating the distributions of SCGE % tail DNA values from 
the CHO cell negative controls at 0, 5, and 24 hour liquid-holding recovery. 
 
LH_0h LH_5h LH_24h 
   0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0.1217 
0 0 0.1422 
0 0.1234 0.1619 
0 0.1411 0.2085 
0 0.1532 0.2234 
0 0.1555 0.2274 
0 0.1588 0.2288 
0 0.1630 0.2308 
0 0.1649 0.2350 
0 0.1687 0.2366 
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0 0.1888 0.2567 
0 0.1950 0.2578 
0 0.2044 0.2681 
0 0.2051 0.2722 
0 0.2134 0.2762 
0 0.2155 0.2785 
0 0.2162 0.2880 
0 0.2175 0.2996 
0 0.2196 0.3036 
0 0.2227 0.3220 
0 0.2292 0.3235 
0 0.2312 0.3251 
0 0.2385 0.3318 
0 0.2446 0.3369 
0 0.2512 0.3376 
0.0759 0.2518 0.3419 
0.1167 0.2534 0.3440 
0.1276 0.2563 0.3574 
0.1398 0.2627 0.3590 
0.1437 0.2668 0.3679 
0.1451 0.2731 0.3696 
0.1629 0.2755 0.3776 
0.1816 0.2783 0.3844 
0.1830 0.2789 0.4009 
0.1841 0.2801 0.4035 
0.1889 0.2814 0.4041 
0.1912 0.2824 0.4057 
0.1933 0.2865 0.4084 
0.1966 0.2903 0.4089 
0.1969 0.2935 0.4198 
0.2068 0.2991 0.4237 
0.2082 0.3024 0.4257 
0.2084 0.3075 0.4418 
0.2104 0.3098 0.4447 
0.2141 0.3102 0.4482 
0.2153 0.3114 0.4635 
0.2174 0.3124 0.4747 
0.2176 0.3137 0.4771 
0.2187 0.3156 0.4819 
0.2203 0.3178 0.4861 
0.2213 0.3179 0.4883 
0.2239 0.3181 0.4999 
0.2243 0.3224 0.5115 
0.2265 0.3302 0.5136 
0.2265 0.3409 0.5206 
0.2281 0.3429 0.5322 
0.2285 0.3474 0.5344 
0.2310 0.3481 0.5379 
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0.2338 0.3484 0.5571 
0.2349 0.3487 0.5597 
0.2350 0.3560 0.5665 
0.2368 0.3619 0.5833 
0.2371 0.3624 0.5861 
0.2381 0.3651 0.5887 
0.2416 0.3772 0.5944 
0.2428 0.3821 0.5970 
0.2442 0.3866 0.6019 
0.2522 0.3902 0.6048 
0.2549 0.3948 0.6256 
0.2560 0.3962 0.6381 
0.2570 0.4017 0.6417 
0.2577 0.4033 0.6643 
0.2584 0.4068 0.6644 
0.2605 0.4104 0.6794 
0.2630 0.4158 0.6962 
0.2661 0.4184 0.6983 
0.2674 0.4192 0.7188 
0.2680 0.4206 0.7232 
0.2758 0.4248 0.7274 
0.2767 0.4295 0.7325 
0.2787 0.4316 0.7382 
0.2852 0.4461 0.7820 
0.2876 0.4464 0.7910 
0.2877 0.4470 0.7912 
0.2889 0.4560 0.7920 
0.2900 0.4576 0.8079 
0.2920 0.4613 0.8145 
0.2950 0.4671 0.8166 
0.2970 0.4684 0.8401 
0.2976 0.4710 0.8623 
0.2996 0.4756 0.8665 
0.3024 0.4935 0.8669 
0.3051 0.4958 0.8736 
0.3059 0.5047 0.8861 
0.3085 0.5056 0.8934 
0.3137 0.5163 0.8947 
0.3158 0.5344 0.9118 
0.3185 0.5351 0.9202 
0.3196 0.5423 0.9290 
0.3314 0.5430 0.9320 
0.3337 0.5451 0.9394 
0.3384 0.5459 0.9603 
0.3428 0.5489 0.9609 
0.3466 0.5492 0.9646 
0.3514 0.5539 0.9728 
0.3519 0.5539 0.9842 
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0.3521 0.5576 0.9870 
0.3531 0.5604 1.0329 
0.3543 0.5610 1.0362 
0.3559 0.5639 1.0427 
0.3603 0.5718 1.0480 
0.3605 0.5724 1.0606 
0.3630 0.5728 1.0801 
0.3682 0.5730 1.0885 
0.3706 0.5735 1.1046 
0.3712 0.5766 1.1116 
0.3724 0.5784 1.1351 
0.3731 0.5933 1.1389 
0.3766 0.5950 1.1437 
0.3784 0.6020 1.1455 
0.3810 0.6064 1.1522 
0.3811 0.6096 1.1536 
0.3823 0.6109 1.1553 
0.3861 0.6147 1.1747 
0.3889 0.6283 1.2237 
0.3933 0.6326 1.2263 
0.3978 0.6395 1.2532 
0.4000 0.6402 1.2616 
0.4051 0.6477 1.2809 
0.4076 0.6572 1.2839 
0.4102 0.6598 1.2926 
0.4131 0.6777 1.3009 
0.4227 0.6793 1.3073 
0.4229 0.6852 1.3177 
0.4264 0.6860 1.3217 
0.4278 0.6880 1.3248 
0.4298 0.6892 1.3265 
0.4306 0.6951 1.3537 
0.4356 0.6984 1.3616 
0.4388 0.6994 1.3746 
0.4424 0.7050 1.3908 
0.4464 0.7059 1.3930 
0.4469 0.7184 1.4248 
0.4496 0.7253 1.4487 
0.4528 0.7264 1.4774 
0.4601 0.7327 1.4784 
0.4602 0.7337 1.4912 
0.4627 0.7499 1.4972 
0.4639 0.7542 1.5054 
0.4663 0.7545 1.5074 
0.4705 0.7570 1.5771 
0.4723 0.7608 1.5935 
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0.4818 0.7636 1.6847 
0.4821 0.7646 1.6911 
0.4854 0.7667 1.6985 
0.4873 0.7707 1.7188 
0.4890 0.7726 1.7197 
0.4892 0.7730 1.7294 
0.4910 0.7730 1.8149 
0.4921 0.7767 1.8310 
0.4928 0.7786 1.8486 
0.4956 0.7798 1.8528 
0.5007 0.7929 1.8617 
0.5082 0.8023 1.8816 
0.5092 0.8089 1.9202 
0.5188 0.8133 1.9284 
0.5189 0.8178 1.9346 
0.5209 0.8211 1.9531 
0.5211 0.8214 1.9853 
0.5226 0.8361 2.0222 
0.5369 0.8389 2.0621 
0.5442 0.8485 2.0746 
0.5445 0.8499 2.0899 
0.5499 0.8516 2.1464 
0.5542 0.8587 2.1937 
0.5590 0.8610 2.2242 
0.5632 0.8613 2.2257 
0.5668 0.8749 2.2458 
0.5739 0.8796 2.2626 
0.5762 0.8803 2.2685 
0.5814 0.8859 2.3055 
0.5819 0.8889 2.3224 
0.5823 0.8953 2.3238 
0.5837 0.9040 2.5038 
0.5850 0.9097 2.5227 
0.5906 0.9099 2.5400 
0.5907 0.9125 2.5778 
0.5992 0.9164 2.5939 
0.6005 0.9164 2.5940 
0.6050 0.9175 2.6814 
0.6052 0.9250 2.6878 
0.6073 0.9259 2.6900 
0.6158 0.9412 2.7046 
0.6179 0.9518 2.7512 
0.6182 0.9525 2.7550 
0.6192 0.9552 2.8100 
0.6269 0.9599 2.8473 
0.6358 0.9752 2.9419 
0.6368 0.9753 2.9759 
0.6369 0.9816 3.0335 
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0.6420 0.9846 3.0600 
0.6485 0.9849 3.0884 
0.6574 0.9857 3.1861 
0.6581 0.9878 3.2045 
0.6603 0.9923 3.3181 
0.6669 0.9937 3.3237 
0.6739 0.9939 3.3826 
0.6750 0.9957 3.3988 
0.6817 0.9999 3.4288 
0.6849 1.0000 3.4782 
0.6852 1.0003 3.4889 
0.6859 1.0042 3.5575 
0.6876 1.0076 3.5610 
0.6972 1.0132 3.8412 
0.6978 1.0204 3.9141 
0.6995 1.0249 3.9582 
0.7079 1.0588 4.0549 
0.7117 1.0630 4.0916 
0.7140 1.0653 4.2410 
0.7266 1.0828 4.2957 
0.7306 1.0855 4.3772 
0.7309 1.0891 4.3866 
0.7337 1.1088 4.4268 
0.7353 1.1369 4.4478 
0.7416 1.1399 4.5167 
0.7508 1.1582 4.5537 
0.7538 1.1597 4.5566 
0.7603 1.1599 4.6008 
0.7649 1.1741 4.7211 
0.7659 1.1762 4.7805 
0.7728 1.1807 4.7938 
0.7748 1.1870 4.9725 
0.7773 1.1895 4.9799 
0.7916 1.1903 5.0223 
0.7937 1.1932 5.0468 
0.7958 1.1951 5.0695 
0.7964 1.2059 5.1180 
0.7974 1.2069 5.1364 
0.8012 1.2077 5.1491 
0.8042 1.2143 5.1679 
0.8074 1.2241 5.2120 
0.8099 1.2379 5.2561 
0.8117 1.2652 5.2602 
0.8139 1.2781 5.3141 
0.8210 1.2831 5.3638 
0.8218 1.3043 5.4277 
0.8256 1.3065 5.6390 
0.8278 1.3120 5.6610 
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0.8289 1.3170 5.6855 
0.8298 1.3230 5.8042 
0.8313 1.3253 5.8066 
0.8392 1.3312 5.8317 
0.8628 1.3553 5.8419 
0.8644 1.3663 5.8792 
0.8678 1.3942 5.9764 
0.8821 1.3972 6.1644 
0.8901 1.4309 6.1936 
0.8956 1.4435 6.2322 
0.8963 1.4932 6.3635 
0.8970 1.4958 6.4953 
0.9153 1.4982 6.6558 
0.9153 1.5219 6.8086 
0.9343 1.5493 6.8317 
0.9356 1.5512 6.9399 
0.9377 1.5522 6.9656 
0.9395 1.5690 6.9955 
0.9403 1.5696 6.9974 
0.9449 1.5804 7.2889 
0.9473 1.5809 7.3087 
0.9482 1.5975 7.3132 
0.9641 1.6142 7.3519 
0.9688 1.6171 7.4154 
0.9723 1.6183 7.6750 
0.9760 1.6317 7.7818 
0.9896 1.6382 7.8130 
0.9950 1.6558 7.8188 
0.9979 1.6582 7.8831 
1.0016 1.6723 7.9175 
1.0064 1.6764 7.9409 
1.0101 1.6867 8.0829 
1.0104 1.6909 8.1009 
1.0143 1.6917 8.1268 
1.0254 1.7244 8.2246 
1.0384 1.7358 8.2503 
1.0430 1.7363 8.2560 
1.0439 1.7601 8.3565 
1.0465 1.7607 8.3587 
1.0524 1.7673 8.4154 
1.0575 1.7743 8.5353 
1.0661 1.7766 8.7370 
1.0677 1.7846 8.8778 
1.0767 1.8021 8.8805 
1.0817 1.8131 8.9188 
1.0929 1.8145 8.9195 
1.0970 1.8223 8.9584 
1.1039 1.8264 9.0177 
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1.1144 1.8331 9.1504 
1.1145 1.8499 9.3068 
1.1261 1.8644 9.3300 
1.1297 1.8705 9.4082 
1.1312 1.8864 9.4213 
1.1416 1.9658 9.5363 
1.1569 1.9704 9.5540 
1.1570 1.9902 9.5743 
1.1604 2.0033 9.7333 
1.1650 2.0088 9.7344 
1.1740 2.0393 9.7725 
1.1790 2.0926 10.1513 
1.1843 2.1010 10.2725 
1.1934 2.1107 10.3189 
1.1977 2.1308 10.3424 
1.2254 2.1388 10.4523 
1.2298 2.1827 10.5307 
1.2304 2.1834 10.5669 
1.2408 2.2124 10.6122 
1.2594 2.2297 10.6348 
1.2891 2.2595 10.7634 
1.2904 2.2814 10.8987 
1.2918 2.2967 10.9072 
1.3152 2.3258 10.9560 
1.3275 2.3446 10.9589 
1.3285 2.3588 10.9702 
1.3290 2.3734 11.1034 
1.3348 2.4375 11.4359 
1.3371 2.4377 11.5769 
1.3468 2.4593 11.5821 
1.3507 2.4634 11.8473 
1.3569 2.4650 11.9577 
1.3605 2.4702 11.9964 
1.3635 2.4908 12.0229 
1.3911 2.4993 12.2064 
1.4154 2.5854 12.3419 
1.4208 2.5900 12.4237 
1.4269 2.6238 12.5325 
1.4459 2.6679 12.6395 
1.4502 2.6947 12.6866 
1.4518 2.6965 12.7362 
1.4628 2.7546 12.8717 
1.4646 2.7564 12.9625 
1.4761 2.7769 13.2463 
1.4792 2.7825 13.4107 
1.4811 2.7831 13.6657 
1.4917 2.7994 13.8560 
1.5002 2.8399 13.9620 
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1.5104 2.8852 14.6061 
1.5293 2.9327 15.4134 
1.5370 2.9609 15.4435 
1.5723 2.9679 15.5653 
1.5928 2.9756 15.8171 
1.5976 3.0206 16.2705 
1.6026 3.0919 16.3645 
1.6068 3.1118 16.5015 
1.6072 3.1988 16.5559 
1.6127 3.2449 16.7784 
1.6185 3.2750 16.8602 
1.6243 3.2938 17.0111 
1.6251 3.3127 17.4043 
1.6559 3.3229 18.2429 
1.6672 3.3391 18.5106 
1.6694 3.3530 18.7334 
1.6696 3.3586 19.6267 
1.6843 3.3822 19.7726 
1.6884 3.3953 21.0635 
1.6937 3.4342 22.8917 
1.7023 3.4367 24.2786 
1.7285 3.4916 
 1.7301 3.4926 
 1.7413 3.5028 
 1.7577 3.5045 
 1.7619 3.5269 
 1.7680 3.5415 
 1.7700 3.5432 
 1.7729 3.5628 
 1.7920 3.5660 
 1.7997 3.5922 
 1.8019 3.6106 
 1.8095 3.6407 
 1.8170 3.6415 
 1.8184 3.6526 
 1.8405 3.6534 
 1.8407 3.6780 
 1.8543 3.6834 
 1.8689 3.6945 
 1.8750 3.7206 
 1.8828 3.7572 
 1.8883 3.7591 
 1.8925 3.8304 
 1.9325 3.8381 
 1.9985 3.8658 
 2.0739 3.8715 
 2.0740 3.8852 
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2.0903 3.9586 
 2.1689 3.9626 
 2.1692 3.9700 
 2.1736 3.9887 
 2.1798 3.9909 
 2.1838 3.9918 
 2.1984 4.0107 
 2.2096 4.0696 
 2.2142 4.0878 
 2.2268 4.0911 
 2.2269 4.0957 
 2.2335 4.1034 
 2.2367 4.1190 
 2.2451 4.1221 
 2.2572 4.1398 
 2.2573 4.2022 
 2.2754 4.2294 
 2.2790 4.2453 
 2.2837 4.2574 
 2.2856 4.2652 
 2.2919 4.2881 
 2.3006 4.3079 
 2.3217 4.3241 
 2.3229 4.3516 
 2.3266 4.4065 
 2.3273 4.4854 
 2.3370 4.4976 
 2.3721 4.5764 
 2.3762 4.5966 
 2.3837 4.6023 
 2.4014 4.6027 
 2.4093 4.7260 
 2.4142 4.7324 
 2.4471 4.9016 
 2.4688 4.9435 
 2.4705 4.9616 
 2.4769 4.9771 
 2.4986 5.0054 
 2.5072 5.0397 
 2.5101 5.0458 
 2.5112 5.0740 
 2.5338 5.1064 
 2.5757 5.1074 
 2.6098 5.1294 
 2.6159 5.1814 
 2.6400 5.2274 
 2.6606 5.2783 
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2.6870 5.3027 
 2.6901 5.3051 
 2.7102 5.3241 
 2.7105 5.4925 
 2.7171 5.5218 
 2.7323 5.5406 
 2.7389 5.5408 
 2.7604 5.5710 
 2.7698 5.5801 
 2.7784 5.5974 
 2.7790 5.6105 
 2.7890 5.6236 
 2.7934 5.6370 
 2.8086 5.6985 
 2.8087 5.8100 
 2.8245 5.9467 
 2.8364 5.9958 
 2.8368 6.0004 
 2.8819 6.0452 
 2.8859 6.0539 
 2.8903 6.1027 
 2.9047 6.1028 
 2.9213 6.1582 
 2.9963 6.1893 
 3.0148 6.2065 
 3.0523 6.2402 
 3.0616 6.2494 
 3.0617 6.3294 
 3.0942 6.3730 
 3.0944 6.4478 
 3.0977 6.4959 
 3.0999 6.5072 
 3.1096 6.5674 
 3.1114 6.5930 
 3.1177 6.5987 
 3.1417 6.6004 
 3.2012 6.6201 
 3.2057 6.6318 
 3.2148 6.7132 
 3.2395 6.7543 
 3.2438 6.8223 
 3.2447 6.8387 
 3.2508 6.8464 
 3.2559 6.8565 
 3.2689 6.8739 
 3.2760 6.9264 
 3.2777 7.0141 
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3.2836 7.0778 
 3.2853 7.0830 
 3.2978 7.1463 
 3.3005 7.1468 
 3.3329 7.1854 
 3.3704 7.2079 
 3.3712 7.2090 
 3.3842 7.2256 
 3.3978 7.2424 
 3.4049 7.2626 
 3.4168 7.3524 
 3.4224 7.3621 
 3.4553 7.4422 
 3.4933 7.4588 
 3.4992 7.4828 
 3.4998 7.7959 
 3.5016 7.8015 
 3.5368 7.9435 
 3.5368 7.9650 
 3.5673 8.0024 
 3.5888 8.1036 
 3.6090 8.2552 
 3.6193 8.3116 
 3.6232 8.3172 
 3.6350 8.3381 
 3.6462 8.3881 
 3.6740 8.4837 
 3.6940 8.5459 
 3.7717 8.5751 
 3.8026 8.6463 
 3.8229 8.7857 
 3.8357 9.0317 
 3.8572 9.0340 
 3.8772 9.0353 
 3.8929 9.0656 
 3.9131 9.0777 
 3.9162 9.1184 
 3.9231 9.1456 
 3.9532 9.2164 
 3.9686 9.5922 
 3.9903 9.5938 
 3.9989 9.6924 
 4.0026 9.7086 
 4.0203 10.0659 
 4.0285 10.1122 
 4.0317 10.1153 
 4.0412 10.1291 
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4.1354 10.1802 
 4.1475 10.2950 
 4.1673 10.3745 
 4.1915 10.4633 
 4.2179 10.4781 
 4.2394 10.5118 
 4.2725 10.5453 
 4.3018 10.6275 
 4.3203 10.6592 
 4.3234 10.7448 
 4.3382 10.7967 
 4.3638 11.1933 
 4.3732 11.1972 
 4.3914 11.2995 
 4.4292 11.3569 
 4.4393 11.5962 
 4.4634 11.6488 
 4.4667 11.7100 
 4.4875 11.7431 
 4.4993 11.9001 
 4.5329 11.9640 
 4.5668 11.9897 
 4.5850 12.0546 
 4.5918 12.2516 
 4.6086 12.2872 
 4.6147 12.3182 
 4.6237 12.5060 
 4.6326 12.5167 
 4.6935 12.5381 
 4.7034 12.5785 
 4.7061 12.6341 
 4.7129 12.8904 
 4.7176 13.0381 
 4.7655 13.0492 
 4.8007 13.2523 
 4.8161 13.3335 
 4.8291 13.4497 
 4.8767 13.5695 
 4.8829 13.6334 
 4.8842 13.6779 
 4.9137 13.7210 
 4.9383 13.7398 
 4.9466 13.7555 
 4.9684 13.8976 
 4.9975 14.0340 
 5.0331 14.1770 
 5.0483 14.3703 
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5.1120 14.6482 
 5.1262 14.6940 
 5.1311 15.0658 
 5.1472 15.1198 
 5.1479 15.4251 
 5.1534 15.7202 
 5.1929 15.7233 
 5.2054 16.0873 
 5.2057 16.1318 
 5.2071 16.1671 
 5.2311 16.3296 
 5.2357 16.6064 
 5.2672 16.6936 
 5.3232 16.9481 
 5.3354 17.3029 
 5.3554 17.5781 
 5.3746 18.2612 
 5.3914 18.5327 
 5.4117 19.0938 
 5.4149 19.1463 
 5.4762 19.3918 
 5.4805 22.0800 
 5.4858 22.1791 
 5.4928 22.2330 
 5.5157 22.4747 
 5.5316 22.9816 
 5.5440 23.5616 
 5.5490 25.0111 
 5.5577 28.1374 
 5.6226 35.1124 
 5.6371 68.9895 
 5.6419 
  5.6669 
  5.6784 
  5.6999 
  5.7440 
  5.7498 
  5.7609 
  5.8070 
  5.8170 
  5.8223 
  5.8463 
  5.8551 
  5.8665 
  5.8949 
  5.9085 
  5.9798 
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6.0198 
  6.0214 
  6.0235 
  6.0603 
  6.0671 
  6.1157 
  6.1292 
  6.1764 
  6.1973 
  6.2021 
  6.2053 
  6.2233 
  6.2312 
  6.2772 
  6.2966 
  6.3026 
  6.3077 
  6.3243 
  6.3464 
  6.3504 
  6.3517 
  6.3862 
  6.3880 
  6.4079 
  6.4435 
  6.4817 
  6.5426 
  6.5558 
  6.6109 
  6.6167 
  6.6358 
  6.6359 
  6.6454 
  6.7184 
  6.7187 
  6.7534 
  6.8975 
  6.8992 
  6.9209 
  6.9479 
  6.9482 
  7.0203 
  7.0359 
  7.0471 
  7.0519 
  7.0562 
  7.0644 
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7.0902 
  7.0953 
  7.1040 
  7.1575 
  7.2032 
  7.2250 
  7.2326 
  7.2604 
  7.3186 
  7.3273 
  7.3456 
  7.3457 
  7.3944 
  7.4519 
  7.4660 
  7.4863 
  7.5018 
  7.5986 
  7.6758 
  7.6763 
  7.7029 
  7.7171 
  7.7283 
  7.7325 
  7.7467 
  7.7765 
  7.7873 
  7.8338 
  7.8431 
  7.8509 
  7.8690 
  7.8836 
  7.8853 
  7.8953 
  7.9179 
  7.9506 
  7.9508 
  7.9550 
  7.9709 
  8.0170 
  8.0355 
  8.0519 
  8.0539 
  8.1077 
  8.1267 
  8.1579 
  8.1606 
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8.1843 
  8.2056 
  8.2085 
  8.2218 
  8.2904 
  8.2930 
  8.3355 
  8.3399 
  8.3498 
  8.3518 
  8.3601 
  8.3969 
  8.4565 
  8.5076 
  8.5079 
  8.5194 
  8.5276 
  8.5390 
  8.5543 
  8.5588 
  8.6260 
  8.6612 
  8.6698 
  8.6744 
  8.6998 
  8.7408 
  8.8021 
  8.8095 
  8.8128 
  8.8418 
  8.8591 
  8.9547 
  8.9664 
  8.9882 
  9.0436 
  9.0800 
  9.1510 
  9.2577 
  9.2679 
  9.2785 
  9.3334 
  9.3344 
  9.3439 
  9.3547 
  9.4076 
  9.5336 
  9.6298 
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9.6540 
  9.7292 
  9.7312 
  9.7337 
  9.7425 
  10.0337 
  10.0518 
  10.1640 
  10.1890 
  10.1920 
  10.2021 
  10.2832 
  10.3461 
  10.3525 
  10.4202 
  10.4311 
  10.4476 
  10.6500 
  10.6678 
  10.6811 
  10.6850 
  10.7367 
  10.7889 
  10.8111 
  10.8310 
  10.8642 
  10.9446 
  10.9801 
  11.0483 
  11.0562 
  11.0899 
  11.1606 
  11.2285 
  11.2553 
  11.2827 
  11.2891 
  11.2950 
  11.3243 
  11.3633 
  11.3773 
  11.4746 
  11.4944 
  11.5434 
  11.5634 
  11.5908 
  11.6036 
  11.6500 
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11.6737 
  11.7726 
  11.8362 
  11.8775 
  11.9270 
  11.9931 
  12.0015 
  12.2321 
  12.3155 
  12.4833 
  12.6200 
  12.6278 
  12.7569 
  12.7864 
  12.9123 
  12.9786 
  12.9943 
  13.0251 
  13.1433 
  13.2326 
  13.4660 
  13.4668 
  13.5709 
  13.6365 
  13.8232 
  13.8561 
  13.8794 
  13.8951 
  14.1355 
  14.1636 
  14.1974 
  14.2584 
  14.3132 
  14.3401 
  14.3460 
  14.3597 
  14.3891 
  14.4258 
  14.4619 
  14.9068 
  14.9422 
  15.0290 
  15.0692 
  15.1560 
  15.3679 
  15.6029 
  15.6395 
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15.8719 
  15.9785 
  16.0323 
  16.1623 
  16.1685 
  16.2551 
  16.2683 
  16.3878 
  16.5679 
  16.6169 
  16.6604 
  17.1338 
  17.3493 
  17.5931 
  18.0474 
  18.3872 
  18.4649 
  18.6098 
  18.6949 
  18.9007 
  18.9745 
  19.1213 
  19.7786 
  20.2280 
  20.6263 
  20.7271 
  22.0765 
  22.7155 
  22.7270 
  23.5302 
  23.6932 
  23.8791 
  24.4230 
  25.6618 
  28.6822 
  29.8110 
  30.6622 
  32.4396 
  36.9139 
  44.6625 
  52.3595 
  66.1187 
  71.6317 





APPENDICES FOR CHAPTER 3 
 
 
Summary of contents:  
 Seventy nine pages. 
 Table B.1: Raw data of CHO cell genomic DNA damage after 4 hours of treatment with 
chloroacetonitrile (CAN), bromoacetonitrile (BAN) and iodoacetonitrile (IAN). 
 Table B.2: Raw data of CHO cell acute cytotoxicity after 4 hours of treatment with 
chloroacetonitrile (CAN), bromoacetonitrile (BAN) and iodoacetonitrile (IAN).  
 Table B.3: Regression analysis of the CHO cell CAN SCGE genotoxicity data. 
 Table B.4: Regression analysis of the CHO cell BAN SCGE genotoxicity data. 
 Table B.5: Regression analysis of the CHO cell IAN SCGE genotoxicity data. 
 Table B.6: Raw data of the DNA repair kinetics in CHO cells treated with CAN (1200 µM), BAN 
(60 µM) and IAN (60 µM).  
 Table B.7: Raw data of the percent viability of CHO cells during the DNA repair kinetics after 
treated with CAN (1200 µM), BAN (60 µM) and IAN (60 µM).  
 Table B.8: CHO cell DNA repair kinetics data normalized to the concurrent 0-time control. 
 Table B.9: Regression analysis of the CHO cell CAN DNA repair kinetics data. 
 Table B.10: Regression analysis of the CHO cell BAN DNA repair kinetics data. 
 Table B.11: Regression analysis of the CHO cell IAN DNA repair kinetics data. 
 Table B.12: Raw data of the histograms illustrating the distributions of SCGE % tail DNA values 




 Table B.13: Raw data of the histograms illustrating the distributions of SCGE % tail DNA values 
from CHO cells treated with BAN without and with 1, 2, 3, 4, 5, 10 and 24 hour liquid-holding 
recovery. 
 Table B.14: Raw data of the histograms illustrating the distributions of SCGE % tail DNA values 
from CHO cells treated with IAN without and with 1, 2, 3, 4, 5, 10 and 24 hour liquid-holding 
recovery. 
 Table B.15: Raw data of the histograms illustrating the distributions of SCGE % tail DNA values 
from the CHO cell negative controls at 0 and 24 hour liquid-holding recovery. 
 Table B.16: Raw data of the plating efficiency of HAA-treated CHO cells. 
 Table B.17: Raw data of the plating efficiency of HAN-treated CHO cells. 







Table B.1 Raw data of CHO cell genomic DNA damage after 4 hours of treatment with chloroacetonitrile 
(CAN), bromoacetonitrile (BAN) and iodoacetonitrile (IAN). The primary measure of DNA damage is 
the percent of the DNA that had migrated from the nucleus into the microgel (% tail DNA). Twenty-five 
randomly chosen nuclei per microgel were analyzed and the % tail DNA values were averaged to 
represent the microgel.  
 
 
num Average SEa SDb
CAN conc. 
(µM)
Slide A Slide B Slide A Slide B Slide A Slide B
0 3.64272 1.96116 1.74276 1.21191 1.41049 1.98830 6 1.99289 0.353 0.864
100 2.21754 4.37266 2.86132 6.10492 2.32559 1.92984 6 3.30198 0.664 1.625
400 22.0987 23.7556 28.5017 10.1226 21.4516 29.4387 6 22.5615 2.829 6.931
600 35.3997 23.8242 22.7507 17.8022 40.5908 31.9305 6 28.7164 3.534 8.656
800 36.1930 36.4094 37.9336 32.5197 43.7722 35.5994 6 37.0712 1.525 3.735
900 43.7084 46.4054 2 45.0569 1.349 1.907
1000 42.4778 34.8863 67.4607 57.3985 65.4046 61.7428 6 54.8951 5.404 13.237
1200 60.5293 48.9537 65.0847 62.9409 64.8041 62.9788 6 60.8819 2.477 6.068
1400 67.6226 71.5714 69.5695 67.1266 54.8826 65.4780 6 66.0418 2.391 5.857
1600 74.7260 71.1449 66.8572 64.0812 57.0839 5 66.7786 3.029 6.773
1800 67.5688 67.8832 72.0506 71.4590 4 69.7404 1.171 2.342
2000 65.4860 77.6190 2 71.5525 6.066 8.579
num Average SEa SDb
BAN conc. 
(µM)
Slide A Slide B Slide A Slide B Slide A Slide B
0 1.95989 3.95020 1.61536 2.81502 3.54138 4.42749 6 3.05156 0.456 1.118
10 0.951737 2.60152 4.63930 2.20560 2.20390 2.82873 6 2.57180 0.491 1.203
20 4.73189 7.29887 9.68580 4.02349 3.26640 2.80745 6 5.30232 1.088 2.666
40 25.1729 9.2209 28.9393 20.1097 11.0390 13.7974 6 18.0466 3.260 7.984
50 24.0237 19.8509 39.3131 51.5661 17.3446 26.6842 6 29.7971 5.359 13.126
55 45.1792 43.8633 63.9535 60.8512 51.0122 46.5937 6 51.9088 3.484 8.534
60 61.2937 56.6847 63.8626 57.8668 48.2192 55.2422 6 57.1949 2.209 5.410
65 61.6118 67.0802 84.6619 85.1150 76.7127 77.5453 6 75.4545 3.855 9.443
70 82.3306 85.6862 92.5099 91.0710 86.4037 84.5830 6 87.0974 1.598 3.914
80 88.9635 93.2285 94.4138 92.4375 91.9199 92.5733 6 92.2561 0.746 1.827
100 96.2988 95.4813 91.3766 3 94.3855 1.523 2.638
num Average SEa SDb
IAN conc. 
(µM)
Slide A Slide B Slide A Slide B Slide A Slide B
0 2.52942 1.01246 2.18911 1.75668 3.65528 0.82735 6 1.99505 0.427 1.046
10 2.32128 0.953169 2.05322 3.33821 3.46340 2.24202 6 2.39522 0.377 0.923
30 8.19238 3.75402 7.92972 9.77290 3.26403 3.67707 6 6.09835 1.164 2.851
40 4.56923 4.76666 12.5772 8.66238 11.4164 16.4002 6 9.73201 1.896 4.644
45 7.48082 8.24485 20.6323 19.1626 19.5076 21.0789 6 16.0178 2.597 6.360
50 14.4175 15.9381 42.6844 41.6367 44.8613 49.3393 6 34.8129 6.305 15.445
55 36.5539 39.4266 45.1948 46.8895 65.3303 54.3606 6 47.9593 4.299 10.530
60 52.4345 50.2757 50.7337 41.6187 75.7784 73.6176 6 57.4097 5.685 13.926
65 75.2622 69.1382 73.7079 83.1950 94.0035 89.0538 6 80.7268 3.938 9.645
70 93.6779 91.5105 93.0830 90.6627 4 92.2335 0.695 1.390
75 85.0621 91.3174 2 88.1898 3.128 4.423
Expt 051811ykBAN Expt 052311ykBAN Expt 060111ykBAN
Expt 061511ykCAN Expt 061711ykCAN Expt 062011ykCAN
aSE: standard error of the mean
bSD: standard deviation
Expt 051811ykIAN Expt 052311ykIAN Expt 060111ykIAN
201 
 
Table B.2 Raw data of CHO cell acute cytotoxicity after 4 hours of treatment with chloroacetonitrile 
(CAN), bromoacetonitrile (BAN) and iodoacetonitrile (IAN). Acute cytotoxicity was analyzed with the 
trypan blue dye exclusion assay.  
 
  061511ykCAN 061711ykCAN 062011ykCAN Acute cytotoxicity total 
CAN conc.  
(µM) 
Live Dead Live Dead Live Dead Live Dead 
% Cell  
viability 
0 128 6 137 10 144 8 409 24 94.46 
100 145 10 156 11 107 4 408 25 94.23 
400 147 4 134 3 112 10 393 17 95.85 
600 210 3 106 6 156 19 472 28 94.40 
800 178 5 115 4 135 4 428 13 97.05 
900 123 1         123 1 99.19 
1000 154 1 132 6 116 3 402 10 97.57 
1200 122 2 129 4 120 3 371 9 97.63 
1400 125 4 129 4 141 0 395 8 98.01 
1600 182 1 131 1 146 4 459 6 98.71 
1800     155 4 155 0 310 4 98.73 
2000     204 0 146 1 350 1 99.72 
                    
  051811ykBAN 052311ykBAN 060111ykBAN Acute cytotoxicity total 
BAN conc.  
(µM) 
Live Dead Live Dead Live Dead Live Dead 
% Cell  
viability 
0 129 2 211 21 137 5 477 28 94.46 
10 144 5 143 8 149 14 436 27 94.17 
20 121 3 111 6 146 12 378 21 94.74 
40 121 4 145 10 127 4 393 18 95.62 
50 168 3 103 4 146 8 417 15 96.53 
55 152 5 150 1 117 5 419 11 97.44 
60 162 3 172 6 154 9 488 18 96.44 
65 145 2 152 4 151 6 448 12 97.39 
70 127 3 171 12 166 0 464 15 96.87 
80 164 5 180 5 109 1 453 11 97.63 
100 139 5 139 3 105 4 383 12 96.96 
                    
  051811ykIAN 052311ykIAN 060111ykIAN Acute cytotoxicity total 
IAN conc.  
(µM) 
Live Dead Live Dead Live Dead Live Dead 
% Cell  
viability 
0 164 6 113 1 206 20 483 27 94.71 
10 142 15 130 6 137 10 409 31 92.95 
30 110 0 120 3 149 4 379 7 98.19 
40 143 4 137 9 139 7 419 20 95.44 
45 126 3 127 3 144 8 397 14 96.59 
50 140 9 143 8 140 1 423 18 95.92 
55 117 1 125 3 135 5 377 9 97.67 
60 153 14 154 7 133 3 440 24 94.83 
65 138 1 131 6 159 8 428 15 96.61 
70     137 6 152 4 289 10 96.66 
75     182 7 149 5 331 12 96.50 
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Table B.3 Regression analysis of the CHO cell CAN SCGE genotoxicity data. 
 
Nonlinear Regression   Wednesday, July 25, 2012, 9:00:21 AM 
 
Data Source: all HANs_3 repeats each in Redo2_haloacetonitriles 




R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.9943 0.9886 0.9861  2.9705  
 
  Coefficient Std. Error t P  
 
a 71.2863 2.0241 35.2181 <0.0001  
b 277.6382 27.6349 10.0467 <0.0001  
x0 721.5647 30.5139 23.6471 <0.0001  
 
Analysis of Variance:  
 
Analysis of Variance:  
  DF SS MS  
Regression 3 30197.9701 10065.9900  
Residual 9 79.4150 8.8239  
Total 12 30277.3851 2523.1154  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression 2 6913.9249 3456.9624 391.7731 <0.0001  
Residual 9 79.4150 8.8239  




Normality Test (Shapiro-Wilk)   Passed (P = 0.4356) 
 
W Statistic= 0.9350 Significance Level = 0.0500 
 
Constant Variance Test  Failed (P = 0.0113) 
 
Fit Equation Description: 
[Variables] 
x = col(1) 
y = col(2) 
reciprocal_y = 1/abs(y) 
reciprocal_ysquare = 1/y^2 
'Automatic Initial Parameter Estimate Functions 
sup(q)=if(mean(q)>=0, max(q), min(q)) 
b1(q,r)=if(sup(r)>0, xwtr(q,r,.5)/4, -xwtr(q,r,.5)/4) 
[Parameters] 
a = sup(y) ''Auto {{previous: 71.2863}} 
b = if(b1(x,y)=0, 1, b1(x,y)) ''Auto {{previous: 277.638}} 








fit f to y 
''fit f to y with weight reciprocal_y 












Table B.4 Regression analysis of the CHO cell BAN SCGE genotoxicity data. 
 
Nonlinear Regression   Wednesday, July 25, 2012, 9:04:56 AM 
 
Data Source: all HANs_3 repeats each in Redo2_haloacetonitriles 




R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.9953 0.9906 0.9883  3.9996  
 
  Coefficient Std. Error t P  
 
a 97.2262 3.4759 27.9711 <0.0001  
b 8.5454 0.9990 8.5536 <0.0001  
x0 55.0910 1.0581 52.0653 <0.0001  
 
Analysis of Variance:  
 
Analysis of Variance:  
  DF SS MS  
Regression 3 37794.5422 12598.1807  
Residual 8 127.9763 15.9970  
Total 11 37922.5185 3447.5017  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression 2 13489.2854 6744.6427 421.6182 <0.0001  
Residual 8 127.9763 15.9970  




Normality Test (Shapiro-Wilk)   Failed (P = 0.0407) 
 
W Statistic= 0.8484 Significance Level = 0.0500 
 
Constant Variance Test  Passed (P = 0.6138) 
 
Fit Equation Description: 
[Variables] 
x = col(6) 
y = col(7) 
reciprocal_y = 1/abs(y) 
reciprocal_ysquare = 1/y^2 
'Automatic Initial Parameter Estimate Functions 
sup(q)=if(mean(q)>=0, max(q), min(q)) 
b1(q,r)=if(sup(r)>0, xwtr(q,r,.5)/4, -xwtr(q,r,.5)/4) 
[Parameters] 
a = sup(y) ''Auto {{previous: 97.2262}} 
b = if(b1(x,y)=0, 1, b1(x,y)) ''Auto {{previous: 8.54539}} 








fit f to y 
''fit f to y with weight reciprocal_y 












Table B.5 Regression analysis for the CHO cell IAN SCGE genotoxicity data. 
 
Nonlinear Regression   Wednesday, July 25, 2012, 9:07:26 AM 
 
Data Source: all HANs_3 repeats each in Redo2_haloacetonitriles 




R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.9945 0.9890 0.9862  4.1667  
 
  Coefficient Std. Error t P  
 
a 99.3082 6.3677 15.5957 <0.0001  
b 7.3274 0.9987 7.3367 <0.0001  
x0 55.7228 1.4296 38.9766 <0.0001  
 
Analysis of Variance:  
 
Analysis of Variance:  
  DF SS MS  
Regression 3 29868.4758 9956.1586  
Residual 8 138.8890 17.3611  
Total 11 30007.3648 2727.9423  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression 2 12462.3047 6231.1524 358.9141 <0.0001  
Residual 8 138.8890 17.3611  




Normality Test (Shapiro-Wilk)   Passed (P = 0.3629) 
 
W Statistic= 0.9250 Significance Level = 0.0500 
 
Constant Variance Test  Failed (P = 0.0209) 
 
Fit Equation Description: 
[Variables] 
x = col(11) 
y = col(12) 
reciprocal_y = 1/abs(y) 
reciprocal_ysquare = 1/y^2 
'Automatic Initial Parameter Estimate Functions 
sup(q)=if(mean(q)>=0, max(q), min(q)) 
b1(q,r)=if(sup(r)>0, xwtr(q,r,.5)/4, -xwtr(q,r,.5)/4) 
[Parameters] 
a = sup(y) ''Auto {{previous: 99.3082}} 
b = if(b1(x,y)=0, 1, b1(x,y)) ''Auto {{previous: 7.32744}} 








fit f to y 
''fit f to y with weight reciprocal_y 












Table B.6 Raw data of the DNA repair kinetics in CHO cells treated with CAN (1200 µM), BAN (60 
µM) and IAN (60 µM). CHO cells were treated for 4 hours and then maintained in fresh serum-free F12 
medium for 0, 1, 2, 3, 4, 5, 10 and 24 hours (liquid holding (LH) recovery time). The primary measure of 
DNA damage is the percent of the DNA that had migrated from the nucleus into the microgel (% tail 
DNA). Fifty randomly chosen nuclei per microgel were analyzed and the % tail DNA values were 









Slide A Slide B Slide A Slide B Slide A Slide B Slide A Slide B Slide A Slide B
0 0 1.44555 5.36062 2.36573 2.16841 2.23912 3.05889 1.12785 2.67704 1.44553 0.948998
1200 0 66.4780 67.5452 71.4820 70.8790 53.2424 50.5131 86.6393 80.4939 76.1991 78.7079
1200 1 40.1499 33.9285 31.9256 27.7707 29.0436 31.0792 40.5000 30.8236 31.7320 35.1518
1200 2 18.6537 17.7883 16.7622 15.1922 11.5711 10.3637 15.0196 17.5154 21.7027 17.0114
1200 3 7.68463 9.12812 7.21894 10.2309 7.22534 10.1502 13.0875 13.6518 16.7490 15.2385
1200 4 6.29296 7.23056 6.46178 5.76068 3.69305 11.2429 16.6516 14.6841 11.7075 9.14558
1200 5 5.01604 5.18677 6.32143 6.09288 9.51049 8.61297 7.25956 10.0845 21.7171 21.1795
1200 10 4.48517 6.94614 6.10198 6.02602 2.48453 3.46302 4.98485 5.84498 3.36851 2.73555
0 24 1.38544 2.38646 2.13149 1.74355 1.22911 2.70744 1.48126 0.81807 2.74775 1.12390





Slide A Slide B Slide A Slide B Slide A Slide B Slide A Slide B
0 0 1.25966 0.993854 1.40884 0.922386 2.86008 0.579878 3.97513 0.450705
60 0 63.3073 65.2709 61.3408 63.5231 82.7047 78.5670 84.9747 81.3419
60 1 33.1644 28.6729 35.4852 31.4976 50.3471 39.6332 59.9963 59.9507
60 2 18.0949 19.2297 23.5586 27.0931 39.7012 39.9257 36.1382 49.7377
60 3 15.7960 7.51916 11.7051 13.0849 43.5516 38.0450 21.9558 26.7007
60 4 14.9173 7.51447 10.6069 10.1366 18.4730 16.7659 32.6840 27.8108
60 5 10.4311 7.81101 8.72176 7.18749 18.3776 14.2613 13.3392 15.2156
60 10 5.55173 2.91165 3.89964 6.96668 9.14963 12.8597 10.1313 8.73536
0 24 2.65816 0.728611 1.54300 0.621775 1.88938 1.03530 0.922628 0.789595





Slide A Slide B Slide A Slide B Slide A Slide B Slide A Slide B
0 0 2.32416 2.74211 1.93535 2.27058 1.31850 0.523633 1.10125 1.53764
60 0 65.2649 55.7417 64.0777 57.3944 60.2983 55.3135 66.6261 64.1978
60 1 38.6554 36.9702 41.9454 40.1165 22.2427 16.9448 23.0777 13.3046
60 2 35.5034 35.9433 39.0028 39.0157 23.5421 16.9527 25.3428 22.2191
60 3 16.0701 12.4914 22.7355 14.3433 12.8090 7.4747 22.3749 14.8885
60 4 7.64693 9.03924 13.7703 10.7907 12.7986 11.7656 11.2958 8.67954
60 5 6.34129 7.57376 16.3207 14.1220 11.2036 14.2469 10.9556 12.6269
60 10 6.50883 6.84642 6.86923 8.22927 5.68660 4.67269 5.45514 7.45114
0 24 1.25125 1.74059 1.01518 3.04596 0.294099 0.791296 0.791629 0.463279
60 24 7.01616 8.79110 6.73367 9.09013 7.47604 4.34950 6.26346 6.61167
Expt 122811ykBAN2Expt 122811ykBAN1Expt 090111ykBAN1 Expt 090111ykBAN2
Expt 080111ykIAN1 Expt 080111ykIAN2 Expt 092411ykIAN1 Expt 092411ykIAN2
Expt 062011ykCAN Expt 062511ykCAN Expt 062711ykCAN Expt 091611ykCAN1 Expt 091611ykCAN2
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Table B.7 Raw data of the percent viability of CHO cells during the DNA repair kinetics after treated 
with CAN (1200 µM), BAN (60 µM) and IAN (60 µM). CHO cells were treated for 4 hours and then 









Live Dead Live Dead Live Dead Live Dead Live Dead Live Dead
% Cell 
viability
0 0 144 4 228 12 213 9 163 7 153 2 901 34 96.36
1200 0 223 9 147 7 155 5 187 8 202 5 914 34 96.41
1200 1 177 8 241 8 267 5 192 2 198 5 1075 28 97.46
1200 2 192 5 183 2 200 1 166 2 139 2 880 12 98.65
1200 3 214 1 277 3 174 4 173 13 192 4 1030 25 97.63
1200 4 195 2 184 11 139 6 200 0 196 6 914 25 97.34
1200 5 201 1 262 8 229 6 139 2 122 1 953 18 98.15
1200 10 122 20 225 5 186 6 138 7 145 4 816 42 95.10
0 24 206 5 243 7 225 14 169 18 174 3 1017 47 95.58
1200 24 169 13 231 3 139 22 150 13 178 22 867 73 92.23





Live Dead Live Dead Live Dead Live Dead Live Dead
% Cell 
viability
0 0 171 3 137 10 104 3 117 0 529 16 97.06
60 0 172 10 158 7 183 4 108 3 621 24 96.28
60 1 161 1 146 0 254 3 171 1 732 5 99.32
60 2 149 3 147 2 220 6 147 1 663 12 98.22
60 3 189 6 157 6 100 2 446 14 96.96
60 4 159 4 174 3 102 1 106 1 541 9 98.36
60 5 200 1 150 3 143 4 228 7 721 15 97.96
60 10 244 9 163 3 129 4 108 1 644 17 97.43
0 24 190 18 139 5 117 4 146 7 592 34 94.57





Live Dead Live Dead Live Dead Live Dead Live Dead
% Cell 
viability
0 0 172 11 122 4 171 11 211 9 676 35 95.08
60 0 151 2 142 3 131 0 210 5 634 10 98.45
60 1 191 10 143 2 153 4 211 6 698 22 96.94
60 2 125 1 150 9 202 3 137 3 614 16 97.46
60 3 158 4 184 3 152 0 157 3 651 10 98.49
60 4 196 6 137 2 185 8 196 1 714 17 97.67
60 5 158 4 170 5 172 4 142 4 642 17 97.42
60 10 183 8 169 2 121 1 131 4 604 15 97.58
0 24 198 21 131 6 179 12 175 10 683 49 93.31
60 24 136 6 192 13 159 5 152 23 639 47 93.15
090111ykBAN2 122811ykBAN1 122811ykBAN2








num Average SEa SDb
LH time 
(hours)
Slide A Slide B Slide A Slide B Slide A Slide B Slide A Slide B Slide A Slide B
0 99.20 100.80 100.42 99.58 102.63 97.37 103.68 96.32 98.38 101.62 10 100.00 0.728 2.303
1 59.91 50.63 44.85 39.01 55.98 59.91 48.46 36.89 40.97 45.38 10 48.20 2.635 8.332
2 27.84 26.55 23.55 21.34 22.30 19.98 17.97 20.96 28.02 21.96 10 23.05 1.077 3.404
3 11.47 13.62 10.14 14.37 13.93 19.57 15.66 16.34 21.62 19.67 10 15.64 1.175 3.715
4 9.39 10.79 9.08 8.09 7.12 21.67 19.93 17.57 15.12 11.81 10 13.06 1.639 5.184
5 7.49 7.74 8.88 8.56 18.33 16.60 8.69 12.07 28.04 27.34 10 14.37 2.514 7.949
10 6.69 10.37 8.57 8.47 4.79 6.68 5.97 6.99 4.35 3.53 10 6.64 0.666 2.105
24 10.23 13.55 2.98 7.60 11.73 17.55 5.48 7.63 7.37 8.77 10 9.29 1.322 4.179
num Average SEa SDb
LH time 
(hours)
Slide A Slide B Slide A Slide B Slide A Slide B Slide A Slide B
0 98.47 101.53 98.25 101.75 102.57 97.43 102.18 97.82 8 100.00 0.773 2.187
1 51.59 44.60 56.84 50.45 62.44 49.15 72.15 72.09 8 57.41 3.715 10.509
2 28.15 29.91 37.73 43.40 49.24 49.51 43.46 59.81 8 42.65 3.739 10.576
3 24.57 11.70 18.75 20.96 54.01 47.18 26.40 32.11 8 29.46 5.105 14.440
4 23.20 11.69 16.99 16.24 22.91 20.79 39.30 33.44 8 23.07 3.245 9.177
5 16.23 12.15 13.97 11.51 22.79 17.69 16.04 18.30 8 16.08 1.291 3.651
10 8.64 4.53 6.25 11.16 11.35 15.95 12.18 10.50 8 10.07 1.264 3.574
24 6.92 7.22 6.38 8.82 12.68 10.39 10.25 10.30 8 9.12 0.767 2.170
num Average SEa SDb
LH time 
(hours)
Slide A Slide B Slide A Slide B Slide A Slide B Slide A Slide B
0 107.87 92.13 105.50 94.50 104.31 95.69 101.86 98.14 8 100.00 2.020 5.713
1 63.89 61.10 69.06 66.05 38.48 29.31 35.28 20.34 8 47.94 6.762 19.125
2 58.68 59.41 64.22 64.24 40.73 29.33 38.74 33.97 8 48.66 5.091 14.400
3 26.56 20.65 37.43 23.62 22.16 12.93 34.21 22.76 8 25.04 2.743 7.759
4 12.64 14.94 22.67 17.77 22.14 20.35 17.27 13.27 8 17.63 1.366 3.864
5 10.48 12.52 26.87 23.25 19.38 24.65 16.75 19.30 8 19.15 2.034 5.752
10 10.76 11.32 11.31 13.55 9.84 8.08 8.34 11.39 8 10.57 0.632 1.788
24 11.60 14.53 11.09 14.97 12.93 7.52 9.58 10.11 8 11.54 0.895 2.532
092411ykIAN1 092411ykIAN2
aSE: standard error of the mean
bSD: standard deviation
062011ykCAN 062511ykCAN 062711ykCAN 091611ykCAN1 091611ykCAN2







Table B.9 Regression analysis of the CHO cell CAN DNA repair kinetics data.  
 
Nonlinear Regression   Wednesday, July 25, 2012, 10:07:14 AM 
CAN repair kinetics 
 
Data Source: All HANs as % in Redo2_haloacetonitriles 




R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.9979 0.9959 0.9942  2.3977  
 
  Coefficient Std. Error t P  
 
y0 9.5264 1.2849 7.4139 0.0007  
a 90.6220 2.6065 34.7683 <0.0001  
b 0.8804 0.0611 14.4002 <0.0001  
 
Analysis of Variance:  
 
Analysis of Variance:  
  DF SS MS  
Regression 3 13577.7987 4525.9329  
Residual 5 28.7457 5.7491  
Total 8 13606.5444 1700.8180  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression 2 6951.0710 3475.5355 604.5319 <0.0001  
Residual 5 28.7457 5.7491  




Normality Test (Shapiro-Wilk)   Passed (P = 0.7256) 
 
W Statistic= 0.9514 Significance Level = 0.0500 
 
Constant Variance Test  Passed (P = 0.4597) 
 
Fit Equation Description: 
[Variables] 
x = col(1) 
y = col(2) 
reciprocal_y=1/abs(y) 
reciprocal_ysquare=1/y^2 
'Automatic Initial Parameter Estimates 
yhat(q)=q[size(q)] 
[Parameters] 
y0 = yhat(y) ''Auto {{previous: 9.52641}} 
a = max(y)-yhat(y) ''Auto {{previous: 90.622}} 








fit f to y 
''fit f to y with weight reciprocal_y 













Table B.10 Regression analysis of the CHO cell BAN DNA repair kinetics data. 
 
Nonlinear Regression   Wednesday, July 25, 2012, 10:08:38 AM 
BAN repair kinetics 
 
Data Source: All HANs as % in Redo2_haloacetonitriles 




R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.9972 0.9944 0.9922  2.7070  
 
  Coefficient Std. Error t P  
 
y0 10.1848 1.7892 5.6925 0.0023  
a 88.0792 2.9438 29.9200 <0.0001  
b 0.5269 0.0396 13.3043 <0.0001  
 
Analysis of Variance:  
 
Analysis of Variance:  
  DF SS MS  
Regression 3 16922.0240 5640.6747  
Residual 5 36.6403 7.3281  
Total 8 16958.6643 2119.8330  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression 2 6563.7256 3281.8628 447.8488 <0.0001  
Residual 5 36.6403 7.3281  




Normality Test (Shapiro-Wilk)   Passed (P = 0.1071) 
 
W Statistic= 0.8550 Significance Level = 0.0500 
 
Constant Variance Test  Passed (P = 0.0588) 
 
Fit Equation Description: 
[Variables] 
x = col(1) 
y = col(5) 
reciprocal_y=1/abs(y) 
reciprocal_ysquare=1/y^2 
'Automatic Initial Parameter Estimates 
yhat(q)=q[size(q)] 
[Parameters] 
y0 = yhat(y) ''Auto {{previous: 10.1848}} 
a = max(y)-yhat(y) ''Auto {{previous: 88.0792}} 








fit f to y 
''fit f to y with weight reciprocal_y 













Table B.11 Regression analysis of the CHO cell IAN DNA repair kinetics data. 
 
Nonlinear Regression   Wednesday, July 25, 2012, 10:10:31 AM 
IAN repair kinetics 
 
Data Source: All HANs as % in Redo2_haloacetonitriles 




R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.9792 0.9588 0.9424  7.2476  
 
  Coefficient Std. Error t P  
 
y0 12.2210 4.5377 2.6932 0.0431  
a 84.9370 7.8721 10.7897 0.0001  
b 0.6028 0.1276 4.7263 0.0052  
 
Analysis of Variance:  
 
Analysis of Variance:  
  DF SS MS  
Regression 3 15953.2104 5317.7368  
Residual 5 262.6370 52.5274  
Total 8 16215.8474 2026.9809  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression 2 6115.6101 3057.8050 58.2135 0.0003  
Residual 5 262.6370 52.5274  




Normality Test (Shapiro-Wilk)   Passed (P = 0.4856) 
 
W Statistic= 0.9266 Significance Level = 0.0500 
 
Constant Variance Test  Failed (P = 0.0287) 
 
Fit Equation Description: 
[Variables] 
x = col(1) 
y = col(8) 
reciprocal_y=1/abs(y) 
reciprocal_ysquare=1/y^2 
'Automatic Initial Parameter Estimates 
yhat(q)=q[size(q)] 
[Parameters] 
y0 = yhat(y) ''Auto {{previous: 12.221}} 
a = max(y)-yhat(y) ''Auto {{previous: 84.937}} 








fit f to y 
''fit f to y with weight reciprocal_y 
















Table B.12 Raw data of the histograms illustrating the distributions of SCGE % tail DNA values from 
CHO cells treated with CAN without and with 1, 2, 3, 4, 5, 10 and 24 hour liquid-holding recovery. 
 
LH_0h LH_1h LH_2h LH_3h LH_4h LH_5h LH_10h LH_24h 
        8.82938 0.01858 0 0 0 0 0 0 
10.9017 0.03193 0 0 0 0 0 0 
13.7598 0.03450 0 0 0 0 0 0 
13.7981 0.07327 0 0 0 0 0 0 
15.1714 0.09674 0 0 0 0 0 0 
15.8492 0.21394 0 0 0 0 0 0 
16.4707 0.30928 0 0 0 0 0 0 
17.7065 0.34539 0 0 0 0 0 0 
17.7073 0.43927 0.001254 0 0 0 0 0 
21.0131 0.65040 0.001473 0 0 0 0 0 
21.6998 1.18736 0.001607 0 0 0 0 0 
23.2550 1.23293 0.002494 0 0 0 0 0 
23.7059 1.37611 0.002876 0 0 0 0 0 
23.8447 1.46813 0.003321 0.001120 0 0 0 0 
25.1772 1.76325 0.004161 0.002977 0 0 0 0 
26.1630 1.86586 0.004731 0.002980 0 0 0 0 
26.2815 2.23414 0.005383 0.003352 0 0.001184 0 0 
26.4795 2.26208 0.008481 0.004300 0 0.001366 0 0 
26.9313 2.33154 0.011027 0.004328 0 0.001412 0 0 
27.1086 2.76098 0.011836 0.005011 0 0.001779 0 0 
27.9400 2.79141 0.013133 0.007274 0 0.002132 0 0 
28.4601 3.23850 0.014880 0.008091 0 0.002499 0 0 
29.8185 3.41395 0.016499 0.009090 0 0.002942 0 0 
30.2477 3.62878 0.020580 0.010410 0.000990 0.003155 0 0 
31.6378 3.69868 0.024643 0.011881 0.001007 0.003235 0 0 
32.1142 3.79441 0.028666 0.013106 0.001250 0.003872 0 0 
32.1509 3.82908 0.029713 0.013988 0.001346 0.004507 0 0 
33.7546 3.83886 0.031691 0.015894 0.001392 0.005039 0 0 
33.7552 3.90296 0.034566 0.018490 0.003649 0.005696 0 0 
33.8864 3.97622 0.035467 0.019052 0.005701 0.005865 0 0 
33.9133 4.15951 0.037290 0.019593 0.005711 0.005906 0.000840 0 
34.2731 4.22959 0.038790 0.019679 0.006750 0.005981 0.000998 0.000630 
34.7368 4.57668 0.048401 0.023605 0.006798 0.006215 0.001212 0.000680 
35.0567 4.72165 0.062882 0.027760 0.008280 0.007577 0.001599 0.000718 
35.7978 4.82076 0.067338 0.027958 0.008570 0.007871 0.001631 0.001021 
35.8472 5.38760 0.069803 0.029456 0.008791 0.008163 0.001649 0.001291 
35.8479 5.39760 0.074155 0.030093 0.009413 0.008985 0.002198 0.001422 
35.8674 5.46136 0.076736 0.032935 0.010718 0.013717 0.002230 0.001436 
36.1362 5.46869 0.077580 0.039820 0.010798 0.014595 0.002253 0.001817 
36.7060 5.73003 0.082056 0.040205 0.010962 0.014704 0.002730 0.001913 
37.1842 5.80346 0.090323 0.041358 0.011087 0.015085 0.002757 0.002196 
37.2228 5.86021 0.098294 0.042603 0.012971 0.016383 0.002845 0.002683 
37.3289 6.77239 0.107730 0.057696 0.013119 0.020220 0.003555 0.002966 
37.9886 6.85045 0.111494 0.064956 0.013393 0.022603 0.004852 0.003406 
38.1561 6.87397 0.116498 0.066024 0.017206 0.028980 0.004911 0.003634 
218 
 
Table B.12 (cont.) 
 
38.5067 6.94888 0.123536 0.067828 0.017880 0.029051 0.005434 0.003703 
38.7382 7.32400 0.124134 0.068095 0.018033 0.029164 0.006063 0.003887 
38.7489 7.32529 0.131478 0.071547 0.018888 0.031927 0.006369 0.004038 
39.1981 7.43299 0.140541 0.074324 0.020176 0.034800 0.007661 0.004105 
40.5148 7.67758 0.145163 0.081345 0.021265 0.034962 0.008177 0.004583 
40.9521 7.74115 0.145170 0.082731 0.024096 0.038825 0.008980 0.005466 
40.9876 7.86423 0.158077 0.086056 0.026137 0.045025 0.009098 0.006201 
41.7460 7.90327 0.158515 0.096245 0.026320 0.045034 0.009341 0.006348 
41.7529 7.99198 0.193358 0.099712 0.026460 0.046656 0.009373 0.006454 
42.0997 8.12956 0.224500 0.103708 0.027750 0.046759 0.009503 0.006578 
42.3220 8.24243 0.265414 0.104654 0.027971 0.053761 0.009687 0.007036 
42.5762 8.32734 0.296557 0.108749 0.033063 0.058974 0.009848 0.007412 
42.7138 8.37929 0.357100 0.114559 0.037242 0.063683 0.010168 0.008044 
42.7194 8.38159 0.359331 0.122287 0.042609 0.065370 0.010237 0.008511 
42.7979 8.60134 0.385775 0.125753 0.049798 0.067246 0.010570 0.008792 
42.8393 8.61148 0.395932 0.129513 0.051880 0.070098 0.010585 0.009106 
43.1110 8.76485 0.401359 0.137206 0.051974 0.078626 0.010887 0.009122 
43.7123 8.80697 0.647389 0.145030 0.056202 0.085041 0.012091 0.009177 
43.7643 8.81398 0.658781 0.146328 0.056652 0.086215 0.012329 0.009411 
44.0560 8.93410 0.703718 0.155729 0.057394 0.086784 0.012464 0.010017 
44.0911 9.03770 0.710923 0.163983 0.060961 0.087281 0.013860 0.011501 
44.7746 9.14882 0.744881 0.167235 0.065791 0.090020 0.013949 0.012268 
44.8449 9.17046 0.762845 0.177743 0.071274 0.090115 0.014702 0.013274 
44.9723 9.35331 0.812567 0.203109 0.079531 0.091936 0.015206 0.013642 
45.0652 9.41023 0.830725 0.220516 0.081525 0.093304 0.017407 0.015139 
45.4283 9.41278 0.832298 0.221309 0.085424 0.096850 0.018438 0.015189 
46.9474 9.76562 0.835287 0.231365 0.093225 0.099939 0.019933 0.017480 
47.1630 9.76758 0.854719 0.280711 0.096234 0.110086 0.020241 0.017493 
47.1978 9.83939 0.940883 0.317938 0.097936 0.111654 0.021614 0.018670 
48.2389 10.2245 0.981902 0.332861 0.108407 0.115322 0.022088 0.019308 
48.8963 10.3444 1.00784 0.340907 0.112189 0.116365 0.022112 0.020299 
49.3181 10.3506 1.01606 0.366146 0.112501 0.123238 0.022271 0.020350 
49.5204 10.4021 1.03640 0.366702 0.112767 0.123660 0.023751 0.020491 
49.8946 10.4512 1.10715 0.383288 0.116228 0.134710 0.023795 0.020757 
49.9151 10.4791 1.14206 0.388496 0.121354 0.144448 0.025686 0.023604 
49.9439 10.5076 1.22375 0.396647 0.123541 0.144738 0.026129 0.026316 
49.9519 10.9575 1.26927 0.399547 0.142181 0.148793 0.026191 0.028526 
50.0644 11.1855 1.44124 0.406100 0.150058 0.175400 0.028136 0.030375 
50.5234 11.4796 1.45059 0.408419 0.163210 0.211613 0.029807 0.031101 
50.7461 11.5372 1.46967 0.444174 0.172816 0.216554 0.030444 0.031734 
51.2931 11.6517 1.47073 0.454146 0.174443 0.228375 0.030698 0.033671 
51.2968 11.8406 1.47779 0.496427 0.180185 0.229993 0.032840 0.034140 
51.4993 12.2337 1.50750 0.542019 0.181518 0.234327 0.036204 0.035409 
51.9041 12.2680 1.52077 0.562173 0.184457 0.240244 0.036567 0.036675 
52.0529 12.3771 1.52497 0.565367 0.189411 0.242019 0.038500 0.037653 
52.0676 12.4169 1.57500 0.601898 0.192286 0.246223 0.041335 0.041652 
52.0814 12.5057 1.61120 0.650242 0.203028 0.247392 0.041355 0.043615 
52.1712 12.5253 1.62939 0.700260 0.206466 0.263252 0.043385 0.046713 
219 
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52.3771 12.6347 1.62944 0.702405 0.220243 0.265833 0.046704 0.047314 
52.4679 12.9288 1.63773 0.733384 0.221568 0.268417 0.047922 0.047324 
52.4906 13.0706 1.66566 0.768771 0.224911 0.285978 0.051924 0.047943 
52.5389 13.1566 1.66670 0.825086 0.227406 0.286268 0.052374 0.048778 
52.5818 13.2941 1.66903 0.828516 0.228736 0.290663 0.053535 0.053515 
52.7168 13.4582 1.67400 0.858265 0.237770 0.301743 0.056978 0.054232 
52.7230 13.8212 1.79166 0.874587 0.250393 0.332979 0.063382 0.056450 
52.8198 13.8858 1.86741 0.882367 0.255441 0.343440 0.066418 0.057220 
52.8384 13.9821 1.95906 0.889590 0.263091 0.354470 0.069402 0.057393 
53.0343 14.0569 2.05134 0.890484 0.268094 0.357023 0.069495 0.057415 
53.0447 14.1944 2.05579 0.893097 0.278604 0.362042 0.072413 0.057967 
53.1288 14.2125 2.08522 0.903709 0.284278 0.384731 0.073024 0.059571 
53.1867 14.2676 2.20411 0.938567 0.286198 0.395026 0.074552 0.061244 
53.5474 14.3499 2.27036 0.955665 0.303728 0.397526 0.074924 0.063586 
53.5893 14.4367 2.28758 0.959120 0.322887 0.404715 0.075334 0.064536 
53.7703 14.6137 2.31567 1.00988 0.331001 0.406767 0.078775 0.065172 
53.9162 14.7078 2.32606 1.01537 0.333973 0.413232 0.079735 0.066900 
54.0225 14.7703 2.39998 1.01722 0.340172 0.417242 0.080667 0.069033 
54.1181 14.9141 2.42125 1.10270 0.346085 0.433320 0.081765 0.071573 
54.1793 14.9210 2.44362 1.10468 0.347110 0.435180 0.086645 0.073627 
54.4440 15.1134 2.46992 1.10731 0.377804 0.437868 0.101187 0.075456 
54.4899 15.1788 2.59462 1.11382 0.383070 0.447413 0.104909 0.075695 
54.5037 15.2851 2.61256 1.15967 0.388375 0.459613 0.105710 0.076043 
54.5418 15.3023 2.62396 1.16529 0.399232 0.479777 0.113361 0.076537 
54.6413 15.3163 2.64680 1.18324 0.408307 0.495806 0.115413 0.077403 
55.1287 15.3918 2.66087 1.22006 0.439558 0.497581 0.121667 0.077735 
55.2076 15.5270 2.74062 1.31514 0.439696 0.505222 0.130189 0.081582 
55.5718 15.6599 2.79050 1.33460 0.448232 0.524016 0.131474 0.089324 
55.7837 15.7400 2.81749 1.36470 0.494152 0.547157 0.132574 0.090703 
55.9326 15.7883 2.95515 1.37191 0.495591 0.575993 0.139080 0.091909 
55.9842 15.9590 3.03823 1.37706 0.498119 0.582786 0.149030 0.095643 
56.2348 16.0786 3.05191 1.38202 0.518400 0.589240 0.149523 0.099369 
56.2730 16.2455 3.08933 1.38371 0.529500 0.622143 0.152545 0.108248 
56.3584 16.3388 3.12333 1.44069 0.534819 0.628108 0.156135 0.115940 
56.5145 16.4714 3.18066 1.46023 0.546566 0.635413 0.160328 0.122509 
56.5156 16.6406 3.19027 1.47992 0.554012 0.642036 0.160448 0.128541 
56.7029 16.6719 3.22308 1.48379 0.580536 0.644039 0.162352 0.139588 
56.7701 16.7599 3.22813 1.51165 0.591562 0.649859 0.174692 0.153077 
56.8316 16.9098 3.26855 1.51618 0.609817 0.654476 0.175033 0.157611 
56.8822 17.0334 3.27624 1.57957 0.616879 0.687530 0.175962 0.158504 
57.1168 17.1549 3.35484 1.58221 0.623790 0.700269 0.180026 0.159437 
57.3943 17.1561 3.56760 1.59560 0.647992 0.707369 0.185428 0.169298 
57.4216 17.1893 3.63098 1.62251 0.652349 0.711259 0.194163 0.170822 
57.5013 17.2419 3.65130 1.62895 0.655616 0.718846 0.203303 0.173411 
57.6462 17.5159 3.65989 1.62917 0.689452 0.754673 0.205860 0.177680 
57.7979 17.5167 3.66915 1.70887 0.712063 0.764217 0.207790 0.179635 
57.8419 17.6994 3.67775 1.80182 0.719514 0.771573 0.209925 0.195777 
58.4156 17.9041 3.71352 1.84793 0.790800 0.771719 0.213905 0.197379 
220 
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58.5188 18.1593 3.72593 1.85169 0.791434 0.786516 0.225702 0.198080 
58.7802 18.2606 3.88851 1.92291 0.811480 0.809016 0.230833 0.203148 
58.8057 18.3225 3.89606 2.00906 0.819986 0.829319 0.231504 0.209525 
58.8566 18.3686 3.96753 2.01410 0.851247 0.834300 0.236037 0.214728 
58.8805 18.3775 4.04982 2.04669 0.851708 0.858802 0.237025 0.225854 
59.1518 18.7958 4.05384 2.04826 0.867576 0.875441 0.246774 0.228863 
59.4667 18.8755 4.14483 2.11393 0.882220 0.911490 0.249561 0.236907 
59.4946 18.8772 4.15018 2.12153 0.893785 0.950211 0.249675 0.238084 
59.5868 18.9146 4.16955 2.13407 0.923049 0.950821 0.258183 0.240330 
59.7993 19.0297 4.20636 2.14458 0.931358 0.966635 0.263608 0.249638 
60.3205 19.0318 4.21774 2.16193 0.981595 0.969338 0.265779 0.262855 
60.3700 19.1309 4.28801 2.17406 0.983528 0.981325 0.267724 0.265163 
60.5046 19.2442 4.32179 2.20389 0.990748 0.998918 0.268560 0.267943 
60.7523 19.3222 4.40951 2.21321 1.00385 1.02441 0.286185 0.277688 
60.7923 19.4528 4.45023 2.21948 1.01754 1.02993 0.296741 0.293359 
60.9737 19.6283 4.59329 2.27878 1.02162 1.04901 0.297775 0.306812 
61.1269 19.6616 4.68681 2.28986 1.03389 1.05310 0.303585 0.309173 
61.3211 19.7618 4.71736 2.30828 1.05638 1.08746 0.306396 0.328291 
61.5540 20.0513 4.76979 2.36472 1.05738 1.09147 0.312241 0.362296 
61.9556 20.0608 4.77154 2.50606 1.08479 1.10382 0.314086 0.364937 
62.1315 20.1041 4.80334 2.50801 1.09343 1.11144 0.320725 0.394952 
62.4223 20.1273 4.96781 2.52776 1.11548 1.11654 0.321034 0.397860 
62.4975 20.1318 5.02231 2.56844 1.15281 1.15238 0.324664 0.428310 
62.8218 20.3795 5.09761 2.63705 1.19403 1.18075 0.327135 0.449233 
63.0643 20.4454 5.13994 2.73684 1.19940 1.19889 0.331056 0.452254 
63.0989 20.4903 5.20571 2.75845 1.20806 1.21696 0.341912 0.457155 
63.0997 20.5735 5.21791 2.76042 1.22161 1.26079 0.344177 0.466884 
63.1257 20.7190 5.21912 2.79785 1.26676 1.27680 0.349538 0.473546 
63.4060 20.7872 5.33642 2.86137 1.28188 1.28796 0.356381 0.549533 
63.4686 20.8344 5.36956 2.92153 1.30656 1.30156 0.370518 0.555138 
63.4724 20.9347 5.44547 2.98745 1.36106 1.33389 0.375000 0.561766 
63.8065 21.1723 5.51781 2.99199 1.40637 1.34821 0.379155 0.593589 
63.8217 21.3813 5.63852 3.01014 1.47431 1.37047 0.387592 0.602014 
63.9691 21.3892 5.77289 3.01200 1.53354 1.38086 0.394699 0.604487 
64.0441 21.4361 5.84637 3.04494 1.53734 1.38315 0.405647 0.624552 
64.3342 21.5002 5.89000 3.09661 1.57239 1.39374 0.411382 0.654737 
64.4179 21.5182 6.06558 3.13263 1.58365 1.43172 0.416441 0.671114 
64.7153 21.5795 6.11624 3.14054 1.63338 1.47247 0.451081 0.685401 
64.7573 21.6587 6.40879 3.14704 1.64075 1.47696 0.453361 0.685779 
64.9332 22.0023 6.43262 3.15448 1.68618 1.54708 0.463423 0.694970 
64.9424 22.0633 6.43746 3.23400 1.69157 1.56175 0.464677 0.703318 
65.0609 22.1482 6.46792 3.29585 1.85089 1.56757 0.466471 0.720680 
65.2266 22.3687 6.55751 3.30005 1.86858 1.59328 0.470896 0.742388 
65.3611 22.5359 6.60016 3.33338 1.92694 1.60980 0.492403 0.754197 
65.4581 22.5710 6.66743 3.40414 1.93265 1.61921 0.557848 0.761928 
65.5184 22.7572 6.69689 3.40644 1.94161 1.63329 0.563277 0.762735 
65.6210 22.8079 6.71789 3.50664 1.99511 1.64248 0.564160 0.769311 
65.6866 22.9524 6.75383 3.50779 2.02526 1.65498 0.621309 0.782846 
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65.7025 23.1815 6.79345 3.52936 2.03560 1.69321 0.628664 0.797320 
65.9914 23.2261 6.82077 3.55656 2.04866 1.71574 0.628995 0.830764 
66.1429 23.3580 6.86346 3.56108 2.06539 1.75709 0.658653 0.841823 
66.2313 23.3683 6.99992 3.57631 2.15401 1.81332 0.663987 0.868288 
66.5071 23.4389 7.02641 3.60194 2.18746 1.84052 0.690657 0.927327 
66.5589 23.4447 7.04190 3.61013 2.19323 1.91510 0.694165 0.955103 
66.8286 23.6404 7.05491 3.63936 2.19527 1.93606 0.721342 0.963718 
66.8508 23.6482 7.13327 3.64296 2.26765 2.04622 0.729064 0.992143 
66.9705 23.6598 7.13974 3.64771 2.47045 2.05286 0.731687 1.02284 
67.2894 23.6840 7.37254 3.66772 2.49705 2.09541 0.770872 1.06058 
67.4299 23.7470 7.43063 3.77805 2.54093 2.25030 0.778084 1.07243 
67.6922 23.9049 7.43250 3.81656 2.56447 2.31742 0.792471 1.08420 
68.0385 23.9458 7.45878 3.82711 2.57831 2.32745 0.827652 1.10539 
68.1680 24.0993 7.57235 3.92331 2.60903 2.33252 0.832929 1.12527 
68.2961 24.3020 7.67779 3.96122 2.63238 2.34502 0.836319 1.15239 
68.3528 24.3536 7.70315 3.97643 2.63570 2.35154 0.862770 1.18139 
68.3914 24.7881 7.71181 4.01648 2.77225 2.37841 0.878977 1.25655 
68.4374 24.8809 7.74150 4.10381 2.77732 2.46910 0.892099 1.27243 
68.7219 25.1583 7.81750 4.13309 2.79645 2.53679 0.893653 1.27878 
68.7238 25.1795 7.87461 4.21219 2.79824 2.54646 0.899753 1.30284 
68.8437 25.2740 7.91272 4.21739 2.80281 2.64075 0.901565 1.30661 
68.9303 25.4017 7.91949 4.30020 2.81038 2.68539 0.919337 1.32788 
68.9781 25.7468 7.94930 4.35662 2.83088 2.73771 0.932843 1.33182 
69.3508 25.7703 7.97691 4.64047 2.85144 2.74777 0.942193 1.33304 
69.3859 25.8122 8.06780 4.65420 2.88759 2.78184 0.977574 1.35181 
69.4769 25.9702 8.08335 4.71958 2.89063 2.83879 1.00817 1.38295 
69.5247 26.0489 8.08351 4.82355 2.94749 2.87938 1.01467 1.38319 
69.6196 26.4323 8.10676 4.89401 3.05237 2.92571 1.02528 1.43648 
69.6273 26.7803 8.12816 4.92685 3.10740 2.99339 1.06087 1.44632 
69.7967 26.8141 8.17817 5.00291 3.14601 3.03884 1.07930 1.47445 
70.0414 26.9150 8.54299 5.06706 3.18148 3.03955 1.09441 1.50184 
70.1054 26.9657 8.66728 5.11316 3.18728 3.15519 1.11058 1.57461 
70.1207 27.2802 8.87803 5.14953 3.19469 3.15718 1.12436 1.59668 
70.2971 27.2859 8.94200 5.17549 3.23120 3.18414 1.12882 1.61825 
70.3628 27.3182 8.94340 5.34465 3.23984 3.19965 1.18652 1.65114 
70.3860 27.3245 8.95004 5.49237 3.25488 3.24094 1.19131 1.70207 
70.3899 27.4478 9.03964 5.58080 3.26081 3.29620 1.19395 1.71582 
70.4276 27.4708 9.05676 5.58313 3.29048 3.31472 1.20419 1.73692 
70.5615 27.5001 9.05923 5.74930 3.30521 3.32040 1.20586 1.81029 
70.6267 27.5027 9.14470 5.76304 3.32308 3.37219 1.22250 1.82396 
70.6499 27.6191 9.14655 5.78674 3.33667 3.43955 1.23012 1.83258 
70.6844 27.8625 9.19569 5.94222 3.35035 3.44237 1.24840 1.83525 
70.7648 27.8661 9.24869 5.94425 3.39547 3.44651 1.26326 1.84330 
71.0606 27.9311 9.26007 5.94736 3.44344 3.45915 1.27255 1.86448 
71.0689 28.2870 9.49478 5.97979 3.46958 3.49190 1.27580 1.95302 
71.1774 28.4183 9.50906 5.98695 3.53001 3.49195 1.34193 1.97461 
71.2055 28.7470 9.52282 6.00011 3.56093 3.50443 1.41090 2.04541 
71.2201 28.7835 9.56610 6.03003 3.63074 3.56738 1.44762 2.07214 
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71.3132 28.7946 9.61136 6.06082 3.68509 3.59131 1.46000 2.09614 
71.3991 29.0168 10.0444 6.28891 3.77126 3.59436 1.46099 2.11164 
71.4179 29.1830 10.0744 6.30952 3.77374 3.61404 1.46663 2.12101 
71.6171 29.3450 10.0861 6.32858 3.77491 3.67944 1.46752 2.14964 
71.6788 29.4880 10.0975 6.35816 3.80665 3.76117 1.47153 2.15609 
71.6870 29.5411 10.1288 6.40631 3.92205 3.82874 1.57246 2.16952 
71.7416 29.7178 10.1743 6.43911 3.95393 3.83468 1.61653 2.18537 
72.0391 30.0146 10.2858 6.52738 3.97971 3.91247 1.63922 2.23142 
72.0393 30.0199 10.4715 6.61489 3.98073 4.05932 1.68685 2.24298 
72.1475 30.0990 10.5463 6.62138 3.99378 4.06238 1.71492 2.28984 
72.1967 30.2324 10.6396 6.66952 4.06283 4.12539 1.71547 2.31085 
72.2577 30.3529 10.6808 6.80118 4.10583 4.13157 1.74366 2.32698 
72.3735 30.3981 10.6952 6.80476 4.11019 4.13636 1.74384 2.33216 
72.5176 30.4774 10.7319 6.82157 4.17284 4.16391 1.75918 2.34994 
72.5664 30.6013 10.8981 6.88767 4.22502 4.16739 1.87552 2.35158 
72.8219 30.7971 11.1141 6.94950 4.45553 4.17705 1.88597 2.37857 
73.0362 30.9934 11.5120 7.06560 4.45711 4.22823 1.90279 2.41167 
73.2360 31.1791 11.6071 7.09752 4.50640 4.43640 1.93258 2.41289 
73.2641 31.2112 11.6099 7.12912 4.51730 4.45374 1.94547 2.46534 
73.3328 31.2986 11.6383 7.14917 4.54712 4.53459 1.94761 2.47839 
73.3841 31.4569 11.6998 7.18588 4.65204 4.63135 1.94909 2.50159 
73.7065 31.5287 12.0164 7.24747 4.71316 4.64135 1.98806 2.51013 
73.8321 31.6036 12.0662 7.27585 4.72136 4.64392 2.00214 2.55297 
74.1049 31.6308 12.0831 7.29285 4.73075 4.66491 2.00716 2.58039 
74.1514 31.6947 12.2287 7.38866 4.76629 4.67968 2.05472 2.68099 
74.1970 31.7941 12.2396 7.43169 4.76854 4.68038 2.11381 2.76838 
74.5311 31.8656 12.3277 7.43177 4.82242 4.71707 2.12412 2.78523 
74.7666 31.9174 12.4827 7.45956 4.92787 4.71754 2.25880 2.81031 
74.8418 31.9258 12.5195 7.48976 4.95644 4.74827 2.27512 2.82946 
74.8978 32.0370 12.6660 7.59301 5.05658 4.80989 2.31195 2.98812 
75.0490 32.0440 12.6836 7.60139 5.08149 4.84161 2.34052 3.05950 
75.0597 32.1686 12.6942 7.68235 5.19099 4.85147 2.37604 3.07085 
75.2880 32.1706 12.7757 7.68925 5.24560 4.88603 2.43129 3.11742 
75.4504 32.3091 12.9792 7.72224 5.32978 4.91333 2.43379 3.11888 
75.5911 32.3306 13.0903 7.79398 5.41575 4.99912 2.44891 3.19684 
75.7700 32.6540 13.3289 7.88962 5.45480 5.08602 2.48529 3.20567 
75.8075 32.6794 13.3834 7.90882 5.47394 5.13660 2.51739 3.21150 
76.4715 32.7069 13.4340 8.02694 5.51382 5.22501 2.52016 3.25181 
76.5542 32.7874 13.5702 8.13396 5.60541 5.23092 2.60513 3.25514 
76.6133 32.8342 13.5926 8.13546 5.65417 5.24691 2.62068 3.31759 
76.7081 33.1182 13.7948 8.15220 5.86294 5.24884 2.62468 3.40504 
76.7760 33.1712 13.8570 8.19950 5.89695 5.32643 2.70041 3.41430 
76.8393 33.5381 13.9423 8.23623 6.00389 5.40446 2.71168 3.43774 
76.8910 33.5442 14.0033 8.25818 6.09601 5.40599 2.75834 3.45889 
76.9595 33.6435 14.0605 8.37560 6.15021 5.50087 2.78623 3.47566 
77.1093 33.6777 14.2878 8.41122 6.19945 5.58541 2.79801 3.48151 
77.3571 33.8072 14.3043 8.51130 6.20407 5.70815 2.92264 3.62727 
77.4220 33.9023 14.3727 8.51716 6.20848 5.71114 2.95012 3.70036 
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77.5391 33.9415 14.4120 8.53443 6.21574 5.73807 3.02729 3.90082 
77.5429 34.0000 14.4310 8.71231 6.37146 5.76437 3.07878 4.13050 
77.5585 34.9169 14.4315 8.73038 6.44291 5.78975 3.10872 4.14012 
77.5677 34.9641 14.5155 8.84953 6.47619 5.79694 3.11639 4.18468 
77.6582 35.1043 14.5667 8.90955 6.50950 5.84572 3.17123 4.21452 
77.8129 35.1559 14.6378 8.94953 6.54777 5.88561 3.17612 4.24962 
77.8293 35.2343 14.6904 8.97594 6.59295 6.11922 3.18274 4.34205 
78.0061 35.4175 14.7189 9.01328 6.62885 6.14737 3.22183 4.38986 
78.2782 35.5786 14.7583 9.05104 6.63650 6.18992 3.22211 4.52042 
78.3480 35.6579 14.7611 9.07666 6.67723 6.19604 3.23462 4.54021 
78.5841 35.7464 14.7927 9.13200 6.72724 6.25466 3.26757 4.55402 
78.6607 36.4582 14.9055 9.21574 6.76420 6.31209 3.32691 4.58060 
78.8863 36.4742 14.9199 9.24189 6.77380 6.32843 3.36079 4.64958 
79.1639 36.5497 14.9348 9.24253 6.79128 6.45524 3.36411 4.71456 
79.6337 36.6203 15.0082 9.24869 6.79571 6.47575 3.37707 4.78916 
79.7965 36.7244 15.2147 9.34723 6.81872 6.74487 3.43391 4.84004 
79.9450 36.9212 15.2527 9.37562 6.89788 6.82364 3.57061 4.85031 
79.9698 37.1365 15.2565 9.40089 6.98339 6.85073 3.57756 4.88160 
79.9834 37.3561 15.3141 9.44147 7.10560 6.95715 3.59214 4.90428 
80.3975 37.6117 15.3824 9.50116 7.10813 6.96320 3.60011 4.98573 
80.4123 37.6390 15.4094 9.56460 7.14602 6.96499 3.63403 5.00526 
80.7146 37.6781 15.6082 9.58406 7.15906 7.00216 3.64299 5.03555 
80.7173 37.7073 15.6897 9.61128 7.21332 7.01771 3.72108 5.04667 
80.7275 37.7591 15.8601 9.61368 7.21924 7.19668 3.73541 5.06540 
80.7411 37.8417 15.9443 9.62941 7.29747 7.25018 3.88342 5.06565 
80.7505 38.1273 16.0044 9.77485 7.32567 7.27704 3.88842 5.07131 
80.8560 38.2540 16.0593 9.86876 7.48291 7.55517 3.88919 5.08468 
81.0738 38.4526 16.0672 9.99342 7.49675 7.55576 3.89614 5.08994 
81.1310 38.9647 16.0979 10.0320 7.53857 7.59962 3.94632 5.18417 
81.3346 39.3593 16.1619 10.0571 7.59543 7.62846 3.99698 5.21516 
81.5519 39.7188 16.1663 10.0967 7.61073 7.64456 4.04173 5.44777 
81.5572 39.8355 16.3849 10.3484 7.62525 7.73708 4.05062 5.47126 
81.6072 40.2170 16.4670 10.4252 7.66155 7.78260 4.06110 5.53659 
81.6316 40.7355 16.5063 10.4327 7.75768 7.81501 4.07869 5.54752 
81.8079 40.8241 16.5438 10.5738 7.84653 7.88455 4.08949 5.56248 
81.8439 41.0249 16.6018 10.5804 7.88143 7.88897 4.12346 5.59752 
82.0160 41.2120 16.6414 10.7280 7.89509 7.91501 4.15664 5.74118 
82.3199 41.2607 16.6477 10.7727 7.92387 7.93874 4.22134 5.81684 
82.4909 41.3563 16.6724 10.8012 8.01449 8.03622 4.24433 5.81852 
82.5699 41.3769 16.8607 10.8096 8.01817 8.08154 4.26778 5.82835 
82.7766 41.4702 17.0258 10.8445 8.13121 8.09847 4.30765 5.83811 
82.9126 41.8976 17.3448 11.1168 8.28634 8.14829 4.33280 5.87323 
82.9554 41.9711 17.3700 11.1970 8.42084 8.25790 4.54604 6.02355 
83.0073 41.9789 17.3923 11.2206 8.71803 8.55839 4.58414 6.03028 
83.0793 42.0523 17.4620 11.3153 8.76504 8.56600 4.63661 6.21250 
83.1968 42.1721 17.8179 11.4056 8.90037 8.75591 4.69350 6.28691 
83.2623 42.2504 17.9589 11.4313 9.07792 8.84589 4.92562 6.30970 
83.3615 42.4089 17.9836 11.5082 9.08605 8.87308 4.92770 6.37008 
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83.8344 42.4179 18.0374 11.5118 9.39646 8.90170 4.94204 6.40847 
83.9253 42.5342 18.3454 11.5160 9.44691 9.01570 4.95661 6.43110 
84.0972 42.5426 18.5352 11.5594 9.53232 9.08534 4.98584 6.43794 
84.2678 42.6025 18.6299 11.5932 9.62175 9.11264 5.04326 6.52077 
84.4045 42.7020 18.8037 11.5962 9.64085 9.13881 5.08559 6.52140 
84.7026 43.0165 18.9925 11.6271 9.64530 9.19846 5.17471 6.59835 
84.7717 43.2039 19.0835 11.6806 9.79820 9.21162 5.20257 6.63326 
85.0031 43.2076 19.1567 11.7083 9.94481 9.52712 5.23877 6.64234 
85.1122 43.2589 19.2540 11.7970 9.98748 9.56593 5.26453 6.65190 
85.3422 43.3012 19.5152 11.8495 10.0727 9.61213 5.36073 6.76702 
85.3575 43.4776 19.5565 11.8513 10.1026 9.61305 5.42347 6.87927 
85.3880 43.8016 20.2753 11.9551 10.1749 9.65853 5.50931 6.91762 
85.4241 43.9706 20.2775 12.1093 10.2213 9.75758 5.55128 6.92882 
85.5095 44.2158 20.3060 12.2377 10.2374 9.78822 5.56691 6.97231 
85.5541 44.3609 20.3065 12.2523 10.2528 9.94922 5.79785 6.97440 
85.6165 44.4993 20.3068 12.2666 10.6324 10.1335 5.88514 6.99477 
85.6668 44.5510 20.5474 12.3068 10.7307 10.3398 5.92649 7.01677 
85.7429 44.5552 20.5720 12.3879 10.8854 10.3933 5.92935 7.33081 
85.7527 44.6513 20.8763 12.4696 10.9467 10.3991 5.93894 7.33103 
85.8171 44.7259 20.9694 12.4803 10.9521 10.6381 6.05788 7.36483 
86.3151 44.8215 21.1598 12.5668 11.0507 10.6724 6.11212 7.37269 
86.3601 45.2620 21.2540 12.5922 11.0774 11.0575 6.17312 7.39000 
86.4234 45.5890 21.6208 12.7667 11.1757 11.0904 6.24274 7.40782 
86.5009 45.9864 21.6615 12.7958 11.2066 11.6487 6.27825 7.45458 
86.5542 46.0258 21.7222 12.8668 11.2621 11.6972 6.29369 7.45504 
86.7139 46.0813 21.7374 13.0195 11.3113 11.7218 6.30064 7.46461 
86.7964 46.0822 22.2702 13.1802 11.3352 11.8819 6.30494 7.51496 
86.8870 46.1026 22.3856 13.1997 11.3998 12.0382 6.41154 7.54630 
86.9281 46.1705 22.5611 13.2106 11.4436 12.0403 6.41538 7.69901 
87.0540 46.2790 22.5899 13.5035 11.5463 12.2705 6.54993 7.85603 
87.1234 46.4581 22.9737 13.6164 11.6738 12.4128 6.55843 7.98103 
87.2135 46.4781 23.2754 13.9641 11.6743 12.6049 6.56059 8.05517 
87.2237 46.5519 23.2829 14.0648 11.8416 12.6616 6.60722 8.07804 
87.3206 46.6739 23.3341 14.1854 12.0548 12.8989 6.61041 8.09746 
87.3583 46.6846 23.5437 14.1984 12.1272 12.9074 6.75746 8.13895 
87.3811 47.0734 23.6059 14.2282 12.3797 12.9622 6.77595 8.14922 
87.5357 47.1312 23.6347 14.2469 12.4723 13.0130 6.78301 8.19340 
87.5636 47.7758 23.7464 14.3238 12.5904 13.0782 6.81633 8.19650 
87.5896 47.8423 23.9204 14.5375 12.7729 13.1792 6.84364 8.22531 
87.6922 47.9765 24.0492 14.5530 13.1340 13.2156 6.91627 8.24578 
87.7272 48.2171 24.1083 14.7044 13.1558 13.4691 7.08550 8.32402 
87.8353 48.5542 24.4139 14.8194 13.1871 13.5204 7.11261 8.34728 
88.1220 48.8276 24.6471 14.9095 13.3004 13.7287 7.12271 8.39568 
88.3253 48.9407 24.7476 14.9672 13.3304 13.7647 7.19379 8.50877 
88.3301 49.4725 25.0574 15.1471 13.4570 13.8269 7.25263 8.58500 
88.3426 49.6625 25.1825 15.3125 13.4908 13.9575 7.25674 8.64823 
88.3785 49.8882 25.3978 15.3146 13.4994 13.9642 7.34362 8.67060 
88.3932 49.9456 26.4038 15.3524 13.6217 14.3321 7.45546 8.69991 
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88.4646 50.0928 26.4575 15.5384 13.6418 14.3411 7.45808 8.89678 
88.6262 50.1223 26.4687 15.7089 13.7542 14.4020 7.62178 8.91126 
88.7275 50.1847 26.9809 15.8275 13.7608 14.4650 7.65722 8.95309 
88.7896 50.7860 27.0158 15.8508 13.9808 14.4711 7.73476 8.96513 
89.1128 50.8809 27.1078 16.1368 14.0777 14.5199 7.77012 9.01659 
89.1249 51.0672 27.2392 16.3254 14.1028 14.9371 7.79118 9.09089 
89.1896 51.5193 27.3448 16.4503 14.1309 15.0888 7.84246 9.17870 
89.2457 51.7093 27.6781 16.5219 14.2092 15.2289 7.91809 9.28337 
89.3318 51.8137 27.7586 16.5688 14.2162 15.2803 7.94763 9.31563 
89.6143 51.8363 27.7911 16.6098 14.2265 15.7238 8.02609 9.34456 
89.6560 51.8946 28.2992 16.6917 14.3423 15.7839 8.08565 9.41892 
89.8182 52.0610 28.3824 16.7360 14.5692 15.8685 8.14510 9.43182 
89.9579 52.6477 28.6542 16.8883 14.6522 15.9664 8.21528 9.44187 
89.9677 52.7950 28.8202 16.9852 14.7142 16.1920 8.45048 9.46929 
89.9827 52.8111 29.1463 16.9898 14.8042 16.7104 8.47543 9.55567 
90.0720 52.8559 30.0891 17.1826 14.8822 16.7732 8.51388 9.67838 
90.3055 52.8741 30.2238 17.5680 15.5613 16.8809 8.53288 9.95696 
90.3732 52.9977 30.2565 17.8112 15.5864 17.1524 8.54877 10.1041 
90.4101 53.5757 30.2650 18.1810 15.5904 17.3672 8.70040 10.1591 
90.5979 53.6603 30.4252 18.2823 15.6701 17.7138 8.72987 10.1654 
90.6028 53.7383 30.5117 18.4919 15.7763 18.0704 8.77174 10.1876 
90.6560 53.7554 30.6524 18.5473 15.8162 18.1424 8.82154 10.2002 
90.6916 53.8323 30.7921 18.5603 15.9713 18.2685 8.86780 10.2394 
90.7666 53.8459 30.9767 18.6002 15.9892 18.3602 8.92651 10.3242 
90.8278 54.1477 31.2421 18.6721 16.2346 18.6796 8.97908 10.3873 
90.8785 54.1926 31.6934 18.7437 16.3309 18.8548 9.08494 10.7994 
90.8853 54.2700 31.8082 18.8483 16.4064 18.9401 9.12720 10.8615 
90.9827 54.2865 31.9226 19.1804 16.4951 19.0052 9.17575 11.0008 
91.0625 54.3622 32.0873 19.3121 16.5845 19.1199 9.35270 11.0396 
91.0824 54.3794 32.3047 19.3542 17.0185 19.1954 9.50546 11.0750 
91.1221 54.5529 32.6399 19.5117 17.0400 19.2623 9.51554 11.2732 
91.1814 54.6999 32.7526 19.9953 17.2090 19.3499 9.52155 11.5745 
91.2282 54.7130 32.7581 20.0259 17.3720 19.3814 9.55797 12.0842 
91.2949 55.0696 33.3348 20.0730 17.6012 19.4936 9.66794 12.1602 
91.3713 55.2722 33.6230 20.3911 17.6370 19.6755 9.74422 12.1617 
91.3913 55.5024 33.7607 20.8609 17.7905 19.9037 9.93224 12.2181 
91.4670 55.6683 33.8992 21.0635 18.0868 19.9711 9.99371 12.3670 
91.5539 55.8043 34.0412 21.2209 18.0887 20.2701 10.2140 12.3798 
91.5829 56.0048 34.6124 21.6527 18.2320 20.3219 10.2387 12.9744 
91.5840 56.0948 34.6651 21.7775 18.3980 20.3373 10.3728 12.9880 
91.5870 56.4118 35.0311 22.0871 18.6162 20.3881 10.4860 13.0768 
91.6399 56.4339 35.0521 22.7946 18.7640 20.5024 10.8760 13.0979 
92.0412 56.5149 35.1798 22.8392 18.8107 20.5311 10.8818 13.1559 
92.0801 56.5153 35.2729 23.1607 19.0487 20.6170 11.0339 13.1686 
92.1478 56.6064 35.3610 23.2899 19.2615 20.7341 11.1282 13.2390 
92.1949 56.6319 35.4376 23.4304 19.3824 21.0714 11.3936 13.6355 
92.4050 56.8217 35.6287 23.4677 19.6114 21.9341 11.5446 13.7296 
92.4060 56.8531 36.0987 23.4921 20.1595 21.9744 11.6108 14.3674 
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92.4174 56.9840 36.1996 23.6637 20.5315 22.0588 11.6846 14.4284 
92.5664 57.0196 36.4364 24.0112 21.0909 22.3751 11.6962 14.5062 
92.6670 57.2502 36.4840 24.2987 21.4911 22.8278 11.8001 14.6293 
92.8592 57.4706 36.5934 24.3121 21.7697 23.2626 11.8693 14.7679 
92.8913 57.6337 36.9442 24.3508 21.7979 23.4575 11.9265 14.8973 
92.9894 58.0639 37.4812 24.7328 21.8736 23.6603 11.9499 15.0031 
93.0388 58.5568 37.5831 25.1243 21.9058 24.2925 11.9654 15.2623 
93.0525 58.9347 37.6797 25.4616 22.4932 24.5417 12.0548 15.2710 
93.1148 58.9381 37.6921 25.4805 23.1143 24.6808 12.0696 15.4462 
93.1181 59.0274 37.7695 25.5268 23.1956 24.7109 12.3112 15.7689 
93.1336 59.0505 38.0837 26.0455 23.7175 25.6584 12.3141 15.7824 
93.1780 59.0526 38.0975 26.6551 23.7326 26.1928 12.3240 15.9569 
93.4576 59.1752 38.1103 26.8286 24.8931 26.5759 12.4070 16.0223 
93.5937 59.2188 38.2088 26.9238 25.3260 27.1579 12.5486 16.2723 
93.6689 59.2647 38.7386 27.1515 25.5152 27.2846 12.5562 16.3359 
93.7822 60.0560 38.7487 27.1586 25.5926 27.8812 12.8768 16.3411 
93.8226 60.4013 39.0066 27.5241 25.8424 27.9170 13.0485 16.6312 
93.8505 60.6005 39.4489 27.9996 26.0347 27.9428 13.2188 16.8105 
93.9652 60.9725 39.5236 28.3389 26.0425 27.9525 13.2671 16.8361 
94.1161 61.2454 39.5340 28.6342 26.0464 28.0639 13.4130 16.8718 
94.2102 61.4663 39.6901 28.6659 26.1764 29.0412 13.4372 17.2513 
94.2555 61.5275 39.9489 29.4447 26.4986 29.0563 13.6595 17.3728 
94.4120 62.1939 39.9902 29.4743 26.6398 29.4779 13.8167 17.4132 
94.4161 62.2064 40.2564 29.7810 26.8815 30.0043 13.9128 17.6526 
94.5509 62.3858 40.3157 30.2795 26.8944 30.8261 13.9187 18.1443 
94.6022 63.2031 40.8999 30.8437 27.4418 31.1917 13.9218 18.3197 
94.6819 63.2103 41.6529 31.1961 27.4900 31.2196 14.0624 18.3947 
94.8491 63.3221 42.3339 32.5239 27.6988 31.3950 14.1389 18.5736 
94.9303 63.9167 42.3784 32.6771 28.5001 31.5048 14.7864 18.7335 
95.0954 63.9948 42.5639 32.8394 28.6043 33.0798 14.8061 18.8748 
95.0958 64.1956 42.5970 32.9798 28.7284 34.6044 14.8992 18.9863 
95.1474 64.6157 43.1611 33.1608 29.4892 34.6524 15.0706 19.9859 
95.1891 65.0125 43.1710 33.3800 29.8150 35.4833 15.2872 20.1029 
95.1903 65.5226 44.5119 34.3237 30.1254 36.5130 15.4254 20.1554 
95.2306 65.6101 44.6066 34.6137 30.5786 36.7456 15.7235 20.6106 
95.2635 65.6517 44.6608 35.1690 30.9518 36.7470 15.8497 20.6302 
95.3727 66.7028 44.6687 35.2742 31.2739 37.1975 15.9130 20.8099 
95.3936 66.8878 44.9016 35.7432 31.5032 38.9675 15.9547 21.7181 
95.4192 67.3073 45.6319 36.1803 31.6711 38.9982 16.0441 22.2025 
95.4267 67.4064 45.7139 36.3498 31.9256 40.2313 16.5328 22.6343 
95.5990 67.4487 47.1549 36.7061 32.1833 40.5336 17.1124 22.7387 
95.9177 68.1490 47.3060 37.9631 32.2745 41.3417 17.1635 22.9284 
95.9595 68.7206 48.5792 38.2435 32.3230 41.4793 17.2615 22.9944 
96.0831 69.3694 49.5377 38.3095 32.9679 41.6796 17.3310 23.2171 
96.2985 69.4611 50.0400 38.6104 33.8518 42.1696 17.8293 23.9857 
96.4272 69.6577 50.7184 38.9140 34.0136 42.8716 18.1931 24.0482 
96.4598 70.7010 50.8017 40.3435 37.2645 44.2631 18.5196 24.3288 
96.6312 71.7392 50.9967 41.1738 37.5944 44.6606 18.7314 24.3504 
227 
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96.6565 73.2114 51.5804 41.2064 38.3258 45.0871 19.1605 24.3629 
96.6823 73.3733 51.5966 41.7577 39.4997 45.5492 19.3914 24.9799 
96.6940 73.9642 52.3220 42.4194 40.1541 45.9649 19.4952 25.5567 
96.7013 74.4111 52.3708 43.2580 40.2337 47.0841 19.7897 26.6149 
96.7382 76.0253 53.0300 43.4681 40.7611 47.6110 20.2243 26.9064 
96.7443 76.4965 53.8556 43.8087 41.0338 48.5385 20.2961 27.2221 
96.7680 76.6422 53.9361 44.0161 41.2683 48.8802 20.5583 27.5199 
96.9609 76.9450 54.0627 44.0245 41.2943 50.8855 20.5639 27.9159 
97.0058 78.0021 55.2751 47.2781 42.0423 52.0335 20.9302 28.2124 
97.0484 78.2663 55.4787 47.9928 42.4769 53.7806 21.0898 28.2670 
97.0699 79.1933 55.7309 49.3660 44.9404 53.7964 21.3365 28.7437 
97.1416 80.9999 57.6883 49.5901 46.7511 54.9342 23.3688 29.9938 
97.2406 83.5732 59.1545 51.6555 48.3681 55.8104 23.4569 30.5711 
97.2997 83.9825 59.8507 52.8609 49.6305 56.8743 23.5640 31.1223 
97.3396 84.9048 59.9358 53.2637 51.7543 57.7718 23.8244 35.4779 
97.3706 85.7181 63.8634 54.8011 52.6653 58.3419 24.1233 35.9228 
97.4841 85.9800 63.9154 55.7784 57.2822 60.6997 25.0361 35.9629 
98.2184 88.5234 63.9687 59.4800 57.3900 64.1854 25.2705 41.3184 
98.2289 88.6223 65.2724 60.3868 62.6293 65.1458 25.4974 44.8725 
98.3698 90.0824 68.4644 65.3950 70.4624 70.2915 26.4511 48.3054 
98.5123 91.4080 71.3508 72.4701 72.4519 70.7517 28.3941 55.2521 
99.6025 94.4101 71.6963 72.9969 74.0827 83.4989 32.0680 85.0258 





Table B.13 Raw data of the histograms illustrating the distributions of SCGE % tail DNA values from 
CHO cells treated with BAN without and with 1, 2, 3, 4, 5, 10 and 24 hour liquid-holding recovery. 
 
LH_0h LH_1h LH_2h LH_3h LH_4h LH_5h LH_10h LH_24h 
        0 0 0 0 0 0 0 0 
12.6755 0.030294 0 0 0 0 0 0 
13.1433 0.052469 0 0 0 0 0 0 
13.8361 0.096888 0 0 0 0 0 0 
15.3620 0.104203 0.000353 0 0 0 0 0 
16.8094 0.280657 0.000856 0 0 0 0 0 
21.2838 0.301803 0.001609 0 0 0 0 0 
21.4020 0.302163 0.003614 0 0 0 0 0 
21.6680 0.330327 0.005395 0 0 0 0 0 
24.0887 0.396323 0.010054 0 0 0 0 0 
26.3767 0.398536 0.013638 0 0 0 0 0 
27.8837 0.414194 0.016461 0 0 0 0 0 
28.3504 0.477131 0.020126 0 0 0 0 0 
29.4202 0.770173 0.020908 0.000701 0 0 0 0 
29.4329 0.958396 0.023219 0.001524 0 0 0 0 
30.7759 1.13672 0.058996 0.001567 0.000580 0 0 0 
30.8328 1.59375 0.085221 0.002941 0.000724 0 0 0 
31.6004 1.67672 0.088283 0.003572 0.000746 0 0 0.000882 
34.0879 1.75861 0.115688 0.004643 0.002560 0 0 0.001049 
34.2388 2.30007 0.129389 0.004741 0.003785 0.000562 0 0.001548 
34.6999 2.41509 0.176493 0.006442 0.003838 0.000941 0 0.001670 
34.7197 2.70482 0.268269 0.007122 0.004509 0.001219 0 0.001762 
35.6816 2.89567 0.285522 0.011158 0.006062 0.001386 0 0.002298 
36.4486 2.97515 0.300573 0.011167 0.006233 0.001910 0 0.002326 
36.4833 3.48139 0.308477 0.011714 0.006985 0.002010 0 0.002330 
36.8695 3.65273 0.332107 0.013876 0.007033 0.002574 0 0.002443 
36.9331 3.69603 0.433248 0.016228 0.010209 0.002927 0 0.002446 
37.8696 4.27580 0.449636 0.017770 0.010412 0.004682 0 0.002454 
38.4510 4.32260 0.516902 0.018949 0.010824 0.006814 0 0.002802 
38.6938 4.47140 0.523727 0.023692 0.011594 0.006849 0 0.003174 
39.3644 4.47359 0.550740 0.024537 0.012747 0.007897 0 0.003277 
40.2817 4.49848 0.571097 0.025156 0.014612 0.008037 0 0.004606 
40.6451 4.65857 0.573898 0.029887 0.015414 0.008285 0 0.005147 
41.1327 5.06049 0.589674 0.029925 0.015966 0.008960 0 0.007206 
41.4688 5.14045 0.715847 0.030293 0.016227 0.010924 0 0.010922 
42.1075 5.79873 0.769335 0.032784 0.016948 0.011646 0 0.011039 
42.3518 5.83080 0.803501 0.034457 0.019444 0.013360 0 0.018562 
43.1701 6.18087 0.943190 0.036100 0.023528 0.013532 0.000692 0.020522 
43.9433 6.68975 0.967834 0.037979 0.024502 0.013629 0.000713 0.020957 
45.0486 7.43439 1.04741 0.045029 0.028292 0.017858 0.001953 0.023344 
45.4388 7.76338 1.11991 0.055830 0.030235 0.020216 0.003333 0.026584 
45.5118 7.86473 1.12644 0.060274 0.031514 0.020276 0.003526 0.027576 
45.7089 8.12647 1.14557 0.060628 0.035539 0.021181 0.003771 0.028213 
45.7156 8.17176 1.15515 0.065045 0.038389 0.026014 0.003910 0.029892 
45.7416 8.79017 1.17112 0.069158 0.038416 0.026354 0.004342 0.030444 
229 
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45.9631 8.80634 1.49655 0.075399 0.039832 0.027259 0.004405 0.031125 
46.0673 8.92617 1.55120 0.077130 0.045446 0.028262 0.005033 0.032377 
46.2877 9.01183 1.64322 0.093205 0.048544 0.029195 0.005054 0.036924 
46.5084 9.66902 1.76086 0.093345 0.048588 0.034284 0.005226 0.039999 
46.5226 9.74549 2.35836 0.107104 0.056807 0.037333 0.005370 0.044116 
46.5531 9.80358 2.43524 0.109106 0.073146 0.037373 0.005455 0.044718 
46.6785 10.1945 2.53637 0.154917 0.082565 0.039822 0.005716 0.045518 
47.0897 10.3777 2.59587 0.232068 0.083359 0.048881 0.005830 0.051808 
47.2829 10.4676 2.68115 0.233671 0.087361 0.050157 0.008040 0.057714 
47.4257 10.7966 2.71437 0.237802 0.090408 0.053662 0.008188 0.060244 
47.5881 11.3635 2.73686 0.252224 0.097670 0.065219 0.008616 0.064963 
48.0498 11.5920 3.12306 0.264124 0.108588 0.071981 0.008641 0.068582 
48.7758 11.8383 3.18622 0.269220 0.126716 0.078690 0.009130 0.070470 
48.8196 12.2376 3.20613 0.275367 0.132285 0.079552 0.009277 0.074258 
49.4362 12.3190 3.30272 0.278601 0.136756 0.098811 0.009933 0.076030 
49.7158 12.7729 3.31946 0.288006 0.152990 0.101354 0.011557 0.077552 
49.7794 13.0562 3.36712 0.288428 0.154305 0.101401 0.012246 0.083625 
50.1800 13.1864 3.47594 0.289883 0.179485 0.108275 0.012656 0.089931 
50.3468 13.4355 3.76691 0.291625 0.181423 0.108511 0.012896 0.107984 
50.5849 13.9775 4.00117 0.327628 0.193404 0.113121 0.014160 0.108188 
51.2404 13.9911 4.09071 0.332165 0.195876 0.120318 0.014169 0.112112 
51.4143 14.0883 4.09616 0.340000 0.198341 0.124180 0.015804 0.114746 
51.4146 14.4229 4.21517 0.363603 0.220028 0.134089 0.015900 0.115079 
51.8349 14.8964 4.23869 0.423358 0.231851 0.141139 0.018003 0.120994 
52.3663 14.9411 4.37647 0.447477 0.240876 0.141387 0.020096 0.131434 
53.1416 15.1568 4.47095 0.476234 0.254683 0.147483 0.020588 0.134072 
53.2265 15.3831 4.49958 0.496363 0.344498 0.156823 0.023650 0.141399 
53.6774 15.4894 4.81425 0.550634 0.349505 0.165234 0.023986 0.151545 
54.4773 15.6102 4.90888 0.563148 0.352529 0.172191 0.026862 0.157964 
54.9262 15.9752 4.95294 0.566728 0.353017 0.185593 0.028012 0.161263 
54.9547 16.1378 4.97813 0.598895 0.395170 0.190781 0.030164 0.171174 
55.3400 16.3034 5.13628 0.614349 0.400333 0.196145 0.031383 0.173002 
55.4223 16.5220 5.23140 0.631864 0.440967 0.209679 0.031459 0.177306 
55.5476 16.6934 5.29433 0.656936 0.455871 0.211678 0.036161 0.179224 
55.9334 16.7083 5.96107 0.658339 0.461883 0.221448 0.040606 0.184799 
56.3432 17.1957 6.11386 0.706040 0.488943 0.226661 0.045137 0.191940 
56.3497 17.3892 6.71610 0.800773 0.530779 0.230277 0.049108 0.192150 
56.8392 17.7955 6.75124 0.828661 0.562908 0.239686 0.051235 0.196669 
56.8443 18.0105 6.89180 0.841472 0.652567 0.253660 0.052014 0.204246 
56.9369 18.1113 6.89185 0.934185 0.655096 0.267782 0.052339 0.204837 
57.1326 18.3575 6.91544 0.941375 0.703839 0.285587 0.056226 0.205521 
57.4618 18.6621 7.07073 0.985385 0.709077 0.287620 0.058642 0.238646 
57.7621 19.0244 7.28107 1.08377 0.712038 0.300326 0.070467 0.277461 
57.7743 19.3118 7.29301 1.14801 0.717020 0.309154 0.072725 0.296946 
58.0191 19.3443 7.36231 1.33203 0.717332 0.319237 0.075897 0.318597 
58.2070 19.5269 7.44803 1.38882 0.814815 0.328467 0.076861 0.323773 
58.3817 19.8198 7.52516 1.41320 0.865374 0.331977 0.083199 0.348114 
58.9774 19.8800 7.54273 1.44684 0.881829 0.515517 0.086093 0.354031 
230 
 
Table B.13 (cont.) 
 
59.3811 19.9595 7.82263 1.53853 0.955402 0.520717 0.086116 0.367144 
59.5741 20.0103 7.97983 1.54438 1.07566 0.530306 0.089192 0.369462 
59.5832 20.1997 8.02332 1.63007 1.08364 0.568845 0.092058 0.373402 
59.6618 20.2066 8.21262 1.67944 1.09258 0.599631 0.10163 0.381995 
59.7809 20.2092 8.30869 1.72207 1.13563 0.609600 0.10408 0.397289 
60.0819 20.4175 8.33298 1.79986 1.13694 0.609729 0.10637 0.403094 
60.1230 20.4719 8.39341 1.80303 1.19116 0.624213 0.12241 0.404134 
60.1863 20.5719 8.44907 1.84910 1.20493 0.684774 0.12606 0.414586 
60.2602 21.0124 8.48130 1.85763 1.20597 0.697903 0.13366 0.431080 
60.3833 21.7143 8.67375 2.09170 1.22433 0.699169 0.15851 0.465948 
60.6018 21.8970 8.76314 2.14593 1.22761 0.705951 0.16938 0.466655 
60.6231 21.9806 8.78146 2.18693 1.25140 0.720893 0.17217 0.491473 
60.8220 21.9999 9.01488 2.26444 1.25543 0.722257 0.17594 0.500154 
60.8439 22.3795 9.08437 2.28672 1.26014 0.750444 0.18467 0.523299 
60.8932 22.5540 9.15726 2.33032 1.26824 0.787264 0.19310 0.532267 
61.1124 22.7215 9.41133 2.41901 1.27187 0.814645 0.22711 0.543252 
61.5631 22.9643 9.49489 2.57346 1.29465 0.919949 0.24805 0.563476 
61.9420 23.2552 9.56099 2.63810 1.34427 0.937480 0.25434 0.568262 
62.4554 23.7107 9.95868 2.64718 1.42468 0.978670 0.28970 0.573489 
62.4906 23.9390 10.6979 2.68073 1.46647 0.989019 0.30357 0.583923 
62.6765 24.1356 11.4307 2.76761 1.53334 0.997406 0.31074 0.618733 
63.1857 24.3579 11.5438 2.77957 1.54924 1.04104 0.34225 0.627954 
63.1968 24.4017 11.8201 2.86994 1.56181 1.04295 0.36361 0.678601 
63.4637 24.6958 12.5335 2.97374 1.59413 1.07852 0.37285 0.690721 
63.7894 25.2727 12.6431 3.01197 1.65599 1.15799 0.37930 0.709041 
63.8813 25.3036 12.6683 3.02706 1.66367 1.16537 0.38056 0.734878 
63.9761 26.0413 12.7055 3.13012 1.70489 1.21345 0.39206 0.764974 
64.3372 26.1348 12.7545 3.16126 1.71077 1.26439 0.39508 0.778271 
64.5272 26.2784 12.8693 3.17680 1.80452 1.27196 0.39546 0.791148 
64.5681 26.3977 12.9398 3.19046 1.80881 1.30555 0.43218 0.817331 
64.8473 26.7763 13.0071 3.29320 1.80905 1.32956 0.43624 0.844790 
65.1493 26.8184 13.2105 3.36015 2.00357 1.40819 0.44606 0.847812 
65.3746 26.9071 13.2397 3.36860 2.05455 1.46443 0.46287 0.867517 
65.5114 26.9431 13.2530 3.40461 2.09016 1.47081 0.47428 0.935574 
65.7382 27.2438 13.3667 3.42125 2.20046 1.57837 0.49710 1.04179 
65.7601 27.3789 13.6602 3.42726 2.22900 1.58900 0.50435 1.05169 
66.0929 27.4278 13.7243 4.20336 2.25367 1.74376 0.50724 1.05259 
66.1410 27.4800 13.7640 4.24823 2.30785 1.75767 0.53091 1.13724 
66.2443 27.9186 13.9232 4.33684 2.34148 1.76573 0.54568 1.30517 
66.9850 28.1287 13.9666 4.53804 2.35764 1.79403 0.58159 1.32189 
67.0139 28.4117 13.9804 4.90415 2.36921 1.88122 0.58528 1.38231 
67.2065 28.5365 14.0548 4.97360 2.36982 1.88971 0.60855 1.47798 
67.4103 28.6012 14.2370 5.26822 2.45141 1.92667 0.65820 1.50891 
67.5858 28.8939 14.2788 5.30879 2.57020 2.02535 0.68477 1.51807 
67.9091 28.9008 14.3502 5.31556 2.57204 2.05707 0.72961 1.59754 
67.9547 28.9955 15.2903 5.34834 2.66969 2.08626 0.73859 1.60567 
67.9731 29.2111 15.4650 5.36138 2.71124 2.09375 0.74268 1.61256 
68.2806 29.2366 15.7347 5.61341 2.78595 2.23892 0.79041 1.66321 
231 
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68.3382 29.4114 15.7986 5.85769 2.90054 2.24932 0.79279 1.67155 
68.4942 29.4855 15.8259 5.85885 2.96063 2.26625 0.82011 1.70261 
68.7205 29.5031 15.8324 5.86947 3.00719 2.35686 0.89718 1.75337 
68.7932 29.6385 15.8602 5.89672 3.02691 2.36165 0.90525 1.84502 
68.8399 29.8050 15.9236 6.03539 3.14372 2.46043 0.91026 1.84614 
68.9023 30.1875 15.9776 6.05637 3.24366 2.46788 0.92551 1.88809 
68.9717 30.1952 16.0452 6.09494 3.31566 2.48325 0.95804 1.89890 
69.0038 30.3271 16.0638 6.16361 3.39609 2.52318 0.98081 1.89963 
69.0126 30.3720 16.4741 6.30502 3.51621 2.61698 1.00412 1.99559 
69.0900 30.5178 16.5071 6.32127 3.60333 2.63331 1.01720 1.99781 
69.3794 30.8716 16.5253 6.33588 3.72525 2.68013 1.03086 2.03145 
69.3994 30.9054 17.1478 6.67572 3.74568 2.69572 1.06015 2.04654 
69.4043 31.0865 17.3716 6.71386 3.85244 2.72538 1.06563 2.06037 
69.5590 31.3637 17.4211 6.81899 3.94490 2.77833 1.06765 2.07289 
69.8440 31.6188 17.6590 6.86677 4.06375 2.82937 1.09285 2.11855 
69.8654 32.2021 18.0822 6.89097 4.11633 2.95161 1.10307 2.15726 
69.9767 32.2402 18.4268 6.95535 4.26928 2.96613 1.12329 2.16797 
70.0341 32.6182 18.4359 6.96605 4.30948 2.98929 1.13416 2.17234 
70.1904 33.4675 19.1574 7.20213 4.57854 3.01683 1.14967 2.25671 
70.3697 33.7551 19.9268 7.39571 4.63804 3.04183 1.16075 2.25881 
70.4913 33.8480 19.9725 7.39595 4.69548 3.05388 1.18956 2.25991 
70.5170 33.8722 20.2852 7.41129 4.70851 3.13514 1.21584 2.27450 
70.5316 34.4731 20.4149 7.43728 4.76640 3.20252 1.22426 2.31679 
70.7045 34.6413 20.5086 7.52329 4.83654 3.23076 1.25862 2.33590 
70.9442 34.6484 20.6392 7.63959 4.94983 3.23562 1.30753 2.34143 
70.9996 34.6524 20.6895 7.82746 5.00574 3.26187 1.37734 2.45530 
71.0571 34.8889 20.7866 7.90364 5.06108 3.26601 1.38110 2.49024 
71.1035 35.6384 20.8195 7.97046 5.06614 3.28801 1.38303 2.49050 
71.1820 36.0357 21.0488 8.01513 5.12691 3.31730 1.43487 2.62163 
71.5060 36.2897 21.3029 8.03225 5.23129 3.33926 1.46637 2.70095 
71.5135 36.3954 21.9342 8.25354 5.39186 3.35639 1.47534 2.73462 
71.8910 36.4262 22.3942 8.29773 5.45642 3.37693 1.50093 2.76165 
71.9267 36.6911 22.4285 8.46336 5.57981 3.50256 1.65824 2.84792 
72.0035 36.8039 22.5829 8.66188 5.58239 3.52518 1.66477 2.85960 
72.0183 36.9515 22.8968 9.10408 5.61260 3.57167 1.74661 2.86910 
72.0906 37.4537 23.0168 9.40650 5.70396 3.59495 1.76770 2.91078 
72.1915 37.5304 23.0715 9.49109 5.72813 3.67354 1.76795 2.91602 
72.2714 37.6294 23.0756 9.67693 5.73496 3.68306 1.88261 2.93747 
72.4563 38.1503 23.2520 9.69817 5.79319 3.68940 1.97598 2.95097 
72.5705 38.2311 23.2802 9.79247 5.92002 3.69597 1.98462 2.97963 
72.9463 38.4480 23.6658 9.96095 5.92305 3.76699 2.08717 3.04712 
73.0115 38.7394 23.9288 10.5160 6.23254 3.83559 2.14087 3.05354 
73.0774 39.2300 24.1860 10.8131 6.25552 3.86198 2.18296 3.05837 
73.1978 39.2420 24.5994 10.9214 6.32217 3.99927 2.19216 3.08041 
73.2113 39.3606 24.8503 10.9655 6.35600 4.02877 2.21200 3.09880 
73.2826 39.6277 24.9533 10.9884 6.41978 4.03257 2.27067 3.11831 
73.7779 40.0561 25.5318 11.0500 6.46790 4.10197 2.36471 3.16278 
73.7924 40.2332 25.6042 11.1084 6.47249 4.13724 2.36488 3.17496 
232 
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74.0873 40.4331 25.9916 11.1270 6.54167 4.14750 2.37458 3.18492 
74.1179 40.9571 26.0577 11.1364 6.57911 4.14943 2.40317 3.20288 
74.1355 41.0790 26.2076 11.1965 6.58947 4.21720 2.41677 3.20419 
74.1578 41.6086 26.2377 11.3626 6.66314 4.32755 2.45294 3.22341 
74.5381 41.7021 26.2949 11.4709 6.70512 4.34056 2.47771 3.24989 
74.5608 41.7058 26.4633 11.8781 6.79808 4.55337 2.48727 3.29697 
74.8168 41.8080 26.9446 12.1292 6.80407 4.57387 2.51273 3.29913 
74.9329 41.8302 27.0538 12.3513 6.83926 4.60236 2.69030 3.31519 
75.0030 42.0033 27.2922 12.3610 6.85828 4.73276 2.73046 3.33522 
75.0815 42.0486 27.3321 12.8559 7.00486 4.79950 2.77756 3.34173 
75.2308 42.1542 27.8561 12.9079 7.15127 4.90163 2.78168 3.36645 
75.8478 42.2621 28.0096 12.9549 7.26045 4.97135 2.79856 3.36980 
75.9908 42.9986 28.0685 13.2292 7.35777 5.11244 2.90056 3.45986 
76.1184 43.5195 28.1857 13.2413 7.36051 5.16324 3.00326 3.55677 
76.2030 43.7423 28.2100 13.2532 7.36118 5.35425 3.07612 3.68506 
76.9022 43.7642 28.4974 13.4116 7.54889 5.37578 3.24988 3.69806 
76.9765 43.7871 28.8337 14.8172 7.58435 5.58644 3.26941 3.69880 
77.3551 43.8144 28.8976 15.1676 7.72998 5.59685 3.31598 3.72538 
77.3893 44.0257 29.0816 15.2174 7.81344 5.61747 3.34602 3.80374 
77.5570 44.6094 29.1663 15.9269 7.88202 5.72964 3.36728 3.92927 
77.6727 44.7065 29.4446 15.9366 7.92706 5.80700 3.41248 3.94837 
77.7318 44.8264 29.4558 16.3959 7.94948 5.83881 3.42130 3.98759 
78.1097 44.9451 29.6838 17.1763 8.01787 5.85582 3.44234 4.08627 
78.1555 45.2011 29.6976 17.2668 8.05274 5.95300 3.45585 4.10676 
78.2972 45.2736 29.7681 17.4943 8.05973 5.99075 3.53802 4.11235 
78.3146 45.5036 30.0045 18.0005 8.08993 5.99376 3.61453 4.21258 
78.5072 45.5135 30.2906 18.0569 8.15315 6.15824 3.62837 4.22883 
78.7328 45.5716 30.9860 18.1711 8.18630 6.25183 3.71222 4.30723 
78.7390 45.6798 31.5886 18.3444 8.21879 6.30782 3.84306 4.35262 
78.8698 46.1871 32.1695 18.4039 8.29329 6.36652 3.86843 4.36752 
78.9774 46.4529 32.3845 18.5005 8.37028 6.37957 3.88874 4.43006 
79.4298 46.7912 32.6110 18.5648 8.41779 6.41036 4.00114 4.46351 
79.7111 46.8284 32.7172 18.6195 8.66752 6.61396 4.11796 4.48246 
79.8847 47.2503 32.7438 18.9396 8.73207 6.63603 4.24270 4.53497 
79.8952 47.2676 32.7640 18.9899 8.95494 6.65236 4.25726 4.54956 
79.9936 47.5142 33.2355 19.0580 9.01126 6.94379 4.25795 4.56198 
80.0244 47.6560 33.2999 19.0923 9.06166 6.94800 4.25998 4.56271 
80.0519 47.7905 33.4559 19.3453 9.18574 6.96078 4.28686 4.61833 
80.0988 48.0181 33.7934 19.3759 9.36904 7.03820 4.35829 4.63450 
80.1044 48.1337 33.9053 19.9170 9.44579 7.10519 4.39504 4.68435 
80.1705 48.3707 34.0982 20.0770 9.47931 7.10535 4.40428 4.68933 
80.6333 48.3907 34.3663 20.2305 9.52007 7.18901 4.53783 4.80078 
80.7482 48.4042 34.4666 20.6035 9.57001 7.20328 4.53891 4.84292 
80.8763 48.6902 34.9943 20.7550 9.81327 7.41725 4.55238 4.89872 
80.9107 48.7877 35.1812 21.1527 10.2366 7.77897 4.57757 4.95681 
81.5534 48.9504 35.3259 21.1936 10.4483 7.82462 4.58995 5.00488 
81.6106 49.0266 35.8004 21.2818 10.6217 7.82594 4.59848 5.02447 
81.6880 49.1121 35.8373 21.4960 10.8330 7.90271 4.67576 5.24501 
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81.8236 49.1491 35.8896 21.6273 10.8424 7.91071 4.69203 5.26545 
81.9505 49.3964 36.2533 21.7597 10.8448 7.92531 4.80618 5.35591 
82.0433 50.2250 36.5379 21.9329 10.9134 7.99173 5.20282 5.38017 
82.3772 50.3965 36.7055 22.0806 10.9757 8.10951 5.23938 5.40885 
82.5433 50.6354 37.6606 22.2828 11.0063 8.16977 5.29738 5.45098 
82.5437 50.9301 37.8194 22.6029 11.2152 8.60721 5.30251 5.45139 
83.0841 51.3607 37.8340 23.2847 11.2289 8.70386 5.33034 5.53956 
83.3189 51.3722 37.8747 23.3784 11.2978 8.80795 5.37748 5.55809 
83.5278 51.4769 38.0624 23.5832 11.4957 8.90314 5.38438 5.57867 
83.5519 51.5391 38.1780 23.7150 11.5862 9.13661 5.46343 5.65248 
83.6537 51.5994 38.4537 23.9415 11.6303 9.15047 5.47772 5.72329 
83.7074 51.6138 38.6021 24.1436 11.7940 9.15283 5.50100 5.74781 
83.7947 51.6369 38.6678 24.1657 11.8359 9.23336 5.52832 5.78772 
83.8687 52.0321 38.9217 24.1949 12.1165 9.34219 5.61166 5.82690 
83.9929 52.2917 39.3945 24.3172 12.1665 9.45391 5.71486 5.86985 
84.0869 52.3548 39.9174 25.1524 12.2109 9.46968 5.80791 5.91972 
84.1072 52.3675 40.3116 25.1667 12.5074 9.48370 5.85295 6.05213 
84.1802 52.4686 40.3953 25.4435 12.6116 9.63120 5.88681 6.19763 
84.4195 52.6142 40.9685 25.6187 12.6896 9.84778 5.93813 6.35284 
84.5499 52.6974 41.2990 25.7461 12.7775 9.92286 6.04432 6.38793 
84.6490 52.7780 41.7535 25.7927 13.0118 9.99766 6.04646 6.39297 
84.6576 52.9048 41.9613 26.0829 13.0602 10.1109 6.07674 6.64861 
84.7221 52.9951 42.1326 26.6746 13.3720 10.2873 6.14361 6.65721 
84.9969 53.1357 42.2636 26.7632 13.5291 10.3069 6.23474 6.67054 
85.0446 53.6591 43.2076 27.0094 13.6111 10.4053 6.27733 6.68460 
85.2336 53.7191 43.2282 27.0395 13.6378 10.8334 6.33296 6.68648 
85.2465 53.8117 43.2626 27.0460 13.9382 11.1792 6.33646 6.69088 
85.2763 53.9755 43.3894 27.3914 14.7665 11.2903 6.40545 6.69839 
85.3656 54.3379 43.5142 27.4191 15.1590 11.3031 6.44325 6.73954 
85.5048 54.4214 43.5350 27.7009 15.2379 11.4145 6.48899 6.74689 
85.5538 54.9866 43.6456 27.9458 15.2464 11.5028 6.62321 6.84667 
85.6013 55.3129 43.6753 27.9618 15.8646 11.5151 6.67845 6.87704 
85.6195 55.5444 43.6871 27.9754 15.9710 11.5472 6.80226 7.30044 
85.8323 55.6837 43.7614 28.0603 16.0635 11.7351 6.90120 7.33795 
85.8450 55.7545 43.9361 28.2582 16.3861 11.7582 6.90151 7.34289 
85.9238 56.2510 44.4422 28.2615 16.4029 11.7915 7.03063 7.35156 
86.2454 56.5437 44.5219 28.4212 16.7470 11.8543 7.29374 7.45731 
86.3435 57.5950 44.5515 28.5907 17.1085 11.8605 7.50186 7.45746 
86.5818 57.9886 44.6391 28.7277 17.3946 11.8896 7.52446 7.47946 
86.7425 58.2539 44.8710 28.9482 17.4803 11.9355 7.56324 7.53362 
86.7575 58.3231 44.8759 30.0990 17.7056 12.0183 7.79398 7.53574 
86.8013 58.4201 45.1405 30.1997 17.9529 12.2530 8.01365 7.55262 
87.0035 59.0703 45.3290 30.2772 18.0271 12.3912 8.07155 7.62962 
87.0657 59.2958 45.4105 31.4608 18.5605 12.4998 8.32422 7.64992 
87.1173 59.4617 45.4458 31.6562 19.5553 12.5297 8.43886 7.83926 
87.2571 59.7048 45.6126 31.6583 19.6235 12.5866 8.48467 7.84855 
87.2892 60.0703 45.8435 32.1408 19.6715 12.6874 8.51028 7.94226 
87.5381 60.1330 45.9100 32.4509 19.7150 12.7192 8.57052 7.99240 
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87.5506 60.1853 46.4809 32.5502 19.9698 12.7271 8.66309 8.00234 
87.5992 60.9028 46.7021 32.6351 20.0174 12.7772 8.67897 8.06757 
87.6538 61.1252 46.9767 32.9069 20.0232 12.9648 8.68461 8.12425 
87.7137 61.1421 47.2068 33.4763 20.7615 12.9690 8.76279 8.25649 
87.7816 61.4395 48.5811 33.4997 20.9475 13.4443 8.94310 8.30969 
87.7879 61.6066 48.6046 33.5897 21.1236 13.6539 8.94665 8.55754 
87.8924 61.7501 48.7211 33.5910 21.3314 14.0627 9.10713 8.64507 
87.9011 62.2042 48.9704 34.3141 22.0649 14.0809 9.12704 8.64524 
87.9590 62.2364 49.4314 34.5675 22.0662 14.2072 9.15651 8.83111 
88.1533 62.4189 49.7580 35.1148 22.9898 14.2417 9.20225 8.84686 
88.2920 62.5412 50.0753 35.9942 23.0453 14.2423 9.32346 8.91676 
88.4616 62.5420 50.1793 36.2730 23.2441 14.7170 9.48045 8.95899 
88.5689 62.8768 50.2046 36.3778 23.5744 15.1049 9.54142 9.11937 
88.6699 62.9351 50.2770 36.4476 23.9410 15.2825 9.57920 9.45914 
88.7854 63.1567 50.6988 36.5043 24.9737 15.2982 9.60255 9.64341 
88.9433 63.4859 51.1349 37.1375 25.4837 15.4164 9.97583 9.68412 
88.9460 63.5453 51.3903 37.5707 25.6599 15.5271 10.0681 9.77827 
89.1168 63.5576 51.6449 37.6284 25.9519 15.6981 10.1057 9.82572 
89.1240 63.5699 51.9925 38.0155 25.9787 15.8154 10.1088 9.83237 
89.2848 63.5701 52.0584 38.1044 26.4018 16.5922 10.3885 9.83370 
89.3569 63.6797 52.3318 38.2377 26.9865 16.6878 10.3933 10.0123 
89.5533 63.7181 52.6324 39.1078 27.0255 16.9147 10.4349 10.3628 
89.5610 63.9881 52.6373 39.7307 27.0437 17.1125 10.5337 10.4705 
89.6020 64.0348 53.1874 40.1572 27.2932 17.6098 10.5376 10.4998 
89.7087 64.1258 53.5639 40.5076 27.5786 17.8580 10.7030 10.6467 
89.8540 64.1292 53.9387 41.0977 27.6532 17.9461 10.8035 10.6829 
90.0028 64.4233 54.2919 42.1355 28.3013 18.0652 10.9564 10.7577 
90.0429 64.9186 54.3069 42.8384 28.3857 18.1400 11.0316 10.8673 
90.0781 64.9201 54.5096 42.8524 29.2099 18.2767 11.4706 11.0142 
90.2647 65.2762 54.5380 43.8255 29.3170 18.4389 11.6278 11.0306 
90.3402 65.3902 54.7171 43.8713 30.2444 18.6177 11.8217 11.0551 
90.4818 65.7442 54.7725 43.9032 30.5172 18.6812 11.9509 11.2155 
90.5237 66.2842 54.9087 44.4878 30.6068 18.6903 12.0338 11.2725 
90.5716 66.3256 55.2965 44.6467 30.6591 18.8398 12.0923 11.3785 
90.7525 66.4650 55.6193 44.9931 31.6944 18.9880 12.1440 11.5331 
90.8767 66.9527 55.7570 45.0078 32.1314 19.2067 12.1925 11.5423 
90.9559 67.0863 55.7899 45.6365 32.1394 19.2909 12.3086 11.5604 
90.9685 67.6008 55.9512 45.8607 33.7747 19.5020 12.8226 11.6866 
91.2963 68.0773 56.4599 46.0259 33.8030 19.6460 12.9104 11.7015 
91.3847 68.2316 57.7702 46.6155 34.2675 19.8501 13.0520 12.3212 
91.4508 68.4463 58.1631 47.0391 34.3127 19.8574 13.0719 12.4245 
91.6213 68.7234 58.4943 47.0760 34.9508 19.9137 13.1832 12.4563 
91.6362 68.9807 58.5189 47.2376 34.9553 19.9891 13.2602 12.7816 
91.6864 69.1975 58.5225 47.4119 35.6780 20.1626 13.3473 12.8566 
91.8396 69.6955 58.6262 47.7339 36.1084 20.4307 13.6374 13.1228 
92.2151 69.7235 58.7157 47.8023 36.7733 20.8539 13.6704 13.1609 
92.3399 70.1486 58.9641 48.0974 37.6875 21.0298 13.7169 13.3110 
92.4783 70.1545 59.0791 48.2314 38.8031 21.8974 13.7258 13.4163 
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92.5814 70.5753 59.1552 48.4626 39.3351 22.1654 13.7674 13.4822 
92.7818 70.9780 59.2812 48.8039 39.6593 22.3996 13.7732 13.5470 
92.7986 71.0266 59.4920 49.0019 40.0416 22.7775 13.8143 13.7775 
92.8829 71.4621 59.8054 49.3546 40.0515 23.0710 13.9051 13.8532 
93.0128 71.4732 59.8567 49.6692 40.8970 24.1254 14.0460 13.8763 
93.0549 71.8420 60.0886 49.7002 42.4772 24.2597 14.1268 14.4225 
93.5873 72.3361 61.0636 49.7120 42.7628 25.7706 14.1497 14.5701 
93.7515 72.6707 61.2194 50.1528 42.7695 25.9125 14.1629 14.8777 
93.9581 72.7110 61.3393 50.3388 43.2044 26.0749 14.2327 14.8990 
94.1854 72.8713 61.4905 51.0189 43.9063 26.4321 14.5363 14.9415 
94.3373 73.1245 62.1003 51.6634 44.8018 26.4557 14.7911 14.9537 
94.4317 73.2077 62.1008 51.7483 45.4003 26.5060 15.3862 15.0708 
94.4492 73.6456 62.2324 52.5605 45.4307 27.4574 15.8903 15.0875 
94.4533 73.9246 62.5352 53.3100 45.9521 27.6083 15.9948 15.1446 
94.7060 74.0730 62.8894 54.1626 46.7900 27.7519 16.5027 15.3379 
94.7270 74.1270 64.0761 54.5077 47.3920 28.2647 16.7753 15.6338 
94.8484 74.2449 64.4363 54.7674 48.1091 28.3303 16.7894 15.6702 
94.8943 74.6251 65.3537 54.8658 49.0288 28.9354 16.8490 15.8445 
94.9185 74.8580 65.5943 55.0796 49.0893 29.0189 16.8756 15.9246 
95.0188 75.1719 65.6235 55.3401 52.2138 29.3705 16.8821 15.9966 
95.2221 75.3155 66.8760 55.6647 52.5915 29.5592 17.0151 16.0527 
95.2575 75.3751 67.0456 56.4857 52.7257 29.8734 17.1599 16.0801 
95.6608 75.9549 67.4020 57.1642 53.4466 30.6741 17.7627 16.1207 
95.7679 76.3730 67.6387 58.1154 53.5373 30.8800 18.9527 16.1997 
95.8884 76.7600 67.6521 59.0421 56.6503 30.9537 19.1134 16.9656 
96.0377 77.0602 68.0016 59.6216 57.2641 31.3690 19.2360 17.0493 
96.0738 77.2245 68.0597 59.6985 57.2717 31.4547 19.2941 17.0672 
96.1133 77.3295 68.8929 59.7233 57.4845 33.9851 19.8587 17.0894 
96.1678 77.4798 69.1827 59.7933 57.6043 35.2821 20.3060 17.3801 
96.2198 77.4800 70.3446 59.9068 57.9996 37.3296 20.3651 17.5737 
96.2393 77.5560 70.9504 60.7148 58.8160 37.7135 21.1282 17.5857 
96.6859 77.6012 71.0273 61.0554 58.8462 37.7589 21.4116 17.6974 
97.1570 77.8224 71.3707 62.0547 59.1662 38.1379 22.0454 17.9148 
97.2145 77.9868 71.6616 62.3996 59.5007 39.3438 22.8934 17.9795 
97.3438 78.1880 72.1243 62.7160 59.7711 39.4586 23.1014 18.2016 
97.3825 78.4247 72.6883 63.8172 61.4192 39.8115 23.1191 18.4412 
97.4522 79.0273 73.2496 64.1460 62.4194 40.0365 25.2488 18.9001 
97.5403 79.6146 73.9638 64.9014 63.4680 40.1459 25.3465 19.5627 
97.5693 80.1844 74.0352 65.7185 66.6240 40.8888 25.3533 19.8197 
97.7717 80.3583 74.1655 66.8184 66.6870 41.3229 25.8972 20.7091 
97.9751 80.6121 74.2813 67.9576 67.6444 43.0367 26.9226 20.7277 
98.0068 81.4150 75.0514 68.2047 67.7283 44.9132 28.1181 20.9504 
98.1093 81.4192 75.6374 68.7102 67.7528 45.4386 28.3392 21.2489 
98.2421 82.2090 76.1098 69.3501 67.9344 46.2013 29.6640 21.3929 
98.3097 82.2598 76.6567 69.7836 68.0568 46.2859 30.0306 21.5135 
98.5352 82.4033 77.2796 70.3059 68.3141 51.6373 30.3432 21.6327 
98.5611 83.1302 77.5068 70.5319 68.4920 54.0725 30.4292 21.7895 
98.6972 83.5088 77.6020 71.1950 71.8426 54.7669 31.7484 22.2208 
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98.7674 83.7000 78.0393 71.3417 73.7486 56.0282 33.1305 23.4938 
98.9380 83.8155 78.2125 72.7212 74.8232 56.0687 33.5398 23.6788 
99.0814 84.0011 78.5360 73.5333 75.3027 58.4727 34.4653 24.2220 
99.2276 84.2012 79.2363 73.5872 76.8542 59.0805 35.2191 24.6054 
99.3470 84.5908 79.2942 73.9363 76.9899 61.7230 35.7826 24.6807 
99.3526 85.5561 82.9504 74.1686 79.0198 61.7746 37.5617 25.4492 
99.3550 86.6946 82.9739 75.1955 79.5697 62.1362 38.4414 26.8021 
99.3754 87.3003 83.1136 75.5555 80.0257 62.1833 40.1298 27.8530 
99.4058 87.5308 84.3834 76.5204 80.4632 64.1072 42.6556 28.3945 
99.5735 88.5143 85.4111 78.8907 81.0932 64.7758 42.7222 30.5140 
99.5831 89.7295 85.9626 80.6545 81.1514 69.3383 45.7774 33.6721 
99.6198 89.7595 86.8360 82.3114 84.4836 70.8502 50.0730 34.4898 
99.6368 92.1350 86.8697 82.3370 84.5038 78.0797 58.3611 36.4979 
99.7800 92.7515 86.9063 82.8157 85.0261 79.2471 58.6137 38.4766 
99.9277 94.2612 93.5279 85.3328 86.1266 79.4082 69.2058 42.9457 
99.9555 95.2679 93.8205 86.9426 86.5445 79.6864 72.4235 43.2171 
100.0000 95.8026 94.3323 91.1442 95.7499 80.7127 72.8642 62.4487 
100.0000 95.9860 97.0737 96.7816 97.3545 81.4152 74.1397 78.5475 





Table B.14 Raw data of the histograms illustrating the distributions of SCGE % tail DNA values from 
CHO cells treated with IAN without and with 1, 2, 3, 4, 5, 10 and 24 hour liquid-holding recovery. 
 
LH_0h LH_1h LH_2h LH_3h LH_4h LH_5h LH_10h LH_24h 
        1.72184 0 0 0 0 0 0 0 
3.99319 0 0.001786 0 0 0 0 0 
5.12593 0 0.007236 0 0 0 0 0 
5.49612 0 0.012873 0 0 0 0 0 
5.83861 0 0.013350 0 0 0 0 0 
6.13382 0 0.070836 0 0 0 0 0 
6.62325 0.001075 0.083221 0 0 0 0 0 
6.90653 0.001913 0.222110 0 0.000783 0 0 0 
9.02286 0.003892 0.291282 0.000290 0.001498 0 0 0 
9.45433 0.006735 0.314562 0.005095 0.001832 0 0 0 
10.5645 0.021456 0.399386 0.005246 0.004931 0 0 0 
11.1126 0.028897 0.404258 0.007114 0.007073 0 0 0 
11.8901 0.047178 0.410043 0.016886 0.007508 0.000810 0 0 
11.9600 0.056643 0.472388 0.026916 0.007771 0.000831 0 0 
13.6143 0.151036 0.549526 0.031748 0.007991 0.001892 0 0 
13.9864 0.174958 0.557900 0.038594 0.010148 0.003133 0 0 
14.0261 0.400716 0.676172 0.050804 0.017626 0.004220 0 0 
14.2828 0.487478 0.750813 0.057119 0.018350 0.006818 0 0 
14.4038 0.512611 0.814032 0.062572 0.019199 0.011357 0 0 
16.7149 0.526954 0.888799 0.091778 0.019213 0.011803 0 0 
17.4530 0.563144 1.04400 0.111331 0.026763 0.013338 0 0 
17.5834 0.717309 1.13235 0.116886 0.027491 0.013930 0 0 
17.7194 0.737133 1.29112 0.143717 0.032295 0.014387 0 0 
17.9994 0.889371 1.31824 0.149158 0.033342 0.022834 0.000974 0 
18.1989 0.996222 1.35223 0.157824 0.034123 0.037815 0.001400 0 
19.4038 1.21112 1.55364 0.183048 0.034415 0.040822 0.001526 0 
21.1739 1.23383 1.79311 0.184406 0.038183 0.041733 0.001562 0.000810 
22.3809 1.27897 1.92684 0.243597 0.052181 0.062854 0.001902 0.001049 
23.0680 1.38043 2.15188 0.252808 0.065775 0.068434 0.001943 0.001260 
23.3288 1.40432 2.34010 0.267402 0.066332 0.069589 0.002362 0.001560 
24.5901 1.52619 2.35232 0.281471 0.080588 0.071209 0.003097 0.001695 
25.0046 1.52730 2.39498 0.310713 0.081410 0.073294 0.003453 0.001888 
25.5721 1.58291 2.59158 0.316154 0.082219 0.075130 0.004662 0.002697 
25.6368 1.66829 2.64876 0.367345 0.084421 0.082658 0.004668 0.004154 
25.9498 1.95557 3.19455 0.390607 0.084954 0.085060 0.004806 0.004545 
26.5786 2.21250 3.42960 0.426980 0.095906 0.086664 0.005646 0.005856 
27.0796 2.25524 3.69938 0.441037 0.098647 0.086951 0.007379 0.007173 
27.7880 2.40605 3.72755 0.477715 0.101015 0.087784 0.008077 0.007675 
27.8759 2.46590 3.77177 0.478316 0.106312 0.103567 0.008337 0.007748 
28.1671 2.51821 3.87378 0.490589 0.122866 0.109123 0.008721 0.009683 
28.2595 2.60860 3.91608 0.522269 0.124824 0.110132 0.009492 0.010127 
28.6592 2.62531 4.29670 0.536395 0.138176 0.115631 0.011629 0.010200 
29.0453 2.66254 4.30031 0.570793 0.168877 0.118044 0.012042 0.010773 
29.4376 2.71214 4.32354 0.591323 0.172701 0.131827 0.012517 0.011873 
29.8052 2.72784 4.64108 0.631806 0.174115 0.138423 0.013613 0.011990 
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29.8087 2.78637 4.68497 0.647348 0.183042 0.143618 0.013872 0.014764 
30.1207 2.80605 5.04157 0.694476 0.210009 0.150941 0.014262 0.015133 
30.1273 3.12613 5.08002 0.702133 0.236076 0.159432 0.015254 0.017390 
31.0259 3.12707 5.27920 0.721452 0.285938 0.173302 0.017477 0.024777 
31.2040 3.15106 5.42961 0.754406 0.286379 0.187877 0.017725 0.025824 
31.3918 3.18786 5.59203 0.821193 0.321244 0.194336 0.018823 0.026429 
31.5257 3.28100 5.70246 0.868657 0.339210 0.195822 0.020372 0.026623 
31.7572 3.30647 5.74332 0.883224 0.339499 0.200618 0.028160 0.037620 
31.7613 3.50011 6.00871 0.923566 0.402767 0.202227 0.030663 0.041040 
31.8104 3.51214 6.12809 0.932340 0.432135 0.211266 0.033866 0.048743 
32.9744 3.56025 6.15863 0.949633 0.482633 0.217062 0.037045 0.048808 
33.1960 3.82834 6.17264 0.954004 0.483570 0.245469 0.039495 0.054550 
33.2216 3.95677 6.31929 1.04374 0.502913 0.246765 0.040650 0.057069 
36.0350 4.39413 6.36152 1.09806 0.520322 0.254871 0.041647 0.069045 
36.1574 4.85138 6.49235 1.11612 0.563490 0.280398 0.046884 0.072650 
36.3893 5.12706 6.55980 1.16224 0.575742 0.284059 0.053702 0.076060 
36.3941 5.27284 7.18902 1.25972 0.578919 0.294520 0.054308 0.076522 
36.5467 5.29691 7.38552 1.26668 0.585215 0.309078 0.055670 0.080850 
36.9896 5.46498 7.50922 1.31708 0.607725 0.355101 0.057455 0.086458 
37.2867 5.51617 7.85316 1.48880 0.620426 0.355197 0.065676 0.088246 
38.0915 5.61947 8.05400 1.49079 0.627010 0.378757 0.071908 0.088397 
38.3961 5.67268 8.53562 1.49474 0.633389 0.463101 0.073474 0.089087 
38.8283 5.75222 8.64816 1.49632 0.663159 0.498310 0.077804 0.089406 
39.5948 6.12242 8.76998 1.62080 0.663239 0.509566 0.082376 0.097384 
39.8920 6.17219 8.91651 1.68079 0.675752 0.513387 0.082612 0.104962 
40.6865 6.36540 9.03064 1.74355 0.692961 0.532945 0.083445 0.109318 
41.1445 6.64250 9.18279 1.76661 0.711123 0.567106 0.092290 0.114579 
41.3721 7.59458 9.22590 1.83157 0.740291 0.577216 0.095686 0.117696 
41.8886 7.69186 9.26581 1.83935 0.744240 0.600339 0.101412 0.124251 
42.0813 7.86560 9.38334 1.90606 0.765931 0.692873 0.102705 0.129972 
42.2297 8.08137 9.46667 1.93412 0.853901 0.697686 0.121996 0.134484 
42.2411 8.15204 9.62290 2.09918 0.861738 0.754827 0.141256 0.145480 
42.3897 8.42938 9.65845 2.12921 0.873466 0.768752 0.150933 0.146703 
43.3265 8.60536 9.76137 2.24974 0.923483 0.832558 0.198300 0.147963 
43.4535 8.75789 9.92946 2.28510 0.934293 0.898021 0.202651 0.157524 
43.6774 8.93548 10.0053 2.42610 0.980439 0.931506 0.207469 0.199836 
43.6962 9.17148 10.0472 2.45714 1.02281 0.945984 0.222015 0.208252 
43.7044 9.86429 10.1139 2.53964 1.07069 0.973774 0.243861 0.213354 
43.9268 10.1162 10.1367 2.54024 1.11986 1.01440 0.250913 0.231338 
43.9341 10.1887 10.4671 2.56432 1.21203 1.03586 0.262603 0.238917 
43.9391 10.2502 10.7517 2.64124 1.27386 1.05564 0.280120 0.246500 
44.2388 10.3110 10.7837 2.68513 1.33059 1.05794 0.283338 0.249400 
44.4151 10.3678 10.9917 2.70165 1.33613 1.07015 0.289035 0.274307 
44.8727 10.4092 11.0857 2.71833 1.36127 1.07528 0.294709 0.279491 
44.9579 10.7991 11.4344 2.72928 1.36600 1.07635 0.315453 0.287115 
45.3865 10.9040 11.5993 2.73109 1.38005 1.09986 0.379547 0.300348 
45.4707 11.0731 11.6139 2.76827 1.52696 1.10450 0.389494 0.306500 
45.9568 11.0946 11.7080 2.83836 1.54812 1.13360 0.398297 0.311145 
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46.2769 11.5247 11.8439 2.88015 1.57027 1.13454 0.424434 0.314295 
46.3146 11.6564 11.9074 2.91148 1.60537 1.14813 0.432402 0.349515 
46.7179 11.6758 12.0454 2.98502 1.63868 1.18241 0.449041 0.390784 
47.0575 12.0243 12.1574 3.08657 1.67694 1.21425 0.458633 0.391580 
47.4027 12.3500 12.2873 3.18291 1.68773 1.31320 0.473177 0.417423 
47.6869 12.5746 12.3611 3.20889 1.70407 1.33471 0.505377 0.433257 
47.7306 12.6553 12.4236 3.30971 1.73620 1.37321 0.507767 0.436399 
47.7764 12.8278 12.4538 3.34079 1.73924 1.38850 0.536780 0.450586 
47.8412 12.9161 12.6787 3.39742 1.77605 1.43992 0.595485 0.458472 
48.0724 12.9593 12.7458 3.41098 1.79333 1.45592 0.623140 0.471686 
48.4671 13.4759 12.8943 3.43941 1.85813 1.55595 0.669516 0.492381 
48.5576 13.5647 13.1941 3.44163 1.88379 1.55907 0.675950 0.515827 
48.7738 13.6026 13.3441 3.45806 1.97673 1.65848 0.695293 0.580172 
48.8869 13.6994 13.3690 3.46409 2.03822 1.74980 0.718820 0.581264 
49.0950 13.7416 13.8251 3.48088 2.08430 1.79461 0.761216 0.584220 
49.1759 13.8632 13.9003 3.49865 2.16959 1.81117 0.783771 0.615765 
49.4096 13.9089 14.0506 3.52399 2.21133 1.84419 0.822022 0.635436 
49.7543 14.0267 14.1413 3.56768 2.23072 1.88672 0.832013 0.638069 
49.7682 14.4240 14.8754 3.61488 2.36238 2.03617 0.843369 0.651801 
49.7926 14.5147 15.1136 3.62101 2.43413 2.20716 0.915905 0.697220 
50.3722 14.5429 15.1869 3.79920 2.44090 2.22379 0.964565 0.700477 
50.4014 15.0762 15.2077 3.85996 2.46303 2.23657 1.01363 0.717667 
50.6008 15.1952 15.3415 3.86190 2.49642 2.29370 1.02524 0.744819 
50.7169 15.4176 15.5337 3.89544 2.50221 2.37636 1.06042 0.782415 
50.7252 15.5430 15.5890 3.92078 2.54885 2.37945 1.07910 0.785707 
51.0262 15.7586 15.7239 4.01502 2.60783 2.38010 1.08630 0.795624 
51.0320 15.7781 15.9859 4.03300 2.62802 2.38797 1.10281 0.827319 
51.1450 15.8431 16.0903 4.07711 2.65142 2.46571 1.12916 0.840245 
51.3659 15.9052 16.2039 4.07902 2.74138 2.54157 1.13385 0.840925 
51.4052 15.9682 16.2109 4.08277 2.75622 2.60809 1.15478 0.934348 
51.4269 16.1702 16.3555 4.09998 2.91932 2.69475 1.22065 0.960147 
51.5428 16.1917 16.4832 4.22284 2.93856 2.77942 1.24519 0.975193 
51.5956 16.3213 16.5410 4.24794 2.99895 2.83087 1.27757 1.05960 
52.2596 16.3617 16.5823 4.38200 3.02685 2.96737 1.27823 1.06068 
52.5924 16.4039 16.7497 4.44299 3.05247 3.00151 1.28976 1.08523 
52.6608 16.4110 16.8407 4.46407 3.09840 3.04176 1.30046 1.10403 
52.9824 16.8926 16.8961 4.48758 3.14470 3.05865 1.31220 1.12790 
53.1298 17.0262 17.0560 4.60215 3.16543 3.11250 1.32460 1.13977 
53.1325 17.0384 17.2581 4.64384 3.19272 3.18816 1.33310 1.23799 
53.6187 17.0827 17.2885 4.70186 3.23432 3.28980 1.33356 1.35474 
53.6239 17.1052 17.4130 4.71013 3.25650 3.29559 1.38284 1.36659 
53.7249 17.5079 17.4471 4.74070 3.27081 3.36538 1.38790 1.41703 
53.9606 17.5211 17.8841 4.74108 3.41478 3.38633 1.44969 1.41875 
53.9746 17.6549 18.3035 4.81770 3.44942 3.46476 1.45014 1.43003 
54.1109 18.2946 18.4772 4.81943 3.48108 3.46803 1.53039 1.43594 
54.1235 18.4774 18.6002 4.83491 3.51267 3.49184 1.55451 1.49319 
54.1372 18.8610 18.6787 4.89337 3.52330 3.57229 1.57256 1.53223 
54.3043 19.4100 18.9194 4.91140 3.57235 3.59880 1.58309 1.57838 
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54.3590 19.5025 18.9655 5.01807 3.60641 3.71634 1.64416 1.58718 
54.8197 19.5423 19.0575 5.02706 3.61602 3.73623 1.67799 1.72619 
55.1536 19.8043 19.1285 5.18731 3.73331 3.75179 1.68987 1.74636 
55.1553 19.8936 19.4147 5.28229 3.74266 3.78725 1.69017 1.75802 
55.1781 19.9240 19.5523 5.28599 3.81424 3.80212 1.76291 1.78413 
55.2630 19.9306 19.7325 5.36777 3.83136 3.80240 1.80139 1.79515 
55.5420 19.9738 19.7485 5.39884 3.83732 3.83080 1.86413 1.79886 
55.6402 20.0939 20.1799 5.40556 3.90106 3.85003 1.89363 1.81544 
56.4648 20.1365 20.1842 5.49056 4.01456 3.88652 1.91689 1.86764 
56.4962 20.4845 20.3765 5.51865 4.02154 4.05542 1.92316 2.04947 
56.5838 20.6291 20.4696 5.54687 4.08672 4.09622 1.96570 2.06235 
56.5903 20.9973 20.6158 5.64407 4.08958 4.25932 1.99711 2.09162 
56.6531 20.9992 20.6818 5.69060 4.12954 4.26176 2.01679 2.15673 
56.7654 21.0105 20.7166 5.78475 4.20695 4.29356 2.12370 2.16525 
56.9525 21.1319 20.7841 5.80710 4.28010 4.34106 2.20957 2.16674 
57.0809 21.1383 20.8770 5.88444 4.28751 4.34179 2.21467 2.17664 
57.1097 21.7616 20.8830 5.93088 4.29430 4.34463 2.24930 2.19028 
58.1522 21.8117 20.9173 6.03465 4.31760 4.44870 2.26393 2.20865 
58.3717 21.8213 21.0549 6.08772 4.45039 4.49124 2.36151 2.37237 
58.7271 21.8958 21.1565 6.12196 4.45313 4.49205 2.39122 2.39228 
58.9779 21.9849 21.2609 6.44773 4.51952 4.51476 2.42250 2.48595 
59.0946 22.0914 21.4574 6.48389 4.62613 4.59492 2.45751 2.49660 
59.3230 22.8218 21.4622 6.73735 4.66059 4.68637 2.47231 2.61549 
59.7647 22.9762 21.8628 6.86310 4.68014 4.72956 2.48123 2.67725 
59.8422 23.6545 21.8797 6.98705 4.72333 4.74709 2.50547 2.67766 
60.0636 23.8556 22.0684 7.00984 4.73107 4.78215 2.50858 2.69789 
60.1404 23.9241 22.0727 7.05402 4.81930 4.90254 2.52523 2.72220 
60.3473 23.9816 22.2688 7.07428 4.83965 4.93818 2.56456 2.79806 
60.3524 24.0247 22.2703 7.09076 4.96176 4.95909 2.58247 3.10362 
60.5108 24.0330 22.3059 7.13179 5.02684 5.03119 2.58339 3.17355 
60.8491 24.2922 22.4143 7.21596 5.02769 5.07444 2.60171 3.20835 
60.9570 24.3330 22.4328 7.32649 5.06297 5.08772 2.80751 3.28768 
61.0446 24.3368 22.5103 7.42932 5.11229 5.16016 2.88341 3.34569 
61.0987 24.4535 22.7083 7.48107 5.11566 5.16358 2.88352 3.41475 
61.1518 24.7137 22.9362 7.56488 5.19778 5.16520 2.92147 3.46535 
61.1624 24.7233 23.7492 7.57889 5.26304 5.17785 2.92510 3.47654 
61.2334 24.7673 23.7715 7.60629 5.28497 5.23392 2.93113 3.50564 
61.2364 25.0187 23.8016 7.62511 5.30045 5.24921 3.14519 3.54740 
61.3304 25.0819 23.8374 7.63956 5.37046 5.28707 3.17324 3.61012 
61.4250 25.2271 23.8618 7.74530 5.42394 5.30960 3.17733 3.63957 
61.5671 25.2581 23.8644 7.84243 5.44543 5.40345 3.18149 3.65022 
61.8929 25.2916 23.9604 7.99939 5.46319 5.41220 3.22393 3.65172 
61.9457 25.5853 23.9911 8.16270 5.54513 5.43825 3.26402 3.69805 
62.0357 25.6678 24.1884 8.18270 5.61751 5.46009 3.29117 3.78777 
62.0451 25.7023 24.2240 8.24322 5.68926 5.55288 3.30780 3.78932 
62.2899 25.7928 24.4154 8.27304 5.69669 5.62510 3.32335 3.87944 
62.3904 25.9417 24.4654 8.33644 5.78950 5.69170 3.37584 3.89937 
62.7748 25.9590 24.5540 8.45260 5.82620 5.70151 3.40875 3.92249 
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62.9061 26.1460 24.5745 8.55804 5.86780 5.74531 3.43322 3.96336 
63.5176 26.2002 24.5900 8.57571 5.89036 5.75136 3.47286 3.96499 
63.6713 26.2389 24.8056 8.58238 5.91766 5.75421 3.54930 4.01509 
63.7634 26.4066 25.3010 8.72284 5.93131 5.90298 3.56185 4.02906 
63.9088 26.4226 25.4662 8.97347 5.99621 6.01949 3.59578 4.04409 
63.9687 26.9882 25.7726 9.00138 5.99969 6.10843 3.63531 4.04571 
64.0533 27.1938 25.8300 9.12815 6.08243 6.18257 3.78595 4.08213 
64.0839 27.4637 26.1992 9.30760 6.09313 6.21129 3.82909 4.34226 
64.3131 27.6148 26.2277 9.42108 6.13688 6.27128 3.89033 4.37874 
64.4313 27.8873 26.3233 9.46860 6.14093 6.37910 3.90836 4.40776 
64.5492 28.0357 26.3427 9.56321 6.16998 6.43638 3.96012 4.41144 
64.5672 28.2490 26.5435 9.59500 6.17270 6.44611 4.03329 4.42719 
64.5882 28.4014 26.8631 9.67692 6.18862 6.57632 4.10379 4.43951 
64.6702 28.5618 27.0551 9.72410 6.31455 6.61665 4.15990 4.46711 
65.0434 28.7702 27.3486 9.84056 6.33785 6.62142 4.19128 4.51336 
65.2278 28.9862 27.5012 9.85371 6.55064 6.67651 4.19726 4.52811 
65.2535 29.1910 27.5198 9.94989 6.59949 6.85310 4.22359 4.56904 
65.5508 29.2810 27.7118 9.95702 6.64661 7.03541 4.26022 4.57353 
65.9005 29.3038 27.8190 9.96867 6.71416 7.03767 4.29139 4.61893 
66.2234 29.3618 28.0616 10.0130 6.91171 7.17757 4.31695 4.73196 
66.4179 29.5228 28.2334 10.1026 6.92160 7.25980 4.32253 4.87282 
66.4666 29.7671 28.4113 10.2930 6.95786 7.29121 4.32493 4.92240 
66.5959 29.8299 28.5881 10.3062 7.08335 7.33361 4.35268 4.95881 
66.6663 29.8323 28.9228 10.4121 7.08366 7.33788 4.39427 5.06003 
66.8803 29.8526 29.0525 10.5687 7.09579 7.36198 4.45068 5.10042 
67.0612 30.0010 29.0829 10.6226 7.12515 7.54224 4.48540 5.10465 
67.3666 30.1914 29.6355 10.6525 7.16482 7.60837 4.50157 5.21731 
67.6207 30.2144 30.0195 10.6758 7.21772 7.63352 4.53773 5.27312 
67.8479 30.2527 30.1801 10.7309 7.25555 7.63413 4.59824 5.27487 
67.8828 30.3387 30.2143 10.8902 7.25907 7.68952 4.72532 5.28922 
68.0676 30.4245 30.2556 10.9156 7.26899 7.74578 4.74607 5.32804 
68.2083 30.4350 30.2639 10.9180 7.41898 7.85846 4.80918 5.49011 
68.8202 30.6242 30.2704 11.0077 7.42760 7.87096 4.82991 5.51491 
68.9773 30.7957 30.4869 11.0397 7.46790 7.89066 4.86293 5.52165 
69.2985 31.3881 30.7822 11.0747 7.68236 7.89731 4.86312 5.62515 
69.2996 31.5648 30.8188 11.1086 7.73410 7.96784 4.93248 6.06697 
69.3870 31.7425 30.8208 11.1486 7.83345 7.97452 4.99906 6.29711 
69.4236 31.7697 31.0618 11.1506 7.88607 8.01157 5.13052 6.30289 
69.4757 31.7834 31.3131 11.1883 7.90532 8.14157 5.18677 6.31448 
69.4986 31.8449 31.5148 11.1985 7.92780 8.21015 5.23270 6.35135 
69.5408 31.8862 31.5423 11.2570 7.95313 8.23766 5.27787 6.41214 
69.8660 32.0745 31.5998 11.3061 7.97142 8.28438 5.30727 6.43984 
69.9272 32.1114 31.8078 11.3267 7.98666 8.35110 5.33084 6.56601 
69.9916 32.1502 31.9339 11.5418 8.01938 8.59964 5.40807 6.59091 
70.2693 32.1698 32.4913 11.8321 8.03826 8.62822 5.56647 6.59560 
70.3862 32.4633 32.5633 11.9126 8.09865 8.74652 5.65355 6.59669 
70.5197 32.5265 33.4817 11.9969 8.14975 8.86659 5.66797 6.62055 
70.9900 32.5849 33.5847 12.1602 8.33137 8.87512 5.73387 6.72794 
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71.1198 32.6404 33.6309 12.2729 8.37944 8.94072 5.73390 6.77373 
71.1258 32.7971 33.7101 12.4339 8.60877 8.99680 5.75217 6.77477 
71.2610 33.0230 33.8563 12.5121 8.62848 9.13331 5.75355 6.80580 
71.3860 33.1048 34.1533 12.5451 8.63056 9.22907 5.80306 6.86319 
71.5427 33.1647 34.1750 12.5851 8.70312 9.30881 5.81296 6.97718 
71.6201 33.3736 34.4179 12.5940 8.70598 9.78514 5.82921 6.98188 
71.7234 33.4905 34.4789 12.6210 8.71242 9.91736 5.85416 6.99426 
72.3419 33.8299 34.5923 12.6613 8.76413 9.94562 5.87008 7.00772 
72.3697 34.0261 34.6180 12.6797 8.79538 10.1205 5.90370 7.11352 
72.4787 34.1588 34.8803 12.7071 8.84582 10.1505 5.91819 7.16781 
72.5834 34.2604 34.9217 12.7191 8.86085 10.2437 5.92832 7.17264 
72.5877 34.2853 34.9773 13.0370 8.88809 10.2756 5.93454 7.17625 
72.6543 34.3407 35.1362 13.5989 9.05534 10.3197 6.04842 7.19867 
72.7767 34.4892 35.2736 13.7880 9.07425 10.4492 6.08097 7.23729 
72.8115 34.7576 35.2763 14.1013 9.13811 10.4492 6.13851 7.31269 
73.0890 34.7886 35.3790 14.1030 9.39548 10.7430 6.18650 7.37181 
73.2729 34.8619 35.4943 14.3501 9.44603 10.7476 6.18684 7.43962 
73.3714 35.1614 35.5609 14.3763 9.50734 10.7531 6.19587 7.51820 
73.4134 35.2165 35.6641 14.4516 9.53601 10.9177 6.30242 7.56790 
73.5184 35.3729 35.6986 14.4567 9.72244 10.9763 6.32569 7.68646 
73.7031 35.5040 35.8698 14.5354 9.72396 11.0303 6.35453 7.69216 
73.7613 35.5101 35.9223 14.5899 9.81449 11.1662 6.51151 7.83256 
73.8688 35.8076 36.0188 14.7637 9.97364 11.1796 6.51171 7.84969 
73.8946 35.9808 36.1734 15.0645 10.2740 11.1799 6.55383 7.85800 
73.9101 36.2454 36.1832 15.1546 10.3336 11.3105 6.55614 8.00381 
73.9400 36.5253 36.2359 15.5988 10.4703 11.3513 6.63663 8.04327 
74.0128 36.5948 36.2767 15.7519 10.5040 11.5081 6.65759 8.07061 
74.1469 36.7098 36.4970 15.7612 10.7927 11.5878 6.67590 8.14179 
74.3628 36.7300 36.5799 15.8874 10.9017 11.6111 6.70024 8.20861 
74.4654 36.9427 36.6175 15.9009 10.9743 11.6730 6.74352 8.21063 
74.4833 36.9474 37.0336 15.9420 10.9830 11.6752 6.75118 8.26237 
74.4993 36.9650 37.1049 16.0649 11.1369 11.7397 6.77695 8.32469 
74.5091 37.1427 37.1182 16.2840 11.1449 11.8507 6.77714 8.36218 
74.5989 37.5098 37.2156 16.4123 11.1583 12.0359 6.81909 8.42908 
74.7648 37.5308 37.3153 16.6507 11.2014 12.0682 6.85816 8.43773 
75.1102 37.7276 38.0882 16.7949 11.2471 12.1019 7.00722 8.47196 
75.1168 37.7797 38.1302 16.8850 11.2519 12.2194 7.08379 8.47356 
75.1201 37.8813 38.3437 16.9507 11.4493 12.3384 7.10787 8.64600 
75.2160 38.1559 38.3872 17.0954 11.5801 12.3702 7.19481 8.74386 
75.4786 38.1798 38.5493 17.2364 11.8892 12.4816 7.30652 8.84828 
75.4896 38.2955 38.6929 17.4570 12.0689 12.4996 7.40771 8.91337 
75.4939 38.6771 38.8469 17.8467 12.1261 12.6191 7.53756 8.97739 
75.5001 38.8985 39.3824 18.2905 12.3416 12.7065 7.55175 9.06565 
75.6076 38.9264 39.4445 18.3890 12.3594 12.7533 7.59110 9.14508 
75.7063 38.9596 39.4763 18.4360 12.4965 12.9596 7.63890 9.15697 
75.8696 39.2170 39.9595 18.4823 12.5601 13.0338 7.65973 9.18132 
76.0674 39.4631 40.1971 18.6906 12.5897 13.1469 7.94737 9.19345 
76.0755 40.8518 40.6904 19.4229 12.8201 13.1959 8.00902 9.22116 
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76.0960 40.8698 40.7358 19.7461 12.8218 13.2820 8.04841 9.32283 
76.1774 41.4358 41.1081 19.7934 12.8904 13.7207 8.27034 9.38582 
76.3565 41.5280 41.6853 20.1127 13.3414 13.7354 8.32260 9.47141 
76.4691 41.7379 41.8920 20.1859 13.3705 13.7551 8.40124 9.50325 
76.6317 41.9760 42.0831 20.1937 13.4673 13.8569 8.42835 9.64012 
76.8347 42.6222 42.1311 20.2431 13.8088 14.1772 8.44198 9.64794 
76.9680 42.7167 42.1630 20.3834 13.8970 14.6675 8.44385 9.70797 
77.2943 42.7337 42.2134 20.8703 14.0673 14.7395 8.53934 9.82596 
77.3365 42.7396 42.2779 21.0948 14.0904 14.7533 8.54110 9.87421 
77.8148 42.8423 42.4591 21.1650 14.1353 15.1913 8.58322 9.92800 
77.8456 42.9158 42.4685 21.2222 14.2515 15.3369 8.68369 9.98872 
78.1003 42.9631 42.5551 21.5505 14.2976 15.3999 8.68679 10.1511 
78.1401 43.2738 42.9010 21.6497 14.3873 15.4076 8.81576 10.1930 
78.2672 43.4872 43.1622 21.8086 14.6146 15.6149 8.82622 10.2320 
78.5149 43.5624 43.2158 21.8878 14.6654 15.6576 8.85141 10.3319 
78.5370 43.7875 43.3336 22.3228 14.6868 15.8846 8.87598 10.3395 
78.5386 43.8607 43.8147 22.9038 14.8143 15.9002 8.87973 10.3490 
78.7331 44.0623 44.0219 23.4980 15.3319 15.9277 8.90175 10.5263 
78.7769 44.1468 44.4060 23.5082 15.3506 15.9277 8.94427 10.6170 
78.9505 44.2336 45.2064 23.7575 15.4958 16.3475 9.01717 10.7476 
79.0166 45.0459 45.2074 23.8885 15.9657 16.3765 9.06431 10.7477 
79.1426 45.4711 45.2298 24.0449 16.1351 16.4609 9.11334 10.8357 
79.5280 45.5244 45.3755 24.0625 16.2346 16.4964 9.17232 11.2500 
79.6307 45.9789 45.4701 24.0775 16.2442 16.8001 9.18975 11.5844 
79.6356 46.3732 45.5586 24.2393 16.3055 16.8122 9.24962 11.6706 
79.6474 46.6941 45.6674 24.3728 16.3350 17.0279 9.28424 11.7989 
79.9923 47.0234 45.7965 24.4602 16.4231 17.2135 9.29835 11.8298 
80.0539 47.2665 46.2316 24.8339 16.7475 17.4367 9.43972 11.8354 
80.1377 47.7693 46.3750 24.8703 16.9784 17.6703 9.55596 11.8748 
80.5821 47.8946 46.5028 24.8885 17.3490 17.6703 9.61564 11.8909 
80.6612 47.9738 47.2165 24.9760 17.4607 17.7321 9.68574 12.0326 
80.7403 48.2532 47.2201 25.0272 17.6977 17.9409 9.81957 12.1578 
80.7631 48.2582 47.3539 25.8573 17.7307 17.9998 9.95613 12.3275 
80.7682 48.3120 47.4519 26.0751 17.8280 18.5872 10.0260 12.4463 
80.9245 49.1104 47.4635 26.2156 18.2857 18.6176 10.1049 12.5118 
81.2432 49.3907 47.6439 26.2664 18.6140 18.9277 10.1530 12.5564 
81.2925 49.4101 47.6744 27.2697 18.7989 19.1418 10.2872 12.6655 
81.3077 49.5536 47.9735 27.2746 18.8300 19.1494 10.3453 12.8293 
81.5501 49.6326 48.0120 27.6061 19.0146 19.1531 10.4003 12.8630 
81.6916 49.7279 48.0554 27.7965 19.2460 19.2517 10.6159 12.8754 
81.7863 50.4200 48.0648 27.8873 19.3527 19.3049 10.6171 12.9135 
81.8021 50.5335 48.1141 28.0360 19.3965 19.3322 10.6263 13.0104 
81.8855 50.6857 48.3902 28.1128 19.6370 19.5106 10.6869 13.0216 
81.9053 50.7480 48.6486 28.5846 20.0385 19.6304 10.7981 13.0264 
82.3868 50.8006 48.7058 28.6410 20.1041 20.1755 10.8605 13.3668 
82.4257 51.0390 48.8885 28.7741 20.4239 21.2583 11.2088 13.4139 
82.4313 51.1256 49.2286 28.8423 20.6675 21.3655 11.3873 13.4301 
82.6491 51.1541 49.3357 28.8830 21.0016 21.4553 11.4211 13.7299 
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82.6861 51.1788 49.5249 29.1502 21.1644 21.7856 11.5095 13.7688 
82.9644 51.2216 49.6003 29.1696 21.3739 22.0897 11.7339 14.0333 
83.0284 51.2279 49.9877 30.3829 21.4184 22.3107 11.8370 14.2588 
83.3819 51.3091 50.5451 30.4065 21.7285 22.3384 11.8692 14.3478 
83.7461 51.4021 50.7551 30.7679 21.7652 22.6572 11.9189 14.4261 
83.8977 51.4658 50.7901 31.2173 22.0662 22.7728 11.9575 14.4716 
84.0577 51.5146 50.9975 31.4700 22.3924 23.1231 12.0156 14.6630 
84.2383 51.5749 51.1708 32.0934 22.4317 23.4545 12.0305 14.8923 
84.2593 52.1329 51.7338 32.3352 22.7088 23.4974 12.1258 14.8943 
84.2968 52.5377 52.4495 32.8552 22.9727 23.5192 12.1628 14.9095 
84.5187 52.8198 52.7805 32.9224 23.1942 23.8179 12.2069 15.2101 
84.5748 52.8940 52.8874 33.3022 23.3739 24.2039 12.2259 15.3871 
84.6998 53.3081 53.0561 33.9538 24.1292 24.2695 12.2741 15.4687 
85.0152 53.4291 53.1297 34.4732 24.3390 24.4290 12.3330 15.6273 
85.2772 53.4596 53.2892 34.4830 24.4139 24.5326 12.3636 15.6852 
85.2790 53.8154 53.6652 34.8041 24.4916 25.0195 12.8614 15.9619 
85.3014 53.8663 54.1254 34.8502 24.5314 25.1561 13.0262 16.2114 
85.3826 53.9086 54.7096 37.6039 24.6676 25.6590 13.2575 16.2643 
85.4621 53.9785 55.9163 37.6355 24.6693 25.7659 13.2945 16.2785 
85.4973 54.0269 56.7739 37.7317 24.8161 27.2293 13.4195 16.5508 
85.6714 54.6545 56.8069 37.7900 25.0302 27.4984 13.5764 16.7799 
85.7645 54.6545 57.5181 38.6250 25.1756 28.1650 13.8678 16.7894 
85.7779 55.1095 57.5828 39.0040 25.3396 28.5052 13.9461 17.5633 
85.7861 55.1181 57.6303 39.4283 25.8923 30.8813 14.1032 17.8520 
86.0229 55.2614 57.7910 39.8998 26.5006 31.0909 14.2395 18.0201 
86.1336 55.4554 57.9313 39.9229 26.8622 31.8418 14.2860 18.0480 
86.3856 55.9181 57.9368 40.6398 27.3657 32.0562 14.3183 18.1274 
86.6223 56.0549 58.0047 41.2090 27.4263 32.1694 14.3733 18.4236 
86.7964 56.9998 58.7515 41.4626 27.9606 32.5586 14.9235 18.5262 
86.9171 57.2874 59.4611 41.9030 28.2903 32.9864 15.0725 18.6117 
86.9934 57.3448 59.4872 41.9948 28.5670 33.9920 15.1610 19.0662 
87.0336 57.4550 59.7420 43.0300 28.7298 34.1201 15.8257 19.1006 
87.3286 57.9311 59.7687 43.7025 29.5035 34.4033 16.0238 19.3087 
87.4075 58.3984 59.9023 44.0204 29.7030 34.6268 16.0524 19.3889 
87.5169 58.5841 60.5300 46.1410 31.0944 34.6576 16.1484 19.4130 
87.8525 58.8859 61.4191 46.7518 31.2315 34.7971 16.3958 19.4383 
87.9743 59.4888 61.9379 47.3272 31.3610 35.0409 17.5379 19.6116 
88.0274 59.7861 62.4801 47.5058 31.5578 35.1885 17.6417 19.7822 
88.1166 60.0346 63.3716 47.7441 31.8001 36.1873 18.1146 19.9878 
88.1930 60.2519 63.7093 48.3239 31.8693 36.2421 19.4795 20.1649 
88.4137 60.6814 63.8084 48.4381 33.7332 36.3279 19.7974 20.2970 
88.8369 60.7067 64.5337 48.7840 34.3236 37.2760 20.7849 20.3565 
89.2502 61.1545 64.5995 49.1079 35.0648 37.7194 20.9243 20.7569 
89.3748 61.6491 64.8158 50.5303 36.0830 38.1103 21.0068 20.8353 
89.5386 61.8247 65.1337 51.6219 36.2119 40.4038 21.0366 20.9216 
90.2771 62.2816 66.3508 51.8270 36.2977 40.4863 21.3544 21.2817 
91.2654 62.7242 67.2904 52.1199 36.3316 41.5565 21.7802 21.3385 
91.2735 63.1657 68.5835 53.0245 37.2075 42.5236 23.4827 21.4679 
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91.8150 65.0953 69.2138 53.6066 37.9817 45.1214 23.8211 22.2276 
92.3452 66.3782 69.2743 54.7120 38.2547 45.1449 24.8613 22.2341 
93.2548 67.1248 71.0903 54.7354 38.4111 45.7065 25.2382 22.2704 
93.3121 67.9187 71.3343 55.0006 39.0135 47.3477 25.3660 22.6007 
93.5742 69.2978 73.4163 55.5474 39.1539 48.2875 25.9992 22.6368 
93.6727 70.1076 74.6023 56.3704 39.3387 49.4727 26.0892 22.7475 
94.0990 72.7325 75.8095 57.8244 40.0561 49.4828 26.4776 23.2817 
94.6344 72.7995 76.0920 57.8729 40.5387 54.5723 26.9839 23.4619 
94.7754 73.4005 79.6000 59.3213 41.0256 56.8091 27.9057 24.0414 
94.8403 73.4096 80.9124 60.9561 41.7767 60.0593 31.1907 25.5114 
94.8473 73.8988 82.4866 63.8284 42.5115 61.4675 34.4807 25.5365 
95.9588 74.1758 82.8571 65.1560 46.5513 63.1287 34.5648 26.4404 
96.1140 74.4704 84.7380 65.4198 53.2279 65.8872 35.3630 30.3174 
96.3460 75.6036 84.7575 70.7919 59.5764 66.8924 44.3234 31.1362 
96.3463 75.9105 85.8855 72.0787 59.7986 68.8586 44.5799 31.9113 
96.8704 80.5891 92.2627 78.7329 64.9234 71.9763 51.7569 33.1842 
97.0917 80.6800 93.4703 83.1832 72.9655 80.4752 55.7215 37.3812 
97.2467 82.1659 94.6602 87.5267 77.1126 80.6623 56.7375 73.3154 





Table B.15 Raw data of the histograms illustrating the distributions of SCGE % tail DNA values from the 
CHO cell negative controls at 0 and 24 hour liquid-holding recovery. 
 
LH_0h LH_24h 


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table B.16 Raw data of the plating efficiency of HAA-treated CHO cells. The blank-corrected 
absorbency values were normalized to the concurrent negative control (%). 
 
  
5 mM 6 mM 7 mM 30 µM 60 µM 90 µM 15 µM 25 µM 35 µM
107.370 68.730 59.478 38.254 90.136 68.549 63.107 48.776 40.068 41.338
95.034 56.395 60.930 42.426 89.955 69.093 68.186 43.515 41.156 32.812
97.029 57.846 58.027 41.519 75.442 59.478 48.050 52.222 35.170 30.998
100.295 58.571 54.580 46.961 84.694 64.376 39.161 37.166 31.905 27.551
97.211 61.837 64.376 38.073 82.517 57.664 58.209 49.683 33.719 31.179
96.848 57.483 51.134 36.077 64.014 51.678 27.370 32.086 36.440 31.723
106.644 62.562 64.014 60.023 74.535 57.664 42.063 48.776 50.590 43.878
99.569 61.111 50.952 46.236 50.952 37.710 37.166 45.692 60.023 67.823
99.310 43.941 54.426 50.747 81.835 73.005 58.105 72.269 39.710 49.828
102.621 48.172 47.252 48.724 72.453 70.798 65.095 86.618 59.945 46.700
98.942 52.035 57.370 53.139 91.032 82.203 65.279 83.307 62.152 39.526
98.942 52.955 52.771 56.634 93.976 77.604 61.784 81.283 47.804 40.814
99.862 51.851 59.761 56.266 93.976 87.905 73.741 90.297 57.737 53.874
99.126 50.195 55.714 47.252 79.076 73.189 63.072 87.905 68.039 53.507
95.263 48.724 59.945 61.232 89.377 83.123 65.831 92.504 73.741 51.667
105.932 45.413 53.691 55.162 85.146 95.999 75.765 86.802 49.460 43.389
101.958 61.701 54.958 43.654 105.330 94.621 87.085 99.380 98.190 57.933
88.275 51.587 51.587 49.603 82.920 78.161 79.747 88.076 88.870 64.279
100.967 57.734 52.380 47.620 88.671 83.317 77.962 76.574 82.127 77.169
93.827 50.793 50.397 49.207 94.422 79.549 86.093 77.566 72.608 57.933
102.355 63.684 55.354 48.413 88.473 84.507 81.730 82.127 72.608 61.502
101.363 61.502 52.181 42.861 89.663 84.705 75.186 100.768 97.595 50.397
109.693 59.916 61.899 54.760 97.000 86.490 74.591 92.638 80.937 76.177
101.562 60.511 60.114 47.025 97.199 83.515 75.979 74.988 69.633 60.511
number 24 24 24 24 24 24 24 24 24 24
Average 100.000 56.052 55.970 48.411 85.116 74.371 64.598 72.126 60.426 49.688
SE 0.954 1.300 0.937 1.382 2.379 2.883 3.268 4.332 4.141 2.871





Table B.17 Raw data of the plating efficiency of HAN-treated CHO cells. The blank-corrected 





460 µM 790 µM 1200 µM 43 µM 52 µM 60 µM 45 µM 53 µM 60 µM
105.440 88.978 82.923 70.057 47.351 30.889 16.698 16.698 4.778 3.453
96.925 81.599 82.356 67.029 44.702 29.565 14.995 13.860 -0.142 -3.169
97.871 87.654 80.274 73.463 46.405 31.079 18.212 13.103 1.750 -3.169
98.439 90.303 87.465 72.706 47.919 29.754 18.590 14.806 -0.520 -1.466
100.142 90.303 82.545 69.678 50.568 35.809 20.861 17.833 -0.142 -3.359
93.898 85.383 72.517 64.948 49.432 29.186 13.482 13.103 -0.520 -4.872
108.278 101.466 91.060 79.518 59.082 39.593 21.807 20.104 8.940 1.939
99.007 88.600 85.951 76.490 61.731 34.295 22.185 18.023 5.913 1.372
108.768 84.926 75.862 58.916 40.394 25.813 12.414 16.355 0.197 4.532
95.961 82.759 75.862 52.020 35.862 20.296 8.670 13.005 -3.547 1.379
97.931 88.670 77.438 60.690 34.877 25.419 12.414 10.640 -2.562 -2.365
95.961 84.138 81.576 64.433 30.542 26.798 14.975 13.005 -3.547 -5.714
99.901 87.291 85.123 67.586 33.103 29.754 19.113 12.020 -1.576 -1.379
95.567 84.926 71.724 51.626 29.163 26.010 8.670 8.473 -4.729 -3.350
106.010 99.901 94.581 64.631 38.818 34.286 17.537 14.384 2.365 -1.182
99.901 87.882 83.941 56.946 30.739 33.695 13.399 13.596 0.394 -5.517
98.888 87.720 71.381 61.246 39.736 24.224 10.367 6.644 -1.008 -1.629
99.509 82.135 74.069 54.628 30.636 30.016 8.919 8.506 3.542 0.853
97.441 74.690 76.758 58.557 34.566 28.154 10.160 9.540 1.267 -0.595
101.991 77.792 75.517 61.867 35.393 30.636 13.883 9.747 0.646 0.026
98.268 86.479 78.826 64.142 38.495 33.118 15.538 8.713 -0.595 -0.801
86.065 76.758 68.485 65.589 32.704 28.775 4.576 7.472 -2.663 -3.490
113.987 91.856 86.686 60.419 43.666 35.807 16.779 7.058 3.128 3.956
103.852 77.999 77.172 67.244 42.632 31.050 15.538 6.644 -1.008 -0.595
number 24 24 24 24 24 24 24 24 24 24
Average 100.000 86.259 80.004 64.351 40.772 30.167 14.574 12.222 0.432 -1.048
SE 1.159 1.299 1.334 1.468 1.807 0.873 0.924 0.797 0.650 0.582






Table B.18 Pearson correlation analysis of physicochemical and toxicological measurements of 
monohaloacetonitriles. 
 
Pearson Product Moment Correlation Wednesday, August 21, 2013, 12:08:31 PM 
 





Number of Samples 
 
  Length (A) log P EHOMO ELUMO t50 (min) 60% SCGE µM  
C-X -- -- -- -- -- --  
 -- -- -- -- -- --  
 0 0 0 0 0 0  
        
Length (A)  0.987 0.992 -0.990 0.616 -0.792  
  0.104 0.0803 0.0908 0.578 0.418  
  3 3 3 3 3  
        
log P   0.958 -1.000 0.480 -0.682  
   0.184 0.0131 0.681 0.522  
   3 3 3 3  
        
EHOMO    -0.964 0.710 -0.862  
    0.171 0.497 0.338  
    3 3 3  
        
ELUMO     -0.498 0.697  
     0.668 0.509  
     3 3  
        
t50 (min)      -0.969  
      0.159  
      3  
        
60% SCGE µM        
        
        
        
 
 
The pair(s) of variables with positive correlation coefficients and P values below 0.050 tend to increase together. For 
the pairs with negative correlation coefficients and P values below 0.050, one variable tends to decrease while the 













APPENDICES FOR CHAPTER 4 
 
 
Summary of contents:  
 Ninety one pages.  
 Appendix C.1 Cell cycle profiles of CHO cells treated without or with 100 µM of AraC with 0, 8, 
14, 20, and 26 hour post-incubation.  
 Appendix C.2 Cell cycle profiles of CHO cells treated with various concentrations of HANs at 26 
hour post-incubation.  
 Appendix C.3 Cell cycle profiles of CHO cells treated with different initial cell loading.  
 Appendix C.4 Cell cycle profiles of CHO cells at 0, 8, 17, 26, 34, 43, and 52 hour post-incubation.  
 Appendix C.5 CHO cell viability and cell numbers during post-incubation after treated without or 
with 900 µM CAN, 12 µM BAN, 6 µM IAN, 50 µM AraC, or 10 mM EMS.  
 Appendix C.6 Cell cycle profiles of CHO cells treated without or with 10 mM EMS for 4 hours 
and harvested at 0, 26, and 52 hour post-incubation.  
 Appendix C.7 Plating efficiency of HAN-treated CHO cells.  






Appendix C.1 Cell cycle profiles of CHO cells treated without or with 100 µM of AraC with 0, 8, 14, 
20, and 26 hour post-incubation. DNA contents in individual cells were measured with LSR II flow 
cytometer and the cell cycle distributions were calculated using the FCS Express software. A 
summary table, cell cycle distribution, and fitted curves as well as the fitting models are provided 
(raw data used for Figure 4.3).   
 
 
Table C.1 Summary of cell cycle distribution (%) of the different treatment groups. 
 
Negative control 
   
Time (hours) 2N 2N to 4N 4N 
0 37.57 43.47 18.96 
8 30.01 62.17 7.81 
14 15.56 53.78 30.67 
20 35.66 51.04 13.30 
26 31.73 53.56 14.71 
    
AraC 100 µM 
   
Time (hours) 2N 2N to 4N 4N 
0 26.35 54.72 18.92 
8 4.02 68.79 27.19 
14 4.07 5.85 90.09 
20 6.96 33.4 59.65 










































%G2 %S G2/G1 %Total B.A.D.






SL S0 21.97 41.04 1.64
SL CL S0 20.96 41.88 1.44
+G2/G1 Fixed 1.11 59.85 4.98
+Aggregates 0.79 59.80 5.19
+S Order = 1 18.96 43.47 1.55
+CVs Fixed 14.47 48.23 1.94
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=43.5, %G2=19.





Number of cells: 10084.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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Dip %S A 
%G2
A %S Chis
SL CV S1 100.00 0.00 19.54 35.17 22.42
SL CL S0 71.36 3.45 0.00 28.62 14.81
+G2/G1 Fixed 0.00 0.00 1.90 26.02 14.71
+Aggregates 75.13 24.87 0.00 28.05 14.70
+S Order = 1 0.00 100.00 7.81 62.17 2.66
+CVs Fixed 82.95 0.00 0.00 0.00 45.44
Interpretation
MultiCycle suggestions (a guideline only):
An aneuploid DNA content is observed.
The average %S=62.2, %G2=7.8
The S Phase confidence is poor




Average %S aneuploid: 62.17
BAD: 0.34
Number of cells: 10094.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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G1 CV %G1 G2 
Mean
G2 CV %G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 292.31 380.78 32.16 535.69 33.00 9.24 58.60 1.83 4.26 n/a 0.70
Aneuploid A 406.18 3.57 15.56 751.53 3.57 30.67 53.78 1.85 95.74 1.39 0.37
Model Dip 
%G2
Dip %S A 
%G2
A %S Chis
SL CV S0 0.00 0.00 31.79 53.05 2.26
SL CL S0 0.00 100.00 31.51 53.41 2.06
+G2/G1 Fixed 8.71 5.99 30.55 54.41 2.14
+Aggregates 0.00 0.00 31.69 53.23 2.04
+S Order = 1 9.24 58.60 30.67 53.78 2.25
+CVs Fixed 33.33 66.67 0.00 11.80 56.40
Interpretation
MultiCycle suggestions (a guideline only):
An aneuploid DNA content is observed.
The aneuploid %S=53.8, %G2=30.7





Average %S aneuploid: 53.78
BAD: 0.48
Number of cells: 10052.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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SL CV S0 19.93 0.00 8.29 49.01 4.66
SL CL S0 0.00 38.62 8.50 48.86 3.94
+G2/G1 Fixed 12.15 0.00 0.00 54.85 7.58
+Aggregates 0.00 0.00 8.01 49.35 3.91
+S Order = 1 0.00 73.15 13.30 51.04 2.24
+CVs Fixed 0.00 97.75 0.00 65.53 4.85
Interpretation
MultiCycle suggestions (a guideline only):
An aneuploid DNA content is observed.
The aneuploid %S=51., %G2=13.3




Average %S aneuploid: 51.04
BAD: 0.27
Number of cells: 10104.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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SL S0 11.70 55.48 1.56
SL CL S0 11.08 56.01 1.08
+G2/G1 Fixed 0.00 67.30 2.48
+Aggregates 0.00 67.10 2.36
+S Order = 1 14.71 53.56 1.37
+CVs Fixed 9.58 57.64 1.84
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=53.6, %G2=14.7




Number of cells: 10071.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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SL CV G21 S0 11.90 52.99 5.21
SL CL S0 9.36 56.18 3.89
+G2/G1 Fixed 11.97 52.90 5.21
+Aggregates 11.77 53.00 4.74
+S Order = 1 18.92 54.72 1.53
+CVs Fixed 14.27 57.26 2.09
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=54.7, %G2=18.9




Number of cells: 10105.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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SL CV G21 S1 5.67 90.14 5.94
SL CL S0 36.06 59.62 1.41
+G2/G1 Fixed 28.51 67.30 2.11
+Aggregates 27.19 68.79 1.91
+S Order = 1 25.07 67.49 2.12
+CVs Fixed 23.55 70.26 2.68
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=68.8, %G2=27.2





Mean Xtra S: 659.37
Number of cells: 10100.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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SL CV G21 S1 94.63 2.28 4.83
SL CL S0 91.80 4.03 1.36
+G2/G1 Fixed 92.62 3.03 3.64
+Aggregates 92.13 3.22 2.44
+S Order = 1 90.09 5.85 1.81
+CVs Fixed 84.04 12.16 6.93
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=5.84, %G2=90.1





Mean Xtra S: 659.37
Number of cells: 10133.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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SL CV G21 S1 29.70 64.64 24.47
SL CL S0 53.62 26.02 2.65
+G2/G1 Fixed 54.49 25.10 2.97
+Aggregates 53.83 25.64 2.65
+S Order = 1 59.65 33.40 1.15
+CVs Fixed 59.41 30.91 1.29
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=33.4, %G2=59.6





Mean Xtra S: 659.37
Number of cells: 10283.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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SL S0 74.13 11.03 2.42
SL CL S0 76.57 10.95 4.54
+G2/G1 Fixed 76.35 8.02 3.76
+Aggregates 75.00 8.38 3.70
+S Order = 1 78.35 7.53 2.29
+CVs Fixed 75.90 13.80 6.53
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=7.53, %G2=78.3





Mean Xtra S: 659.37
Number of cells: 10518.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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Appendix C.2 Cell cycle profiles of CHO cells treated with various concentrations of HANs at 26 
hour post-incubation. DNA contents in individual cells were measured with LSR II flow cytometer 
and the cell cycle distributions were calculated using the FCS Express software. A summary table, 
cell cycle distribution, and fitted curves as well as the fitting models are provided (raw data used 
for Figure 4.4).   
 
 
Table C.2 Summary of cell cycle distribution (%) of the different treatment groups. 
 
CAN Concentration (µM) 2N 2N to 4N 4N 4N to 8N 8N 
0 48.11 45.13 6.76 0 0 
700 7.85 58.91 33.23 0 0 
750 12.38 51.26 36.36 0 0 
800 8.40 37.02 45.62 8.97 0 
850 16.29 18.72 55.44 9.55 0 
900 26.70 15.13 58.17 0 0 
      
BAN Concentration (µM) 2N 2N to 4N 4N 4N to 8N 8N 
0 44.01 47.09 8.90 0 0 
9 52.78 30.95 16.28 0 0 
10 21.34 20.64 36.97 21.05 0 
11 11.30 26.28 33.08 29.35 0 
12 2.08 18.17 46.27 33.50 0 
13 0.68 29.35 29.63 40.34 0 
      
IAN Concentration (µM) 2N 2N to 4N 4N 4N to 8N 8N 
0 49.17 42.41 8.42 0 0 
2 41.21 46.96 11.84 0 0 
3 30.89 51.82 17.29 0 0 
4 31.24 43.36 25.40 0 0 
6 1.58 5.78 56.81 33.68 2.15 








































SL S0 2.73 46.85 2.08
SL CL S0 0.00 50.39 1.17
+G2/G1 Fixed 0.00 52.07 4.04
+Aggregates 0.00 53.94 4.26
+S Order = 1 6.76 45.13 1.33
+CVs Fixed 6.87 45.03 1.32
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=45.1, %G2=6.76




Mean Xtra S: 659.37
Number of cells: 7140.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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SL CV G21 S0 46.95 41.54 1.88
SL CL S0 33.23 58.91 1.22
+G2/G1 Fixed 47.00 41.52 1.88
+Aggregates 45.05 43.54 1.46
+S Order = 1 44.33 50.60 1.73
+CVs Fixed 35.44 54.57 1.80
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=58.9, %G2=33.2




Mean Xtra S: 659.37
Number of cells: 5125.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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SL CV G21 S0 0.00 6.77 38.45 48.65 2.07
SL CL S0 3.34 95.46 30.44 61.30 1.40
+G2/G1 Fixed 0.00 0.00 38.29 48.97 2.05
+Aggregates 0.00 0.00 36.36 51.26 1.48
+S Order = 1 0.00 0.00 36.42 51.26 2.10
+CVs Fixed 0.00 0.00 39.31 60.69 1391135.00
Interpretation
MultiCycle suggestions (a guideline only):
An aneuploid DNA content is observed.
The average %S=50.8, %G2=36.1




Average %S aneuploid: 51.26
BAD: 2.81
Mean Xtra S: 659.37
Number of cells: 5128.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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SL CV G21 S1 0.00 72.06 0.00 17.67 1.02
SL CL S0 0.00 69.42 0.00 13.42 1.03
+G2/G1 Fixed 0.00 69.73 0.00 18.39 1.01
+Aggregates 0.00 69.99 0.00 14.31 1.07
+S Order = 1 0.00 70.09 0.00 17.74 1.06
+CVs Fixed 7.35 75.51 0.00 17.60 0.95
Interpretation
MultiCycle suggestions (a guideline only):
A near-tetraploid aneuploid DNA content is
observed.
The tetraploid %S=17.6, %G2=0.





Average %S aneuploid: 17.60
BAD: 1.91
Mean Xtra S: 659.37
Number of cells: 3094.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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SL CV G21 S1 0.00 48.12 0.00 14.25 1.12
SL CL S0 0.00 39.76 0.00 9.50 1.34
+G2/G1 Fixed 0.00 40.63 0.00 19.96 1.26
+Aggregates 0.00 40.08 0.00 10.68 1.30
+S Order = 1 0.00 40.84 0.00 18.69 1.27
+CVs Fixed 5.43 50.57 0.00 15.16 1.12
Interpretation
MultiCycle suggestions (a guideline only):
A near-tetraploid aneuploid DNA content is
observed.
The tetraploid %S=15.2, %G2=0.
The S Phase confidence is poor




Average %S aneuploid: 15.16
BAD: 1.92
Mean Xtra S: 659.37
Number of cells: 3596.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
295 
 




































%G2 %S G2/G1 %Total B.A.D.






SL CV S1 65.37 12.36 1.12
SL CL S0 58.93 13.99 0.96
+G2/G1 Fixed 59.58 14.37 1.17
+Aggregates 58.17 15.13 0.98
+S Order = 1 65.37 12.36 1.12
+CVs Fixed 65.23 12.28 1.11
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=15.1, %G2=58.2




Mean Xtra S: 659.37
Number of cells: 3568.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S1 11.06 45.15 1.49
SL CL S0 4.32 49.62 0.99
+G2/G1 Fixed 8.90 45.92 1.63
+Aggregates 7.02 46.67 1.11
+S Order = 1 8.90 47.09 1.47
+CVs Fixed 5.00 50.30 1.57
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=47.1, %G2=8.9




Mean Xtra S: 659.37
Number of cells: 10187.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S1 31.58 25.28 1.66
SL CL S0 16.28 30.95 1.34
+G2/G1 Fixed 23.45 25.62 2.07
+Aggregates 16.87 29.60 1.40
+S Order = 1 29.15 26.33 1.63
+CVs Fixed 23.18 29.29 1.75
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=30.9, %G2=16.3




Mean Xtra S: 659.37
Number of cells: 5133.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G1 G2 Mean G2 
CV
%G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 382.39 6.24 50.83 704.23 6.24 0.00 49.17 1.84 41.98 n/a 4.12








SL CV G21 S1 0.00 49.22 0.00 38.51 1.55
SL CL S0 0.00 49.05 0.00 38.07 1.56
+G2/G1 Fixed 0.00 49.18 0.00 38.27 1.56
+Aggregates 0.00 48.88 0.00 36.24 1.55
+S Order = 1 0.00 49.17 0.00 36.28 1.57
+CVs Fixed 0.00 0.00 0.00 33.00 3.89
Interpretation
MultiCycle suggestions (a guideline only):
An aneuploid DNA content is observed.
The aneuploid %S=36.3, %G2=0.





Average %S aneuploid: 36.28
BAD: 2.89
Mean Xtra S: 659.37
Number of cells: 5145.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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%G1 G2 Mean G2 
CV
%G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 388.11 6.15 22.86 738.19 6.15 23.97 53.17 1.90 49.42 n/a 7.01








SL CV G21 S1 2.31 66.66 0.00 42.46 1.68
SL CL S0 5.36 64.46 0.00 17.96 1.75
+G2/G1 Fixed 0.00 68.31 0.00 45.29 1.77
+Aggregates 0.79 65.77 0.00 20.89 1.76
+S Order = 1 23.97 53.17 0.00 58.02 1.71
+CVs Fixed 0.35 67.96 0.00 39.89 1.69
Interpretation
MultiCycle suggestions (a guideline only):
A near-tetraploid aneuploid DNA content is
observed.
The tetraploid %S=58., %G2=0.





Average %S aneuploid: 58.02
BAD: 5.13
Mean Xtra S: 659.37
Number of cells: 3654.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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%G1 G2 Mean G2 
CV
%G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 162.92 4.98 4.91 300.14 5.08 25.71 69.38 1.84 1.79 n/a 55.30
Aneuploid A 378.48 8.65 8.87 646.51 8.65 13.50 77.64 1.71 22.98 2.32 14.43







A %S B 
%G2
B %S Chis
SL CV G21 S1 35.93 56.34 9.57 82.19 0.00 44.38 1.21
SL CL S0 67.78 25.57 10.96 83.15 50.69 16.00 1.22
+G2/G1 Fixed 80.70 8.11 30.70 64.90 0.00 47.72 1.22
+Aggregates 67.44 32.37 6.91 90.05 0.00 41.19 1.46
+S Order = 1 25.71 69.38 13.50 77.64 0.00 43.73 1.23
+CVs Fixed 35.80 60.44 19.08 70.96 0.00 43.37 1.22
Interpretation
MultiCycle suggestions (a guideline only):
Multiple aneuploid DNA contents are observed.
The D.I. 2.32 aneuploid  %S=77.6, %G2=13.5
The S Phase confidence is fair
Note: % cells, inter-model error, 
The D.I. 4.6 aneuploid  %S=43.7, %G2=0.





Average %S aneuploid: 51.66
BAD: 10.15
Mean Xtra S: 659.37
Number of cells: 3658.00
Number of cycles: 3.00
Cycle fit model: 3 Cycle
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%G1 G2 Mean G2 
CV
%G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 390.72 1.43 2.19 848.58 1.45 3.75 94.06 2.17 31.20 n/a 8.37








SL CV G21 S1 20.47 72.98 74.49 14.48 1.59
SL CL S0 3.20 94.37 0.00 57.21 1.43
+G2/G1 Fixed 0.32 96.16 92.04 3.87 1.46
+Aggregates 15.73 78.50 75.59 2.08 1.58
+S Order = 1 3.75 94.06 0.00 58.63 1.43
+CVs Fixed 0.00 0.00 96.80 0.00 2.39
Interpretation
MultiCycle suggestions (a guideline only):
A near-tetraploid aneuploid DNA content is
observed.
The tetraploid %S=58.6, %G2=0.





Average %S aneuploid: 58.63
BAD: 7.01
Mean Xtra S: 659.37
Number of cells: 3646.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S1 10.29 40.83 0.99
SL CL S0 1.75 45.66 1.05
+G2/G1 Fixed 7.21 40.53 1.22
+Aggregates 4.50 42.46 1.16
+S Order = 1 8.42 42.41 0.98
+CVs Fixed 4.84 45.17 1.03
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=42.4, %G2=8.42





Mean Xtra S: 659.37
Number of cells: 4853.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S1 12.80 46.13 1.35
SL CL S0 6.98 49.30 1.37
+G2/G1 Fixed 9.88 45.96 1.89
+Aggregates 9.42 46.28 1.60
+S Order = 1 11.84 46.96 1.35
+CVs Fixed 9.29 48.91 1.42
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=47., %G2=11.8




Mean Xtra S: 659.37
Number of cells: 5091.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S1 20.35 49.29 2.26
SL CL S0 10.05 53.47 2.17
+G2/G1 Fixed 13.62 49.20 3.56
+Aggregates 12.57 49.68 2.75
+S Order = 1 17.29 51.82 2.12
+CVs Fixed 14.61 53.25 2.23
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=51.8, %G2=17.3





Mean Xtra S: 659.37
Number of cells: 5122.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S1 28.94 40.38 3.46
SL CL S0 17.39 45.88 2.13
+G2/G1 Fixed 21.61 42.40 4.26
+Aggregates 17.69 44.82 2.29
+S Order = 1 25.40 43.36 3.33
+CVs Fixed 22.91 44.66 3.44
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=43.4, %G2=25.4





Mean Xtra S: 659.37
Number of cells: 5122.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
306 
 

































%G1 G2 Mean G2 
CV
%G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 345.82 3.58 21.42 643.66 3.58 0.00 78.59 1.86 7.36 n/a 22.42








SL CV G21 S0 0.00 80.12 2.13 41.61 1.23
SL CL S0 0.00 78.06 2.08 42.65 1.26
+G2/G1 Fixed 0.00 78.26 2.12 41.63 1.22
+Aggregates 0.00 78.11 2.08 42.59 1.24
+S Order = 1 0.00 77.81 2.13 41.20 1.24
+CVs Fixed 0.00 78.59 2.32 36.36 1.16
Interpretation
MultiCycle suggestions (a guideline only):
A near-tetraploid aneuploid DNA content is
observed.
The tetraploid %S=36.4, %G2=2.32




Average %S aneuploid: 36.36
BAD: 6.12
Mean Xtra S: 659.37
Number of cells: 1567.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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%G1 G2 Mean G2 
CV
%G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 333.23 3.73 20.08 619.12 3.73 0.00 79.92 1.86 2.98 n/a 40.02








SL CV G21 S0 0.00 77.10 2.19 27.49 1.14
SL CL S0 0.00 77.16 2.19 28.48 1.18
+G2/G1 Fixed 0.00 76.65 2.19 27.69 1.13
+Aggregates 0.00 77.03 2.20 28.25 1.16
+S Order = 1 0.00 76.02 2.21 26.92 1.15
+CVs Fixed 0.00 79.92 2.23 25.96 0.93
Interpretation
MultiCycle suggestions (a guideline only):
A near-tetraploid aneuploid DNA content is
observed.
The tetraploid %S=26., %G2=2.23




Average %S aneuploid: 25.96
BAD: 5.53
Mean Xtra S: 659.37
Number of cells: 1580.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
308 
 
Appendix C.3 Cell cycle profiles of CHO cells treated with different initial cell loading. Treatment 
conditions are negative control, 900 µM CAN, 12 µM BAN, and 6 µM IAN with 26 hour post-
incubation. DNA contents in individual cells were measured with LSR II flow cytometer and the 
cell cycle distributions were calculated using the FCS Express software. A summary table, cell cycle 
distribution, and fitted curves as well as the fitting models are provided (raw data used for Figure 
4.5).   
 
 
Table C.3 Summary of cell cycle distribution (%) of the different treatment groups. 
 
Initial loading: 2x105 cells 
    
Treatment group 2N 2N to 4N 4N 4N to 8N 8N 
Negative 34.59 53.24 12.17 0 0 
CAN 900 µM 18.22 17.73 64.05 0 0 
BAN 12 µM 6.21 35.14 40.35 17.34 0.97 
IAN 6 µM 1.09 9.44 49.18 39.78 0.51 
      
Initial loading: 4x105 cells 
    
Treatment group 2N 2N to 4N 4N 4N to 8N 8N 
Negative 65.14 23.94 10.92 0 0 
CAN 900 µM 20.85 21.12 58.03 0 0 
BAN 12 µM 25.30 49.50 25.20 0 0 





Negative control, initial cell loading 2×10
5





































%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S1 12.55 52.94 1.14
SL CL S0 5.78 56.77 1.35
+G2/G1 Fixed 9.32 53.25 1.73
+Aggregates 8.82 53.43 1.50
+S Order = 1 12.17 53.24 1.15
+CVs Fixed 8.52 56.12 1.26
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=53.2, %G2=12.2





Number of cells: 6652.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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Negative control, initial cell loading 4×10
5





































%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S1 12.38 22.40 1.35
SL CL S0 9.52 24.46 1.13
+G2/G1 Fixed 12.07 22.56 1.36
+Aggregates 10.04 23.66 1.19
+S Order = 1 10.92 23.94 1.27
+CVs Fixed 9.48 25.03 1.34
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=23.9, %G2=10.9




Number of cells: 6639.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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CAN 900 µM, initial cell loading 2×10
5





































%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S2 61.79 16.76 6.88
SL CL S0 59.25 19.25 1.57
+G2/G1 Fixed 57.40 16.12 5.68
+Aggregates 56.29 16.60 5.14
+S Order = 1 64.05 17.73 1.53
+CVs Fixed 62.73 17.65 1.67
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=17.7, %G2=64.1




Number of cells: 5488.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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CAN 900 µM, initial cell loading 4×10
5





































%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S2 62.70 15.94 4.35
SL CL S0 55.71 22.38 1.25
+G2/G1 Fixed 56.74 18.45 3.96
+Aggregates 55.95 18.94 3.62
+S Order = 1 58.03 21.12 1.44
+CVs Fixed 55.80 22.30 1.67
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=21.1, %G2=58.




Number of cells: 5885.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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BAN 12 µM, initial cell loading 2×10
5

































%G1 G2 Mean G2 
CV
%G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 350.71 4.20 10.45 657.39 4.27 30.40 59.15 1.87 59.40 n/a 4.88








SL CV G21 S1 31.37 59.34 2.38 42.54 2.68
SL CL S0 17.05 70.80 0.00 31.52 2.26
+G2/G1 Fixed 12.93 73.95 0.00 31.15 2.34
+Aggregates 11.52 74.99 0.00 33.02 2.39
+S Order = 1 30.40 59.15 2.38 42.72 2.30
+CVs Fixed 37.88 52.74 2.19 53.31 2.29
Interpretation
MultiCycle suggestions (a guideline only):
A near-tetraploid aneuploid DNA content is
observed.
The tetraploid %S=42.7, %G2=2.38
The S Phase confidence is poor




Average %S aneuploid: 42.72
BAD: 3.34
Number of cells: 5698.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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BAN 12 µM, initial cell loading 4×10
5





































%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S2 30.31 44.57 2.97
SL CL S0 26.52 47.66 1.66
+G2/G1 Fixed 30.83 44.40 2.96
+Aggregates 27.29 46.80 1.66
+S Order = 1 25.20 49.50 2.93
+CVs Fixed 16.05 58.91 3.48
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=49.5, %G2=25.2





Number of cells: 5203.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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IAN 6 µM, initial cell loading 2×10
5

































%G1 G2 Mean G2 
CV
%G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 347.85 4.97 5.20 727.83 4.92 49.91 44.90 2.09 21.02 n/a 4.65








SL CV G21 S1 0.00 0.00 1.23 0.00 10.17
SL CL S0 0.00 84.20 0.60 50.83 2.66
+G2/G1 Fixed 0.00 83.99 0.61 51.09 2.63
+Aggregates 0.00 84.21 0.60 51.57 2.64
+S Order = 1 49.91 44.90 0.65 50.37 1.67
+CVs Fixed 0.00 0.00 0.00 0.00 8.94
Interpretation
MultiCycle suggestions (a guideline only):
A near-tetraploid aneuploid DNA content is
observed.
The tetraploid %S=50.4, %G2=0.65
The S Phase confidence is poor




Average %S aneuploid: 50.37
BAD: 3.60
Number of cells: 5231.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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IAN 6 µM, initial cell loading 4×10
5

































%G1 G2 Mean G2 
CV
%G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 345.37 2.89 53.55 633.58 2.89 0.00 46.45 1.83 60.36 n/a 3.52








SL CV G21 S1 13.17 41.31 1.92 72.30 2.37
SL CL S0 0.20 47.48 1.62 58.80 2.48
+G2/G1 Fixed 6.49 44.07 1.90 63.55 2.42
+Aggregates 6.66 44.13 1.87 64.64 2.44
+S Order = 1 0.00 46.45 1.73 51.54 2.41
+CVs Fixed 13.52 41.19 1.93 73.38 2.39
Interpretation
MultiCycle suggestions (a guideline only):
An aneuploid DNA content is observed.
The aneuploid %S=51.5, %G2=1.73
The S Phase confidence is poor




Average %S aneuploid: 51.54
BAD: 2.95
Number of cells: 5016.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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Appendix C.4 Cell cycle profiles of CHO cells at 0, 8, 17, 26, 34, 43, and 52 hour post-incubation. 
Treatment conditions are negative control, 900 µM CAN, 12 µM BAN, and 6 µM IAN. DNA 
contents in individual cells were measured with LSR II flow cytometer and the cell cycle 
distributions were calculated using the FCS Express software. A summary table, cell cycle 
distribution, and fitted curves as well as the fitting models are provided (raw data used for Figures 
4.6 and 4.7).   
 
 
Table C.4 Summary of cell cycle distribution (%) of the different treatment groups. 
 
Negative control 
     
Time (hours) 2N 2N to 4N 4N 4N to 8N 8N 
0 36.21 42.61 21.17 0 0 
8 31.97 37.51 30.53 0 0 
17 31.18 39.93 28.89 0 0 
26 22.23 48.56 29.22 0 0 
34 28.28 47.99 23.74 0 0 
43 33.60 43.51 22.89 0 0 
52 31.40 45.97 22.63 0 0 
      CAN 900 µM 
     
Time (hours) 2N 2N to 4N 4N 4N to 8N 8N 
0 33.33 41.58 25.09 0 0 
8 23.22 56.59 20.18 0 0 
17 8.83 60.74 23.18 6.83 0.41 
26 11.10 49.67 28.45 6.85 3.93 
34 9.82 28.53 41.67 14.25 5.74 
43 10.28 33.30 35.37 12.94 8.12 
52 15.55 31.11 31.08 13.36 8.90 
      BAN 12 µM 
     
Time (hours) 2N 2N to 4N 4N 4N to 8N 8N 
0 29.32 49.32 21.36 0 0 
8 17.41 54.20 28.39 0 0 
17 7.41 27.75 53.06 7.60 4.20 
26 10.58 35.49 31.54 17.08 5.32 
34 11.04 27.28 31.36 16.03 14.29 
43 10.22 31.70 23.73 21.63 12.71 
52 23.83 23.20 22.97 20.90 9.10 
      IAN 6 µM 
     
Time (hours) 2N 2N to 4N 4N 4N to 8N 8N 
0 27.43 50.68 21.90 0 0 
8 11.55 33.67 54.77 0 0 
17 2.55 4.47 75.76 7.56 9.67 
26 9.09 18.36 53.67 10.84 8.05 
34 5.92 18.08 21.63 30.83 23.55 
43 6.63 26.21 18.02 36.59 12.56 











































%G2 %S G2/G1 %Total B.A.D.






SL CV S0 22.52 41.63 1.83
SL CL S0 21.51 42.29 0.96
+G2/G1 Fixed 22.44 41.77 1.82
+Aggregates 21.17 42.61 0.96
+S Order = 1 22.47 41.74 1.84
+CVs Fixed 21.17 42.58 1.83
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=42.6, %G2=21.2




Number of cells: 5572.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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SL CV S0 24.68 27.10 5.95
SL CL S0 23.73 27.49 4.39
+G2/G1 Fixed 24.69 27.10 5.92
+Aggregates 23.42 27.86 4.39
+S Order = 1 30.53 37.51 3.08
+CVs Fixed 30.47 37.17 3.08
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=37.5, %G2=30.5




Number of cells: 9914.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
320 
 





































%G2 %S G2/G1 %Total B.A.D.






SL CV S0 29.87 39.24 3.38
SL CL S0 28.89 39.93 1.45
+G2/G1 Fixed 23.32 46.04 3.89
+Aggregates 22.11 46.96 2.03
+S Order = 1 35.52 35.44 3.30
+CVs Fixed 24.78 42.94 3.77
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=39.9, %G2=28.9




Number of cells: 9998.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S1 28.66 48.88 3.71
SL CL S0 14.54 56.94 2.95
+G2/G1 Fixed 18.63 52.53 5.28
+Aggregates 16.96 53.98 3.11
+S Order = 1 29.22 48.56 3.63
+CVs Fixed 18.04 55.86 4.84
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=48.6, %G2=29.2





Number of cells: 9896.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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SL CV G21 S1 25.60 45.16 3.33
SL CL S0 14.69 51.19 2.05
+G2/G1 Fixed 19.96 45.29 4.08
+Aggregates 18.74 46.16 2.59
+S Order = 1 23.74 47.99 2.98
+CVs Fixed 22.11 48.68 2.99
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=48., %G2=23.7





Number of cells: 9808.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV S0 24.14 42.56 3.62
SL CL S0 23.18 43.19 1.72
+G2/G1 Fixed 24.12 42.59 3.60
+Aggregates 22.89 43.51 1.71
+S Order = 1 31.33 39.09 3.35
+CVs Fixed 27.02 41.39 3.47
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=43.5, %G2=22.9




Number of cells: 9978.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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SL CV G21 S1 15.21 50.09 5.27
SL CL S0 8.27 53.58 2.51
+G2/G1 Fixed 14.67 47.03 5.31
+Aggregates 11.92 48.96 3.05
+S Order = 1 22.63 45.97 3.53
+CVs Fixed 11.73 53.32 4.54
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=46., %G2=22.6





Number of cells: 10043.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV S0 17.28 43.41 1.00
SL CL S0 16.86 43.62 0.95
+G2/G1 Fixed 17.23 43.46 0.99
+Aggregates 16.71 43.80 0.95
+S Order = 1 25.09 41.58 0.87
+CVs Fixed 24.28 41.85 0.87
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=41.6, %G2=25.1




Number of cells: 2241.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
326 
 







































%G2 %S G2/G1 %Total B.A.D.






SL CV S0 12.94 58.56 0.97
SL CL S0 12.39 58.91 0.87
+G2/G1 Fixed 12.92 58.59 0.97
+Aggregates 12.25 59.05 0.86
+S Order = 1 20.18 56.59 0.80
+CVs Fixed 18.98 57.24 0.80
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=56.6, %G2=20.2




Number of cells: 1788.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 212.27 4.55 11.14 401.48 4.57 12.26 76.60 1.89 79.30 n/a 1.04








SL CV G21 S0 0.00 84.29 0.00 18.74 1.14
SL CL S0 0.00 84.28 0.00 18.65 1.15
+G2/G1 Fixed 0.00 84.28 0.00 18.65 1.13
+Aggregates 0.00 84.28 0.00 18.65 1.14
+S Order = 1 12.26 76.60 1.99 32.99 0.80
+CVs Fixed 8.99 78.48 1.71 27.44 0.82
Interpretation
MultiCycle suggestions (a guideline only):
A near-tetraploid aneuploid DNA content is
observed.
The tetraploid %S=33., %G2=1.99
The S Phase confidence is fair




Average %S aneuploid: 32.99
BAD: 0.90
Number of cells: 6047.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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%G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 242.28 4.55 18.27 479.60 4.55 0.00 81.73 1.98 60.77 n/a 1.04








SL S0 0.00 81.70 9.84 17.59 1.32
SL CL S0 0.00 81.73 10.13 18.20 1.35
+G2/G1 Fixed 0.00 81.44 0.00 26.54 1.70
+Aggregates 5.98 73.70 9.24 16.06 1.36
+S Order = 1 0.00 81.73 10.02 17.45 1.33
+CVs Fixed 0.00 0.00 1.04 98.96 20.91
Interpretation
MultiCycle suggestions (a guideline only):
A near-tetraploid aneuploid DNA content is
observed.
The tetraploid %S=17.4, %G2=10.





Average %S aneuploid: 17.45
BAD: 0.97
Number of cells: 9276.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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%G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 219.15 4.95 21.21 408.87 4.94 17.17 61.63 1.87 46.30 n/a 2.67








SL CV S0 16.69 61.83 10.69 26.27 1.36
SL CL S0 25.57 55.45 10.52 29.48 1.32
+G2/G1 Fixed 14.96 63.36 4.06 33.19 1.64
+Aggregates 7.69 65.73 10.24 21.38 1.50
+S Order = 1 17.17 61.63 10.68 26.53 1.37
+CVs Fixed 78.60 0.00 0.00 24.96 7.94
Interpretation
MultiCycle suggestions (a guideline only):
A near-tetraploid aneuploid DNA content is
observed.
The tetraploid %S=26.5, %G2=10.7





Average %S aneuploid: 26.53
BAD: 1.84
Number of cells: 9620.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
330 
 






































%G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 221.74 5.49 18.73 413.10 5.48 20.57 60.70 1.86 54.86 n/a 2.11








SL CV G21 S1 19.25 62.39 12.69 32.71 1.42
SL CL S0 20.63 58.58 13.87 32.14 1.47
+G2/G1 Fixed 16.46 60.11 8.14 35.45 1.68
+Aggregates 16.09 60.44 8.60 35.65 1.68
+S Order = 1 20.57 60.70 17.98 28.67 1.25
+CVs Fixed 30.16 52.02 18.19 39.09 2.42
Interpretation
MultiCycle suggestions (a guideline only):
An aneuploid DNA content is observed.
The aneuploid %S=28.7, %G2=18.




Average %S aneuploid: 28.67
BAD: 1.67
Number of cells: 9087.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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G1 CV %G1 G2 
Mean
G2 CV %G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 224.91 5.14 26.96 423.43 5.13 19.12 53.93 1.88 57.68 n/a 1.38








SL CV G21 S1 15.27 56.68 21.54 53.13 1.12
SL CL S0 17.36 55.61 13.17 40.16 1.36
+G2/G1 Fixed 18.22 53.89 0.00 52.32 1.46
+Aggregates 19.04 53.46 0.00 55.26 1.50
+S Order = 1 19.12 53.93 21.04 31.56 1.26
+CVs Fixed 27.18 48.96 0.00 75.29 2.57
Interpretation
MultiCycle suggestions (a guideline only):
A near-tetraploid aneuploid DNA content is
observed.
The tetraploid %S=31.6, %G2=21.





Average %S aneuploid: 31.56
BAD: 1.20
Number of cells: 7559.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV S0 13.92 49.44 1.28
SL CL S0 13.39 49.75 1.05
+G2/G1 Fixed 13.94 49.43 1.28
+Aggregates 13.24 49.92 1.05
+S Order = 1 21.75 49.26 0.81
+CVs Fixed 21.36 49.32 0.80
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=49.3, %G2=21.4




Number of cells: 4082.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV S0 28.69 53.96 1.10
SL CL S0 28.39 54.20 0.78
+G2/G1 Fixed 31.03 51.25 1.16
+Aggregates 30.73 51.48 0.84
+S Order = 1 29.43 53.57 1.10
+CVs Fixed 29.44 53.56 1.10
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=54.2, %G2=28.4




Number of cells: 4215.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 208.67 5.42 21.08 385.28 5.40 0.00 78.92 1.85 35.16 n/a 3.20








SL S0 3.61 78.44 7.72 13.58 0.80
SL CL S0 12.51 70.88 7.78 12.07 0.83
+G2/G1 Fixed 28.97 57.78 4.39 24.00 0.87
+Aggregates 0.00 78.92 6.47 11.72 0.79
+S Order = 1 3.65 78.42 7.71 13.58 0.81
+CVs Fixed 0.00 78.84 8.08 12.74 0.81
Interpretation
MultiCycle suggestions (a guideline only):
A near-tetraploid aneuploid DNA content is
observed.
The tetraploid %S=11.7, %G2=6.47





Average %S aneuploid: 11.72
BAD: 2.48
Number of cells: 2330.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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%G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 236.04 6.88 22.97 429.41 6.88 0.00 77.03 1.82 46.07 n/a 2.49








SL CV G21 S1 0.00 78.96 12.71 31.09 1.44
SL CL S0 8.20 70.16 5.93 41.73 1.75
+G2/G1 Fixed 0.00 73.86 7.59 28.87 1.99
+Aggregates 4.65 70.84 7.13 31.96 1.75
+S Order = 1 0.00 77.03 9.87 31.66 1.75
+CVs Fixed 0.00 76.69 10.10 31.67 1.72
Interpretation
MultiCycle suggestions (a guideline only):
A near-tetraploid aneuploid DNA content is
observed.
The tetraploid %S=31.7, %G2=9.87





Average %S aneuploid: 31.66
BAD: 1.85
Number of cells: 7235.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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%G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 216.79 5.08 21.49 412.20 5.09 25.42 53.08 1.90 51.39 n/a 4.34





A %G2 A %S Chis
SL CV S0 29.59 49.25 26.53 39.16 1.60
SL CL S0 41.64 39.33 100.00 0.00 10.70
+G2/G1 Fixed 28.24 50.24 2.75 63.48 2.34
+Aggregates 0.00 62.44 17.67 13.04 3.34
+S Order = 1 25.42 53.08 29.40 32.98 1.48
+CVs Fixed 36.90 44.05 28.96 44.10 1.60
Interpretation
MultiCycle suggestions (a guideline only):
A near-tetraploid aneuploid DNA content is
observed.
The tetraploid %S=33., %G2=29.4





Average %S aneuploid: 32.98
BAD: 3.43
Number of cells: 8918.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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%G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 214.49 5.12 20.08 402.41 5.17 17.62 62.30 1.88 50.89 n/a 5.44








SL CV S0 22.84 57.85 19.25 39.20 1.63
SL CL S0 27.69 54.27 15.05 46.31 1.55
+G2/G1 Fixed 18.06 61.52 5.24 55.02 1.85
+Aggregates 12.50 58.24 15.32 24.34 2.33
+S Order = 1 17.62 62.30 25.88 44.05 1.50
+CVs Fixed 30.41 50.94 23.40 55.18 1.63
Interpretation
MultiCycle suggestions (a guideline only):
A near-tetraploid aneuploid DNA content is
observed.
The tetraploid %S=44.1, %G2=25.9





Average %S aneuploid: 44.05
BAD: 4.54
Number of cells: 8831.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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G1 CV %G1 G2 
Mean
G2 CV %G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 222.41 4.62 45.71 420.63 4.62 9.79 44.50 1.89 52.14 n/a 2.10








SL CV G21 S1 10.35 39.48 22.09 24.55 1.53
SL CL S0 6.78 57.64 0.00 100.00 3.91
+G2/G1 Fixed 11.24 44.69 9.52 52.79 2.07
+Aggregates 11.77 47.87 0.00 100.00 4.82
+S Order = 1 9.79 44.50 19.02 43.67 1.33
+CVs Fixed 16.54 45.31 0.48 75.51 1.64
Interpretation
MultiCycle suggestions (a guideline only):
An aneuploid DNA content is observed.
The average %S=44.1, %G2=14.2





Average %S aneuploid: 43.67
BAD: 1.95
Number of cells: 8775.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV S0 22.46 50.28 2.07
SL CL S0 21.92 50.67 1.47
+G2/G1 Fixed 22.47 50.26 2.06
+Aggregates 21.90 50.68 1.46
+S Order = 1 28.83 49.31 1.83
+CVs Fixed 30.01 48.89 1.83
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=50.7, %G2=21.9




Number of cells: 5319.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV S0 55.73 32.64 1.44
SL CL S0 55.45 32.90 1.05
+G2/G1 Fixed 54.98 33.50 1.44
+Aggregates 54.77 33.67 1.05
+S Order = 1 51.26 36.11 1.40
+CVs Fixed 51.81 35.19 1.40
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=33.7, %G2=54.8




Number of cells: 4713.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 214.17 6.56 16.72 374.86 6.56 53.98 29.30 1.75 15.27 n/a 16.62








SL S0 53.95 29.29 11.41 8.92 1.17
SL CL S0 27.60 56.30 11.42 8.47 1.41
+G2/G1 Fixed 0.00 78.24 3.67 12.38 2.36
+Aggregates 26.46 53.15 10.80 8.15 1.42
+S Order = 1 53.98 29.30 11.41 8.92 1.18
+CVs Fixed 0.00 0.00 0.93 89.13 214.18
Interpretation
MultiCycle suggestions (a guideline only):
A near-tetraploid aneuploid DNA content is
observed.
The tetraploid %S=8.91, %G2=11.4





Average %S aneuploid: 8.92
BAD: 4.29
Number of cells: 4881.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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G1 CV %G1 G2 
Mean
G2 CV %G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 246.12 17.15 24.81 492.23 17.15 25.07 50.13 2.00 36.63 n/a 6.86





A %G2 A %S Chis
SL CV S1 92.57 0.00 35.06 42.30 3.29
SL CL S0 25.07 50.13 12.70 17.11 1.91
+G2/G1 Fixed 65.06 29.15 100.00 0.00 4.91
+Aggregates 33.62 64.98 100.00 0.00 15.92
+S Order = 1 92.46 0.68 41.04 34.87 3.10
+CVs Fixed 90.31 0.50 11.12 77.82 7.03
Interpretation
MultiCycle suggestions (a guideline only):
An aneuploid DNA content is observed.
The average %S=29.2, %G2=17.2





Average %S aneuploid: 17.11
BAD: 8.87
Number of cells: 8446.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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%G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 218.21 5.79 18.40 413.79 5.83 25.36 56.24 1.90 32.15 n/a 11.42








SL S0 27.03 54.27 30.45 45.87 2.47
SL CL S0 0.00 99.32 0.00 88.98 1164720.00
+G2/G1 Fixed 27.29 54.64 6.97 73.72 3.61
+Aggregates 13.08 61.36 28.21 38.02 2.12
+S Order = 1 25.36 56.24 34.71 45.44 1.91
+CVs Fixed 0.00 0.00 45.70 0.00 8.52
Interpretation
MultiCycle suggestions (a guideline only):
A near-tetraploid aneuploid DNA content is
observed.
The tetraploid %S=45.4, %G2=34.7





Average %S aneuploid: 45.44
BAD: 7.61
Number of cells: 7861.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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%G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 215.78 9.34 20.18 412.64 9.34 0.00 79.82 1.91 32.84 n/a 11.94








SL CV G21 S1 9.08 67.79 23.97 38.49 1.90
SL CL S0 16.80 67.93 18.94 55.02 1.64
+G2/G1 Fixed 3.98 67.87 25.00 33.58 1.85
+Aggregates 4.69 73.59 14.50 43.40 1.84
+S Order = 1 0.00 83.57 17.87 65.43 1.69
+CVs Fixed 0.00 79.82 18.70 54.48 1.59
Interpretation
MultiCycle suggestions (a guideline only):
A near-tetraploid aneuploid DNA content is
observed.
The tetraploid %S=54.5, %G2=18.7





Average %S aneuploid: 54.48
BAD: 8.76
Number of cells: 7860.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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%G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 212.07 5.55 29.33 381.71 5.55 2.43 68.24 1.80 44.53 n/a 9.56








SL CV G21 S1 0.00 68.86 20.66 38.94 1.75
SL CL S0 3.30 75.58 15.69 60.34 1.39
+G2/G1 Fixed 0.00 69.06 19.51 40.40 1.75
+Aggregates 2.43 68.24 14.62 42.22 1.54
+S Order = 1 0.00 69.22 14.41 48.05 1.65
+CVs Fixed 0.00 0.00 23.95 50.95 3.52
Interpretation
MultiCycle suggestions (a guideline only):
A near-tetraploid aneuploid DNA content is
observed.
The tetraploid %S=42.2, %G2=14.6
The S Phase confidence is poor




Average %S aneuploid: 42.22
BAD: 13.04
Number of cells: 2881.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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Appendix C.5 CHO cell viability and cell numbers during post-incubation after treated without or 
with 900 µM CAN, 12 µM BAN, 6 µM IAN, 50 µM AraC, or 10 mM EMS (raw data used for 
Figure 4.8).  
 
Cell number (# per well) 





CAN 900 µM BAN 12 µM IAN 6 µM AraC 50 µM EMS 10 mM 
0 358470 320600 327320 339080 340340 543410 
8 481530 277760 298900 335580 − − 
17 722475 242700 214050 215625 − − 
26 1277550 171225 235350 268725 489750 708400 
34 1771800 195075 240675 212850 − − 
43 2883000 247275 338100 322275 − − 
52 4164000 227400 427350 372525 541875 1032500 
      
    
Viability (%)   





CAN 900 µM BAN 12 µM IAN 6 µM AraC 50 µM EMS 10 mM 
0 97.60 96.36 96.38 94.81 91.62 99.52 
8 89.07 92.96 94.70 98.51 − − 
17 94.38 93.78 92.18 95.22 − − 
26 94.48 94.59 91.49 96.89 90.24 96.77 
34 91.67 95.81 97.60 94.37 − − 
43 96.69 93.03 88.52 94.62 − − 





Appendix C.6 Cell cycle profiles of CHO cells treated without or with 10 mM EMS for 4 hours and 
harvested at 0, 26, and 52 hour post-incubation. DNA contents in individual cells were measured 
with LSR II flow cytometer and the cell cycle distributions were calculated using the FCS Express 
software. A summary table, cell cycle distribution, and fitted curves as well as the fitting models are 
provided (raw data used for Figure 4.9).   
 
 
Table C.5 Summary of cell cycle distribution (%) of the different treatment groups. 
 
Negative control 
     
Time (hours) 2N 2N to 4N 4N 4N to 8N 8N 
0 31.69 54.85 13.47 0 0 
26 36.31 38.04 20.22 5.23 0.20 
52 52.52 27.31 20.16 0 0 
      
EMS 10 mM 
     
Time (hours) 2N 2N to 4N 4N 4N to 8N 8N 
0 27.16 64.55 8.30 0 0 
26 14.50 40.03 41.04 3.73 0.71 
52 25.78 41.81 32.41 0 0 
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%G2 %S G2/G1 %Total B.A.D.






SL CV S0 14.57 54.45 3.35
SL CL S0 18.71 50.42 1.99
+G2/G1 Fixed 20.52 48.81 2.96
+Aggregates 19.78 49.37 1.97
+S Order = 1 13.47 54.85 2.85
+CVs Fixed 11.19 57.54 2.92
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=54.8, %G2=13.5




Number of cells: 9574.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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G1 CV %G1 G2 
Mean
G2 CV %G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 225.30 3.12 46.00 413.46 3.12 5.81 48.19 1.84 78.94 n/a 0.14








SL CV S1 6.53 48.43 2.23 27.29 0.99
SL CL S0 4.10 51.65 0.00 43.33 2.16
+G2/G1 Fixed 4.50 49.89 0.00 46.26 2.33
+Aggregates 3.03 52.84 0.00 43.61 2.19
+S Order = 1 5.81 48.19 0.96 24.82 0.97
+CVs Fixed 0.23 57.37 0.80 47.62 1.06
Interpretation
MultiCycle suggestions (a guideline only):
An aneuploid DNA content is observed.
The aneuploid %S=24.8, %G2=0.96
The S Phase confidence is poor




Average %S aneuploid: 24.82
BAD: 0.14
Number of cells: 9808.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL S0 8.56 29.67 4.42
SL CL S0 7.00 30.31 3.19
+G2/G1 Fixed 5.95 33.19 4.44
+Aggregates 2.77 34.60 3.35
+S Order = 1 20.16 27.31 2.39
+CVs Fixed 11.96 29.94 4.10
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=27.3, %G2=20.2




Number of cells: 9664.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S1 9.85 61.69 3.98
SL CL S0 4.12 66.69 1.78
+G2/G1 Fixed 10.09 60.21 3.12
+Aggregates 9.47 60.69 2.45
+S Order = 1 8.30 64.55 2.20
+CVs Fixed 7.02 65.53 2.21
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=64.5, %G2=8.3





Number of cells: 9461.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total D.I. B.A.D.
Diploid 237.34 4.98 17.04 447.25 4.98 35.93 47.03 1.88 85.11 n/a 0.42








SL CV G21 S1 28.07 52.72 3.47 14.77 1.62
SL CL S0 31.33 46.73 0.00 29.16 2.19
+G2/G1 Fixed 25.76 50.21 3.06 18.84 2.68
+Aggregates 26.42 49.97 1.45 11.16 2.57
+S Order = 1 35.93 47.03 4.74 25.04 1.31
+CVs Fixed 36.28 46.66 4.79 26.05 1.31
Interpretation
MultiCycle suggestions (a guideline only):
An aneuploid DNA content is observed.
The aneuploid %S=25., %G2=4.74
The S Phase confidence is poor




Average %S aneuploid: 25.04
BAD: 0.35
Number of cells: 9420.00
Number of cycles: 2.00
Cycle fit model: 2 Cycle
353 
 



































G2 CV %G2 %S G2/G1 %Total B.A.D.






SL CV G21 S1 34.01 40.98 2.82
SL CL S0 9.09 57.55 1.86
+G2/G1 Fixed 21.65 45.82 3.52
+Aggregates 18.00 47.84 2.14
+S Order = 1 32.41 41.81 2.93
+CVs Fixed 2.85 65.04 3.94
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=41.8, %G2=32.4
The S Phase confidence is poor




Number of cells: 9318.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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Appendix C.7 Plating efficiency of HAN-treated CHO cells. The blank-corrected absorbency values 
were normalized to the concurrent negative control (raw data used for Figure 4.12). 
 
 
Table C.6 Cell density of negative control CHO cells measured as the blank-corrected absorbency values 




































































































































































































Table C.7 Cell density of IAN-treated CHO cells measured as the blank-corrected absorbency values 





2 µM 3 µM 4 µM 5 µM 6 µM 8 µM 
 
52.517 46.735 39.357   13.235 9.845 
 
91.600 58.101 22.408   7.652 7.253 
 
90.603 81.431 25.997   15.828 8.649 
 
84.821 69.068 33.774   14.033 8.051 
 
81.830 55.110 34.970   16.027 8.649 
 
81.431 46.735 38.759   12.039 26.196 
 
77.642 83.425 60.892   20.613 12.438 
 
61.491 42.149 30.184   19.018 7.652 
 
94.990 32.577 38.759   17.822 11.441 
 
75.249 37.762 19.417   10.643 2.268 
 
93.195 52.119 20.613   19.417 5.259 
 
85.618 36.366 33.574   11.839 6.456 
 
78.041 74.651 29.586   26.396 7.851 
 
84.621 48.330 26.396   11.441 10.244 
 
84.422 62.089 37.562   24.003 21.810 
 
81.630 65.080 28.589   21.211 19.816 
 
95.466 57.472 65.844 24.202 23.343   
 
89.670 67.132 71.639 24.846 19.265   
 
89.885 88.167 79.796 26.992 17.118   
 
88.597 87.953 78.723 31.071 19.909   
 
94.178 87.953 91.173 25.490 22.055   
 
76.576 94.822 69.278 23.129 19.050   
 
87.523 96.968 57.472 29.353 20.767   
 
82.587 89.241 80.225 56.829 18.406   
 
87.738 95.680 39.227 33.646 19.265   
 
98.041 97.183 41.159 21.197 18.406   
 
103.408 87.523 34.076 50.818 33.002   
 
91.387 87.953 37.081 23.343 25.275   
 
99.329 79.152 55.970 24.846 33.432   
 
97.183 81.299 66.917 20.338 18.621   
 
107.915 84.948 42.447 29.568 28.280   
 
103.193 69.708 45.237 24.202 30.641   
 
88.799 72.205 62.838   39.695 39.017 
 
95.963 81.064 71.124   40.458 46.328 
 
96.620 81.954 73.350   41.115 34.036 
 
101.854 84.285 64.639   42.492 42.047 
 
88.905 90.686 78.584   43.128 35.477 
 
99.566 95.073 71.040   43.637 36.092 
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Table C.7 (cont.) 
 
 
98.591 93.610 77.779   42.153 37.512 
 
102.427 91.555 82.272   44.781 39.589 
 
90.071 84.137 63.452   48.066 27.805 
 
97.086 90.368 68.963   50.291 26.661 
 
91.682 95.369 65.826   45.926 32.786 
 
97.743 87.379 87.443   36.198 33.231 
 
91.449 95.687 80.131   38.190 33.782 
 
100.562 92.381 71.379   42.386 36.495 
 
104.843 92.678 77.694   46.773 35.711 
 
101.240 98.040 80.555   34.291 34.842 
number 48 48 48 16 48 32 
Average 90.412 76.486 55.295 29.367 27.242 23.290 
SE 1.543 2.735 3.066 2.561 1.767 2.439 







Table C.8 Cell density of BAN-treated CHO cells measured as the blank-corrected absorbency values 





2 µM 3 µM 4 µM 6 µM 8 µM 10 µM 12 µM 14 µM 
 
108.998 97.791 73.438 41.541 50.808       
 
85.722 58.998 38.955 89.170 32.489       
 
91.110 72.575 44.989 48.006 24.731       
 
83.351 58.351 54.903 42.834 27.101       
 
88.739 115.032 51.670 64.386 50.162       
 
71.282 58.998 79.903 35.075 26.670       
 
112.877 80.119 110.938 79.041 33.998       
 
88.739 67.834 52.963 33.998 25.162       
 
85.291 66.325 109.213 41.756 34.213       
 
102.963 58.136 102.748 43.481 26.670       
 
103.179 70.205 48.006 42.188 26.239       
 
96.498 59.213 118.481 46.498 29.256       
 
83.136 93.912 86.153 67.188 77.101       
 
83.351 77.748 77.532 31.843 29.041       
 
90.894 82.489 76.670 52.748 29.688       
 
61.153 49.084 63.739 33.567 30.119       
 
97.158   89.013   30.855 39.380 17.784   
 
83.708   56.808   51.693 21.383 18.541   
 
93.370   94.127   66.469 22.141 23.656   
 
81.435   98.863   42.221 45.063 24.414   
 
91.475   112.692   83.329 29.150 19.299   
 
96.590   72.152   58.323 36.159 19.110   
 
72.910   79.162   80.867 35.022 31.423   
 
104.736   91.286   63.059 28.960 25.551   
 
79.541   64.386   40.706 34.454 21.004   
 
71.205   67.606   77.457 39.190 18.541   
 
68.932   59.650   33.318 33.318 24.793   
 
81.435   62.870   76.131 36.349 9.638   
 
88.634   91.854   31.234 39.380 14.942   
 
77.646   53.019   36.159 34.833 13.048   
 
76.131   71.016   53.587 34.833 20.625   
 
79.541   49.420   37.675 30.855 22.520   
 
97.803   93.834   57.784   32.312 31.810 
 
95.557   104.454   64.610   32.683 21.299 
 
91.805   103.953   70.738   30.916 20.623 
 
102.012   96.429   73.225   37.546 23.283 
 
93.725   100.856   73.159   39.400 23.676 
 
105.283   111.389   83.300   43.827 36.085 
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Table C.8 (cont.) 
 
 
108.947   108.096   77.390   35.780 22.193 
 
120.178   107.006   81.163   29.869 25.595 
 
89.297   88.054   71.480   37.917 31.309 
 
103.495   96.821   53.968   36.259 36.368 
 
102.579   97.410   57.850   36.826 21.909 
 
107.726   84.434   72.134   45.702 25.028 
 
106.897   99.111   61.034   40.228 26.925 
 
110.474   101.401   86.571   38.745 20.121 
 
107.791   103.059   71.524   36.194 30.676 
 
111.019   105.458   78.066   44.459 24.723 
number 48 16 48 16 48 16 32 16 
Average 92.423 72.926 83.458 49.582 53.136 33.779 28.861 26.351 
SE 1.929 4.402 3.148 4.220 2.981 1.552 1.763 1.330 




















Table C.9 Cell density of CAN-treated CHO cells measured as the blank-corrected absorbency values 





200 µM  400 µM 600 µM 800 µM 900 µM 1000 µM 1200 µM 
 
  104.344 50.960 33.585   38.370 5.886 
 
  82.184 42.902 21.246   31.571 7.397 
 
  48.946 46.931 28.045   27.794 6.390 
 
  87.472 48.694 27.794   27.038 8.908 
 
  48.190 44.665 30.312   30.312 7.901 
 
  47.183 39.125 26.786   30.815 5.634 
 
  51.464 52.219 38.621   34.341 12.937 
 
  50.960 41.895 26.031   18.728 15.455 
 
  79.163 57.759 17.469   17.218 6.641 
 
  55.744 34.341 17.218   14.448 7.901 
 
  47.938 52.975 15.203   19.736 6.138 
 
  47.938 58.766 35.348   13.189 4.123 
 
  71.357 69.342 33.333   18.980 10.670 
 
  48.190 36.103 31.571   16.966 4.375 
 
  98.552 43.658 40.132   25.779 13.944 
 
  50.708 37.362 22.254   22.254 13.692 
 
98.159 70.042 29.205 12.469 9.121     
 
85.662 48.173 22.957 12.915 7.782     
 
95.035 81.423 24.742 15.593 25.188     
 
89.010 78.075 25.635 12.245 7.336     
 
93.919 90.126 26.527 28.089 12.469     
 
82.092 73.835 20.725 16.485 7.782     
 
91.018 74.505 29.428 27.866 15.593     
 
106.192 89.456 25.411 19.163 9.791     
 
51.520 68.926 20.948 15.146 10.460     
 
47.280 58.215 17.155 13.584 6.220     
 
61.116 38.801 24.073 9.344 13.808     
 
79.861 73.612 34.561 16.039 12.022     
 
64.463 70.042 27.643 15.370 14.700     
 
86.332 80.753 43.040 17.155 8.452     
 
117.573 53.752 48.396 17.601 14.477     
 
98.605 78.298 25.858 16.709 13.138     
 
68.608 73.360 29.693   11.566   -5.285 
 
99.142 70.104 51.889   15.525   -5.945 
 
97.756 71.798 45.180   19.749   -4.515 
 
97.360 70.038 36.402   15.064   -1.325 
 
76.088 85.547 45.224   18.891   -2.029 
 
91.399 79.189 37.942   20.849   -3.107 
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Table C.9 (cont.) 
 
 
98.086 70.720 36.952   19.287   -1.215 
 
88.165 70.500 43.464   20.475   -2.271 
 
54.463 69.202 24.391   13.942   -5.901 
 
76.308 83.787 29.187   16.999   -2.579 
 
92.147 68.652 53.099   15.899   -4.185 
 
85.459 64.406 49.601   9.916   -2.337 
 
86.559 79.277 31.166   14.162   -3.569 
 
76.989 78.529 37.172   15.437   -1.347 
 
90.871 100.110 35.918   15.635   -1.787 
  81.983 67.772 47.379   15.591   -2.007 
number 32 48 48 32 32 16 32 
Average 84.663 69.820 38.305 22.210 13.979 24.221 2.768 
SE 2.827 2.248 1.697 1.507 0.792 1.894 1.159 





Table C.10 Cell density of EMS- and AraC-treated CHO cells measured as the blank-corrected 





5 mM 10 mM 25 µM 50 µM 
 
74.687 28.561 43.240 47.487 
 
77.607 37.683 48.474 51.473 
 
71.253 37.576 51.212 50.132 
 
81.642 34.142 52.628 60.861 
 
72.412 34.184 58.067 55.626 
 
70.717 40.280 53.689 51.473 
 
86.707 36.181 47.487 52.907 
 
86.922 38.434 55.701 50.057 
 
74.988 34.442 44.376 46.145 
 
78.980 30.922 49.051 56.316 
 
79.238 35.687 53.708 56.390 
 
75.954 32.746 50.616 52.236 
 
80.976 37.705 44.096 55.328 
 
86.407 38.220 47.934 49.237 
 
75.117 40.924 48.790 57.564 
 
84.196 37.769 51.268 54.118 
 
76.684 30.149 44.655 36.590 
 
73.872 36.095 49.033 49.312 
 
69.751 39.701 49.834 46.835 
 
77.778 26.371 47.542 43.854 
 
74.001 33.390 48.846 44.022 
 
75.846 38.735 54.490 48.343 
 
81.620 40.817 51.733 45.792 
 
82.629 38.585 48.697 51.268 
 
69.697 34.693 46.722 45.636 
 
81.314 31.604 47.059 47.789 
 
80.707 34.617 52.636 54.414 
 
79.532 37.744 50.035 56.230 
 
74.340 43.600 58.626 51.438 
 
74.264 38.881 57.316 56.380 
 
80.196 40.435 46.235 52.805 
 
80.158 37.422 50.278 47.396 
 
77.410 31.282 49.417 27.706 
 
82.925 33.746 49.118 34.575 
 
80.499 30.277 61.171 54.358 
 
87.814 36.418 61.714 34.968 
 
80.404 37.062 47.414 40.882 
 
80.499 40.909 52.262 47.826 
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Table C.10 (cont.) 
 
 
85.730 41.629 62.800 50.709 
 
78.661 37.043 51.476 41.069 
 
70.455 23.910 50.484 32.722 
 
78.869 25.217 58.794 30.345 
 
77.694 33.916 56.043 34.406 
 
95.546 21.219 52.468 31.112 
 
84.024 31.699 48.425 33.826 
 
84.365 33.746 56.211 43.690 
 
83.474 31.756 61.620 45.037 
 
91.055 29.235 56.043 40.059 
number 48 48 48 48 
Average 79.367 34.945 51.657 46.849 
SE 0.808 0.699 0.709 1.187 







Appendix C.8 Raw data of the DNA strand breaks measured by single cell gel electrophoresis assay. 
Treated cells were harvested at 0 and 26 hour post-incubation. Values shown are the mean % tail 






CAN 900 µM BAN 12 µM IAN 6 µM AraC 50 µM 
0 hour 0.194800 2.21670 23.2395 60.6644 1.54210 


















APPENDICES FOR CHAPTER 5 
 
 
Summary of contents:  
 Thirty nine pages.  
 Appendix D.1 Cell cycle profiles of CHO cells treated with various concentrations of HAAs at 26 
hour post-incubation.  
 Appendix D.2 Cell cycle profiles of CHO cells treated without and with 100, 200, 300, 400 and 
500 µM BAA at 26 hour post-incubation.  
 AppendixD.3 Cell cycle profiles of CHO cells treated without or with 50 µM IAA at 0, 4, and 8 
hour post-incubation.  
 Appendix D.4 Plating efficiency of HAA-treated CHO cells 






Appendix D.1 Cell cycle profiles of CHO cells treated with various concentrations of HAAs at 26 
hour post-incubation. DNA contents in individual cells were measured with LSR II flow cytometer 
and the cell cycle distributions were calculated using the FCS Express software. A summary table, 
cell cycle distribution, and fitted curves as well as the fitting models are provided (raw data used 
for Figure 5.1).   
 
 
Table D.1 Summary of cell cycle distribution (%) of the different treatment groups. 
 
CAA Concentration (µM) 2N 2N to 4N 4N 
0 35.91 59.04 5.05 
2 34.76 57.61 7.63 
3 37.47 60.22 2.31 
4 35.75 58.28 5.98 
6 35.47 62.68 1.86 
8 30.33 68.05 1.63 
    BAA Concentration (µM) 2N 2N to 4N 4N 
0 33.21 62.17 4.62 
30 30.43 65.77 3.80 
60 30.25 65.35 4.41 
90 30.45 65.54 4.01 
120 29.26 65.60 5.14 
150 28.69 61.60 9.71 
    IAA Concentration (µM) 2N 2N to 4N 4N 
0 42.88 53.92 3.21 
10 44.57 52.48 2.95 
20 44.25 53.11 2.64 
30 41.33 55.44 3.23 
40 42.42 53.50 4.08 










































%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S1 8.34 55.48 2.16
SL CL S0 5.05 59.04 1.55
+G2/G1 Fixed 9.59 54.41 2.16
+Aggregates 8.94 54.85 1.79
+S Order = 1 4.01 59.77 1.91
+CVs Fixed 3.66 60.11 1.90
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=59., %G2=5.05




Mean Xtra S: 659.37
Number of cells: 10077.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S1 10.42 54.18 2.66
SL CL S0 7.63 57.61 1.98
+G2/G1 Fixed 12.09 53.18 2.85
+Aggregates 11.12 53.86 2.15
+S Order = 1 3.60 61.00 2.33
+CVs Fixed 1.80 62.68 2.35
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=57.6, %G2=7.63




Mean Xtra S: 659.37
Number of cells: 10096.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S0 5.11 57.53 2.72
SL CL S0 2.31 60.22 2.03
+G2/G1 Fixed 5.11 57.53 2.72
+Aggregates 4.46 57.92 2.10
+S Order = 1 1.07 61.02 2.51
+CVs Fixed 2.25 59.84 2.50
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=60.2, %G2=2.31




Mean Xtra S: 659.37
Number of cells: 10102.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S0 5.76 58.59 2.21
SL CL S0 5.98 58.28 1.63
+G2/G1 Fixed 5.75 58.58 2.21
+Aggregates 5.55 58.70 1.63
+S Order = 1 1.42 61.87 1.70
+CVs Fixed 2.22 61.18 1.69
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=58.3, %G2=5.98




Mean Xtra S: 659.37
Number of cells: 10086.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S0 3.59 61.22 2.41
SL CL S0 1.86 62.68 1.75
+G2/G1 Fixed 3.59 61.21 2.41
+Aggregates 2.98 61.54 1.76
+S Order = 1 1.71 63.12 2.41
+CVs Fixed 1.25 63.42 2.45
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=62.7, %G2=1.86




Mean Xtra S: 659.37
Number of cells: 10045.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S0 2.13 67.53 1.60
SL CL S0 1.63 68.05 1.08
+G2/G1 Fixed 2.13 67.52 1.60
+Aggregates 2.19 67.24 1.06
+S Order = 1 1.55 67.97 1.59
+CVs Fixed 1.71 68.02 1.67
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=68., %G2=1.62




Mean Xtra S: 659.37
Number of cells: 10031.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
376 
 





































%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S0 5.66 61.26 1.81
SL CL S0 4.62 62.17 1.28
+G2/G1 Fixed 5.66 61.26 1.81
+Aggregates 5.13 61.65 1.28
+S Order = 1 5.86 61.40 1.79
+CVs Fixed 5.63 61.62 1.79
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=62.2, %G2=4.62




Mean Xtra S: 659.37
Number of cells: 10042.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S0 5.29 64.38 1.91
SL CL S0 3.80 65.77 1.47
+G2/G1 Fixed 5.29 64.38 1.90
+Aggregates 4.77 64.76 1.48
+S Order = 1 3.90 65.74 1.90
+CVs Fixed 3.78 65.83 1.89
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=65.8, %G2=3.8




Mean Xtra S: 659.37
Number of cells: 9052.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S0 5.53 64.29 2.00
SL CL S0 4.41 65.35 1.58
+G2/G1 Fixed 5.53 64.29 2.00
+Aggregates 5.11 64.59 1.58
+S Order = 1 2.77 66.39 1.85
+CVs Fixed 3.82 65.42 1.85
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=65.3, %G2=4.41




Mean Xtra S: 659.37
Number of cells: 10048.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S0 4.60 65.06 1.85
SL CL S0 4.01 65.54 1.40
+G2/G1 Fixed 4.60 65.05 1.85
+Aggregates 4.23 65.31 1.40
+S Order = 1 2.80 66.32 1.78
+CVs Fixed 2.84 66.32 1.77
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=65.5, %G2=4.01




Mean Xtra S: 659.37
Number of cells: 10053.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S0 4.98 65.87 2.55
SL CL S0 5.14 65.60 2.01
+G2/G1 Fixed 4.98 65.87 2.55
+Aggregates 4.65 66.11 2.01
+S Order = 1 2.74 67.27 2.33
+CVs Fixed 2.82 67.23 2.32
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=65.6, %G2=5.14




Mean Xtra S: 659.37
Number of cells: 10055.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S0 6.94 64.45 1.73
SL CL S0 9.71 61.60 1.23
+G2/G1 Fixed 6.94 64.44 1.73
+Aggregates 6.60 64.73 1.29
+S Order = 1 6.82 63.80 1.47
+CVs Fixed 4.19 66.23 1.49
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=61.6, %G2=9.71




Mean Xtra S: 659.37
Number of cells: 10042.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S0 7.60 49.10 2.13
SL CL S0 3.21 53.92 1.33
+G2/G1 Fixed 7.60 49.11 2.13
+Aggregates 7.07 49.50 1.94
+S Order = 1 4.26 53.28 1.64
+CVs Fixed 4.55 53.01 1.64
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=53.9, %G2=3.21




Mean Xtra S: 659.37
Number of cells: 9947.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S0 7.04 48.23 1.37
SL CL S0 2.95 52.48 1.10
+G2/G1 Fixed 7.04 48.23 1.37
+Aggregates 6.51 48.55 1.24
+S Order = 1 3.95 51.88 1.22
+CVs Fixed 4.01 51.78 1.22
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=52.5, %G2=2.95




Mean Xtra S: 659.37
Number of cells: 4983.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S0 6.60 48.89 1.32
SL CL S0 2.64 53.11 0.99
+G2/G1 Fixed 6.57 48.91 1.32
+Aggregates 6.43 48.99 1.21
+S Order = 1 2.79 52.98 1.15
+CVs Fixed 3.50 52.33 1.16
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=53.1, %G2=2.64




Mean Xtra S: 659.37
Number of cells: 4965.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S0 7.33 50.97 1.24
SL CL S0 3.23 55.44 0.86
+G2/G1 Fixed 7.33 50.96 1.22
+Aggregates 7.09 51.09 1.10
+S Order = 1 4.32 54.73 1.01
+CVs Fixed 4.46 54.61 1.01
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=55.4, %G2=3.23




Mean Xtra S: 659.37
Number of cells: 4963.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S0 7.79 49.66 1.23
SL CL S0 4.08 53.50 0.94
+G2/G1 Fixed 7.78 49.67 1.23
+Aggregates 7.19 50.08 1.06
+S Order = 1 5.79 52.38 1.09
+CVs Fixed 4.98 53.08 1.09
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=53.5, %G2=4.08




Mean Xtra S: 659.37
Number of cells: 4958.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
387 
 





































%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S0 9.04 49.63 1.17
SL CL S0 4.61 54.54 0.82
+G2/G1 Fixed 9.04 49.63 1.17
+Aggregates 8.79 49.84 1.07
+S Order = 1 5.91 53.55 0.95
+CVs Fixed 5.90 53.52 0.95
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=54.5, %G2=4.61




Mean Xtra S: 659.37
Number of cells: 4958.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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Appendix D.2 Cell cycle profiles of CHO cells treated without and with 100, 200, 300, 400 and 500 
µM BAA at 26 hour post-incubation. DNA contents in individual cells were measured with LSR II 
flow cytometer and the cell cycle distributions were calculated using the FCS Express software. A 
summary table, cell cycle distribution, and fitted curves as well as the fitting models are provided 
(raw data used for Figure 5.2).   
   
 
Table D.2 Summary of cell cycle distribution (%) of the different treatment groups.  
 
BAA Concentration (µM) 2N 2N to 4N 4N 
0 43.72 51.58 4.70 
100 40.41 56.45 3.14 
200 35.22 54.24 10.54 
300 33.33 56.88 9.79 
400 31.87 50.75 17.38 









































%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S0 8.67 47.21 2.33
SL CL S0 4.70 51.58 1.43
+G2/G1 Fixed 8.67 47.21 2.33
+Aggregates 8.32 47.40 1.95
+S Order = 1 7.23 50.34 1.57
+CVs Fixed 5.81 51.47 1.63
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=51.6, %G2=4.7




Mean Xtra S: 659.37
Number of cells: 9910.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S0 7.03 52.14 1.45
SL CL S0 3.14 56.45 0.94
+G2/G1 Fixed 7.00 52.18 1.45
+Aggregates 6.20 52.79 1.29
+S Order = 1 5.47 55.39 1.08
+CVs Fixed 4.76 55.96 1.09
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=56.5, %G2=3.14




Mean Xtra S: 659.37
Number of cells: 4958.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S0 9.02 52.43 1.54
SL CL S0 5.28 56.63 1.16
+G2/G1 Fixed 9.00 52.46 1.54
+Aggregates 8.89 52.52 1.40
+S Order = 1 10.54 54.24 0.83
+CVs Fixed 7.15 56.79 0.99
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=54.2, %G2=10.5




Mean Xtra S: 659.37
Number of cells: 4966.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S0 10.54 52.83 1.79
SL CL S0 6.69 57.38 1.40
+G2/G1 Fixed 10.40 53.18 1.78
+Aggregates 10.44 52.94 1.67
+S Order = 1 12.89 54.80 1.44
+CVs Fixed 9.79 56.88 1.11
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=56.9, %G2=9.79




Mean Xtra S: 659.37
Number of cells: 5065.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S0 12.92 50.32 2.08
SL CL S0 9.75 53.92 1.61
+G2/G1 Fixed 12.91 50.35 2.08
+Aggregates 12.21 50.93 1.75
+S Order = 1 17.38 50.75 1.35
+CVs Fixed 13.29 53.38 1.51
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=50.8, %G2=17.4




Mean Xtra S: 659.37
Number of cells: 4944.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL CV G21 S0 14.15 49.00 2.22
SL CL S0 11.13 52.60 1.70
+G2/G1 Fixed 14.15 49.00 2.22
+Aggregates 13.92 49.13 1.93
+S Order = 1 17.91 50.31 1.28
+CVs Fixed 14.36 52.46 1.49
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=50.3, %G2=17.9




Mean Xtra S: 659.37
Number of cells: 4976.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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Appendix D.3 Cell cycle profiles of CHO cells treated without or with 50 µM IAA at 0, 4, and 8 
hour post-incubation. DNA contents in individual cells were measured with LSR II flow cytometer 
and the cell cycle distributions were calculated using the FCS Express software. A summary table, 
cell cycle distribution, and fitted curves as well as the fitting models are provided (raw data used 
for Figure 5.3).   
 
 
Table D.3 Summary of cell cycle distribution (%) of the different treatment groups.  
 
Negative control 
   Time (hours) 2N 2N to 4N 4N 
0 29.20 53.74 17.06 
4 47.78 12.34 39.88 
8 45.41 47.49 7.10 
    IAA 50 µM 
   Time (hours) 2N 2N to 4N 4N 
0 26.73 57.77 15.50 
4 44.34 15.34 40.32 










































%G2 %S G2/G1 %Total B.A.D.






SL S0 20.53 51.16 1.15
SL CL S0 20.24 51.37 1.09
+G2/G1 Fixed 1.18 68.64 3.35
+Aggregates 0.84 68.88 3.35
+S Order = 1 17.06 53.74 0.98
+CVs Fixed 17.05 53.74 0.97
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=53.7, %G2=17.1





Mean Xtra S: 659.37
Number of cells: 4997.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL S0 41.02 11.05 1.78
SL CL S0 40.82 11.14 1.76
+G2/G1 Fixed 5.63 23.90 9.87
+Aggregates 7.24 23.26 10.07
+S Order = 1 39.88 12.34 1.64
+CVs Fixed 39.46 12.64 1.69
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=12.3, %G2=39.9





Mean Xtra S: 659.37
Number of cells: 4976.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL S0 0.00 33.89 6.39
SL CL S0 0.00 33.98 6.46
+G2/G1 Fixed 0.00 33.81 6.35
+Aggregates 0.00 33.98 6.42
+S Order = 1 7.10 47.49 1.59
+CVs Fixed 7.07 46.66 1.63
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=47.5, %G2=7.1





Mean Xtra S: 659.37
Number of cells: 4982.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL S0 20.32 53.61 1.17
SL CL S0 20.15 53.73 1.13
+G2/G1 Fixed 1.21 71.62 2.84
+Aggregates 0.68 71.95 3.04
+S Order = 1 15.50 57.77 0.96
+CVs Fixed 14.12 59.36 0.99
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=57.8, %G2=15.5




Mean Xtra S: 659.37
Number of cells: 4994.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL S0 42.03 13.21 1.64
SL CL S0 41.90 13.23 1.63
+G2/G1 Fixed 6.34 29.56 9.27
+Aggregates 5.65 29.76 9.26
+S Order = 1 40.32 15.34 1.50
+CVs Fixed 38.04 16.79 2.02
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=15.3, %G2=40.3





Mean Xtra S: 659.37
Number of cells: 4975.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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%G2 %S G2/G1 %Total B.A.D.






SL S0 7.73 25.92 6.15
SL CL S0 7.16 26.04 5.96
+G2/G1 Fixed 0.00 32.01 6.87
+Aggregates 0.00 31.57 6.91
+S Order = 1 9.40 45.87 1.53
+CVs Fixed 9.43 46.20 1.51
Interpretation
MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=45.9, %G2=9.4





Mean Xtra S: 659.37
Number of cells: 4980.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle
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Appendix D.4 Plating efficiency of HAA-treated CHO cells. The blank-corrected absorbency values 
were normalized to the concurrent negative control (raw data used for Figure 5.4). 
 
 
Table D.4 Cell density of negative control CHO cells measured as the blank-corrected absorbency values 




























































Table D.5 Cell density of IAA-treated CHO cells measured as the blank-corrected absorbency values 





10 uM 15 uM 20 uM 25 uM 30 uM 
 
104.557 90.055 95.987 108.209 83.574 
 
105.591 96.113 96.324 103.100 87.543 
 
106.246 101.433 106.858 120.452 108.019 
 
115.787 102.045 106.351 108.040 106.225 
 
97.865 103.058 79.120 104.071 95.965 
 
108.483 112.494 105.887 103.607 94.002 
 
101.749 88.007 80.408 103.565 97.063 
 
109.708 98.034 66.708 61.663 92.060 
 
89.211 103.016 89.569 91.807 72.492 
 
95.142 92.335 99.807 103.333 47.309 
 
100.166 78.973 101.982 85.369 83.553 
 
109.011 97.654 111.882 104.874 104.747 
 
99.259 107.639 104.008 99.174 88.155 
 
105.570 107.533 101.074 93.221 51.995 
 
106.499 83.152 107.111 100.293 86.825 
 
95.459 93.538 59.278 60.016 53.261 
number 16 16 16 16 16 
Average 103.144 97.192 94.522 96.925 84.549 
SE 1.673 2.294 3.862 4.022 4.770 






Table D.6 Cell density of BAA-treated CHO cells measured as the blank-corrected absorbency values 











100.399 105.077 58.081 66.800 43.833 
 
81.685 66.374 46.598 52.339 46.810 
 
84.024 77.007 42.557 81.260 35.540 
 
93.381 101.249 57.230 38.729 94.232 
 
79.771 51.489 41.494 41.281 39.793 
 
106.353 106.991 46.172 40.005 38.091 
 
127.406 55.316 52.977 85.938 50.425 
 
103.801 82.323 53.402 67.012 54.040 
 
111.882 45.534 75.306 53.615 51.489 
 
118.049 41.281 40.643 53.828 43.833 
 
90.191 52.127 41.707 73.179 32.775 
 
82.323 97.422 62.121 50.425 84.875 
 
109.755 106.778 81.898 46.598 48.511 
 
62.759 47.023 41.494 45.534 37.666 
 
100.611 71.265 45.534 54.040 45.109 
 
60.207 59.782 53.828 49.575 52.764 
number 16 16 16 16 16 
Average 94.537 72.940 52.565 56.260 49.987 
SE 4.705 6.018 3.065 3.614 4.191 






Table D.7 Cell density of CAA-treated CHO cells measured as the blank-corrected absorbency values 





2 mM 3 mM 4 mM 6 mM 8 mM 
 
98.592 96.063 93.305 95.603 93.764 
 
92.845 94.914 99.971 105.489 76.523 
 
92.615 84.799 102.730 93.305 82.270 
 
104.339 104.799 110.086 96.293 88.017 
 
95.603 96.523 102.500 96.753 87.098 
 
91.236 110.086 98.132 101.810 73.534 
 
99.052 117.213 119.741 106.638 94.684 
 
112.615 98.822 105.259 99.741 81.121 
 
97.443 102.960 96.063 96.983 80.661 
 
96.753 102.040 89.626 91.925 79.511 
 
104.109 105.489 104.799 93.075 78.132 
 
100.201 89.626 108.247 98.592 71.925 
 
113.305 115.374 91.006 99.741 88.017 
 
99.052 109.397 91.236 87.557 76.063 
 
113.534 104.569 115.144 102.040 76.983 
 
103.190 104.799 104.109 87.787 71.466 
number 16 16 16 16 16 
Average 100.905 102.342 101.997 97.083 81.236 
SE 1.797 2.178 2.175 1.388 1.810 




Appendix D.5 Raw data of the DNA strand breaks measured by single cell gel electrophoresis assay. 
CHO cells were treated with different concentration of HAAs in a 96-well microplate or a 6-well 
plate for 4 hours. Values shown are the mean % tail DNA of 50 nuclei of each treatment group (raw 
data used for Figures 5.5, 5.6 and 5.7). 
 
CAA concentration (mM) %Tail DNA with 96 well %Tail DNA with 6 well 
0 1.5843 0.5038 
3 2.4260 0.5367 
4 2.6446 3.4106 
6 18.8711 4.2083 
7 8.3836 4.8530 
 
BAA concentration (µM) %Tail DNA with 96 well %Tail DNA with 6 well 
0 2.0186 1.3259 
40 2.7490 0.9086 
60 6.3469 1.0179 
80 7.8496 1.1773 
100 22.3574 2.4504 
 
IAA concentration (µM) %Tail DNA with 96 well %Tail DNA with 6 well 
0 1.2938 0.6983 
10 6.5756 1.7640 
20 19.5038 10.8328 
25 22.7087 13.6607 
30 26.8348 21.7422 
 
 
 
